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Chapter 1. Enantioselective Synthesis of a GlyT1 Inhibitor 
1.1 Background 
  Schizophrenia is among the most mysterious and costly mental disorders in terms of human 
suffering and social expenditure.1 This disorder, which is a severe and chronic mental illness, has 
prevalence estimates ranging from 0.5% to 1% of the world population.2 Though schizophrenia 
has traditionally been associated with mental illness alone, patients diagnosed with this disorder 
typically die 12 to 15 years earlier than the average population. Studies have also determined that 
schizophrenia causes more loss of life than most cancers and physical illnesses.1 Thus, in depth 
studies and potential treatments for this prevalent disorder remain of high importance. 
  Today, the leading treatments for this disorder are atypical antipsychotic medicines that 
belong to the family of dopamine D2 and serotonin 5-HT2a receptor antagonists. Although these 
drugs are effective in the management of symptoms such as hallucinations, paranoia, delusions, 
and disorganized speech and thinking, they demonstrate little effect toward improving the more 
negative symptoms (drowsiness, muscle spasms, blurred vision) or cognitive function. 
Additionally, these leading medicines have unsatisfactory side effect profiles because of their 
promiscuous pharmacology.2  
  Due to this unsatisfactory state of the disease and treatment options, there is a need for the 
development of improved, safer therapeutic agents for the treatment of schizophrenia. Over the 
past two decades, clinical research has shown that abnormally low functioning levels of N-methyl-
D-aspartate (NMDA) receptors may play a key role in the pathophysiology of schizophrenia. 
Restoration of NMDA receptor activity is considered a potential therapeutic avenue.2 Glycine, a 
common amino acid and coagonist for NMDA activation,3 has been found to potentiate the NMDA 
response in mouse brain neurons via an allosteric activation of the NMDA receptor.4 Though 
elevation of glycine levels in the brain is a pivotal finding, exogenous administration of glycine is 
something that must be prevented.  
                                                          
1 van Os, J.; Kapur, S. The Lancet 2009, 374, 635-645. 
2 Pinard, E.; Alanine, A.; Alberati, D.; Bender, M.; Borroni, E.; Bordeaux, P.; Brom, V.; Burner, S.; Fischer, H.; 
Hainzl, D.; Halm, R.; Hauser, N.; Jolidon, S.; Lengyel, J.; Marty, H.-P.; Meyer, T.; Moreau, J.-L.; Mory, R.; 
Narquizian, R.; Nettekoven, M.; Norcross, R. D.; Puellmann, B.; Schmid, P.; Schmitt, S.; Stadler, H.; Wermuth, R.; 
Wettstein, J. G.; Zimmerli, D. J. Med. Chem. 2010, 53, 4603-4614. 
3 Kleckner, N.; Dingledine, R. Science 1988, 241, 835-837.  
4 Johnson, J. W.; Ascher, P. Nature 1987, 325, 529-531. 
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 Of the studies that have been conducted, one of the best preventive methods is through 
glycine transporter 1 (GlyT1) inhibition. GlyT1 is a type of glycine transporter that is widely 
expressed in glial cells throughout the nervous system.5 Research has shown that GlyT1 
transporters can play a variety of roles including serving as a key novel target for the treatment of 
disorders such as schizophrenia.2 It has also been determined that GlyT1 inhibition can reduce 
allodynia and hyperalgesia in a range of chronic pain models.5 Additional studies have further 
confirmed that GlyT1 is essential for glycine-mediated protection of human intestinal epithelial 
cells against oxidative damage.6 Thus, synthesis of a desired GlyT1 target (1) is of high importance 
due to its potential impact on biological activity (Figure 1). 
1.2 Previously Synthesized GlyT1 Inhibitors 
  Previous clinical studies have demonstrated that sarcosine (N-methylglycine), a 
prototypical GlyT1 inhibitor, can lead to improved positive, negative, and cognitive symptoms in 
schizophrenic patients along with standard therapy. However, this compound cannot be classified 
as an optimal therapeutic agent due to its poor pharmacological profile. Thus, efforts have been 
made toward the development of improved sarcosine-based GlyT1 inhibitors, such as 2, 3, and 4 
(Figure 2). Unfortunately, the poor pharmacological profile was sustained as these sarcosine 
derivatives suffered from undesirable effects including hypoactivity, ataxia (lack of muscle 
coordination), and reduced respiratory activity.2 
  Based on these findings, a variety of pharmaceutical companies shifted their attention 
toward the identification and development of non-sarcosine-based GlyT1 inhibitors. Some of the 
successfully synthesized GlyT1 targets include a rich set of highly structurally diverse non-amino-
                                                          
5 Jeong, H.J.; Vandenberg, R. J.; Vaughan, C. W. Brit. J. Pharmacol. 2010, 161(4), 925-935. 
6 Howard, A.; Tahir, I.; Javed, S.; Warning, S.; Ford, D.; Hirst, B. J. Physiol. 2010, 588, 995-1009. 
Figure 1. Structure of GlyT1Inhibitor 1 
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acid chemotypes, 5, 6, and 7, as well as a non-sarcosine-based spiropiperidine 8. Furthermore, 
benzoylpiperazines such as 9 and 10 were shown to be more novel chemotypes as they exhibited 
EC50 potencies of 15 nM and 16 nM respectively in regards to GlyT1 inhibition via high-
throughput screening (Figure 2).2 Despite these improvements, the issues of a poor 
pharmacological profile were not resolved with these specific targets. 
  Hoffmann-La Roche has successfully synthesized and is continuing to develop a promising 
benzoylpiperazine chemotype. RG1678 (11) has been classified as the first potent and selective 
GlyT1 inhibitor to have a beneficial effect in schizophrenic patients based on a 2010 phase II 
clinical trial (Figure 3).2 
Figure 2. Previously Published GlyT1 Inhibitors 
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1.3 PBAM-Catalyzed Asymmetric Synthesis of a GlyT1 Inhibitor7 
  A concise synthesis of a desired GlyT1 target has been successfully completed via a 
collaborative effort between the laboratories of Craig W. Lindsley and Jeffrey N. Johnston at 
Vanderbilt University. Target molecule 1 has been identified by the Lindsley group as a potent 
GlyT1 inhibitor and a potential therapeutic for the treatment of schizophrenia.8 The more potent 
enantiomer of this compound was found to bind 104 times better than its antipode. When examining 
the structure of compound 1, retrosynthetic analysis shows that a key carbon-carbon bond can be 
made via an asymmetric aza-Henry addition between nitroazetidine 12 and imine 13 through the 
use of chiral proton catalysis. Successful installation of this key carbon-carbon bond is critical as 
it will facilitate the development of the more potent enantiomer of GlyT1 inhibitor 1 via functional 
group manipulation of the scaffold (Scheme 1). 
                                                          
7 Davis, T. A.; Danneman, M. W.; Johnston, J. N. Chem. Commun. 2012, 48, 5578-5580. 
8 Lindsley, C. W.; Conn, J. P.; Williams, R.; Jones, C. K.; Sheffler, D. J., Sulfonyl-azetidin-3-yl-methylamine 
Amide Analogs As GlyT1 Inhibitors, Methods For Making Same, And Use Of Same In Treating Psychiatric 
Disorders. U.S. Patent WO 2010/114907 A1, October 7, 2010.  
Figure 3. Structure of RG1678 (11) 
Scheme 1. Retrosynthetic Analysis of GlyT1 Inhibitor 1 
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  The synthesis of the desired GlyT1 inhibitor was initiated by subjecting commercially 
available hydroxyazetidine hydrochloride 15 to benzyl chloroformate under basic conditions in 
order to furnish Cbz-protected hydroxyazetidine 16 in quantitative yield. Compound 16 was then 
treated with triflic anhydride in the presence of pyridine to yield triflate 17 in 80% yield. Treatment 
of 17 with sodium iodide resulted in the expected nucleophilic substitution providing iodoazetidine 
18 (88% yield), which was then treated with sodium nitrite to afford nitroazetidine 12 in modest 
yield (43% yield, Scheme 2). 
  With the desired nitroazetidine in hand, the stage was now set for the key enantioselective 
aza-Henry addition. This addition of azetidine 12 into Boc-protected imine 13 was to be carried 
out using our Brønsted basic Pyrrolidine Bis(AMidine) [PBAM] organocatalysts. Before applying 
the nitroazetidine motif as the nucleophile however, additions of 2-nitropropane, the simplest 
secondary nitroalkane, were conducted in order to examine the feasibility of this reaction system.  
  Additions of 2-nitropropane into imine 13 were carried out by Tyler Davis. He found that 
when using PBAM free base 19 as the catalyst at ambient temperature, the desired adduct (20) was 
obtained in 63% yield and 52% ee after a 24 hour reaction time (Scheme 3). The triflic acid salt of 
PBAM (19•HOTf) showed improvement as adduct 20 was furnished in comparable yield and 
enhanced enantioselection. This indicates that use of a polar ionic hydrogen bond is necessary in 
order to achieve optimal selectivity. 
Scheme 2. Synthesis of Nitroazetidine 12 
 
Scheme 3. Enantioselective 2-Nitropropane Additions 
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  Seeing that reasonable yields and promising levels of enantioselection were achieved with 
2-nitropropane, Tyler Davis then submitted nitroazetidine 12 as the donor for this reaction system. 
When using PBAM•HOTf as the catalyst at room temperature, he found that the desired aza-Henry 
adduct (14) was afforded in 86% yield and 78% ee (Scheme 4). This reaction proved to be 
surprisingly fast as full conversion was observed after 70 minutes. When lowering the temperature 
to 0 °C, increased yield and enantioselectivity was observed after a slightly prolonged reaction 
time of 4 hours. 
  Further optimization was achieved upon lowering the temperature to -20 °C. Under these 
chilled conditions, PBAM•HOTf provided adduct 14 in 87% yield and 86% ee over the course of 
24 hours (Scheme 5). Additionally, 7-substituted PBAM catalysts were also tested with ambitions 
of achieving higher degrees of enantioselectivity. 7(MeO)PBAM•HOTf (19a•HOTf) proved to be 
ideal as the desired adduct was furnished in 93% yield and 92% ee. 7(tBu)PBAM•HOTf 
(19b•HOTf) was also successful, affording adduct 14 in 99% yield and 90% ee. Unfortunately 
when lowering the temperature to -78 °C, minimal conversion was observed after 24 hours. 
  With enantiomerically enriched aza-Henry adduct (14) in hand, efforts toward the desired 
GlyT1 target continued through the formation of a key intermediate (21) that results from a 
straightforward denitration. Intermediate 21 was obtained by free radical-mediated reduction by 
treating 14 with tributyltin hydride (nBu3SnH) and azobisisobutyronitrile (AIBN) (Scheme 6). 
Scheme 4. Aza-Henry Addition of Nitroazetidine 12 Catalyzed by PBAM•HOTf 
 
Scheme 5. Optimization of Aza-Henry Addition with Nitroazetidine 12 
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AIBN, which serves as a radical initiator, propagates with nBu3SnH ultimately cleaving the nitro-
carbon bond to yield 1,3-diamine 21. From this key scaffold, multiple routes could be envisioned 
to the desired target. 
  The first route to target 1 began with cleavage of the Boc protecting group. By treating 
intermediate 21 with an excess of acid, the HCl salt of free amine 22 was acquired. This salt, which 
was carried on without further purification, was then treated with chloride 23 under basic 
conditions to provide 24 in 42% yield over two steps (Scheme 7). 
  Intermediate 24 was treated with KOH in an attempt to saponify the Cbz group and 
subsequently decarboxylate to afford secondary amine 25. Initial attempts of this saponification 
using 40% KOH with varying methanol to water ratios failed to give the desired amine. 
Nucleophilic attack on the activated benzyl position of the Cbz group with trimethylsilyl iodide 
also proved fruitless. Furthermore, the use of stronger nucleophiles, such as LiOOH, did not result 
in the intended cleavage of the Cbz group via saponification (Scheme 8). 
Scheme 6. Stannane-Mediated Denitration to Key Scaffold 21 
 
Scheme 7. Synthesis of Dichlorbenzamide 24 from Key Scaffold 21 
 
Scheme 8. Saponification Attempts En Route to Amine 25 
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  Although these attempts did not result in the formation of the desired secondary amine 
(25), a notable discovery was made. When treating intermediate 24 with 40% KOH in the presence 
of excess methanol, two products (26 and 27) were consistently obtained. Though it was 
determined for compound 26 that the Cbz group was successfully cleaved, it was also evident that 
a methyl ester was made in lieu of the intended carbamic acid. Upon chromatographic separation 
and isolation of ester 26 (40% yield), an azetidine to azetidine isomerization was observed during 
this saponification attempt as well (Scheme 9). Support of this isomerization was confirmed by 
observations of desired 3JHC couplings through an HMBC (600 MHz) experiment (see structure 
elucidation, Chapter 8). 
  The second product isolated from this reaction, compound 27 (16% yield), also showed 
azetidine to azetidine isomerization. Unlike methyl ester 26 however, the Cbz group was still intact 
Scheme 9. Isolated By-Products of an Attempted KOH Saponification 
 
Scheme 10. Azetidine Isomerizations in Literature 
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(Scheme 9). This isomerization was once again supported by HMBC (600 MHz) experimentation 
(see structure elucidation, Chapter 8). 
  Examples of azetidine isomerizations are known in literature. Amongst those reported 
include an aziridine to azetidine isomerization,9 as well as an azetidine to pyrrolidine 
isomerization.10 One study in particular has shown the isomerization of an azetidine ring to an 
oxazine ring via ring expansion11 (Scheme 10). A formation of an oxazine ring can be ruled out in 
our case as HMBC experimentation would result in 3 crosspeaks associated with the imine carbon 
of the oxazine ring. From the HMBC experimentation conducted, 3 crosspeaks were never 
observed for any distinct downfield carbon (Scheme 11). Though acquisition of these isomers 
proved to be an interesting study, the intended route toward the desired GlyT1 target (1) was 
unsuccessful. 
  An alternative route toward the desired GlyT1 inhibitor was initiated by having 
intermediate 21 undergo hydrogenolysis in order to afford amine 28 via Cbz-cleavage. Treatment 
of this secondary amine with sulfonyl chloride 29 under basic conditions furnished the desired 
sulfonamide (30) in 56% isolated yield over 2 steps. Subsequent Boc deprotection and acylation 
with benzoyl chloride 32 afforded the desired GlyT1 target (1) in 27% yield over 2 steps (Scheme 
12). HPLC analysis verified that the more potent enantiomer was present in high 
enantioenrichment. This was verified by observation of comparable HPLC retention times 
according to a patent belonging to Craig W. Lindsley and co-workers.8,12 The synthesized target 
was then submitted to Lindsley and colleagues to determine the potency of this compound. Tests 
                                                          
9 Stankovic, S.; Catak, S.; D’hooghe, M.; Goossens, H.; Tehrani, K. A.; Bogaert, P.; Waroquier, M.; Van 
Speybroeck, V.; De Kimpe, N. J. Org. Chem. 2011, 76, 2157-2167. 
10 Feula, A.; Male, L.; Fossey, J. S. Org. Lett. 2010, 21, 5044-5047. 
11 Iwakura, Y.; Nabeya, A.; Nishiguchi, T.; Ichikawa, Y. J. Org. Chem. 1965, 30, 3410-3413. 
12 Observed retention times can be found in the experimental section and compared to the retention times found in 
U.S. patent document WO 2010/114097 A1 cited above.  
Scheme 11. Oxazine Isomer Not Observed by HMBC Experimentation 
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indicated good potency as the IC50 value for the GlyT1 target was 800 pM. Observations of 
expected 1JHC couplings through an HSQC (600 MHz) experiment further confirmed the structural 
assignment (see structure elucidation, Chapter 8). 
1.4 Future Work 
Future work for the GlyT1 chemistry may include the synthesis of other desired targets 
(i.e. derivatives) that could possibly show comparable potency to the GlyT1 target that was 
successfully synthesized. The same key intermediate (21) that was used to ultimately synthesize 
target 1 would also be used in the syntheses of these derivatives. If the syntheses of similar GlyT1 
targets are pursued, it is likely that these targets could be successfully synthesized with little or no 
obstruction as the only major change would be the installation of different acyl groups onto 
scaffold 21.  
 
 
 
 
 
 
 
 
Scheme 12. Successful Synthetic Route Towards Desired GlyT1 Target (−)-1 
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Chapter 2. PBAM-Catalyzed Additions of Nitromethane into Ketimine 
Centers – Part I: Sulfonyl Ketimines 
2.1 Background 
 The p53 gene is one of the most intensely investigated tumor-suppressor proteins to date. 
This gene, a transcription factor,13 is widely considered the guardian of cell division and plays a 
critical role in cell cycle control and apoptosis (programmed cell death). Extensive studies have 
shown that p53 is the most frequently mutated gene in all forms of human cancer.14 Hollstein and 
co-workers have reported that a p53 gene mutation is present among cancers of the colon, lung, 
esophagus, breast, liver, brain, reticuloendothelial tissues, and hemopoietic tissues.15 Needless to 
say, it is of vast importance to investigate methods of regulating the mutation of the p53 protein. 
 MDM2 is a protein that prevents apoptosis of cancer cells by negatively regulating the 
transcription factor p53.16 The MDM2 gene can be classified as a cellular proto-oncogene that is 
amplified in approximately 7% of all human cancers. Over-expression of the MDM2 protein 
typically occurs by enhanced transcription or translation, and when this proto-oncogene is 
combined with a p53 mutation, the prognosis can become much more severe.17 This p53-MDM2 
protein–protein interaction arises when MDM2 binds directly to the p53 transactivation domain 
and targets p53 for proteasomal degradation.18 Inhibition of this protein–protein interaction can 
reactivate p53 and be considered as a promising approach to cancer therapy. Furthermore, small 
molecules could possibly serve as motifs that can sufficiently disrupt the MDM2-p53 interaction.   
 The Nutlins (short for Nutley inhibitors), which were identified by Vassilev and co-
workers, are a class of cis-imidazoline compounds that can effectively disrupt the p53-MDM2 
protein-protein interaction with median inhibitory concentration values in the 100 to 300 nM 
range.19 The development of these Nutlin compounds serves as the first potent and selective small 
                                                          
13 Levine, A. J. Cell 1997, 88, 323-331. 
14 Jaiswal, P. K.; Goel, A.; Mittal, R. D. BioSci. Trends 2011, 5, 205-210. 
15 Hollstein, M.; Sidransky, D.; Vogelstein, B,; Harris, C. Science 1991, 253, 49-53.  
16 Doemling, A. US Patent 2011/0313167 A1 
17 Alarcon-Vargas, D.; Ronai, Z. Carcinogenesis 2002, 23, 541-547.  
18 Baek, S.’ Kutchukian, P. S.; Verdine, G. L.; Huber, R.; Holak, T. A.; Lee, K. W.; Popowicz, G. M. J. Am. Chem. 
Soc. 2012, 134, 103-106. 
19 Vassilev, L. T.; Vu, B. T.; Graves, B.; Carvajal, D.; Podlaski, F.; Filipovic, Z.; Kong, N.; Kammlott, U.; Lukacs, 
C.; Klein, C.; Fotouhi, N.; Liu, E. A. Science 2004, 303, 844-848.  
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molecule inhibitors of the p53-MDM2 interaction. More specifically, the Nutlins selectively 
activate the p53 pathway in cells only with wild type but not mutant p53.20  
 When examining the structures of the three featured Nutlin compounds (33-35), various 
similarities can be seen (Figure 4). Each imidazoline ring core possesses a piperazine-derived urea 
functionality at the 1-position along with an alkoxy-substituted aromatic ring at the 2-position. 
Additionally, these potent Nutlins possess halogenated aromatic rings at the 4- and 5-positions of 
the imidazoline as well.  
 Vassilev and colleagues determined that Nutlin-3 was the most potent inhibitor of the p53-
MDM2 interaction. They also concluded that one enantiomer was approximately 150 times more 
potent than its antipode. Additional studies have shown that the more potent enantiomer, (−)-
Nutlin-3 (35), has been used as a small molecule probe of cell biology and continues to be 
                                                          
20 Carvajal, D.; Tover, C.; Yang, H.; Vu, B. T.; Heimbrook, D. C.; Vassilev, L. T. Cancer Res. 2005, 65, 1918-1924. 
Figure 4. Structures of Nutlin Compounds 33-35 
 
Scheme 13. Aza-Henry Addition en Route to (−)-Nutlin-3 
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developed as a chemotherapeutic.21 Hoffmann-La Roche has continued extensive development of 
this potential anticancer compound, with RG7112 entering clinical trials in 2011. 
 At Vanderbilt University, an efficient asymmetric synthesis of (−)-Nutlin-3 was 
developed.21 The framework of this synthesis was established upon the formation of a key cis-
stilbene diamine backbone. This diamine was prepared following a PBAM-catalyzed aza-Henry 
addition between aryl nitroalkane 37 and aryl imine 36. 6,7(MeO)2PBAM (19c) proved to be the 
optimal organocatalyst for this system as adduct 38 was afforded in near-quantitative yield with 
high levels of enantio- and diastereoselection (Scheme 13). The masked cis-stilbene diamine was 
readily converted to (−)-Nutlin-3 through a short synthetic sequence. 
 Other Nutlin analogs are potent inhibitors of p53-MDM2. RG7112 (39) is a dimethyl cis-
imidazoline Nultin derivative that has been successfully synthesized and is currently being 
developed by Hoffmann-La Roche. Like Nutlin-3, this compound is a selective inhibitor of p53-
MDM2 binding and frees p53 from negative control, activating the p53 pathway in cancer cells 
leading to cell cycle arrest and apoptosis.22 The enantioselective synthesis of RG7112 is of 
considerable interest as this molecule has shown promising results in early phases of trials in 
cancer patients.23 
 Structural comparisons can be made between RG7112 and (−)-Nutlin-3 (Figure 5). Both 
molecules possess an imidazoline ring core with a urea functionality at the 1-position as well as 
aromatic substituents at the 2-, 4-, and 5-positions. The key difference between these two 
compounds, however, lies at the 4- and 5-positions of the imidazoline. RG7112 possesses 
methylated quaternary centers at these two positions while the same positions in Nutlin-3 are 
                                                          
21 Davis, T. A.; Johnston, J. N. Chem. Sci. 2011, 2, 1076-1079. 
22 Beryozkina, A. et al. J Clin. Oncol. 29: 2011 (suppl; abstr 3039) . 
23 Millard, M.; Pathania, D.; Grande, F.; Xu, S.; Neamati, N. Curr. Pharm. Design 2011, 17, 536-559. 
Figure 5. Structural Differences Between (−)-Nutlin-3 and RG7112 
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methines. The presence of these quaternary centers in RG7112 (39) will ultimately change the 
dynamic as to how this target will be synthesized.  
 As previously shown, the backbone of the imidazoline entity of Nutlin-3 was readily 
developed through the PBAM-catalyzed enantioselective aza-Henry addition of a phenyl 
nitroalkane donor into a Boc-protected aldimine (Scheme 13). Yet as for RG7112, the development 
of the corresponding dimethyl cis-diamine backbone is more challenging. First, the use of a 
secondary aryl nitroalkane nucleophile is necessary. While secondary nitroalkane donors exhibited 
considerable success in the GlyT1 chemistry (Chapter 1), their effectiveness has been limited to 
additions into aldimine centers. The greater challenge of developing the desired backbone, 
however, is through a ketimine electrophile. While additions into aldimines can be readily 
achieved, additions into ketimines are more difficult since there is a greater degree of steric bulk 
about the electrophilic center. The increased sterics can alternate reactivity. Another known 
problem when handling ketimines is tautomerization into their more stable enamine form. 
Therefore, the use of a stable ketimine is a necessity as it allows for the possibility of achieving 
high-yielding aza-Henry additions as a result of minimal tautomerization. Despite these 
challenges, it is plausible that the dimethyl cis-diamine intermediate (40) of RG7112 can be 
acquired through a PBAM-catalyzed aza-Henry addition of a secondary aryl nitroalkane (41) into 
a methyl-derived ketimine (42) upon efficient optimization (Scheme 14). 
 Before applying aryl nitroalkane 41 as the nucleophile, nitromethane was to be used in 
order to examine the feasibility of ketimine additions. A variety of aza-Henry additions of 
nitromethane into ketimine centers have been previously reported in literature (Scheme 15). Terada 
and colleagues demonstrated that simple organic bases, such as 1,1,3,3-tetramethylguanidine 
(TMG), can facilitate the addition of nitromethane into N-diphenylphosphinoyl ketimines.24 TMG 
                                                          
24 Pahadi, N. K.; Ube, H.; Terada, M. Tetrahedron Lett. 2007, 48, 8700-8703. 
Scheme 14. Retrosynthetic Analysis of RG7112 
 
15 
 
can also promote the addition of nitromethane into N-thiophosphoryl ketimine centers as described 
by Tang.25 Despite these successes, these aza-Henry additions were not catalyzed solely by organic 
bases. Feng illustrated that inorganic bases, such as sodium carbonate, allow for high-yielding 
additions into tosyl-protected ketimines.26 Asymmetric additions of nitromethane into ketimine 
centers were also present in literature. Ruano has shown that nitromethane can be incorporated 
into N-sulfinyl ketimines in a diastereoselective manner when catalyzed by tetra-n-
butylammonium fluoride (TBAF) or sodium hydroxide.27 In this same work, Ruano determined 
that the direction of diastereoselectivity was dependent upon which base was being used. Highly 
enantioselective additions into ketimine centers were reported when Feng and colleagues used a 
chiral N,N’-dioxide-copper(I) complex (43) as the catalyst.28 Here, they were able to add 
nitromethane into tosyl ketimines in high yield and up to 96% ee. 
                                                          
25 Hu, K.; Wang, C.; Ma, X.; Wang, Y.; Zhou, Z.; Tang, C. Tetrahedron Asymmetr. 2009, 20, 2178-2184. 
26 Wang, L.; Tan, C.; Liu, X.; Feng, X. Synlett 2008, 13, 2075. 
27 Ruano, J. L. G.; Topp, M.; Lopez-Cantarero, J.; Aleman, J.; Remuinan, M. J.; Cid, M. B. Org. Lett. 2005, 7, 4407-
4410.  
28 Tan, C.; Liu, X.; Wang, L.; Wang, J.; Feng, X. Org. Lett. 2008, 10, 5305-5308. 
Scheme 15. Examples of Nitromethane Additions into Ketimine Centers 
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 To the best of our knowledge, there is only one known example of highly enantioselective 
organocatalyzed aza-Henry additions into ketimines. Wang and colleagues use a simple quinine 
thiourea motif (44) to catalyze the addition of nitromethane as well as nitroethane and 1-
nitropropane into trifluoromethyl quinazolinone centers.29 The corresponding 
dihydroquinazolinones are furnished in high yields and with excellent enantioselection (up to 98% 
ee). This type of aza-Henry addition is then used as a key step in the asymmetric preparation of 
anti-HIV drug DPC 083 (45) (Scheme 16). 
 Our goal was then to develop highly enantioselective aza-Henry additions of primary, 
secondary, and tertiary nucleophiles into ketimine centers via the use of our Brønsted basic 
Pyrrolidine Bis(AMidine) [PBAM] organocatalysts. If these types of aza-Henry additions are 
readily achieved, this will lead to a much broader scope of adducts and will facilitate the ultimate 
goal to synthesize RG7112. 
2.2 Synthesis of Sulfinyl and Sulfonyl Ketimines and Examination of Their 
Reactivity 
 Initial attempts to prepare an aryl alkyl ketimine proved to be challenging. Acquisition of 
a TMS-protected ketimine was of particular interest due to the easy manipulation of the silyl group. 
Unfortunately, multiple attempts toward synthesizing a ketimine of this type were fruitless. 
Despite these failures, a Cbz-protected ketimine (46) was successfully synthesized via literature 
                                                          
29 Xie, H.; Zhang, Y.; Zhang, S.; Chen, X.; Wang, W. Angew. Chem. Int. Ed. 2011, 50, 11773-11776.  
Scheme 16. aza-Henry Additions into Quinazolinones en Route to DPC 083 by Wang 
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procedure30 in high yields and ketimine to enamine ratios (Figure 6). Attempts toward successfully 
installing nucleophiles as simple as nitromethane into this specific ketimine via PBAM-catalyzed 
aza-Henry reactions were unsuccessful as results indicated either tautomerization or hydrolysis. 
From these findings, it was evident that other ketimines had to be made in order to get a sense of 
reactivity for these aza-Henry additions. 
 Two ketimines that were of interest included sulfinyl ketimine 48 and tosyl ketimine 49. 
These ketimines, which exhibit a great degree of stability, could be readily synthesized according 
to the literature protocols of Ruano.31,32 Commercially available p-tolyl disulfide 50 was subjected 
to N-bromosuccinimide in the presence of methanol to afford sulfinate 51 quantitatively. 
Treatment of sulfinate 51 with lithium hexamethyldisilazide (LHMDS) gave sulfinamide 52 (48% 
over 2 steps), which was then condensed with acetophenone (53) furnishing sulfinyl ketimine 48 
in moderate yield (60%). Subsequent oxidation of 48 with MCPBA afforded the corresponding 
tosyl ketimine 49 in good yield (81%) (Scheme 17). 
 In order to gain a sense of reactivity for aza-Henry additions into ketimines, literature 
findings were repeated. As previously mentioned, Ruano and Terada have demonstrated successful 
nitromethane additions via the use of simple bases such as TBAF, TMG, and sodium hydroxide 
                                                          
30 Ahman, J. B.; Boulton, L. T. Patent WO 2006064340 
31 Ruano, J. L. C.; Aleman, J.; Cid, M. B.; Parra, A. Org. Lett. 2005, 84, 179-182. 
32 Ruano, J. L. C.; Aleman, J.; Parra, A.; Cid, M. B. Org. Synth. 2007, 84, 129-138. 
Figure 6. Structure of Cbz-Ketimine 46 and Tautomerization to its Corresponding Enamine 47 
 
Scheme 17. Synthesis of Sulfinyl Ketimine 48 and Tosyl Ketimine 49 
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(NaOH).24,27 Additions into sulfinyl ketimine 48, via Ruano’s methods, were repeated using these 
three bases as catalysts. 
 Studies were initiated when sulfinyl ketimine 48 was treated with 20 mol% of TBAF in the 
presence of neat nitromethane. After an 18 hour reaction period, 66% conversion to adducts 54a 
and 54b was seen by proton NMR in a 3:1 dr (Table 1, entry 1). Raising the amount of TBAF to a 
full equivalent resulted in 96% conversion to 54a and 54b with minimal diastereoselectivity (entry 
2). When a full equivalent of TMG was used as the catalyst in the presence of neat nitromethane, 
97% conversion to the desired adducts was seen by crude NMR (entry 3). Once again, low degrees 
of diastereoselection were observed.  
 When NaOH was used as the catalyst in the presence of neat nitromethane, 4 Å molecular 
sieves, and a Lewis acid, 52% conversion to adducts 54a and 54b was seen in a 1:17 dr (Scheme 
18). These findings, which were consistent with Ruano’s, show that a Lewis acid-mediated 
addition with NaOH not only reverses the direction of diastereoselectivity, it also affords the 
desired products in a much higher degree of selection relative to TBAF or TMG. 
 Ketimine additions with secondary nucleophiles proved to be problematic. Upon treating 
ketimine 48 with neat nitroethane in the presence of TBAF or TMG, low conversion (30%) was 
observed over prolonged reaction times (Scheme 19). The aza-Henry adducts 55a and 55b were 
Table 1. Nitromethane Additions into Ketimine 48 with TBAF and TMG 
 
Scheme 18. Nitromethane Additions into Ketimine 48 with NaOH 
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not isolated, nor were their diastereomeric ratios determined, due to low conversion and 
ambiguities in the crude NMR spectrum. The lack of reactivity may be due to the fact that 
nitroethane is more sterically hindered relative to nitromethane. This will result in a more 
congested system about the ketimine center upon attempted addition. 
 After getting a sense of reactivity with achiral bases, additions of nitromethane into sulfinyl 
ketimine 48 were attempted with our chiral PBAM organocatalyst. Upon subjecting 50 mol% of 
PBAM free base (19) to 150 equivalents of nitromethane in the presence of THF (co-solvent), no 
sign of addition could be detected (Scheme 20). This could be due to the fact that PBAM may not 
be Brønsted basic enough to promote the nucleophilicity needed for nitromethane to effectively 
add into a sulfinyl ketimine center. Additionally, the catalyst binding mode with this bulkier 
electrophile may not be ideal as high degrees of congestion may be prevalent, thus inhibiting the 
desired aza-Henry addition. 
 As previously seen in Scheme 18, high dr adduct (17:1) was acquired when using NaOH 
with a Lewis acid. In order to see if PBAM promotes addition into sulfinyl ketimine 48, an 
equilibrium experiment was conducted. The high dr adduct was treated with PBAM over the 
course of 18 hours. If starting material or a significant drop in dr was observed, it can be implied 
that PBAM is promoting this addition and that the equilibrium is favoring the side of the reactants. 
Unfortunately, when running this experiment, no drop in dr was seen reaffirming that PBAM is 
not making nitromethane nucleophilic enough to promote addition into the ketimine (Scheme 21). 
 Studies were continued by examining aza-Henry additions into tosyl ketimine 49. With a 
higher oxidation state, it was believed that this ketimine would be more reactive relative to sulfinyl 
Scheme 19. Attempted Nitroethane Additions into Ketimine 48 with TBAF and TMG 
 
Scheme 20. Attempted Nitromethane Addition into Ketimine 48 with PBAM 
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ketimine 48. This was tested by subjecting the tosyl ketimine to neat nitromethane in the presence 
of TBAF and TMG. After a 96-hour reaction time, proton NMR indicated complete conversion of 
starting material, as well as formation of double adduct 56 in both cases (Table 2, entries 1 and 2). 
When reaction times were decreased to 18 hours, the same results were obtained (entries 3 and 4). 
Acquisition of double adducts when using tosyl ketimine 49 versus acquisition of single adducts 
with sulfinyl ketimine 48 clearly indicates that the tosyl ketimine is a more reactive species as 
expected. 
 The formation of the double adduct is believed to arise from a Michael acceptor precursor 
(57). When nitromethane adds into the tosyl ketimine center, the desired aza-Henry adduct (58) is 
formed in situ. Present in the adduct, however, is a good leaving group in the tosyl amide. The two 
methylene protons alpha to the tosyl group are considerably acidic and can be readily deprotonated 
by base to cause β-elimination of the tosyl group resulting in Michael acceptor 57. This 
electrophilic acceptor can receive a second equivalent of nitromethane, resulting in the observed 
double adduct (Scheme 22). 
Scheme 21. Equilibrium Experiment Conducted with PBAM 
Table 2. Nitromethane Additions into a Tosyl Ketimine to Yield Double Adduct 56 
 
Scheme 22. Formation of Double Adduct 56 via Michael Acceptor 57 
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Due to the high reactivity of tosyl ketimine 49, more hindered nucleophiles were applied 
in order to determine if sufficient addition could be achieved (Scheme 23). When tosyl ketimine 
49 was treated with neat nitroethane in the presence of TBAF and TMG, no adduct could be 
detected after prolonged reaction times. aza-Henry reactions with a tertiary 2-nitropropane 
nucleophile were also attempted with the same bases. Once again, neither case yielded the desired 
adduct. 
Despite the lack of reactivity with more hindered nitroalkanes, tosyl ketimine 49 appears 
to be the most reactive ketimine we have encountered up to this point when it comes to additions 
of nitromethane. Therefore, this ketimine was the electrophile of choice when attempting PBAM-
catalyzed aza-Henry additions.  
2.3 PBAM-Catalyzed aza-Henry Additions into Sulfonyl Ketimine Centers 
 With a reactive tosyl ketimine (49) in hand, PBAM-catalyzed aza-Henry additions of 
nitromethane could be conducted. Studies were initiated when ketimine 49 was treated with PBAM 
free base (19) in the presence of neat nitromethane at room temperature. After a three day reaction 
period, the desired aza-Henry adduct (58) was acquired in 65% isolated yield but was determined 
to be racemic by HPLC analysis (Table 3, entry 1). Using PBAM•HOTf (19•HOTf) as the catalyst 
under the same conditions, a slight increase in yield was observed as well as what appeared to be 
a low level of enantioselection (entry 2). PBAM•HNTf2 (19•HNTf2) proved to be a more effective 
catalyst as adduct 58 was furnished in 78% yield and 13% ee (entry 3). Yet when the more 
Brønsted basic 8(MeO)PBAM (19d) motif was applied as the catalyst, only double adduct (56) 
was observed (entry 4). This gives a clear indication that 8(MeO)PBAM is the most reactive 
organocatalyst thus far due to increased Brønsted basicity from electron-donating methoxy 
Scheme 23. Attempted Additions of Nitroethane and 1-Nitropropane into Ketimine 49 
 
22 
 
substituents on the quinoline rings. Because of its high reactivity, this catalyst was carried into 
further studies. 
 With this highly reactive 8(MeO)PBAM catalyst, studies were continued to examine 
reactivity and possibly develop high levels of enantioselection. As previously shown, double 
adduct was observed upon treating ketimine 49 with 50 mol% of 8(MeO)PBAM in neat 
nitromethane at ambient temperature over 72 hours (Table 3, entry 4). This indicates that reaction 
conditions need to be modified in order to reduce the chance of β-elimination (Scheme 22) and 
promote the possibility of acquiring the desired single adduct (58). The most direct way of 
achieving this would be through reducing the catalyst loading and shortening reaction times. When 
the catalyst loading was reduced to 20 mol% and the reaction time was shortened to 13 hours, the 
desired aza-Henry adduct (58) was acquired in 47% isolated yield but with no enantioselection 
(Table 4, entry 1). Further decreasing the reaction time to 3.5 hours resulted in slightly enhanced 
yield, but no degree of enantioselection could be detected (entry 2). Significantly reducing the 
quantity of nucleophile to 5 and 2 equivalents in the presence of catalyst 19d at room temperature 
resulted in 25% and 29% isolated yields of the adduct as racemates (entries 3 and 4). Temperature 
studies also proved to be fruitless as lowering the temperature to -20 °C afforded the product in 
17% yield and 2% ee (entry 5). When the temperature was lowered even further to -78 °C, 
reactivity was completely inhibited even after prolonged reaction times (entries 6 and 7). Changing 
the catalyst loading to 10 mol% did not show much improvement as adduct 58 was furnished in 
22% yield and 7% ee over the course of 24 hours (entry 8). Lastly, the use of more dilute conditions 
slightly diminished yield and selection (entry 9). These studies indicate that 8(MeO)PBAM was 
Table 3. Catalyst Screen for Nitromethane Additions into Tosyl Ketimine 49 
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not the most ideal catalyst for this reaction system as low to moderate yields of adduct were 
acquired with very little degree of enantioselectivity. 
 The triflimide salt of 8(MeO)PBAM (19e•HNTf2) was briefly examined to see if 
introduction of a counterion can enhance enantioselection. Upon subjecting 20 mol% of 
8(MeO)PBAM•HNTf2 to ketimine 49 in the presence of neat nitromethane at room temperature, 
trace amounts of product were detected by NMR after an extensive reaction period (Table 5, entry 
1). When the amount of nucleophile was reduced to 20 equivalents, adduct 58 was acquired in 
33% isolated yield. Unfortunately, minimal enantioselection was observed once again (entry 2). 
This indicates that introduction of a salt to the Brønsted basic 8(MeO)PBAM catalyst does not have 
a significant effect in regards to enantioenrichment. 
 The low to moderate yields of adduct acquired during the course of these runs with 
8(MeO)PBAM (19d) and 8(MeO)PBAM•HNTf2 (19d•HNTf2) is mainly owed to the elimination 
Table 4. Reactivity Study with 8(MeO)PBAM 
 
Table 5. Reactivity Study with 8(MeO)PBAM•HNTf2 
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of the tosyl group (Scheme 22). This, of course, was due to the high Brønsted basicity of this 
catalyst relative to other PBAM catalysts. Control of reactivity in order to furnish high yields and 
minimize elimination is an optimization process that must be achieved when using this particular 
catalyst. 
 Although it appears that controlling the reactivity of this highly reactive 8(MeO)PBAM 
catalyst is something that needs to be resolved, enhancement of enantioselection is another area of 
these aza-Henry additions that needs optimization as the highest ee achieved up to this point is 
13% ee (Table 3, entry 3). Since counterion control, as well as concentration, temperature, and 
equivalents modifications did not result in dramatic increase of enantioselection (Table 4, Table 
5), efforts shifted toward making ketimines with different electronic properties in order to see if 
enantioselectivity is influenced by the nature of the substrate.  
Two particular ketimines of interest that were made included an electron-withdrawing 
nosyl ketimine 59 and an electron-donating methoxy-derived ketimine 60. Simple condensations 
of nosyl sulfonamide 61 and para-methoxyphenyl sulfonamide 62 in the presence of acetophenone 
and Ti(OEt)4 furnished ketimines 59 and 60 in 7% and 21% yields respectively (Scheme 24). With 
these two ketimines in hand, the stage was now set to examine the difference in selectivity between 
electron-deficient and electron-rich electrophiles.  
 The catalysts to be used in this enantioselective study consisted of PBAM, 
PBAM•HOTf, and PBAM•HNTf2. The 8MeOPBAM catalyst could be problematic in this case 
because of its high reactivity and its ability to readily eliminate, especially with the highly reactive 
nosyl ketimine. Less reactive catalysts were purposefully chosen in order to minimize elimination 
so that adduct could be acquired and ee’s could be readily determined.  
Scheme 24. Synthesis of Electron-Withdrawing and Electron-Donating Ketimine Species 
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Before additions into more electron-deficient and electron-donating ketimines took place, 
aza-Henry additions into the tosyl ketimine with only 2 equivalents of nitromethane were 
conducted. This was to see if using 2 equivalents of nucleophile, versus 150 equivalents (Table 3), 
would result in a large difference in enantioselection as neat nitromethane may inhibit ideal catalyst 
binding. 
To initiate this study, tosyl ketimine 49 was subjected to 20 mol% of PBAM in the presence 
of 2 equivalents of nitromethane over 96 hours at room temperature. Upon isolation, aza-Henry 
adduct 58 was acquired in 13% yield and 5% ee (Scheme 25). PBAM•HOTf, under the same 
conditions, resulted in slightly diminished yield and slightly enhanced ee. PBAM•HNTf2 was 
comparable to PBAM•HOTf as adduct 58 was furnished in 11% yield and 11% ee. 
Additions into the less reactive methoxyphenyl ketimine (60) were conducted when this 
electrophile was treated with 20 mol % of PBAM in the presence of 2 equivalents of nitromethane. 
After 96 hours, aza-Henry adduct 63 was obtained in 10% yield and 2% ee (Scheme 26). 
PBAM•HOTf and PBAM•HNTf2 gave identical results as adduct 63 was afforded in 27% yield 
and 11% ee for both cases. 
Additions into the more reactive nosyl ketimine 59 were more challenging since this 
electron deficient nosyl group is more prone to β-elimination. Thus, extra care had to be taken in 
order to obtain product so that enantioselectivity could be determined. When treating this nosyl 
Scheme 25. Aza-Henry Additions into Tosyl Ketimine 49 
 
Scheme 26. Aza-Henry Additions into Methoxylphenyl Ketimine 60 
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ketimine with only 10 mol % of PBAM in the presence of 2 equivalents of nitromethane, the 
desired aza-Henry adduct 64 was obtained in 25% isolated yield and 12% ee after a 24 hour 
reaction period (Scheme 27). PBAM•HOTf resulted in a minor improvement in yield but no 
change in ee. Diminished yield but slightly enhanced enantioselectivity was seen with 
PBAM•HNTf2 as this catalyst afforded adduct 64 in 12% yield and 15% ee. This was the highest 
ee observed up to this point.  
A variety of conclusions can be drawn from this study. First, enantioselectivity does not 
appear to be enhanced when using 2 equivalents of the nucleophile versus 150 equivalents. The 
use of electron-donating substituents on the electrophile does not appear to affect selectivity as the 
best enantioselectivity achieved with this ketimine was 11% ee. Furthermore, incorporation of an 
electron-withdrawing moiety on the ketimine electrophile minimally enhances the selectivity of 
this system as ee values as high as 15% were obtained. Needless to say, altering the electronics of 
the electrophile at the para- position of the aryl ring does not appear to significantly enhance 
enantioselection. 
2.4 Future Work 
No promising degrees of enantioselection were seen for this aza-Henry system upon using 
a variety of PBAM catalysts and changing the electronic nature of the ketimine. Based on this lack 
of success, efforts now shifted toward the development of a more selective catalyst. Nagasawa and 
co-workers have developed guanidine-thiourea bifunctional organocatalysts that can facilitate 
Henry additions,33 that is the addition of nitro-nucleophiles into aldehydes. It has also been 
demonstrated that this addition can be done diastereoselectively.34 These catalysts became of 
considerable interest when Han and colleagues demonstrated that they can be used for the 
                                                          
33 Sohtome, Y.; Takemura, N.; Iguchi, T.; Hashimoto, Y.; Nagasawa, K. Synlett 2006, 1, 144-146. 
34 Sohtome, Y.; Hashimoto, Y.; Nagasawa, K. Adv. Synth. Catal. 2005, 347, 1643-1648.  
Scheme 27. aza-Henry Additions into Nosyl Ketimine 59 
 
27 
 
facilitation of aza-Henry addition reactions.35 The combination of these findings along with the 
findings of Terada in which he used tetramethylguanidine as a base, has prompted us to synthesize 
guanidine-derived BAM catalysts. These catalysts, when fully developed, can also be applied to 
aza-Henry reactions into aldimines for comparative studies. It may prove useful to examine their 
effectiveness in other known aza-Henry systems before applying them to ketimine additions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
35 Huang, W.; Peng, C.; Guo, L.; Hu, R.; Han, B. Synlett 2011, 20, 2981-2984. 
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Chapter 3. The Guided Development of Asymmetric Mono(Amidine) 
Organocatalysts for the Enantioselective Synthesis of Nutlin Analogs 
3.1 Background 
 Previously, PBAM-catalyzed aza-Henry additions into ketimine centers have proven 
troublesome. After exploring a variety of free-base and protonated versions of symmetric 
bis(amidine) catalysts for this particular system, no promising degree of enantioselection was 
achieved, as the highest ee obtained to this point was 15% ee. Various modifications of the 
ketimine electrophile, including the installation of different protecting groups as well as electronic 
alterations, were examined in order to improve enantioselection, but to no avail. Therefore, the 
next course of action to be taken would involve restructuring the current catalysts being used via 
installation of different functional groups.  
 After investigating the literature, it was found that organocatalysts bearing guanidine 
and/or thiourea moieties facilitated the selective addition of nitroalkane nucleophiles into a variety 
of sp2-hybridized centers. More specifically, Nagasawa and colleagues have shown that a 
guanidine-thiourea bifunctional organocatalyst (65) results in the Henry (nitroaldol) addition of 
nitromethane into aliphatic cyclic aldehydes and branched aliphatic aldehydes with high 
Scheme 28. Examples of Nitromethane Additions into Aldehydes and Esters with Nagasawa’s Catalyst (65) 
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enantioselection.36 This guanidine-thiourea catalyst also allows for highly diastereoselective 
Henry additions into protected α-amino- and α-hydroxy aldehydes as well as α-ketoesters while 
maintaining high levels of enantioselectivity (Scheme 28).37,38 When analyzing the transition states 
of these reactions with catalyst 65, it is proposed that the guanidine group coordinates with 
nitromethane through ionic interactions, while the thiourea group acts as a Brønsted acid and 
interacts with the aldehyde (or ester), thus lowering the LUMO energy of the carbonyl group 
(Figure 7). These interactions can then promote the addition of nitromethane in an enantioselective 
manner. 
 The utility of this bifunctional guanidine-thiourea catalyst backbone was not limited to 
Henry additions of nitromethane into aldehydes and esters. After slight modifications of the 
catalyst structure, Nagasawa and colleagues were able to develop bifunctional catalyst 66, which 
readily promoted the Mannich-type reaction of aromatic α-amido sulfones with malonates, 
affording β-amino acid derivatives in high yields and with excellent enantioselectivity.39 Han and 
co-workers were able to expand on these findings with another derivative of Nagasawa’s catalyst. 
Using guanidine-thiourea motif 67, they were able facilitate the aza-Henry (or nitro-Mannich) 
additions of a wide array of nitroalkanes into N-Boc-protected imines, giving the desired 1,2-
diamino adducts in sufficient levels of diastereoselection and high degrees of enantioselection 
(Scheme 29).40 
                                                          
36 Sohtome, Y.; Hashimoto, Y.; Nagasawa, K. Adv. Synth. Catal. 2005, 347, 1643-1648. 
37 Sohtome, Y.; Takemura, N.; Iguchi, T.; Hashimoto, Y.; Nagasawa, K. Synlett 2006, 1, 144-146. 
38 Takada, K.; Takemura, N.; Cho, K.; Sohtome, Y.; Nagasawa, K. Tetrahedron Lett. 2008, 49, 1623-1626. 
39 Takada, K.; Tanaka, S.; Nagasawa, K. Synlett 2009, 10, 1643-1646. 
40 Huang, W.; Peng, C.; Guo, L.; Hu, R.; Han, B. Synlett 2011, 20, 2981-2984. 
Figure 7. Proposed Transition State of the Guanidine-Thiourea Catalyzed Henry Reaction 
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 Despite the success with Nagasawa’s catalyst backbone, additional studies have shown that 
a bifunctional guanidine-thiourea system is not entirely necessary in order to achieve aza-Henry 
additions of nitroalkanes into aldimine or ketimine centers. Instead, catalysts bearing just a 
thiourea or guanidine entity alone have resulted in considerable success. Tang and colleagues have 
demonstrated that with commercially available 1,1,3,3-tetramethylguanidine (TMG), the additions 
of nitromethane into N-diethoxythiophosphorylimines and N-diphenylthiophosphinoylimines can 
Scheme 29. Examples of Mannich and aza-Henry Reactions with Guanidine-Thiourea Organocatalysts 
 
Scheme 30. Examples of aza-Henry Additions with Other Guanidine and Thiourea Catalysts 
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be accomplished in high yields and short reaction times.25 In this same work, they were also able 
to induce good degrees of stereoselection for the same reaction system using Takemoto’s chiral 
thiourea organocatalyst (68). Furthermore, Terada showed that the addition of nitromethane into 
diphenylphosphinoyl ketimine centers can be achieved in high yields using TMG as the catalyst 
(Scheme 30).24 
3.2 Synthetic Efforts Towards Amidine-Guanidine Asymmetric Catalysts 
 Based on the success in literature, we sought to restructure our traditional bis(amidine) 
catalyst framework in such a way that a thiourea or guanidine functionality could be incorporated. 
Due to the availability of various diimide species and other guanidinating reagents, the synthesis 
of an asymmetric bifunctional amidine-guanidine organocatalyst was the first priority (Figure 8). 
It was then necessary to synthesize a free amine intermediate that would readily allow for the 
installation of various guanidine moieties.  
 In order to arrive at a key free amine intermediate, it was determined that the amidine 
portion of the catalyst backbone had to be developed first. This was initiated by treating resolved, 
enantiopure R,R-cyclohexane diamine (69) with phthalic anhydride (70) in the presence of para-
toluene sulfonic acid monohydrate according to literature protocol.41 This resulted in the acid salt 
of phthalimide 71 in high yield (98%). Aqueous base wash of acid salt 71 would subsequently give 
the free base of the mono-protected diamine (72) in 84% yield. A chloro-substituted quinoline 
moiety was then installed via a Buchwald-Hartwig amination reaction in which amine 72 was 
treated with 2,4-dichloroquinoline (73) in the presence of cesium carbonate and catalytic amounts 
of 2,2’-bis(diphenylphosphino)-1,1’-binaphthyl (BINAP) and 
bis(dibenzylideneacetone)palladium (Pd(dba)2) in order to furnish amidine 74 in modest yield 
(42%). Phthalate deprotection with hydrazine monohydrate afforded amidine-amine species 75 in 
                                                          
41 Kiak, M.; Gawronski, J. Tetrahedron: Asymmetry 2003, 14, 1559-1563. 
Figure 8. Backbone Structure of Desired Amidine-Guanidine Catalyst 
 
 
32 
 
99% yield. This amidine-amine, which would serve as the key intermediate, can readily lead to the 
incorporation of a variety of guanidine derivatives as previously mentioned (Scheme 31).  
 Initial attempts towards the installation of a guanidine entity proved to be fruitless. When 
key intermediate 75 was subjected to N,N’-diisopropylcarbodiimide under high temperatures in 
the presence of a variety of solvents, no desired addition product could be isolated. When searching 
for alternate conditions, it was found that Shen and co-workers were able to add a wide range of 
aliphatic and aromatic amines into diimide centers in the presence of SmI2.
42,43 In this reaction 
pathway, it is believed that the samarium species can activate the diimide by forming a Sm(III) 
complex, which would promote the insertion of an amine, ultimately resulting in the formation of 
a desired guanidine. Unfortunately, when applying this SmI2 approach to our own reaction system, 
no desired guanidine was obtained. Lastly, an acylation approach was attempted in which the 
amidine-amine intermediate (75) was treated with the HCl salt of pyrazole carboxamide (76) in 
the presence of THF at high temperature. Again, no sign of an amidine-guanidine moiety could be 
detected (Scheme 32).  
 Due to the lack of success of forming a guanidine functionality at this stage of the synthesis, 
an alternate route was proposed. Instead of trying to directly install a guanidine onto intermediate 
75, we sought to subject amidine 74 to SNAr conditions in order to incorporate a pyrrolidine ring 
at the 4-chloro position of the quinoline ring. The incorporation of this pyrrolidine motif could 
possibly facilitate the formation of a guanidine species in subsequent steps. However, when 
                                                          
42 Du, Z.; Li, W.; Zhu, X.; Xu, F.; Shen, Q. J. Org. Chem. 2008, 73, 8966-8972. 
43 Zhu, X.; Xu, F.; Shen, Q. Chin. J. Chem. 2009, 27, 19-22. 
Scheme 31. Synthesis of Amidine-Amine Intermediate 75 
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analyzing the structure of intermediate 74, a potential problem that could arise is that the phthalate 
ring would be attacked and opened by pyrrolidine before the aromatic substitution reaction could 
take place on the quinoline. Keeping in mind this potential problem, amidine 74 was treated with 
pyrrolidine in the presence of trifluorotoluene under microwave conditions. Upon purification, our 
desired product, compound 77, was not observed. Rather, it was determined that both the 
substitution and the phthalate ring-opening did indeed take place, affording amidine-amide 
compound 78 in 80% isolated yield (Scheme 33).  
 Although acquired amidine-amide product 78 was not initially desired, we saw this 
compound as a potential enantioselective organocatalyst as a chiral pocket was present within the 
structure. Before this motif was applied to a ketimine reaction system, however, we wanted to test 
this potential amidine-amide catalyst on a previously developed aza-Henry system. The system 
that was chosen was the enantioselective aza-Henry addition en route to Nutlin-3, in which 
arylnitroalkane 37 is added into N-Boc protected arylimine 36, resulting in a masked cis-stilbene 
diamine backbone. As seen in previous studies, traditional bis(amidine) catalysts have resulted in 
a good degree of success for this particular system.21 Optimal symmetric bis(amidine) catalysts 
included 8MeOPBAM (19d), which furnished the adduct in 99% yield, 89% ee, and 7:1 dr and 
6,7(MeO)2PBAM (19c), which gave the adduct in 97% yield, 91% ee, and 13:1 dr. When applying 
amidine-amide moiety 78, dubbed XBenzPyrrolidineAM, as the catalyst to this system, the desired 
adduct was obtained in 78% yield, 89% ee, and 29:1 dr (Scheme 34). In essence, the first 
Scheme 32. Attempts Towards the Synthesis of an Amidine-Guanidine Organocatalyst 
 
 
Scheme 33. Synthesis of Amidine-Amide Catalyst 78 
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asymmetric amidine-amide catalyst subjected to this system showed comparable results with the 
most optimal symmetric BAM catalysts. This prompted us to further develop and investigate 
additional asymmetric amidine-amide organocatalysts in order to determine if this aza-Henry 
reaction system, en route to Nutlin-3, could be optimized to an even higher degree. 
3.3 Development of Asymmetric Amidine-Amide Organocatalysts and Their 
Application Towards the aza-Henry Addition en Route to Nutlin-3 
 Seeing that XBenzPyrrolidineAM (78) performed well compared to traditional BAM 
catalysts, we sought a more direct approach for the synthesis of other amidine-amide catalysts. 
One route to be taken would involve subjecting key amine 75 to standard amide coupling 
conditions followed by the installation of the pyrrolidine entity via nucleophilic aromatic 
substitution. An amidine-amide species that was of considerable interest, and could be readily 
constructed through this pathway, was a 3,5-bis(trifluoromethyl)benzamide-amidine 
organocatalyst (78a). This catalyst, coined 3,5(CF3)2BenzAM, can be synthesized by first treating 
intermediate 75 with 3,5-bis(trifluoromethyl)benzoic acid (79), EDC, and a catalytic amount of 
DMAP in order to afford benzamide 80a in 78% yield. A subsequent SNAr reaction of this 
intermediate with pyrrolidine furnished the desired 3,5(CF3)2BenzAM motif in 69% yield (Scheme 
35).  
 When subjecting 3,5(CF3)2BenzAM catalyst (78a) to the benchmark aza-Henry addition, 
we were delighted to see that higher levels of enantioselection and diastereoselection were 
Scheme 34. Comparative Results of the Nutlin-3 aza-Henry System 
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achieved compared to previously reported results. 3,5(CF3)2BenzAM gave the desired adduct in 
72% yield, 96% ee, and 53:1 dr under standard reaction conditions, making this the most selective 
and efficient organocatalyst for the Nutlin-3 aza-Henry system up to this point (Scheme 36). 
 Achieving these degrees of selectivity led to the development of additional amidine-amide 
catalyst precursors via the amide coupling pathway. Treatment of key intermediate 75 with a series 
of commercially available carboxylic acids in the presence of EDC furnished a variety of desired 
amides in modest to good yields (45-79%). Amongst these amides were standard and substituted 
benzamides, naphthamides, and picolinamides (80a-80f) (Scheme 37). 
Scheme 35. Synthesis of 3,5(CF3)2BenzAM (78a) 
 
Scheme 36. Improvements on the Nutlin-3 Aza-Henry System with 3,5(CF3)2BenzAM (78a) 
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Formation of these amide motifs was not limited to EDC couplings with carboxylic acids. 
Rather, an acylation pathway was also available with key intermediate 75. By subjecting this amine 
to a number of acyl chlorides under basic conditions, additional amidine-amide moieties could be 
obtained. This acylation approach lead to the installation of adamantyl and anthracenyl amides, 
pivalamides, acetamides, and other benzamides (80g-80n) (Scheme 38). Good yields (71-88%) 
were typically acquired throughout these acylations. 
 With catalyst precursors 80a-80n in hand, the stage was now set for the SNAr reaction en 
route to the desired catalysts with pyrrolidine as the nucleophile. These reactions were conducted 
under microwave conditions and were typically completed within 90 minutes. A wide range in 
yields was observed for these substitutions as yields varied from 19% to 83% (Scheme 39). 
Scheme 37. Synthesis of Amidine-Amide Catalyst Precursors 80a-80f 
 
Scheme 38. Synthesis of Amidine-Amide Catalyst Precursors 80g-80n 
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 Before applying these newly developed asymmetric amidine-amide catalysts (78a-78n) to 
the aza-Henry addition en route to Nutlin-3 (35), other asymmetric organocatalysts bearing 
functionalities other than an amide were prepared for comparative purposes. One motif that was 
prepared was amidine-thioamide 78o. The thioamide functionality was introduced in a 
straightforward manner as 3,5(CF3)2BenzAM (78a) was treated with Lawesson’s reagent in order 
to afford the desired product (78o) in 46% yield (Scheme 40). 
 Another functional group that was of interest and could be readily incorporated into our 
catalyst backbone structure was a sulfonamide species. By treating amine 75 with commercially 
available 3,5bis(trifluoromethyl)benzenesulfonyl chloride (81) under basic conditions, we could 
arrive at sulfonamide precursor 80p in good yield (81%). A subsequent nucleophilic aromatic 
Scheme 39. SNAr Reactions en Route to Amidine-Amide Catalysts 78a-78n 
 
Scheme 40. Synthesis of Amidine-Thioamide Catalyst 78o 
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substitution reaction of this precursor with pyrrolidine afforded the desired amidine-sulfonamide 
catalyst (78p) in 69% yield (Scheme 41). 
 Application of the newly developed amidine-amide catalyst library toward the Nutlin-3 
aza-Henry system yielded interesting results in terms of reactivity and selectivity. Steric and 
electronic modifications of the amide functionality can lead to possible hypotheses as to how the 
asymmetric chiral pocket behaves for this reaction system. When the amide portion of this catalyst 
structure is a standard benzamide moiety (78b), the desired adduct is obtained in 71% yield, 27:1 
dr, and 91% ee (Scheme 42). Although the expansion of the ring system from a benzamide to both 
1- and 2-naphthamides (78c and 78e) did result in improved yields, no significant enhancement of 
diastereo- and enantioselection could be detected. However, when further expanding the amide 
portion of the catalyst to an anthracenyl amide (78j), selection was increased to a considerable 
degree as the desired product was isolated in 35:1 dr and 98% ee despite a slightly diminished 
yield (68%). This increase in enantioselection when going from a naphthamide to an anthracenyl 
amide indicates that sterics are an important component when it comes to creating the most 
selective chiral pocket for this particular reaction system.  
 Steric influence of these amidine-amide catalysts was not limited to solely the ring size of 
the amide. Higher levels of selection were also achieved via introduction of substituents at the 
ortho, meta, and para positions of the benzamide motif. This was reflected by the results observed 
with both the 2,4,6(Me)3benzamide- and the 
3,5(Me)2benzamide-amidine organocatalysts (78g and 
78d). These two catalysts afforded the desired aza-Henry adduct in higher yields, comparable dr’s, 
Scheme 41. Synthesis of Amidine-Sulfonamide Catalyst 78p 
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and improved ee’s relative to their standard benzamide counterpart 78b, reaffirming that better 
enantioselection can be achieved with proper steric modification (Scheme 42). 
 Further comparisons can be made with catalysts 78h and 78i via electronic alterations. 
When introducing an electron-donating methoxy functionality at both ortho positions of the 
benzamide ring (catalyst 78h), diminishment in enantioselection is seen as the aza-Henry adduct 
is acquired in only 75% ee relative to 2,4,6(Me)3benzamide-amide catalyst 78g, which gave the 
product in 94% ee. Yet, when an electron-withdrawing nitro group is incorporated at an ortho 
position of the ring (catalyst 78i), marginal improvement is observed as the product is afforded in 
99% yield, 46:1 dr, and 84% ee (Scheme 42). Analysis of the electron-donating and electron-
withdrawing benzamides presents the possibility that additional electrons/lone pairs from both the 
methoxy and the nitro entities may interfere with the catalyst-substrate binding, ultimately 
resulting in lower levels of selectivity. This possibility was further supported by the results 
acquired with 3,5(CF3)2BenzAM catalyst 78a, which yielded the adduct in better ee and dr (96% ee 
and 53:1 dr) compared to methylated counterpart 78d (95% ee and 13:1 dr). Like nitrobenzamide 
catalyst 78i, this catalyst (78a) possesses electron-withdrawing substituents in trifluoromethyl 
groups. In contrast to the nitro group however, these trifluoromethyl groups do not possess a free 
lone pair that can readily disrupt the catalyst binding pathway and result in less selection. Thus, it 
Scheme 42. aza-Henry Results with Amidine-Amide Catalysts 78a-78n 
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is shown that diastereoselection and enantioselection can be slightly enhanced when electron-
withdrawing character is introduced without interruption of catalyst binding. 
 Application of acetamide-derived amidine-amide catalysts to this aza-Henry system also 
showed high degrees of efficiency (Scheme 42). Pivalamide 78m, dubbed PivalAM, proved to be 
the most efficacious amidine-acetamide organocatalyst as this moiety provided the aza-Henry 
adduct in 88% yield, 45:1 dr, and 98% ee. These results signified the most optimal combination of 
yield, diastereoselection, and enantioselection for this reaction system up to this point. A change 
in electronics resulted in a considerable drop in dr and a slightly diminished ee as 
trichloropivalamide catalyst 78n gave the desired product in 86% yield, 9.5:1 dr, and 97% ee. 
Changing the electronics of the pivalamide species will alter the hydrogen bond donor ability of 
the amide which in turn can affect binding, causing a drop in diastereo- and enantioselection. A 
bulkier triphenylacetamide-amidine catalyst (78k) was also subjected to the benchmark reaction 
system. This catalyst fared considerably well as the adduct was obtained in 92% yield, 50:1 dr, 
and 94% ee. The last amidine-acetamide organocatalyst to be tested was adamantyl motif 78l. This 
proved to be the least sufficient amidine-acetamide catalyst as the adduct was afforded in only 
90% ee despite a high yield and dr (91% yield, 43:1 dr). A drop in enantioselection from PivalAM 
78m (98% ee) to adamantyl amide 78l (90% ee) reestablished the idea that optimal selectivity, 
especially enantioselectivity, can be achieved with the correct combination of both sterics and 
electronics.  
 A heteroaromatic picolinamide catalyst (78f) was the last amidine-amide moiety to be 
subjected to the Nutlin-3 aza-Henry reaction. Upon completion of addition with 78f as the catalyst, 
the product was acquired in 83% yield, 53:1 dr, and 75% ee (Scheme 42). Although a high yield 
and dr were obtained, this picolinamide-amidine catalyst displayed a lower degree of 
enantioselectivity relative to its standard phenyl counterpart, amidine-benzamide 78b, which 
furnished the adduct in 91% ee. The diminishment in enantiomeric excess when using 
picolinamide 78f as the catalyst can once again be attributed to the idea that an extra lone pair of 
electrons on the pyridine ring is readily interfering with the catalyst’s mode of binding, a trend that 
was observed with the methoxy- and nitrobenzamide-amidine catalysts (78h and 78i).  
 Two other catalyst types that were tested in this aza-Henry system included amidine-
thioamide 78o and amidine-sulfonamide 78p. Thioamide catalyst 78o proved to be inefficient 
relative to its amide analog, 3,5(CF3)2BenzAM (78a), as the adduct was obtained in only 29% yield, 
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5:1 dr, and 72% ee indicating a significant decrease in yield, and a large drop in selectivity (Scheme 
43). Amidine-sulfonamide motif 78p did not fare much better as this catalyst afforded the desired 
product in 33% yield, 26:1 dr, and 85% ee. The results obtained by 78o and 78p confirm that 
amidine-amide moieties give far superior degrees of reactivity and selectivity for this particular 
addition reaction. Changing the amide functionality to a thioamide or sulfonamide will increase 
the acidity of the proton on the functional group, which can once again disrupt ideal catalyst 
binding and result in diminished yields and selectivity. 
 Previously, it was mentioned that the most optimal catalysts for the Nutlin-3 aza-Henry 
system, prior to the development of the amidine-amide catalyst library, were 8MeOPBAM (19d) 
and 6,7(MeO)2PBAM (19c) which gave the desired adduct in up to 13:1 dr and 91% ee. Yet when 
subjecting these newly developed amidine-amide catalysts to the same system, the desired product 
was obtained in up to 56:1 dr and 98% ee indicating a significant improvement in diastereo- and 
enantioselection. The two catalysts that gave the optimal combination of yield and selectivity were 
3,5(CF3)2BenzAM (78a) and PivalAM (78m) (Figure 9). These amidine-amide motifs were used in 
further studies and applications as well. 
Scheme 43. Comparative Results with Thioamide and Sulfonamide Catalysts 
 
Figure 9. Optimal Catalysts Chosen for Further Studies 
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3.4 Proposed Catalyst Binding Modes 
 Although the mechanistic pathway for these catalysts has not been completely studied at 
this point, it is evident that the combination of amidine and amide motifs allows for a fully 
bifunctional organocatalyst for this aza-Henry addition en route to Nutlin-3 (35). Having both the 
amidine and amide functionalities in the same chiral pocket can lead to a number of proposed 
transition states. In model A, the hydrogen of the amide can act as hydrogen bond donor to activate 
the N-Boc-protected imine electrophile (Figure 10). Conversely, the nitrogen of the quinoline ring 
serves as a Brønsted base to deprotonate the nitroalkane to form the nucleophilic nitronate. The 
simultaneous activation of the electrophile and generation of the nucleophile can allow for the 
formation of the desired masked cis-stilbene diamine adduct in a diastereo- and enantioselective 
fashion. 
 In another possible model, model B, the quinoline can fully deprotonate the nitroalkane, 
generating a positively-charged amidinium and a negatively-charged nitronate. The protons of the 
amidinium species can readily coordinate with the carbonyl of the Boc group and the nitrogen of 
the imine causing activation of the electrophile. Simultaneously, an oxygen of the nitronate, 
bearing a negative charge, can coordinate with the proton of the amide (Figure 11). Here, the amide 
can be oriented in one of two ways relative to the cyclohexyl ring. If the amide is oriented in an s-
trans fashion, the substituent α to the carbonyl of the amide may be sterically repulsed by the 
cyclohexyl ring. However, if the amide is arranged in an s-cis manner, then the amide substituent 
may sterically interact with the non-coordinating oxygen of the nitronate. The varying sizes of the 
amide substituents, as shown in the catalyst library, can have an effect on the degree of steric 
repulsion. The size of the substituent may dictate if the amide will orient itself cis or trans relative 
to the cyclohexane ring, which may ultimately affect selectivity. Furthermore, varying the 
electronics of the amide entity may inductively influence the amide’s hydrogen bond donor ability. 
Figure 10. Proposed Amidine-Amide Activation and Stereochemical Model A 
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This can affect the strength of coordination with the nitronate, which, in turn, may further influence 
the degrees of diastereo- and enantioselection of this addition. 
 Opposite to model B, it is also plausible that coordination between functionalities can be 
reversed. For a third model, model C, the quinoline once again deprotonates the nitroalkane 
generating an amidinium and a nitronate. Unlike the previous model however, model C proposes 
that the negatively-charged nitronate readily binds to both protons of the positively-charged 
amidinium, while the nitrogen of the imine binds to the hydrogen of the amide (Figure 12). Again, 
the amide functionality has the ability to orient itself in an s-cis or s-trans manner. Yet in this case, 
it is believed that the lowest-energy transition state will be achieved if the amide is arranged in an 
s-cis fashion as steric interactions should be minimized. An s-trans arrangement would be 
disfavored as there would be a considerable amount of steric repulsion between the amide 
substituent and the cyclohexyl ring as seen in model C. Once again, this model is susceptible to 
variations in the size and electronics of the amide motif as they can alter steric interaction and 
amide acidity. These variations can change the levels of selectivity of this reaction system as a 
consequence.   
 Lastly, model D proposes a binding pattern similar to model C, but with different charge 
coordination. Upon deprotonation of the nitroalkane by the quinoline, the resulting amidinium ion 
Figure 11. Proposed Amidine-Amide Activation and Stereochemical Model B 
 
Figure 12. Proposed Amidine-Amide Activation and Stereochemical Model C 
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can be in equilibrium with the carbonyl of the Boc-imine and generate an acidic oxonium ion. 
Here, the proton of the oxonium can readily coordinate with the carbonyl of the amide while the 
nitrogen of the imine can bind to the hydrogen of the amide. Conversely, the negatively-charged 
nitronate can coordinate with the lone proton of the amidine (Figure 13). If the aryl Boc-imine 
were to bind to the amide moiety in this proposed fashion, then it is believed that the amide would 
have to be in an s-trans orientation for easier accessibility versus an s-cis conformation. Forcing 
the amide to be in an s-trans arrangement in this model may once again cause steric repulsion 
between the amide substituent and the cyclohexyl ring. If the degree of steric repulsion was the 
only change taking place with varying sizes of the amide, then the ability of the amide substituent 
to have an effect on selectivity may be significantly reduced as this interaction is occurring outside 
of the chiral pocket. Furthermore, model D also hypothesizes that the aromatic portion of the imine 
is within the chiral pocket. As a consequence, it is possible that the sterics of the imine can have a 
critical influence on the selectivity of this addition. This is a potential phenomenon that needs to 
be examined more closely. Finally, it is also plausible that the acidity of the amide proton can 
change the degree of activation of the electrophile and ultimately have an effect on reactivity. Data 
shows that when going from an amide to a thioamide/sulfonamide species, reactivity is 
significantly diminished. It is feasible through this model that having an amide proton of higher 
acidity can cause unwanted interactions in this chiral pocket and, consequently, result in less imine 
activation and reactivity. 
 Based on the proposed transition states, it is reaffirmed that both the amidine and the amide 
components allow for a completely bifunctional organocatalyst system for the aza-Henry addition 
en route to Nutlin-3. The binding of these asymmetric catalysts is unique in the sense that unlike 
the traditional bis(amidine) organocatalysts, introduction of a salt is unnecessary as both Brønsted 
sites are present in its free base form. If a salt is indeed introduced to these amidine-amide moieties, 
Figure 13. Proposed Amidine-Amide Activation and Stereochemical Model D 
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the lone Brønsted basic site of the quinoline will be protonated and reactivity will be lost as a result 
(Figure 14). 
3.5. In-Depth Analysis of Catalyst Trends 
 Subjection of these catalysts to the Nutlin-3 aza-Henry addition yielded data points that 
could be considered for potential trends. These trends mainly center upon sterics, electronics, and 
amide acidity. 
 When examining the effects of sterics, a general trend that was observed was that an 
increase of amide size results in an enrichment of enantioselection. This trend was consistent 
among ring expansion of the amide functionality. As previous data indicates (Scheme 44), a 
change from a benzamide to a naphthamide does not result in an increase of enantioselection as ee 
is maintained at 91%. Yet when exchanging a naphthamide (78c or 78e) for an anthracenyl amide 
(78j), a substantial jump in selectivity is observed as this catalyst affords adduct 38 in 98% ee. 
This difference in enantioselectivity may revolve around the ability of the amide substituent to 
Figure 14. Deactivation of the Catalyst via Introduction of a Salt 
 
Scheme 44. Steric Trends Observed with Asymmetric Amidine-Amide Catalysts 
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rotate about the C-C sigma bond attached to the carbonyl of the amide. The rotation about this 
sigma bond, with asymmetric ring systems, can alter the size and shape of the chiral pocket, 
ultimately affecting enantioselection. When a 1- or 2-naphthyl ring is introduced as the amide 
substituent, two different chiral pockets can be acquired upon rotating 180° since they are non-
symmetric substituents. It is plausible that the naphthamide moieties arrange themselves in such a 
way that they minimize their interaction in the chiral pocket as it is the lowest energy conformation 
(Figure 15). If the naphthamide substituents are arranged in this way, this may create a chiral 
environment similar to having a benzamide motif present. As a result, the degrees of 
enantioselection should be very similar. Yet when introducing a bulkier, symmetric anthracenyl 
functionality, this may change the chiral environment as the same conformation will be achieved 
upon rotating 180°. In other words, an anthracenyl amide does not have the ability to adapt a lower 
energy orientation. Part of the anthracenyl ring is forced inside creating a more shallow and narrow 
chiral pocket. This smaller pocket appears to be preferred for this aza-Henry system as the adduct 
was acquired in considerably higher ee (98% ee). 
 This same phenomenon was observed upon incorporation of substituents at the ortho, meta, 
and para positions of benzamide catalyst 78b. As previously mentioned, installation of methyl 
substituents at the ortho and para positions of the benzamide ring (catalyst 78g) resulted in higher 
selectivity as the desired adduct was afforded in 94% ee relative to standard benzamide 78b, which 
gave adduct 38 in 91% ee (Scheme 44). Installation of these methyl substituents at both meta 
positions did not seem to make much of a difference as the adduct was acquired in 95% ee. Altering 
Figure 15. Ring Expansion and its Influence on Enatioselection 
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the electronics of these methyl substituents to electron-withdrawing trifluoromethyl groups also 
had minimal enhancement in enantioselection as the adduct was obtained in 96% ee. What is 
consistent throughout these findings is that enantioselection is enhanced as steric bulk is increased 
via incorporation of neutral or electron-withdrawing substituents on the benzamide ring (Figure 
16). The proposal made with the anthracenyl-amide catalyst (78j) also applies to the methylated 
benzamide catalysts. Each of the substituted benzamides are symmetric and larger compared to a 
standard benzamide. As the bulkier methylated benzamides rotate about the C-C sigma bond 
attached to the carbonyl of the amide, the same conformation will be achieved upon a 180° rotation. 
Like the anthracenyl amide, these methylated benzamides do not have the ability to choose a lower 
energy orientation. As a consequence, these methyl groups (i.e. more steric bulk) are once again 
forced inside creating a more shallow and narrow chiral pocket. This results in higher degrees of 
enantioselection relative to benzamide catalyst 78b, a very similar trend that was seen with ring 
expansion. 
 Electronic variations of the amide substituent also yielded an interesting trend. As shown 
in the steric trends, 3,5(CF3)2BenzAM (78a), furnishes adduct 38 in 96% ee relative to standard 
benzamide counterpart 78b, which affords the adduct in 91% ee (Scheme 45). Although it is 
believed that this increase in enantioselectivity is largely due to increased steric bulk, some of it 
can be attributed to the electron-withdrawing character of the trifluoromethyl substituents as well. 
Not all electron-withdrawing motifs resulted in enhanced enantioselection, however. When 
introducing an electron-withdrawing nitro group at the ortho position, as shown in catalyst 78i, a 
drop in enantioselection was observed (84% ee). The nitro group is within proximity of the amide 
proton and depending on how this organocatalyst binds, it is feasible that one of the lone pairs of 
the nitro group is intramolecularly coordinated to the acidic proton of the amide (Figure 17). This 
unwanted interaction will disrupt the intended transition state in the sense that the proton of the 
Figure 16. Steric Interaction and its Influence on Enantioselection 
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amide will not bind as well to the imine or nitronate. This, in turn, may inhibit activation and 
reactivity as well as enantioselection. This hypothesis is also supported when two electron-
donating methoxy substituents are installed onto the benzamide ring. This particular catalyst (78h) 
gives the intended adduct in only 75% ee. Once again, lone pairs of electrons on these methoxy 
substituents may interact with the amide proton ultimately causing a diminished ee. When drawing 
conclusions based on these electronic alterations, it appears that electron-withdrawing groups can 
enrich enantioselection as long as there is no extra electronic activity (i.e. lone pairs) that can 
readily disrupt the ideal catalyst binding mode. 
 Acidity of the amide proton was another variable that lead to an interesting trend. The pKa 
value of the Brønsted acidic proton can vary by changing the amide substituents to other 
functionalities. This can lead to different degrees of reactivity and selectivity. Benzamide catalyst 
78b posseses an amide proton with a pKa value of approximately 23 in DMSO, and when subjected 
to the benchmark aza-Henry addition, the desired adduct is furnished in 71% yield, 27:1 dr, and 
91% ee (Scheme 46). When electron-withdrawing trifluoromethyl substituents are placed at the 
Scheme 45. Electronic Trends Observed with Asymmetric Amidine-Amide Catalysts 
 
Figure 17. Proposed Disruptions of Binding via Unwanted Intramolecular Coordination 
 
49 
 
meta positions of the benzamide ring, the amide proton becomes more acidic with a pKa value of 
17. Though this catalyst gives similar reactivity and diastereoselection compared to benzamide 
78b, enantioselection is increased to 96% ee. Once again, this jump in enantioselectivity may be a 
direct result of increased steric bulk. Yet, it is also possible that the increased acidity plays a role 
in the acquisition of this higher ee as well. Acidity of this proton was lowered even further upon 
the installation of thioamide and sulfonamide moieties (78o and 78p). The approximate pKa values 
for the thioamide and sulfonamide protons were 10.5 and 9.7 respectively (DMSO scale).44,45 
When applying these catalysts to the aza-Henry addition however, considerably lower levels of 
enantioselection as well as diastereoselection and reactivity were observed, indicating that these 
more acidic thioamide and sulfonamide protons may be inhibiting the catalyst binding mode. In 
other words, lesser degrees of selection and reactivity may be due to unwanted intramolecular 
interactions, a phenomenon previously proposed in the electronics trend. In this case however, it 
is possible that the Brønsted basic quinoline ring can have a high binding affinity for the proton as 
it becomes more and more acidic (Figure 18). This intramolecular coordination will affect the 
abilities of the quinoline and amide to properly bind with the imine and nitronate resulting in 
diminished reactivity and selectivity. In essence, it is believed that increasing the proton acidity to 
a pKa of 17 may enhance enantioselection. Yet, if the proton is too acidic (pKa ~ 10), the ideal 
catalyst transition state may be disrupted and optimal results will not be acquired.  
                                                          
44 Ripin, D. H.; Evans, D. A. pKa Table.1 <evans.rc.fas.harvard.edu/pdf/evans_pka_table.pdf>  
45 Bordwell pKa Table (Acidity in DMSO). <www.chem.wisc.edu/areas/reich/pkatable/index.htm> 
Scheme 46. Acidity Trends Observed with Asymmetric Amidine-Amide Catalysts 
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3.6 Application of the Amidine-Amide Organocatalysts 
 Prior to the development of these asymmetric amidine-amide catalysts, the aza-Henry 
addition en route to Nutlin-3 was already optimized using symmetric BAM catalysts. According 
to previous studies, 6,7(MeO)2PBAM afforded adduct 19c in 97% yield, 13:1 dr, and 91% ee. This 
enriched adduct could then be converted to (−)-Nutlin-3 (35) via a short reaction sequence 
(Scheme 47). 
 However, when applying optimal BAM catalysts such as 6,7(MeO)2PBAM (19c) and 
8MeOPBAM (19d) to aza-Henry additions en route to Nutlin-3 analogs, diminished 
enantioselections were observed (60-80% ee). Seeing that the asymmetric catalysts enhanced 
enatioselectivity for the Nutlin-3 aza-Henry system, we saw this as an opportunity to apply these 
new amidine-amide catalysts to the synthesis of Nutlin-3 derivatives (Scheme 48). To our delight, 
we observed that our two most optimal amidine-amide catalysts, 3,5(CF3)2BenzAM (78a) and 
PivalAM (78m), furnished the new aza-Henry adducts in much higher degrees of enrichment (80-
99% ee). With the 3,5(CF3)2BenzAM and PivalAM catalysts, a library of over 40 different aza-
Henry adducts en route to Nutlin analogs were synthesized with various nitroalkanes and imines 
in high enantioselection.46 These two asymmetric catalysts tolerated aryl imines and aryl 
nitroalkanes possessing a number of substituents including different halogens, methyl groups, and 
                                                          
46 Vara, B. A.; Mayasundari, A.; Tellis, J. C.; Danneman, M. W.; Arredondo, V.; Davis, T. A.; Min, J.; Finch, K.; 
Guy, R. K.; Johnston, J. N. J. Org. Chem. 2014, 79, 6913-6938. 
Figure 18. Intramolecular Interaction Between the Quinoline and Acidic Proton 
 
Scheme 47. Optimization of the (−)-Nutlin-3 System 
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methoxy groups. These highly enriched adducts could then be carried onto their corresponding 
Nutlin derivatives via the same reaction sequence as previously reported. These analogs are then 
sent to St. Jude’s Children’s Research Hospital where our collaborator, Dr. Kiplin Guy, analyzes 
these derivatives in their binding assyas. These potency studies will provide findings regarding the 
binding interaction with the MDM2 protein, and will guide future efforts toward developing more 
potent analogs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 48. Development of (−)-Nutlin-3 Analogs 
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Chapter 4. PBAM-Catalyzed Additions of Nitromethane into Ketimine 
Centers – Part II: Boc-Protected Trifluoromethyl Ketimines 
4.1 Synthesis of a Trifluoromethyl Ketimine and Examination of its Reactivity 
 After seeing that electronic modifications of the tosyl protecting group did not result in 
promising levels of enantioselection, efforts then focused on restructuring the ketimine 
electrophile. When synthesizing a different ketimine however, the enhancement of reactivity and 
selectivity must be taken into consideration. One functional group that can readily promote 
reactivity and ultimately enhance enantioselectivity is a standard electron-withdrawing 
trifluoromethyl group.  
 The synthesis of a trifluoromethyl ketimine can have a number of benefits. First, this sort 
of ketimine will allow for a high degree of imine activation as the electron-withdrawing 
trifluoromethyl group is within the closest possible proximity of the electrophilic center. Secondly, 
if a ketimine center possessing both a trifluoromethyl group and aryl group is successfully 
synthesized, then the issue of tautomerization, as seen with Cbz-ketimine 46 (Figure 6), should not 
be of concern. In addition, the suppression of the ketimine-to-enamine tautomerization will allow 
for the introduction of Cbz and N-Boc protecting groups, which have, historically, allowed for the 
highest degrees of selection relative to any other protecting group.7,21,47,48,49,50,51,52,53,54 
Furthermore, if a Boc-protected aza-Henry adduct is acquired, then β-elimination of the Boc 
carbamate should be minimized as the Boc carbamate is not as good of a leaving group relative to 
a tosyl amine. Taking these effects into account, a trifluoromethyl ketimine that was of interest 
and could be synthesized in a straightforward manner was phenyl Boc-protected trifluoromethyl 
ketimine 82 (Figure 19). 
 Desired trifluoromethyl ketimine 82 could be readily synthesized according to literature 
protocols.55,56,57 Acylation of commercially available Boc anhydride (83) with hydrazine 
                                                          
47 Nugent, B. M.; Yoder, R. A.; Johnston, J. N. J. Am. Chem Soc. 2004, 126, 3418-3419. 
48 Singh, A.; Yoder, R. A.; Shen, B.; Johnston, J. N. J. Am. Chem. Soc. 2007, 129, 3466-3467. 
49 Shen. B.; Johnston, J. N. Org. Lett. 2008, 10, 4397-4400. 
50 Singh, A.; Johnston, J. N. J. Am. Chem. Soc. 2008, 130, 5866-5867. 
51 Wilt, J. C.; Pink, M. Johnston, J. N. Chem. Commun. 2008, 35, 4177-4179. 
52 Davis, T. A.; Wilt, J. C.; Johnston, J. N. J. Am. Chem. Soc. 2010, 132, 2880-2882. 
53 Shen, B. Makley, D. M.; Johnston, J. N. Nature 2010, 465, 1027-1033. 
54 Dobish, M. C.; Villalta, F.; Waterman, M. R.; Lepesheva, G. I.; Johnston, J. N. Org. Lett. 2012, 14, 6322-6325. 
55 Melendez, R. E.; Lubell, W. D. J. Am. Chem. Soc. 2004, 126, 6759-6754. 
56 Cali, P.; Begtrup, M. Synthesis 2002, 1, 63-66. 
57 Sangamesh, B. et al. U.S. Patent WO 2011/009943 A1, January 27, 2011. 
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monohydrate resulted in tert-butyl carbazate 84 in 73% isolated yield after vacuum distillation. 
Treatment of this carbazate with sodium nitrite under acidic conditions will result in the 
corresponding azide in situ which, upon treatment with triphenylphosphine, can be converted to 
iminophosphorane 85 via a Staudinger reduction (74% yield). With iminophosphorane 85 in hand, 
the stage was now set for an aza-Wittig reaction that would lead to the intended ketimine. When 
heating iminophosphorane 85 and commercially available 2,2,2-trifluoroacetophenone 86 in the 
presence of toluene over the course of 24 hours, ketimine 82 was furnished in modest yield upon 
chromatographic separation (61% yield) (Scheme 49). 
 After successfully synthesizing ketimine 82, efforts were then shifted toward examining 
the reactivity of this electrophile. When treating ketimine 82 with a stoichiometric amount of 
1,1,3,3-tetramethylguanidine (TMG) in neat nitromethane, we were delighted to see that this aza-
Henry addition proceeded cleanly as the desired adduct (87) was afforded in 98% yield over the 
course of 13 hours (Scheme 50). Additionally, observation of only a single adduct indicated that 
the Boc protecting group was not prone to β-elimination under basic conditions, a phenomenon 
that was observed with the tosyl protecting group. With a cleaner aza-Henry reaction system and 
Figure 19. Structure of Boc-Protected Trifluoromethyl Ketimine 82 
 
Scheme 49. Synthesis of  Boc-ProtectedTrifluoromethyl Ketimine 82 
 
Scheme 50. Examination of Reactivity with Ketimine 82 
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a more stable adduct, studies were now centered upon optimizing an asymmetric version of this 
addition with our bis(amidine) organocatalysts. 
4.2 PBAM-Catalyzed Additions of Nitromethane into Trifluoromethyl Ketimine 
Centers 
 Acquisition of a manageable isolated yield was the first objective to be achieved when 
running this aza-Henry addition in an asymmetric fashion. This was done primarily by prolonging 
the reaction time and increasing the equivalents of nucleophile. When subjecting ketimine 82 to 2 
equivalents of nitromethane and 50 mol% of PBAM (19) in toluene (0.1 M) at ambient 
temperature, minimal conversion to adduct 87 was seen after a 5 day reaction period (Scheme 51). 
Yet when the amount of nitromethane nucleophile was increased from 2 equivalents to 20 
equivalents, the desired product was acquired in 26% isolated yield and -7% ee according to HPLC 
analysis. Although it is evident that more equivalents of nucleophile leads to product, no promising 
degree of enantioselection was observed with this new Boc-protected trifluoromethyl ketimine 
electrophile. 
 The next variable that was examined for this reaction system was the influence of added 
Brønsted acid. Previous studies have shown that the introduction of an acid salt to PBAM results 
in similar or increased levels of selectivity for a number of aza-Henry addition systems. When the 
triflic acid salt of PBAM (19•HOTf) was used as the catalyst for this system, adduct 87 was 
obtained in 31% yield and 45% ee, a considerably higher degree of enantioselectivity relative to 
PBAM free base (19) (Scheme 52). Upon submission of the triflimidic acid salt (PBAM•HNTf2), 
the desired adduct was furnished in 38% yield and 51% ee, the highest enantioselection achieved 
to this point. These results show that the introduction of an acid not only reverses the direction of 
selectivity, it also results in a much higher level of enantioselection as well.  
 Additionally, one of the most optimal asymmetric amidine-amide catalysts, 
3,5(CF3)2BenzAM (78a), was tested in this aza-Henry system. For this particular case however, the 
catalyst did not fare as well as the traditional bis(amidine) catalysts as adduct 87 was acquired in 
Scheme 51. Acquisition of Adduct 87 in Isolatable Yield 
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33% yield and -25% ee (Scheme 52). Needless to say, PBAM•HNTf2 was the catalyst chosen to 
be carried onto further studies. 
 The effects of concentration and catalyst loading were the next two variables that were 
examined. Up to this point, acquisition of adduct 87 in 38% yield and 51% ee was the optimal 
result. This was achieved with a 50 mol% catalyst loading of PBAM•HNTf2 and a 0.1 M 
concentration of toluene. When the solvent concentration was increased to 0.25 M, adduct 87 was 
furnished in 64% yield and 48% ee (Table 6, entry 2) indicating that increased concentrations lead 
to higher yields, but slightly diminished ee. Conversely, lowering the catalyst loading to 20 mol% 
results in a decrease in yield and a slight enhancement in selectivity as the desired adduct was 
afforded in 56% yield and 49% ee (entry 3). The reaction conditions used in entry 3 were carried 
into further studies. 
 With a 20 mol% catalyst loading of PBAM•HNTf2, a more in-depth solvent concentration 
study was conducted. When increasing the concentration of toluene from 0.25 M to 0.5 M, a 
decrease in both yield and enantioselection was observed (Table 7, entry 2). Further increasing the 
concentration to 1 M resulted in a considerable increase in yield but a continued diminishment in 
ee as adduct 87 was acquired in 71% yield and 42% ee (entry 3). Due to the gradual decrease in 
Scheme 52. Effects of Counterions and Asymmetric Catalysts 
 
Table 6. Effects of Concentration and Catalyst Loading 
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enantioselection upon increasing the concentration, 0.25 M was still considered to be the most 
optimal concentration at this point.  
 A more in-depth nucleophile equivalence study was also conducted. Although it was 
previously determined that going from 2 to 20 equivalents of nitromethane resulted in isolatable 
yields (Scheme 51), there was still the possibility that 20 equivalents of nucleophile may not be 
optimal as such an excess may result in catalyst deactivation by nitroalkane binding (e.g. 
solvation). Therefore, lesser amounts of nucleophile were examined to see if both yield and ee 
could be enhanced. When dropping the amount of nitromethane from 20 equivalents to 10 
equivalents, a slight increase of enantioselection was achieved. In this same run however, a 
considerable drop in yield was also observed (Table 7, entry 5). Dropping the equivalents further 
to 5 equivalents of nitromethane resulted in lower yield and no change in enantioselection as 
adduct 87 was furnished in 29% yield and 51% ee (entry 6). Since the minimal increase in ee 
cannot account for the larger loss in yield, 20 equivalents of nitromethane was still considered to 
be the optimal amount of nucleophile at this point. 
 Other BAM catalysts with more Brønsted basic character were also tested to see if 
reactivity and selectivity could be enhanced. As previously mentioned, 8(MeO)PBAM was 
determined to be the most reactive catalyst for the tosyl ketimine aza-Henry system. When 
8(MeO)PBAM was subjected to the trifluoromethly ketimine aza-Henry addition, no improvement 
was seen as the intended product was obtained in only 42% yield and -7% ee (Scheme 53). Other 
available BAM catalysts of higher Brønsted basicity, such as 6(MeO)PBAM and 6,7(MeO)2PBAM, 
Table 7. In-Depth Concentration and Nitromethane Equivalence Studies 
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performed worse relative to 8(MeO)PBAM as the adduct was acquired in lower yields and minimal 
ee. 
 Studies continued with the examination of additional counterions. After submitting a 
number of sulfonic acid salts of PBAM to the aza-Henry system, none gave superior results relative 
to PBAM•HNTf2 as the most optimal sulfonic acid salt, nonafluorosulfonic acid, afforded adduct 
87 in 27% yield and 43% ee (Scheme 54). The bis(triflyl)methane salt (PBAM•CH2Tf2) appeared 
to be the only salt comparable to PBAM·HNTf2 as this catalyst furnished the desired product in 
44% yield and 50% ee. While the lithium triflimide analog (PBAM•LiNTf2) gave a comparable ee 
value relative to the triflimidic acid salt (45% ee), a significant drop in yield was observed as the 
adduct was obtained in only 19% yield. The bis(triflyl)methane salt, along with PBAM•HNTf2, 
was carried onto further studies due to similarity in catalyst behavior. 
 The next variable that was altered was temperature. Traditionally, lowering the temperature 
results in an increase in enantioselection. This trend held true for this particular reaction system. 
When the reaction temperature was lowered from room temperature to 0 °C, an increase in 
enantioselectivity was observed at the expense of decreased yield (Table 8, entry 2). Lowering the 
Scheme 53. Application of More Brønsted Basic BAM Catalysts 
 
Scheme 54. Examination of Other Counterions 
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temperature to -20 ºC had little effect on reactivity relative to 0 ºC, yet higher enantioselection was 
observed as adduct 87 was afforded in 34% yield and 66% ee (entry 3). Unfortunately, when 
running this reaction at -78 ºC, reactivity was inhibited as minimal conversion was seen over the 
course of 5 days (entry 4). However, when repeating this run at a higher concentration (0.5 M), 
the desired product was obtained in 6% isolated yield and 80% ee (entry 5). Although this was the 
highest degree of selectivity observed for this system, -20 ºC was chosen as this temperature 
provided a more fruitful and manageable yield. Thus, the most optimal reaction conditions up to 
date include a 20 mol% catalyst loading of PBAM•HNTf2, 20 equivalents of nitromethane, a 0.25 
M solvent concentration, and a temperature of -20 ºC. 
 Before this aza-Henry addition was conducted on a larger scale, it had to be reaffirmed that 
PBAM•HNTf2, was the best catalyst under the chosen conditions, As previously shown, 
PBAM•CH2Tf2 showed comparable results at room temperature (Scheme 54). Yet when 
submitting the same catalyst under more chilled conditions, adduct 87 was afforded in only 20% 
yield and 65% ee, which proved to be inferior relative to PBAM•HNTf2 (Scheme 55). Additionally, 
it had to be verified that the cyclohexane backbone of PBAM•HNTf2 was indeed ideal. Upon 
subjecting a catalyst with a stilbene backbone, StilbPBAM•HNTf2 (88•HNTf2), to the aza-Henry 
Table 8. Effects of Temperature 
 
Scheme 55. Confirmation of PBAM·HNTf2 as the Optimal Catalyst 
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system, the intended product was furnished in 15% yield and 16% ee. These results confirm that 
PBAM·HNTf2 is the best catalyst for this particular reaction. 
 A great degree of consistency was exhibited upon scaling up this aza-Henry addition. When 
using 20 mg of substrate, the desired adduct is acquired in 34% yield and 66% ee. The same degree 
of reactivity and selectivity is seen upon a 50 fold increase of electrophile. When submitting 1 
gram of the ketimine, adduct 87 is furnished in 33% yield and 66% ee (Scheme 56). This 
consistency indicates that the aza-Henry adduct can be taken on to its corresponding Nutlin analog 
in gram quantities. 
4.3 Progress Towards the Synthesis of a Trifluoromethyl Ketimine Nutlin Analog 
Now that the asymmetric addition of nitromethane into trifluoromethyl ketimine 82 has 
been developed to a degree, efforts now shifted toward the synthesis of a trifluoromethyl Nutlin 
derivative. The desired analog, imidazoline 89, is modified off of Nutlin-3 (35), a previously 
developed small molecule therapeutic. Target 89 and Nutlin-3 are similar in structure such that 
they both possess an imidazoline ring core with a urea functionality at the 1-position as well as 
aromatic substituents at the 2- and 5-positions. Key differences between the two molecules can 
also be seen. Target 89 possesses a trifluoromethyl quaternary center at the 5-position of the 
imidazoline where as the same position in Nutlin-3 is a methine. Furthermore, Nutlin-3 possesses 
an aromatic substituent at the 4-position, while target 89 consists of a fully saturated methylene 
Scheme 56. Scale-Up of the Aza-Henry Addition 
 
Figure 20. Structural Differences Between (−)-Nutlin-3 and Target 89 
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(Figure 20). Before synthesizing compound 89 in enantioenriched form however, a synthesis was 
to be developed and optimized using racemic material. 
 It was believed that imidazoline 89 could be readily synthesized via the same reaction 
sequence that was developed for the synthesis of Nutin-3.21 After acquisition of racemic aza-Henry 
adduct, nitroalkane 87 was reduced to free amine 90 in near quantitative yield upon treatment with 
CoCl2 and NaBH4 in the presence of MeOH (Scheme 57). Amide coupling of amine 90 with 
carboxylic acid 91 in the presence of EDC and DMAP proceeded smoothly as desired amide 92 
was furnished in 97% isolated yield. Treatment of 92 with trifluoroacetic acid resulted in Boc-
deprotection giving the intended amine (93) in quantitative yield. From here, it was envisioned 
that amine 93 could be treated with CDI resulting in a reactive isocyanate in situ. This isocyanate 
would then be treated with 2-oxopiperazine 94 affording urea 95, which could then be taken onto 
imidazoline 89 via a subsequent chemoselective dehydrative cyclization reaction. Unfortunately, 
formation of urea 95 from tertiary amine 93 proved to be problematic. 
 Amine 93 was treated with a variety of isocyanate sources under a number of reaction 
conditions in order to successfully develop the corresponding isocyanate in situ. Upon treating 
amine 93 with CDI, the isocyanate source used in the (−)-Nutlin-3 synthesis, no evidence of 
isocyanate formation could be detected even when heating to extreme temperatures (Table 9, 
entries 1 and 2). The use of triphosgene as the isocyanate source proved to be fruitless as no desired 
urea was formed at ambient as well as elevated temperatures (entry 3). Phosgene, the most reactive 
source of isocyanate, also yielded no signs of product when used both stoichiometrically and neat 
Scheme 57. Progress Toward the Synthesis of Target 89 
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(entries 4-6). Near-quantitative recoveries of starting material throughout these attempts further 
support the idea that no isocyanate is being formed in situ. 
 The lack of isocyanate formation with these simple electrophiles may be due to poor 
reactivity of amine 93. The reduced reactivity can be a result of steric and electronic factors. When 
looking at sterics, amine 93 is a tertiary amine, which can create a high degree of congestion even 
when attacking an electrophile as simple as phosgene. As for electronics, this amine is within close 
proximity of an electron-withdrawing group. This inductive effect will reduce the basicity of the 
amine as a result. Therefore, measures had to be taken to increase the nucleophilicity of this amine. 
One direct approach would be to use bases stronger than N,N-diisopropylethylamine (DIPEA), 
such as DBU and LHMDS. 
Table 9. Attempts Toward Forming Urea 95 Using Various Isocyanate Sources 
 
Scheme 58. Attempts Toward Forming Urea 95 via Isocyanate 96 with DIPEA and DBU 
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 As previously shown, DIPEA was not sufficiently basic to promote the nucleophilicity 
needed to form the isocyanate in situ as starting material was consistently recovered in near-
quantitative yields (Table 9). DBU, a stronger base, was also insufficient to initiate the reaction as 
no change by TLC analysis was detected over an extensive reaction period. In addition, starting 
amine was obtained in 95% recovery (Scheme 58). Yet when LHMDS was used as the base, a 
cyclic by-product was observed. Upon chromatographic separation, this heterocyclic by-product, 
identified either as cyclic urea 97a or cyclic carbamate 97b, was acquired in 22% isolated yield 
(Scheme 59). Although one-dimensional (1H and 13C) and two-dimensional (HSQC and HMBC) 
NMR techniques do not indicate a distinguishable difference between urea 97a and carbamate 97b, 
it is believed that the isolated by-product is the cyclic urea simply based on the increased 
favorability of a 5-membered ring system versus a 7-membered ring system. Furthermore, the 
chemical shift values observed in the 13C NMR spectrum correspond more directly with reported 
values of a cyclic urea versus a cyclic carbamate.58 
 Despite what the correct structure of the cyclic by-product may be, acquisition of this 
heterocycle is encouraging in the sense that LHMDS is rendering amine 93 nucleophilic to 
promote reactivity. The proposed pathway toward the heterocyclic by-product begins with 
LHMDS both deprotonating the amide and activating the amine of 93. This activated amine can 
readily react with phosgene generating isocyanate 96 in situ. Subsequent intramolecular attack of 
the amide functionality into isocyanate 96 affords cyclized by-product 97a or 97b as a result 
(Scheme 60). This intramolecular addition will be favored over intermolecular addition of 
piperazine 94, hence why acyclic urea 95 was not observed in this case. At this point, conditions 
have not been found in which a base can promote the formation of isocyanate 96 without 
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Scheme 59. The Use of LHMDS and Isolation of a Cyclic By-Product 
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subsequent intramolecular attack of the amide moiety. With this, efforts now shifted toward 
treating amine 93 with available isocyanate electrophiles. 
 Reacting this amine with accessible isocyanates was seen as a direct way to introduce an 
acyclic urea functionality. The resulting ureas from these isocyanates could then be converted into 
desired urea 95 upon subsequent acylation with a 2-oxopiperazine nucleophile. One readily 
available isocyanate source that was of interest, and may ultimately allow for the synthesis of the 
desired piperazine urea, was phenyl isocyanate 98.  
 Phenyl isocyanate 98 proved to be a highly reactive species as sufficient conversion to urea 
99 was achieved without the use of base. Upon treating amine 93 with a stoichiometric amount of 
Scheme 60. Proposed Mechanism Toward Heterocyclic By-Products 
 
Table 10. Synthesis of Urea 99 and Optimization 
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isocyanate according to literature protocol,59 58% conversion was seen by 1H NMR over the course 
of 48 hours. This led to a 45% isolated yield of urea 99 upon chromatographic separation (Table 
10, entry 1). Increasing the amount of isocyanate to 6 equivalents resulted in 83% conversion under 
the same reaction conditions (entry 2). No isolated yield was reported for this run, however. Using 
isocyanate 98 neat (30 equiv.) proved to be most optimal as full conversion to urea 99 was seen, 
leading to a 91% isolated yield (entry 3). 
 This addition of amine 93 into phenyl isocyanate was repeated once more with the 
incorporation of DBU. Here, it was believed that the presence of base will increase the 
nucleophilicity of the amine, which in turn would facilitate the addition and eliminate the need for 
excess electrophile. Based on this hypothesis, amine 93 was treated with 2 equivalents of 
isocyanate and 4 equivalents of DBU in the presence of benzene. Interestingly, after a 48 hour 
reaction period, the heterocyclic by-product (97a or 97b) was once again observed instead of the 
intended urea (Scheme 61). Seeing this heterocycle by 1H NMR indicates that urea 99 was formed 
in situ followed by intramolecular acylation with the amide functionality. The observed acylation 
also shows that aniline is an efficient leaving group. This finding was beneficial as acylation 
attempts en route to piperazine urea 95 could be conducted using 2-oxopiperazine as the 
nucleophile. 
 Acylation attempts toward desired urea 95 began when phenyl urea 99 and 2-oxopiperazine 
were heated to 65 °C in DCM over the course of 18 hours. This attempt proved to be fruitless as 
starting urea was acquired in 99% recovery (Table 11, entry 1). The lack of conversion prompted 
the use of a strong base in order to enhance the nucleophilicity of piperazine 94. Therefore, the 
next acylation attempt involved treating the piperazine with n-butyllithium before introducing 
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Scheme 61. Formation of a Heterocyclic By-Product via Urea 99 
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phenyl urea 99. After an 18 hour reaction period with DCM as the solvent, no conversion was seen 
by 1H NMR (entry 2). One potential problem that may be causing the lack of conversion is that 
the piperazine motif was not readily dissolving. Taking into account that this solubility issue may 
revolve around the solvent type, the previous reaction was repeated with THF as the solvent. Once 
again, the piperazine failed to dissolve resulting in no conversion to piperazine urea 95 as starting 
material was recovered in 91% yield (entry 3). Seeing that piperazine 94 was not soluble in both 
DCM and THF, it was then hypothesized that the solubility of the piperazine is substrate dependent 
rather than solvent dependent. 
 Taking into consideration that piperazine solubility may be dependent on the substrate, 
phenyl urea 99 was carried onto its corresponding imidazoline. The chemoselective dehydrative 
cyclization proceeded smoothly as treatment of urea 99 with triphenylphosphine oxide and triflic 
anhydride afforded imidazoline 100 in 65% isolated yield over the course of 16 hours (Scheme 
62). One benefit of synthesizing this imidazoline ring core is that there is no competing amide 
Table 11. Failed Acylation Attempts En Route to Piperazine Urea 95 
Scheme 62. Chemoselective Dehydrative Cyclization to Imidazoline 100 
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functionality when it comes to a subsequent acylation attempt with 2-oxopiperazine 94. 
Unfortunately, imidazoline 100 proved to be unstable upon standing as decomposition was 
observed by 1H NMR. Thus, no acylations with this substrate could be attempted. 
 The inability to form desired piperazine urea 95 may be a direct result of insufficient 
electrophilicity of the phenyl urea precursor. A potential solution would be to form a more 
activated urea as this would facilitate the acyl substitution with the oxopiperazine nucleophile. One 
species that would allow for a more electrophilic urea is 4-nitrophenyl isocyanate 101, as this motif 
possesses an electron-withdrawing nitro group. Treatment of free amine 93 with 10 equivalents of 
4-nitrophenyl isocyanate in the presence of benzene afforded the desired nitrophenyl urea (102) in 
55% yield after 3 days (Scheme 63). With this more reactive nitrophenyl urea in hand, the stage 
was now set for subsequent acylation attempts with piperazine 94. 
 The first acylation attempt with this new nitrophenyl urea involved heating urea 102 and 
piperazine 94 to 65 °C in the presence of DCM. No conversion to the desired piperazine urea was 
Scheme 63. Synthesis of Nitrophenyl Urea 102 
 
Table 12. Failed Acylation Attempts with Nitrophenyl Urea 102 
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seen over an 18 hour reaction period as starting material was recovered in near-quantitative yield 
(Table 12, entry 1). Heating these reagents to 120 °C in the presence of toluene also resulted in no 
conversion (entry 2). Another acylation attempt involved heating urea 102 and piperazine 94 to 
175 °C without the presence of solvent. Once again, no sign of the desired piperazine urea (95) 
could be detected after 18 hours (entry 3). 
 These failed acylation attempts with nitrophenyl urea 102 prompted us to convert this 
substrate to its corresponding imidazoline. Once again, the chemoselective dehydrative cyclization 
was successful as imidazoline 103 was furnished in 17% isolated yield after 18 hours (Scheme 
64). Unfortunately, as seen with imidazoline 100, this Nutlin derivative was also prone to 
decomposition upon standing. Again, no acylation attempts with imidazoline 103 could be 
attempted. 
4.4 Future Work 
 As previously discussed, intramolecular acylation attempts with a 2-oxopiperazine 
nucleophile proved to be unsuccessful even with a highly electrophilic 4-nitrophenyl urea moiety. 
Therefore, other measures had to be taken in order to promote the desired acylation en route to 
piperazine urea 95. One approach would be to further activate urea 102 via nitrosation. Nitrosations 
prove to be an effective method of amide activation as they can provide an electrophilic amide for 
hydrolysis (saponification). Evans demonstrated this in his total synthesis of vancomycin where 
nitrosation of a methyl amide led to a mild, late stage saponification.60 Herein, we are hoping to 
                                                          
60 Evans, D. A.; Wood, M. R.; Trotter, B. W.; Richardson, T. I.; Barrow, J. C.; Katz, J. L. Angew. Chem. Int. Ed. 
1998, 37, 2700-2704. 
Scheme 64. Chemoselective Dehydrative Cyclization to Imidazoline 103 
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activate the nitroaniline portion of urea 102 so that intramolecular acylation with piperazine 94 
can be achieved with this highly reactive electrophile (Scheme 65). 
 If acylation attempts via this nitrosation method are indeed successful, the resulting urea 
95 can be carried onto its corresponding Nutlin derivative (89) via a chemoselective dehydrative 
cyclization. Once the desired Nultin analog has been successfully synthesized with the racemate, 
the same synthetic route can be repeated with the enantioenriched material. This will lead us to 
our ultimate goal, which is to synthesize 89 as a single enantiomer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 65. Proposed Nitrosation Route Towards the Desired Piperazine Urea 
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Chapter 5. Oxidative Inter-/Intermolecular Alkene Diamination of Hydroxy 
Styrenes with Electron-Rich Amines via Hypervalent Iodine61 
5.1. Background 
 1,2-Diamines are ubiquitous among natural products, pharmaceutical agents, chiral ligands 
and bases, and other organic reagents. The biological activity associated with many of these 
systems and their synthetic utility has ensured that the development of new methods for the 
preparation of vicinal diamines is of high importance.62 To date, many synthetic strategies for the 
preparation of 1,2-diamine scaffolds have been established, facilitating access to naturally 
occurring vicinal diamines and those within pharmaceuticals. 
 In the natural world, vicinal diamines are commonly found in the form of non-
proteinogenic α,β-diamino carboxylic acids.62 The simplest members of this group include 2,3-
diaminopropionic acid (105) and 2,3-diaminobutanoic acid (106), which can be found as 
                                                          
61 Danneman, M. W.; Hong, K.; Johnston, J. N. Org. Lett. 2015, 17, 2558-2561. 
62 De Jong, S.; Nosal, D. G.; Wardrop, D. J. Tetrahedron 2012, 68, 4067-4105.  
Figure 21. Naturally Occurring, Non-Proteinogenic vic-Diamino Acids and Their Derivatives 
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components of non-ribosomal peptide antibiotics such as bleomycin (107) (Figure 21).63 L-
Capreomycidine (108), a key structural subunit of the tuberculostatic agent capreomycin 1B (109), 
has also been identified as a component of non-ribosomal peptides.64 Additionally, certain α,β-
diamino acids are of considerable interest due to their biological role as excitatory amino acids 
(EAA). L-Quisqualic acid (110), isolated from the traditional Chinese medicine Shih-chun-tze, is 
a highly potent agonist of EAA receptors in both mammals and insects.62 (−)-Dysibetaine (111), 
isolated from the marine sponge Dysidea herbacea, is also a neuroexcitotoxin, which may bind to 
the glutamate receptors present in the central nervous system of mice.65 Other α,β-diamino acids 
include streptothricin F (112), an antibiotic,66 and nucleotide sugar UDP-2,3-diacetamido-2,3-
dideoxy-D-mannuronic acid (UDP-2,3-DDMA) (113), a key building block in the biosynthesis of 
the lipopolysaccharide of Pseudomonas aeruginosa, an opportunistic pathogen.67  
 Numerous alkaloid natural products are known to possess 1,2-diamine scaffolds that are 
associated with significant biological activity. Loline (114), a pyrrolizidine alkaloid, is known for 
its insecticidal activity,68 while the pentacyclic citrinadin A (115) exhibits cytotoxicity against 
murine leukemia L1210 and human epidermoid carcinoma KB cell lines (Figure 22).69 The vicinal 
diamine moiety is also present in tetrahydroisoquinoline-derived alkaloids, such as lemonomycin 
(116), an antitumor antibiotic.70 Pactamycin (117), a terrestrial alkaloid isolated from a 
fermentation broth of Streptomyces pactum, exhibits activity against Gram-positive and Gram-
negative bacteria.71 In addition to terrestrial sources, marine organisms have proven to be a rich 
source of biologically active 1,2-diamines as well. These marine alkaloids include the 
antineoplastic agent agelastatin A (118),72 anti-tuberculosis agent manadomanzamine A (119),73 
                                                          
63 Galm, U.; Hager, M. H.; Van Lanen, S. G.; Ju, J.; Thorson, J. S.; Shen, B. Chem. Rev. 2005, 105, 739-758. 
64 DeMong, D. E.; Williams, R. M. J. Am. Chem. Soc. 2003, 125, 8561-8565. 
65 Sakai, R.; Oiwa, C.; Takaishi, K.; Kamiya, H.; Tagawa, M. Tetrahedron Lett. 1999, 40, 6941-6944. 
66 Jackson, M. D.; Gould, S. J.; Zabriskie, M. T. J. Org. Chem. 2002, 67, 2934-2941. 
67 (a) Wenzel, C. Q.; Daniels, C.; Keates, R. A. B.; Brewer, D.; Lam, J. S. Mol. Microbiol. 2005, 57, 1288-1303; (b) 
Larkin, A.; Imperiali, B. Biochemistry 2009, 48, 5446-5455. 
68 Schardl, C. L.; Grossman, R. B.; Nagabhyru, P.’ Faulkner, J. R.; Mallik, U. P. Phytochemistry 2007, 68, 980-996. 
69 (a) Tsuda, M.; Kasai, Y.; Komatsu, K.; Sone, T.; Tanaka, M.; Mikami, Y.; Kobayashi, J. Org. Lett. 2004, 6, 3087-
3089; (b) Mugishima, T.; Tsuda, M.; Kasai, Y.; Ishiyama, H.; Fukushi, E.; Kawabata, J.; Watanabe, M.; Akao, K.; 
Kobayashi, J. J. Org. Chem. 2005, 70, 9430-9435. 
70 Ashley, E. R.; Cruz, E. G.; Stoltz, B. M. J. Am. Chem. Soc. 2003, 125, 15000-15001.  
71 Hanessian, S.; Vakiti, R. R.; Dorich, S.; Banerjee, S.; Lecomte, F.; DelValle, J. R.; Zhang, J.; Deschenes-Simard, 
B. Angew. Chem. Int. Ed. 2011, 50, 3497-3500. 
72 Hama, N.; Matsuda, T.; Sato, T.; Chida, N. Org. Lett. 2009, 11, 2687-2690.  
73 Allin, S. M.; Duffy, L. J.; Towler, J. M. R.; Page, P. C. B. Elsegood, M. R. J.; Saha, B. Tetrahedron 2009, 65, 
10230-10234.  
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and eudistomin C (120), a member of the eudistomin family that displays activity against both 
RNA and DNA viruses.74 
 Vicinal diamines are also found in a wide array of pharmaceutical agents. For example, 
fluoroquinoline antibacterial agent moxifloxacin (121)75 and anticancer agent 12276 both possess 
a 1,2-diamine functionality within conformationally restricted bicyclononane ring systems (Figure 
23). Target compound Sch 425078 (123), an anti-emetic agent and NK1-antagonist, contains a 1,2-
diamine framework in the form of a cyclic urea.77 α-Galactosylceramide analog HS161 (124) is a 
potent stimulator of invariant natural killer T cells,78 while sphingoid analog SG14 (125) is a 
specific inhibitor of human sphingosine kinase, an emerging target for cancer therapeutics.79 
Furthermore, stilbene diamine derivative 126 has been shown to be a potent inhibitor of hepatitis 
C virus RNA replication,80 whereas cis-imidazoline Nutlin-3 (35) exhibits anticancer activity via 
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Figure 22. Examples of Naturally Occurring Alkaloids That Possess the 1,2-Diamine Framework 
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MDM2-p53 protein-protein inhibition.81,82 Other small molecule therapeutics bearing vicinal 
diamines include ethambutol analog SQ109 (127), which shows potent activity against multi-drug 
resistant tuberculosis,83 as well as viral neuraminidase inhibitors oseltamivir (128)84 and zanamivir 
(129),85 which are used for the treatment of influenza A and B.  
5.2. Known Methods of Alkene Diamination 
 As previously mentioned, there are many known strategies for the preparation of 1,2-
diamine scaffolds. The most direct and efficient means of accessing these systems is through the 
diamination of alkenes. Alkene diamination is an area that has been explored extensively, and as 
a result, can be achieved via a variety of methods. 
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Figure 23. Pharmaceutically Active, Synthetic 1,2-Diamines 
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 One method of diamination involves the treatment of alkenes with binary nitrogen oxides. 
Jacobsen demonstrated the efficiency of these nitrogen oxides by using dinitrogen tetroxide (N2O4) 
to ultimately arrive at C2-symmetric trans-1,2-diamine 130 (Scheme 66).
86 Here, the reaction of 
N2O4 with dimethylcyclohexene 131 under chilled conditions affords dinitro species 132 as the 
trans-diastereomer. Subsequent palladium-mediated hydrogenation of 132 yielded desired 
diamine 130, which was resolved by way of its mandelate salt. 
 Wilkinson and colleagues have successfully conducted the nitronitrosylation of alkenes 
under medium pressure (Scheme 67).87 This reaction was readily achieved by the 
disproportionation of nitric oxide (NO) to nitrous oxide (N2O) and nitrogen dioxide (NO2). 
Mechanistically, it is envisioned that this transformation proceeds through a radical pathway in 
which NO2 adds to alkene 133, generating a β-nitro radical (134). This radical can then trap NO at 
100 psi to arrive at nitronitrosylation product 135. To complement these findings, dinitrogen 
trioxide (N2O3) can be effectively employed for nitronitrosylation of alkenes as well (Scheme 67). 
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Scheme 66. Jacobsen’s Synthesis of Diamine 130 via Dinitrogen Tetroxide 
 
Scheme 67. Nitronitrosylations of Alkenes with Nitric Oxide and Dinitrogen Trioxide 
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This particular transformation is well documented and is compatible with a range of cyclic alkenes 
and dienes including dicyclopentadiene,88 cyclooctadiene,89 and indenes.90 
 Alkene nitronitrosylation has also been achieved via the in situ generation of nitrogen 
oxides. Demir and Findik have reported a convenient method in which silver nitrite (AgNO2) and 
trimethylsilyl chloride (TMSCl) can be used for the generation of N2O3.
91 Treatment of alkenes, 
such as cyclohexene (133), with this AgNO2-TMSCl combination in acetonitrile ultimately affords 
the desired β-nitroso-nitrite compounds and their corresponding dimers (Scheme 68). 
 Adekenov and co-workers made a serendipitous discovery in which alkene dinitration can 
be promoted via the combination of nitrosyl chloride and N2O4. Although it is well known that the 
treatment of alkenes with nitrosyl chloride almost exclusively leads to β-nitroso chlorides, 
bisnitration is favored when N2O4 is present, even as a minor impurity. Adekenov demonstrated 
this phenomenon through the dinitration of terpenes. Upon exposure of achillin (137) to this 
nitrosyl chloride-nitrogen oxide system, the corresponding 1,2-dinitro compound (138) was 
afforded in 37% isolated yield. Higher rates and yields (80%) were observed with increasing 
amounts of N2O4 (Scheme 69).
92 
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Scheme 68. Alkene Nitronitrosylation via In Situ Generation of N2O3 with AgNO2/TMSCl 
 
Scheme 69. Dinitration of Unsaturated Terpene Achillin (137) with Nitrosyl Chloride and Dinitrogen Tetroxide 
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 Another synthesis of vicinal diamines from alkenes utilizes photochemistry, as reported by 
Chow.93,94,95,96 Photolysis of cyclohexene (133), in the presence of a stoichiometric amount of N-
nitrosodimethylamine, can generate trans-addition product 139 in high yield (Scheme 70). 
Subsequent treatment of 139 with hyponitrous acid (HNO) furnishes nitrosohydroxylamine 140, 
which can then be reduced and acylated to arrive at diamine 141. 
 Nitroamidation is also an efficient means for alkene diamination. Scheinbaum illustrates 
this concept by reacting alkenes with nitronium tetrafluoroborate (NO2BF4) in acetonitrile in order 
to synthesize α-nitro amides.97 For example, when propene (142) is treated with NO2BF4, 
carbocation 143 is formed. Acetonitrile traps this intermediate, generating nitrilium ion 144, which 
undergoes hydrolysis to give the desired nitroamidation product (145), albeit in moderate yield 
(Scheme 71).98 Mellor and colleagues expanded on this nitroamidation method by transforming a 
wider range of substrates, particularly styrenes, to their corresponding nitroamides with higher 
yields through the use of CH2Cl2 as a co-solvent. Styrene (146) itself was readily converted to 
nitroamide 147 in 84% isolated yield.99 
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Scheme 70. Photoaddition of N-Nitrosodimethylamine with Cyclohexene (133) en Route to Masked Diamine 141 
 
Scheme 71. Nitroamidation of Alkenes with Nitrogen Tetrafluoroborate and Acetonitrile 
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 Other reagent combinations are known to promote nitroamidation of alkenes. Vankar and 
co-workers have developed a nitroamidation method that involves the treatment of alkenes with 
ceric ammonium nitrate (CAN) and sodium nitrite (NaNO2) in acetonitrile.
100 Oxidation of nitrite 
under these conditions generates nitrogen dioxide, which adds to cyclohexene (133), forming β-
nitroalkyl radical 134. One-electron oxidation with CAN gives carbocation 148, which 
subsequently undergoes a Ritter reaction to give nitroamide 149. Vankar has also employed an 
acetyl chloride, silver nitrate (AgNO3), and acetonitrile reagent combination for the nitroamidation 
of glycols and other alkenes (Scheme 72). Good yield and d.r. is demonstrated though the 
conversion of benzylated glycal 150 to nitroamide 151 under these reaction conditions.101 
 Iron-mediated redox chemistry has proven effective for the synthesis of 1,2-diamines, most 
notably through the bis-azidation of alkenes. Minisci and colleagues illustrated this phenomenon 
via a ferrous sulfate-mediated alkene diazidation with hydrogen peroxide (H2O2) as the oxidant 
and sodium azide (NaN3) as the azide source (Scheme 73).
102 In a closely related approach, Minisci 
also reported the use of both ferrous sulfate (FeSO4) and ferric sulfate (Fe2(SO4)3) to promote the 
bis-azidation of more complex olefins.103 Steroidal compound 152, for example, was readily 
converted to its corresponding diazide (153) upon exposure to this Fe(II)/Fe(III) system. The 
efficacy of this system was improved when Galli and co-workers showed that the incorporation of 
ammonium peroxydisulfate ((NH4)2S2O8) resulted in increased reactivity.
104 When subjected to 
the ferric/ferrous sulfate system in the presence of ammonium peroxydisulfate, styrene (146) was 
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Scheme 72. Vankar’s Alkene Nitroamidation Methods 
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transformed to diazide 154 in 89% yield. This is a vast improvement compared to Minisci’s 
conditions, which affords 154 in only 40% yield.  
 Alkene diazidation can be achieved through manganese-mediated redox reactions as well. 
Fristad found that treatment of alkenes with Mn(OAc)3 and sodium azide in acetic acid at elevated 
temperatures results in the formation of 1,2-diazides (Scheme 74).105 Snider subsequently reported 
a modification of Fristad’s protocol in which replacement of acetic acid with trifluoroacetic acid 
and acetonitrile ultimately affords the desired diazides in improved yield.106 This revised protocol 
was further extended to dihydropyran systems as their corresponding diazido compounds were 
furnished in good yields. 
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Scheme 73. Ferrous Sulfate- and Ferric/Ferrous Sulfate-Mediated Diazidations of Alkenes 
Scheme 74. Mn(III)-Mediated Diazidations of Alkenes 
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 Heavy metal-based protocols have also been applied towards the bis-azidation of olefins. 
Lead(IV) acetate azide ([Pb(OAc)4-n(N3)n]), which is generated by the reaction of lead(IV) acetate 
and trimethysilyl azide (TMSN3), has proven to be an effective azide transfer reagent. Zbiral 
demonstrates this by reacting lead(IV) acetate azide with alkenes in acetonitrile at 20 °C to arrive 
at vicinal diazides (Scheme 75).107 More specifically, [Pb(OAc)4-n(N3)n] readily converts styrene 
(146) to diazide 154 in 70% isolated yield. While Zbiral has shown the usefulness of lead(IV) 
acetate azide with acyclic olefins, Draper reported that this same reagent can be used for the 
transformation of cyclic alkenes to 1,2-diazides as well.108 For example, when steroidal dienone 
159 is treated with lead(IV) acetate azide, diazido compound 160 can be afforded in 61% yield. 
 Closely related to lead(IV) acetate azide, thallium(III) acetate azide ([Tl(OAc)3-n(N3)n]) can 
also be employed for alkene bis-azidation. Like its lead analog, thallium(III) acetate azide is 
prepared by reacting thallium(III) acetate with TMSN3. Application of this particular azide transfer 
reagent by Zbiral was fruitful as both cyclic and acyclic alkenes could be converted to their desired 
vicinal diazides (Scheme 76).109 Cyclohexene (133) and 4-allylanisole (161) were transformed into 
their corresponding aziridinylazothallium compounds (162 and 163), upon exposure to 
thallium(III) acetate azide. Subsequent thermolysis of 162 and 163 resulted in the formation of 
diazido compounds 164 and 165 in 38% and 30% yields respectively. 
 Aside from alkene diazidation, heavy metal protocols have been used for the direct 
diamination of alkenes as well. Barluenga has reported an efficient method for olefin diamination 
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Scheme 75. Reaction of [Pb(OAc)4-n(N3)n] with Acyclic and Cyclic Olefins 
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using thallium(III) acetate (Scheme 77).110 This is exemplified through the transformation of 
cyclohexene (133) to diamine (166). Cyclohexene, when subjected to aniline and Tl(OAc)3, is 
thought to proceed through aminothallation en route to organothallium intermediate 167. 
Substitution of the thallium entity via an SN1 pathway with another equivalent of aniline yields the 
desired diamine (166) in high yield. 
 In addition to thallium, mercury(II)-mediated protocols can be used for the synthesis of 
vicinal diamines. Barluenga has demonstrated that mercury(II) reagents, most notably mercury(II)  
tetrafluoroborate (HgO•2HBF4), can undergo alkene aminomercuration to form β-amino 
alkylmercury(II) salts (Scheme 78).111 Substitution of the mercury moiety with nucleophilic amine 
generates the desired diamine. Like thallium-mediated diaminations, primary and secondary 
amines are tolerated with mercury(II). 
 Transition metal catalysis can be classified as the most extensively explored and dominant 
area of chemistry when it comes to the diamination of olefins. Numerous transition metals have 
been applied towards the synthesis of vicinal diamines including cobalt, ruthenium, osmium, 
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Scheme 76. Zbiral’s Reaction of [Tl(OAc)3-n(N3)n] with Cyclohexene and 4-Allylanisole 
Scheme 77. Barluenga’s Addition of Aromatic Amines to Alkenes in the Presence of Thallium(III) Acetate 
Scheme 78. Barluenga’s Addition of Aromatic Amines to Alkenes in the Presence of Mercury(II) Tetrafluoroborate 
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palladium, nickel, copper, and gold. With these possibilities, transition metal catalysis can achieve 
alkene diamination to a high degree of generality.  
 The use of metal nitrosyl complexes are amongst the earliest applications of transition 
metals en route to diamination. Brunner and Loskot report a ligand-based reaction of cobalt 
nitrosyl complex 169 with bicyclo[2.2.1]hep-2-enes.112 This nitrosyl complex, which is generated 
from the reaction of cyclopentadienylcobalt dicarbonyl (170) and nitric oxide, can undergo 
addition to strained alkenes to form cobalt dinitrosoalkane complexes. Good reactivity is 
demonstrated as nitrosyl complex 169 readily converts norbornene (171) to dinitrosoalkane 
complex 172 in 90% isolated yield (Scheme 79). This process is diastereoselective as only the exo 
compounds are formed. Bergman improved on Brunner’s and Loskot’s findings by using cobalt 
dinitrosoalkane complexes as intermediates in order to access free 1,2-diamines.113 In this study, 
in situ reduction of dinitrosoalkane ligands with LiAlH4 affords the corresponding unmasked 
diamines in good yield and with high levels of diastereoselection. 
 In 2011, Bergman and Toste reported ruthenium-mediated alkene bis-nitrosylations as 
well.114 Here, treatment of (cymene)ruthenium dichloride dimer (174) with nitric oxide in THF 
generates dinitrosyl complex 175 (Scheme 80). This complex can readily react with strained 
alkenes in the presence of chelating ligands to arrive at six-coordinate, ruthenium-based 
dinitrosoalkane complexes. 
                                                          
112 (a) Brunner, H.; Loskot, S. Angew. Chem., Int. Ed. Engl. 1971, 10, 515-516; (b) Brunner, H.; Loskot, S. J. 
Organome. Chem. 1973, 61, 401-414. 
113 (a) Becker, P. N.; White, M. A.; Bergman, R. G. J. Am. Chem. Soc. 1980, 102, 5676-5677; (b) Becker, P. N.; 
Bergman, R. G. Organometallics 1983, 2, 787-796. 
114 Crimmin, M. R.; Bergman, R. G.; Toste, F. D. Angew. Chem. Int. Ed. 2011, 50, 4484-4487.  
Scheme 79. Diaminations of Alkenes Using Cyclopentadienylnitrosylcobalt Dimer 169 
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 Imidoosmium(VIII) reagents have also proven effective in the field of alkene diamination. 
Sharpless and colleagues were the first to report the use of tris(tert-butylimido)osmium (177) to 
promote diaminations of terminal and trans-disubstituted alkenes.115 To illustrate, styrene (146) 
and dimethyl fumarate (178) were transformed to their osmium-derived diimido complexes (179 
and 180) upon exposure to imidoosmium 177 (Scheme 81). These complexes can be reduced to 
their corresponding 1,2-di-tert-butylamines (181 and 182) when treated with LiAlH4. 
Additionally, Schrock and co-workers employed a more sterically encumbered aryl 
trisimidoosmium complex (183) for the synthesis of masked vicinal diamines.116 This complex 
proved fruitful as simple alkenes such as ethylene (184) and norbornene (171) were converted to 
metallaimidazolidines 185 and 186 in 78% and 46% yields. 
                                                          
115 Chong, A. O.; Oshima, K.; Sharpless, K. B. J. Am. Chem. Soc. 1977, 99, 3420-3426. 
116 (a) Schofield, M. H.; Kee, T. P.; Anhaus, J. T.; Schrock, R. R.; Johnson, K. H.; Davis, W. M. Inorg. Chem. 1991, 
30, 3595-3604; (b) Anhaus, J. T.; Kee, T. P., Schofield, M. H. Schrock, R. R. J. Am. Chem. Soc. 1990, 112, 1642-
1643. 
Scheme 80. Reaction of Alkenes with Dinitrosyl Complex 175 
Scheme 81. Stoichiometric Diamination of Alkenes with Imidoosmium(VIII) Complexes 
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 Muñiz and colleagues expanded on the studies of Sharpless and Schrock by deploying 
strategies that effectively control the absolute facial selectivity of imidoosmium(VIII)-mediated 
diaminations. One approach in particular involves the use of chiral auxiliaries in order to achieve 
alkene diamination in a diastereoselective fashion.117 This is exemplified as reactions of electron-
deficient (−)-8-phenylmenthyl acrylate derivatives (187) with imidoosmium 188 proceed through 
the Re-face, furnishing masked diamines (189) with high levels of diastereoselection (Scheme 82). 
An enantioselective catalytic variant has also been developed, which employs a Ti-TADDOLate 
catalyst and imidoosmium 188 as the stoichiometric nitrogen source.118 Under these conditions, 
electron-deficient crotonyl oxazolidinones (190) are readily converted to their osmium-derived 
1,2-diamines (191) with good to excellent levels of enantioselection. 
 Palladium is one of the more broadly effective transition metals when it comes to the 
diamination of olefins. The first palladium-assisted alkene diamination was reported in 1978 by 
Bäckvall.119 Here, stoichiometric quantities of trans-bis(benzonitrile)dichloropalladium(II) are 
used to promote the synthesis of vicinal diamines from simple 1,2-disubstituted alkenes. Hex-3-
ene (192), for example, undergoes trans-aminopalladation to amino alkylpalladium(II) species 193 
upon exposure to the stoichiometric palladium and dimethylamine (Scheme 83). Oxidation of 193 
with MCPBA gives a palladium(IV) species, which is reductively displaced by another equivalent 
of dimethylamine, ultimately affording diamine 194 in 45% yield with high syn-selectivity. 
                                                          
117 Muñiz, K. New. J. Chem. 2005, 29, 1371-1385. 
118 (a) Muñiz, K.; Nieger, M. Chem. Commun. 2005, 2729-2731; (b) Almodovar, I.; Hövelmann, C. H.; Streuff, J.; 
Nieger, M.; Muñiz, K. Eur. J. Org. Chem. 2006, 704-712. 
119 (a) Bäckvall, J.-E. Tetrahedron Lett. 1978, 19, 163-166; (b) Bäckvall, J.-E. Acc. Chem. Res. 1983, 16, 335-342. 
Scheme 82. Diastereo- and Enantioselective Diaminations with Imidoosmium 188 
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 Although Bäckvall’s stoichiometric diamination showed great promise for the 
advancement of palladium-mediated protocols, catalytic versions of this process were not 
discovered until 2005 when Booker-Milburn and co-workers reported the first palladium(II)-
catalyzed intermolecular diamination of alkenes.120 They found that treatment of 1,3-dienes, such 
as isoprene, with N,N’-diethylurea (195) in the presence of catalytic bis(acetonitrile)palladium 
dichloride and benzoquinone led to the formation of cyclic ureas 196 and 197 in 81% yield with a 
77:23 regioisomer ratio (Scheme 84). Furthermore, Muñiz and colleagues demonstrated the first 
palladium(II)-catalyzed intramolecular alkene diamination with alkenyl-substituted ureas (198).121 
When subjected to catalytic palladium(II) acetate and stoichiometric quantities of hypervalent 
iodine oxidant (PhI(OAc)2) under basic conditions, these terminal alkenes were transformed to 
their desired cyclic ureas (199) with five-, six-, and seven-membered fused rings in excellent yield. 
 In addition to terminal alkenes, Muñiz has shown that palladium(II)-catalyzed 
intramolecular diaminations can also be achieved with internal alkenes.122 Upon exposure to the 
palladium(II)acetate-phenyl iodine diacetate (Pd(OAc)2-PhI(OAc)2) combination in the presence 
of base, homoallylic sulfonamide 200 readily undergoes double annulation to afford bis(indoline) 
                                                          
120 Bar, G. L. J.; Lloyd-Jones, G. C.; Booker-Milburn, K. I. J. Am. Chem. Soc. 2005, 127, 7308-7309. 
121 (a) Streuff, J.; Hövelmann, C. H.; Nieger, M.; Muñiz, K. J. Am. Chem. Soc. 2005, 127, 14586-14587; (b) Muñiz, 
K.: Hövelmann, C. H.; Streuff, J. J. Am. Chem. Soc. 2008, 130, 763-773.  
122 Muñiz, K. J. Am. Chem. Soc. 2007, 129, 14542-14543. 
Scheme 83. Bäckvall’s Stoichiometric Pd-Mediated 1,2-Diamination of Alkenes 
Scheme 84. Pd(II)-Catalyzed Intermolecular and Intramolecular Diaminations of Alkenes 
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201 in 89% isolated yield (Scheme 85). Aliphatic- and naphthyl-derived homoallylic sulfonamides 
are tolerated in this reaction as well. 
 Another notable advancement by Muñiz in the area of palladium-catalyzed alkene 
diamination is the incorporation of copper(II) salts as terminal oxidants. One system in which this 
palladium-copper catalyst-oxidant combination can be effectively employed is through the 
intramolecular cycloguanidation of terminal alkenes (Scheme 86).123 With Pd(OAc)2 as the 
catalyst and CuCl2 as the terminal oxidant, N-alkenyl guanidines (202) can be converted to their 
respective Boc- or Cbz- protected bicyclic guanidines (203) in up to 99% yield. 
 In an extension of their work on the intramolecular diamination of tethered ureas, Muñiz 
and colleagues have developed a doubly intermolecular variant of their methodology. This 
particular method features the regioselective transfer of nitrogen from two distinct sources in 
bis(tosylimide) and saccharin (Scheme 87).124 For example, when using 
bis(benzonitrile)palladium dichloride as the precatalyst and iodosobenzene dipivalate as the 
oxidant, vinyl cyclohexane (204) can undergo addition to afford heterodiamine 205 in 78% 
isolated yield with complete regioselectivity. 
                                                          
123 Hövelmann, C. H.; Streuff, J.; Berlot, L.; Muñiz, K. Chem. Commun. 2008, 2334-2336. 
124 Iglesias, A.; Pérez, E. G.; Muñiz, K. Angew. Chem. Int. Ed. 2010, 49, 8109-8111.  
Scheme 85. Muñiz’s Pd(II)-Catalyzed Intramolecular Diamination of Internal Alkenes en Route to Bis(indolines) 
Scheme 86. Pd(II)-Catalyzed Intramolecular Cycloguanidation of Alkenes with Copper Chloride as the Oxidant 
Scheme 87. Doubly Intermolecular Pd(II)-Catalyzed Diamination of Terminal Alkenes 
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 Complementary to Muñiz’s doubly intermolecular protocol, Michael and co-workers have 
reported the intra/intermolecular diamination of terminal alkenyl amides, carbamates, and ureas 
(Scheme 88).125 Here, N-fluoro-bis(phenylsulfonyl)imide (NFBS) is used as an external 
electrophilic aminating agent. When treated with NFBS, catalytic palladium(II) trifluoroacetate 
and a triethylammonium benzenesulfonamide additive, these terminal alkenes (206) readily 
undergo cyclization en route to their 2-aminomethyl pyrrolidine derivatives (207) in moderate to 
good yield. This methodology by Michael is beneficial not only for its generality and 
functional/protecting group tolerance, but because these diamination products can be differentially 
deprotected under mild conditions as well. 
 Nickel catalysis has also been used as a means for alkene diamination. Muñiz and 
colleagues demonstrate the efficacy of nickel(II) salts in the intramolecular diamination of N-
alkenyl sulfamides, ureas, and guanidines (Scheme 89).126 Upon exposure to catalytic nickel(II) 
and phenyliodine diacetate (PhI(OAc)2) in the presence of base, these terminal alkenes (208) are 
transformed to their corresponding diamines (209) in up to 94% yield and with a high degree of 
generality. 
 Chemler and co-workers have pioneered the use of copper(II) carboxylates for the 
diamination of olefins. In 2005, this group successfully employed copper(II) acetate to promote 
the intramolecular diamination of γ-alkenyl and δ-alkenyl-substituted sulfamides (Scheme 90).127 
To illustrate, alkenyl sulfamide 210 undergoes cyclization to afford its corresponding 5-membered 
                                                          
125 (a) Sibbald, P. A., Michael, F. E. Org. Lett. 2009, 11, 1147-1149; (b) Sibbald, P. A.; Rosewall, C. F., Swartz, R. 
D.; Michael, F. E. J. Am. Chem. Soc. 2009, 131, 15945-15951. 
126 Muñiz, K.; Streuff, J.; Hövelmann, C.; Nuñez, A. Angew. Chem. Int. Ed. 2007, 46, 7125-7127.  
127 Zabawa, T. P.; Kasi, D.; Chemler, S. R. J. Am. Chem. Soc. 2005, 127, 11250-11251. 
Scheme 88. NFBS-Promoted Intra/Intermolecular Diamination of Terminal Alkenes 
Scheme 89. Nickel(II)-Catalyzed Intramolecular Alkene Diamination 
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cyclic sulfamide (211) when subjected to stoichiometric quantities of copper(II) acetate under 
basic conditions. Additionally, δ-alkenyl-substituted sulfamides were smoothly converted to their 
6-membered cyclic sulfamides under identical reaction parameters. 
 Although copper(II) acetate has proven effective for the intramolecular diamination of 
alkenyl sulfamides, this particular species does suffer from a low degree of solubility, resulting in 
methodological limitations. As a result, Chemler has introduced copper(II) neodecanoate 
([Cu(nd)2]) as a second-generation mediator for the diamination of alkenes.
128 When exposing this 
copper(II) carboxylate to γ-alkenyl-substituted sulfamide 212 in the presence of base at elevated 
temperatures, the desired cyclic sulfamide (213) is furnished in 65% isolated yield as a single 
diastereomer (Scheme 91). It is also worthy to note that these revised conditions facilitate the 
generation of a broader ranges of bis(amino) products including ureas, bis(anilines), and α-amido-
pyrroles. 
 In 2010, Chemler and colleagues expanded on their original diamination methodology by 
reporting an intra/intermolecular variation that involves external nucleophiles such as azide, 
sulfonamides, benzamides, and anilines.129 This particular study employs copper(II) 2-
ethylhexanoate ([Cu(eh)2]) to facilitate the diamination of 2-substituted 1-allyl-1-benzyl ureas 
(214) (Scheme 92). Once the urea functionality undergoes intramolecular ring closure on the 
alkene, intermolecular nucleophilic attack by an external amino source generates the second C-N 
bond ultimately affording 4-substituted imidazolinones (215). 
                                                          
128 Zabawa, T. P.;Chemler, S. R. Org. Lett. 2007, 9, 2035-2038. 
129 Sequeira, F. C.; Turnpenny, B. W.; Chemler, S. R. Angew. Chem. Int. Ed. 2010, 49, 6365-6368. 
Scheme 90. Chemler’s Intramolecular Diamination of Alkenyl-Substituted Sulfamides with Copper(II) Acetate 
Scheme 91. Chemler’s Copper(II) Neodecanoate-Promoted Intramolecular Diamination of Terminal Alkenes 
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 Chemler took this intra/intermolecular approach one step further by achieving a variant 
with promising levels of enantioselection.129 Here, chrial bis(oxazoline) ligand 216 is used in 
conjunction with catalytic copper(II) triflate and MnO2 as the terminal oxidant to promote the 
enantioselective intra/intermolecular diamination of mesyl-protected allylaniline 217 (Scheme 
93). With electron-deficient bis(tosylimide) as the external amino source, masked diamine 218 is 
acquired in 64% yield and 71% ee under these reaction conditions. 
 Recently, Wang and Shen reported a copper-catalyzed intra/intermolecular diamination of 
unactivated alkenes with hydroxylamines.130 These hydroxyl amines are novel in this study as they 
serve as a source of electron-rich amines. The efficacy of this system is demonstrated through the 
direct conversion of alkenyl amides to amino-substituted lactams. For example, when unsaturated 
amide 219 is treated with O-benzoyl hydroxylmorpholine (220) in the presence of catalytic 
copper(II) acetate, morpholine-substituted lactam 221 is furnished in 80% yield (Scheme 94). 
Other cyclic and aliphatic secondary amines are tolerated in this reaction system as well. 
 Gold catalysis has also proven to be an effective avenue towards alkene diamination. In 
2009, Muñiz and co-workers reported the use of gold(I) to facilitate the doubly intramolecular 
diamination of alkenyl-derived ureas.131 When subjecting triphenylphosphine gold(I) acetate as 
                                                          
130 Shen, K.; Wang, Q. Chem. Sci. 2015, 6, 4279-4283. 
131 Iglesias, A.; Muñiz, K. Chem. Eur. J. 2009, 15, 10563-10569. 
Scheme 92. Copper(II) 2-Ethylhexanoate-Promoted Intra/Intermolecular Alkene Diamination 
Scheme 93. Enantioselective Copper-Catalyzed Intra/Intermolecular Diamination of Allylaniline 217 
Scheme 94. Example of Copper-Catalyzed Diamination of Unactivated Alkenes with a Hydroxylamine 
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the catalyst and PhI(OAc)2 as the oxidant, N-γ-alkenyl ureas (222) can readily convert to their 
corresponding bicyclic imidazolinones (223) in high yield (Scheme 95). 
 To complement Muñiz’s doubly intramolecular protocol, Nevado and de Haro have 
reported a gold-catalyzed intra/intermolecular diamination of N-γ-alkenyl tosylated amines 
(224).132 When using cationic complex [(Ph3P)AuSbF6] as the catalyst and Selectfluor (225) as an 
oxidant, these alkenyl tosylated amines undergo a 6-endo-trig cyclization that traps a nitrile 
solvent. Subsequent in situ hydrolysis of the nitrile moiety ultimately results in the generation of 
N-piperidin-3-yl carboxamides (226) in moderate to good yield (Scheme 96). 
Shi and co-workers have extensively explored the use of strained diaziridinones and their 
analogs as versatile nitrogen sources for metal-mediated alkene diaminations. In 2007, Shi first 
reported the use of di-tert-butyldiaziridinone (227) as a nitrogen source in the diamination of 
conjugated dienes (228).133 Treatment of these dienes with 227 and a catalytic amount of 
tetrakis(triphenylphosphine)palladium(0) at elevated temperatures results in the formation of 
                                                          
132 De Haro, T.; Nevado, C. Angew. Chem. Int. Ed. 2011, 50, 906-910. 
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Scheme 95. Gold-Catalyzed Intramolecular Diaminaton of N-γ-Alkenyl-Substitued Ureas 
Scheme 96. Gold-Catalyzed Oxidative Intra/Intermolecular Diamination of N-γ-Alkenyl Tosylated Amines 
Scheme 97. Symmetric and Asymmetric Pd-Catalyzed Diaminations of Dienes with Di-tert-Butyldiaziridinone 
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imidazolidinones (229) in high yield and with excellent regioselectivity (Scheme 97). Shortly 
thereafter, the same group reported a highly efficacious enantioselective variant of this 
methodology by employing Pd2(dba)3 as the palladium(0) source and BINOL-based phosphorous 
amidite 232 as the chiral ligand.134 
In addition to dienes, Shi has also found that monosubstituted and 1,1-disubstituted olefins 
undergo palladium(0)-catalyzed dehydrogenative diamination at the allylic and homoallylic 
positions in the presence of excess di-tert-butyldiaziridinone (227).135 Under solvent free 
conditions, slow addition of 227 to these terminal alkenes (233) in the presence of a catalytic 
tetrakis(triphenylphosphine)palladium(0) at 65 °C leads to the formation of cyclic ureas 234 in 
good yield with complete regio- and stereoselectivity (Scheme 98). Furthermore, the catalytic 
asymmetric version of this allylic/homallylic diamination was readily achieved via the 
incorporation of a chiral ligand. When subjecting mono- and disubstituted alkenes (235) to a 
catalytic amount of Pd2(dba)3 with H8-BINOL-derived phosphorus amidite 236 as the chiral 
reagent, the corresponding cyclic ureas (237) are furnished in high yield and up to 95% ee.136 
Another notable discovery made by Shi and colleagues is that the use of copper(I) salts and 
phosphine ligands can effectively determine the regiochemistry of diamination when using 
diaziridinone 227 in the presence of conjugated dienes and trienes. One system shows that a 
combination of copper(I) chloride and triphenyl phosphite (P(OPh)3) readily promotes the 
diamination reaction of 227 with dienes and trienes (238) exclusively at the terminal position 
(Scheme 99).137 Conversely, when starving the reaction system of phosphine ligands, copper(I) 
                                                          
134 Du, H.; Yuan, W.; Zhao, B.; Shi, Y. J. Am. Chem. Soc. 2007, 129, 11688-11689. 
135 Du, H.; Yuan, W., Zhao, B.; Shi, Y. J. Am. Chem. Soc. 2007, 129, 7496-7497. 
136 Du, H.; Zhao, B.; Shi, Y. J. Am. Chem. Soc. 2008, 130, 8590-8591. 
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Scheme 98. Symmetric and Asymmetric Pd-Catalyzed Dehydrogenative Allylic/Homallylic Diaminations 
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salts, particularly copper(I) bromide, direct diene diamination to the internal alkene position.138 
Both respective approaches achieve their corresponding diamination in modest to good yield. 
Shi has also applied this copper(I)-phosphine ligand combination to the synthesis of 1,2-
diamines from aryl-activated 1,1-disubstituted olefins (242).139 When employing catalytic 
quantities of copper(I) chloride and triphenylphosphine in a 1:1 ratio, a wide range of styrene 
derivatives (242) can undergo diamination with di-tert-butyldiaziridinone at elevated temperatures 
resulting in the formation of desired imidazolidinones (243) in high yield (Scheme 100). 
Additionally, naphthyl-derived alkenes are tolerated thereby broadening the substrate scope.  
As for nitrogen sources, Shi has reported that motifs other than di-tert-butyldiaziridinone 
(227) have proven effective for alkene diamination. N,N-di-tert-butylthiadiaziridine 1,1-dioxide 
(244) can undergo addition to a range of activated alkenes to afford cyclic sulfamides.140 For 
example, when styrene (146) is treated with thiadiaziridine dioxide 244 in the presence of a CuCl-
P(n-Bu)3 combination, sulfamide 245 is furnished in 94% isolated yield (Scheme 101). In an 
analogous manner, di-tert-butyldiaziridinimide 246 can be used to promote the diamination of 
various alkenes en route to their corresponding cyclic N-cyano guanidines.141 To illustrate, 4-
                                                          
138 Zhao, B.; Peng, X. G.; Cui, S. L.; Shi, Y. A. J. Am. Chem. Soc. 2010, 132, 11009-11011. 
139 Wen, Y.; Zhao, B.; Shi. Y. Org. Lett. 2009, 11, 2365-2368. 
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Scheme 99. Phosphine-Ligand-Dependent Regioselective Diaminations of Conjugated Dienes and Trienes 
Scheme 100. Copper(I)-Catalyzed Diamination of Disubstituted Terminal Alkenes 
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vinylbiphenyl (247) is readily transformed to cyano guanidine 248 in 86% yield upon exposure to 
a CuCl-P(PPh3)3 system with diaziridinimide 246 as the nitrogen source.  
 Pericyclic reactions provide a pathway to 1,2-diamines from alkenes. Among the 
most notable approaches is that reported by Sharpless and Singer in which they use selenium 
dioxide bis(amide) 249 to accomplish alkene diamination with exclusive cis selectivity.142 
Bis(imide) 249 is generated in situ by the oxidation of selenium powder in the presence of p-
toluenesulfonamide (250) and its sodium salt (251) (Scheme 102). This compound can then 
undergo a [4+2] cycloaddition with cyclic 1,3-diene 252 to yield cycloadduct 253. Subsequent 
ring-opening with p-toluenesulfonamide affords 254, which undergoes a [2,3]-sigmatropic 
rearrangement to give 255. The desired cis-diamine product (256) is furnished upon 
desulfurization of selenium(II) amide 255. 
Numerous halogen-mediated approaches have been employed for the synthesis of vicinal 
diamines from alkenes. One method, in particular, that has proven effective is the use of 
                                                          
142 Sharpless, K. B.; Singer, S. P. J. Org. Chem. 1976, 41, 2504-2506. 
Scheme 101. Copper(I)-Catalyzed Alkene Diaminations with Thiadiaziridine Dioxide 244 and Diaziridimine 246 
Scheme 102. 1,2-Diamination of 1,3-Dienes with Selenium Dioxide Bis(Imide) 249 
92 
 
dihaloarylsulfonamide-acetonitrile combinations. This type of reaction system was first reported 
in 2003 by Li and colleagues in order to promote the imidazolination of α,β-unsaturated carbonyl 
compounds.143 Treatment of α,β-unsaturated ketones and esters, such as methyl cinnamate (257), 
with N,N-dichloro-p-toluenesulfonamide (258), 4 Å molecular sieves, and the complex generated 
from Rh2(pbf)4 and PPh3 in the presence of acetonitrile affords the desired trans-substituted 2-
dichloromethyl-2-imidazolines 259 in moderate to high yield and with excellent diastereoselection 
(Scheme 103). This type of transformation is thought to proceed through a Ritter-type reaction of 
an aziridinium ion intermediate.  
Subsequent studies by Li and co-workers have revealed that the same imidazolination of 
α,β-unsaturated carbonyl compounds can be achieved with a more reactive dihaloarylsulfonamide 
in the absence of a catalyst.144 When enone 260 is treated with N,N-dichloro-2-
nitrobenzenesulfonamide (261), 4 Å molecular sieves and acetonitrile, the corresponding 
dichloromethyl diamine (262) is furnished in 71% isolated yield and with high levels of 
diastereoselectivity (Scheme 104). Li further improved on his findings by developing a protocol 
that avoids the inconvenience of handling unstable N,N-dichlorosulfonamides 258 and 261.145 
Exposure of enone 260 to p-toluenesulfonamide (250) and N-chlorosuccinimide (NCS) at 50 °C 
results in the in situ generation of dichlorosulfonamide 258, ultimately yielding the expected 
imidazoline product 262 in sufficient yield and d.r.  
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Scheme 103. Imidazolination of α,β-Unsaturated Ketone 257 with a TsNCl2/MeCN/Rh2pbf4•PPh3 Reagent 
Combination 
Scheme 104. Improved Methods for the Direct Imidazolination of α,β-Unsaturated Ketones 
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In a related approach, Wang and colleagues reported a system that incorporates NCS, 
NaN3, and NaI as the additive, to promote the inter/intramolecular aminoazidation of γ-alkenyl 
protected amines en route to azidopiperidines.146 To demonstrate, alkenyl protected amine 263, 
when subjected to this NCS, NaN3, and NaI combination at elevated temperatures, readily converts 
to azidopiperidine 264 in 92% yield (Scheme 105). It should be noted that this inter/intramolecular 
aminoazidation displays high favorability towards its 6-endo-trig piperidine product relative to its 
5-exo-trig pyrrolidine regioisomer. 
Other chloroamine-acetonitrile systems have proven sufficient for the diamination of 
olefins. In 2003, Booker-Milburn and co-workers reported a one-pot method for cis- 
imidazolination of alkenes via the use of an N-chlorosaccharin-acetonitrile-KOEt combination 
(Scheme 106).147 Styrene (146), when exposed to acetonitrile, can undergo a Ritter-type reaction 
with the electrophilic chlorinating agent N-chlorosaccharin (265) to arrive at nitrilium ion 266. 
Subsequent capture of 266 with the saccharin anion affords β-chlorosulfonylamidine 267, which 
upon treatment with KOEt undergoes an intramolecular cyclization to give imidazoline 269.  
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147 Booker-Milburn, K. I.; Guly, D. J.; Cox, B.; Procopiou, P. A. Org. Lett. 2003, 5, 3313-3315. 
Scheme 105. Inter/Intramolecular Aminoazidation of γ-Alkenyl Amines with NCS, NaN3, and NaI 
Scheme 106. cis-Imidolizidination of Alkenes with N-Chlorosaccharin, CH3CN, and KOEt 
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Ramesh and Kumar have also shown that chloramine-T in acetonitrile can be used to 
facilitate the diamination of enol ethers.148 To illustrate the efficacy of this one-pot method, 
treatment of tri-o-acetyl-D-glucal (270) with stoichiometric amounts of chloramines-T in the 
presence of catalytic iodine results in the formation of β-D-gluco 1,2-disulfonamide 271 in 69% 
isolated yield (Scheme 107).  
Iodine azide (IN3) is another halogen-based reagent that can be used for the diamination, 
more specifically diazidation, of olefins. Sasaki demonstrates the utility of this substrate through 
the diazidation of medium-sized cyclic alkenes.149 For example, when subjecting tropone 
ethyleneketal (272) to both iodine azide and sodium azide in acetonitrile, iodoazide 273 is 
furnished, although not isolated (Scheme 108). Subsequent displacement of the iodide group with 
excess azide gives unstable diazide 274, which is trapped as its respective 1,3-dipolar cycloadduct 
(275) upon treatment with dimethyl acetylenedicarboxylate (DAC). 
Tamura has also reported that this iodine azide/sodium azide combination can readily 
promote the diazidation of benzofurans (Scheme 109).150 The mechanistic pathway, however, is 
slightly different. Exposure of benzofuran 276 to IN3 yields iodoazide 277. Elimination of the 
iodide moiety results in the formation of oxonium 278. A second equivalent of azide can add into 
the oxonium, affording the desired diazide in 93% yield, but with low levels of diastereoselection. 
                                                          
148 (a) Kumar, V.; Ramesh, N. G. Chem. Commun. 2006, 4952-4954; (b) Kumar, V.; Ramesh, N. G. Org. Biomol. 
Chem. 2007, 5, 3847-3858.  
149 Sasaki, T.; Kanematsu, K.; Yukimoto, Y. J. Org. Chem. 1972, 37, 890-894. 
150 (a) Kwon, S.; Okada, T.; Ikeda, M.; Tamura, Y. Heterocycles 1977, 6, 33-36; (b) Tamura, Y.; Chun, M. W.; 
Kwon, S.; Bayomi, S. M.; Okada, T.; Ikeda, M. Chem. Pharm. Bull. 1978, 26, 3515-3520. 
Scheme 107. Diamination of Glucal 270 Using I2 and Chloroamine-T 
Scheme 108. Diazidation of a Cyclic Polyene with IN3 and NaN3 
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Furthermore, acyl and tosyl indoles can be converted to their corresponding diazides under the 
same reaction conditions and through an analogous mechanistic pathway.151  
To expand on the versatility of iodine azide, this reagent can be used to transform trans-
stilbenes to their corresponding 1,2-diaryl-1,2-diazidoethanes (Scheme 110).152 When trans-
stilbene 280 is treated with IN3 in the presence of excess azide, diazidoethane 281 is furnished in 
65% yield and with high d.r. The fact that the anti-addition product is acquired in such large excess 
relative to its syn-adduct indicates that this transformation may go through a β-azidocarbocation 
intermediate. Trapping of excess azide from the less hindered face would give the anti-product of 
281. 
Additionally, 1,3-diene systems can undergo 1,2-diazidation as reported by Hassner.153 In 
this particular study, the reaction of E,E-diphenylbutadiene (282) with IN3 generates diazide 283 
in 60% isolated yield. Hassner also showed that the treatment of the same diene (282) with BrN3 
in pentane affords bromoazide analog 284 in 80% yield (Scheme 111).  
                                                          
151 Tamura, Y.; Kwon, S.; Tabusa, F.; Ikeda, M. Tetrahedron Lett. 1975, 16, 3291-3294. 
152 (a) Müller, R.; Gust, R.; Schönenberger, H.; Klement, U. Chem. Ber. 1991, 124, 2381-2389; (b) Gust, R.; 
Bernhardt, G.; Spruss, T.; Krauser, R.; Koch, M.; Schönenberger, H.; Bauer, K. H.; Schertl, S.; Lu. Z. Arch. Pharm. 
1995, 328, 645-653. 
153 Hassner, A.; Keogh, J. Tetrahedron Lett. 1975, 16, 1575-1578.  
Scheme 109. Diazidation of Benzofurans and Indoles with IN3 
Scheme 110. Diazidation of trans-Stilbene 280 Using IN3 
Scheme 111. Hassner’s Divergent Reactions of Diene 282 with BrN3 and IN3 
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Another pathway that has proven fruitful for the synthesis of vicinal diamines is the 
intermolecular aminohalogenation of alkenes. Though the competitive oxidation of alkyl and aryl 
amines may be problematic, Lavilla and colleagues have reported a highly efficient method for the 
vicinal diamination of 1,4-dihydropyridines in the presence of iodine (Scheme 112).154 Exposure 
of N-alkyl-1,4-dihydropyridine 285 to I2 and an excess of pyrrolidine leads to the formation of 
trans-2,3-diaminotetrahydropyridine 286 in high yield. Mechanistically, it is believed that the 
iodonium intermediate formed from the reaction of the olefin with I2 is opened with pyrrolidine to 
arrive at intermediate 287. Internal displacement of the iodide generates an aziridinium ion which 
then undergoes ring opening at the 1-position with another equivalent of pyrrolidine to give the 
desired diamine.  
 In 2012, Hennecke and co-workers repored the use of NIS to promote the doubly 
intramolecular diamination of alkenes en route to 2,2’-bipyrrolidines.155 When phenyl-derived 
alkenyl diamine 288 was subjected to a stoichiometric amount of NIS in dichloromethane, 
bipyrrolidine 289 was furnished in 67% yield (Scheme 113). A number of other aryl- and alkyl-
substituted alkenyl diamines were also tolerated, and anti-selective diamination was consistently 
observed.  
Halogen-mediated cycloguanidinations of alkenes have been explored to a considerable 
degree. The first reports of this form of alkene diamination were made by Al-Mourabit and 
colleagues when they demonstrated the bromine-mediated cycloguanidination of N-acylated 
                                                          
154 (a) Lavilla, R.; Kumar, R.; Coll, O.; Masdeu, C.; Bosch, J. Chem. Commun. 1998, 2715-2716; (b) Lavilla, R.; 
Kumar, R.; Coll, O.; Masdeu, C.; Spada, A.; Bosch, J.; Espinosa, E.; Molins, E. Chem.-Eur. J. 2000, 6, 1763-1772. 
155 Müller, C. H.; Fröhlich, R.; Daniliuc, C. G.; Hennecke, U. Org. Lett. 2012, 14, 5944-5947. 
Scheme 112. Iodine-Mediated Vicinal Diamination of 1,4-Dihydropyridine 285 
Scheme 113. Intramolecular anti-Selective Diamination of Alkenes with NIS en Route to 2,2’-Bipyrrolidines  
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dihydropyridines.156 Treatment of carbomethoxydihydropyridine (290) with bromine or NBS in 
the presence of excess Boc-guanidine afforded bicycles 291a and 291b. Subsequent acid-mediated 
deprotection of the Boc groups furnished cyclic guanidine 292 in 71% isolated yield (Scheme 114). 
Tepe and co-workers utilized a closely related cycloguanidination step in their recent synthesis of 
oroidin-type alkaloid (±)-dibromophakellin (293). When dipyrrolopyrazinone 294 was exposed to 
Boc-guanidine in the presence of NBS, cyclic guanidine 295 could be furnished, albeit in 29% 
yield. Acid-mediated deprotection of the Boc moiety proceeded more smoothly as 
dibromophakellin was obtained in high yield (Scheme 115).157  
Further studies by Al-Mourabit revealed that 2-aminopyrimidine (296) can also be used as 
a guanidinating agent (Scheme 116). Treatment of N-acylpyrrole tetrahydropyridine 297 with NBS 
in the presence of 2-aminopyrimidine results in the formation of intermediate 298. Subsequent 
displacement of the bromide group and generation of HBr gives the desired guanidine (299) in 
52% isolated yield.158 
                                                          
156 Abou-Jneid, R.; Ghoulami, S.; Martin, M. T.; Dau, E. T.; Travert, N.; Al-Mourabit, A. Org. Lett. 2004, 6, 3933-
3936.  
157 Hewlett, N. M.; Tepe, J. J. Org. Lett. 2011, 13, 4550-4553. 
158 (a) Picon, S.; Tran, H. D.; Martin, M. T.; Retailleau, P.; Zaparucha, A.; Al-Maourabit, A.; Org. Lett. 2009, 11, 
2523-2526; (b) Schroif-Gregoire, C.; Travert, N.; Zaparucha, A.; Al-Mourabit, A.; Org. Lett. 2006, 8, 2961-2964. 
Scheme 114. Al-Mourabit’s Bromine-Mediated Cycloguanidination of Dihydropyridines 
Scheme 115. Tepe’s Synthesis of (±)-Dibromophakellin via Alkene Cycloguanidination 
Scheme 116. Cycloguanidination of Dihydropyridines with 2-Aminopyrimidine 
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Recently, Zhang and co-workers reported the use of NIS to promote the doubly 
intramolecular diamination of N-alkenyl thioureas.159 For example, treatment of benzyl-protected 
alkenyl thiourea 300 with stoichiometric quantities of NIS in the presence of NaHCO3 afforded 
diamination product 301 in 34% yield (Scheme 117). Additionally, aminosulfuration was observed 
as a competitive process as aminosulfuration product 302 was isolated in 22% yield from the same 
reaction mixture. 
 Hypervalent iodine reagents display high synthetic utility in the field of alkene diamination. 
In light of their ready availability, low toxicity, and reduced environmental impact, these 
iodine(III) species have gradually replaced a number of heavy metal-mediated protocols. Among 
the earliest methods of using aryl-λ3-iodanes en route to diamination is that reported by Zbiral and 
Ehrenfreund. Here, unsaturated esters (303) are subjected to the combination of PhI(OAc)2 and 
TMSN3 to achieve the synthesis of vicinal diazides (304). Despite the advance, this approach 
suffered from low yields and a very limited substrate scope (Scheme 118).160 
 Moriarty and Khosrowshahi later reported a similar, but considerably more effective 
iodine(III)-mediated alkene diazidation.161 When subjecting alkenes, such as trans-β-
methylstyrene (305) to the combination of sodium azide and iodosobenzene in the presence of acid 
at elevated temperatures, iodonium ion intermediate 306 is formed (Scheme 119). Subsequent 
displacement of the iodonium species with azide affords diazide 307 in 69% yield and in 9:1 d.r. 
Further success of this reaction was demonstrated as benzofuran and indole scaffolds are readily 
converted to their respective diazides as well. 
                                                          
159 Zhang, J.; Zhang, X.; Wu, W.; Zhang, G.; Xu, S.; Shi, M. Tetrahedron Lett. 2015, 56, 1505-1509. 
160 Ehrenfreund, J.; Zbiral, E. Tetrahedron 1972, 28, 1697-1704. 
161 Moriarty, R. M.; Khosrowshahi, J. S. Tetrahedron Lett. 1986, 27, 2809-2812. 
Scheme 117. Zhang’s NIS-Mediated Doubly Intramolecular Diamination of N-Alkenyl Thioureas 
Scheme 118. Diazidation of α,β-Unsaturated Esters with PhI(OAc)2 
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 Alkene diazidation can also be achieved through the use of iodosobenzene in conjunction 
with trimethylsilyl azide (TMSN3). Armimoto and co-workers illustrate the efficacy of this 
hypervalent iodine/silyl azide combination via the smooth conversion of allylsilanes to their 
corresponding vicinal diazides (Scheme 120).162 Additionally, Magnus and colleagues show that 
this same reagent combination can promote the diazidation of triisopropylsilyl (TIPS) enol ethers 
under chilled conditions.163 For example, reaction of enol ether 312 with iodosobenzene and 
TMSN3 in the presence of catalytic amounts of TEMPO at -78 °C affords diazide 313 in 91% 
isolated yield. Yet, if the same reaction is run at 0 °C, β-azidation (314) is observed. Thus, 
diazidation of enol ethers with iodine(III) and azide is highly dependent on temperature. 
 In 2011, Muñiz and co-workers reported a breakthrough method that employs a 
chiral hypervalent iodine species to promote the doubly intermolecular, enantioselective 
diamination of styrenes (Scheme 121).164 Aside from being metal-free and practical, this approach 
is notable as it is the first example of a doubly intramolecular, enantioselective alkene diamination. 
When using bis(mesylimide) as the nitrogen source in the presence of Ishihara’s C2-symmetric 
                                                          
162 Arimoto, M.; Yamaguchi, H.; Fujita, E.; Nagao, Y.; Ochiai, M. Chem. Pharm. Bull. 1989, 37, 3221-3224. 
163 Magnus, P.; Roe, M. B.; Hulme, C. J. Chem. Soc., Chem. Commun. 1995, 263-265. 
164 Roben, C.; Souto, J. A.; González, Y.; Lishchynskyi, A.; Muñiz, K. Angew. Chem. Int. Ed. 2011, 50, 9478-9482.  
Scheme 119. Synthesis of Vicinal Diazides Using Iodosobenzene 
Scheme 120. Vicinal Diaminations of Alkenes Employing PhIO/TMSN3 
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chiral iodane 315,165 a variety of styrenes can be converted to their respective diamines in good 
yields and with high levels of enantioselection. 
 Furthermore, Muñiz and colleagues were able to apply this methodology towards the 
synthesis of the immunomodulator and veterinary anthelmintic (S)-levamisole (316) (Scheme 
122). Styrene (146) is converted to masked diamine 317 in good yield and ee via the 
enantioselective diamination as previously described. Hydride reduction of 317 with Red-Al 
afforded bis-mono protected diamine 318 in 86% isolated yield. Benzoylation, radical 
desulfination, and acid hydrolysis afforded the corresponding unmasked diamine as the bis-HCl 
salt (319) in 77% yield over 3 steps. Liberation of 319 to its free base form and subsequent 
treatment with carbon disulfide results in the formation of the precursor mercaptoimidazoline. This 
intermediate can then be treated with ethylene dibromide under basic conditions in order to furnish 
(S)-levamisole (316) (30% yield over 2 steps). 
 Muñiz continued to demonstrate the efficacy of hypervalent iodine in doubly 
intermolecular vicinal alkene diaminations by considerable scope expansion (Scheme 123). When 
using bis(tosylimide) as the nitrogen source in the presence of PhI(OAc)2, a variety of styrenes 
were readily transformed to their desired diamines in high yields. The bis(mesylimide) diamine 
library was also significantly expanded via microwave irradiation. It is also notable that the 
diamine library was not limited to just styrene substrates. Numerous alkyl-substituted alkenes were 
                                                          
165 Uyanik, M.; Yasui, T.; Ishihara, K. Angew. Chem. Int. Ed. 2010, 49, 2175-2177. 
Scheme 121. Muñiz’s Enantioselective, Metal-Free Intermolecular Diamination of Styrenes 
Scheme 122. Muñiz’s Enantioselective Synthesis of (S)-Levamisole via Intermolecular Diamination 
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converted to their respective bistosylimide diamine scaffolds upon exposure to PhI(OAc)2 as 
well.166 
 Dinuclear iodine(III) species also proved effective in inter/intermolecular alkene 
diamination as described by Muñiz and colleagues (Scheme 124).167 Upon reaction optimization, 
treatment of styrene (146) with substoichiometric quantities of bisimido dinuclear iodine(III) 
species 320 and stoichiometric quantities of bis(tosylimide) afforded diamine 321 in 74% isolated 
yield. Additionally, deoxygenated dinuclear iodine(III) compound 322 showed slightly superior 
reactivity as styrene was converted to 323 without the need for external bistosylimide. 
 To complement iodine(III)-promoted inter/intermolecular alkene diaminations, Chiba and 
colleagues reported that hypervalent iodine promotes inter/intramolecular vicinal diamination of 
alkenes (Scheme 125).168 Here, a variety of amidines are smoothly converted to their desired 
                                                          
166 Souto, J. A.; González, Y.; Iglesias, A.; Zian, D.; Lishchynskyi, A.; Muñiz, K. Chem. Asian. J. 2012, 7, 1103-
1111. 
167 Röben, C.; Souto, J. A.; Escudero-Adán, E. C.; Muñiz, K. Org. Lett. 2013, 15, 1008-1011. 
168 Chen, H.; Kaga, A.; Chiba, S. Org. Lett. 2014, 16, 6136-6139. 
Scheme 123. Iodine(III)-Promoted Intermolecular Diaminations of Styrenes and Alkyl-Substituted Alkenes 
Scheme 124. Intermolecular Alkene Diaminations via the Use of Dinuclear Iodine(III) 
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dihydroimidazoles upon exposure to PhI(NTs2)2 or PhI(NMs2)2. For example, when amidine 324 
is subjected to PhI(NTs2)2 in dichloromethane at elevated temperatures, dihydroimidazole 325 is 
provided in 79% yield. The bismesylimide analog (326) can also be furnished when PhI(NMs2)2 
is employed as the source of iodine(III). 
 In 2014, Hong and Johnston demonstrated a highly efficacious inter/intramolecular alkene 
diamination approach that utilizes PhI(OAc)2 and KI en route to forming 3-aminoindolines 
(Scheme 126).169 Here, tosyl-protected vinylaniline 327 can be treated with an array of 
commercially available primary and secondary amines in the presence of the aforementioned 
oxidant/additive combination in order to provide desired indoline compounds (328) in moderate 
to high yields. 
 As for iodine(III)-mediated doubly intramolecular vicinal diaminations of alkenes, notable 
discoveries have been made by both Muñiz and Shi. Muñiz and co-workers reported that a 
                                                          
169 Hong, K.; Johnston, J. N. Org. Lett. 2014, 16, 3804-3807. 
Scheme 125. Inter/Intramolecular Alkene Diamination with PhI(NTs2)2 and PhI(NMs2)2 
Scheme 126. Inter/Intramolecular Diaminations of Vinylanilines en Route to 3-Aminoindolines 
Scheme 127. PhI(OAc)2/KI-Mediated Intramolecular Diamination of Alkenyl Sulfamides  
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halide/oxidant (KBr/PhI(OAc)2) combination, similar to that of Hong and Johnston’s work, can 
promote the diamination of alkenyl sulfamides (329) to their corresponding cyclic sulfamides 
(330) in practically quantitative yields (Scheme 127).170 Shi and colleagues reported that a variety 
of formamidines (331) can be converted to their respective tricyclic ureas (332) upon treatment 
with NIS and PhI(OAc)2 under very mild conditions (Scheme 128).
171 
Wirth and co-workers further pioneer intra/intramolecular vicinal diaminations by 
reporting an enantioselective version of this type of diamination using chiral hypervalent iodine 
catalyst 333 (Scheme 129).172 Through reaction optimization, it was found that iodine(III) species 
333 in the presence of TMSOTf and BF3•OEt2 could readily convert diaminosulfone 334 to cyclic 
diaminosulfone 335 in good yield and with excellent enantioselection. This highly enantioselective 
approach was applied to the formation of numerous diamino heterocyclic products as shown in 
Scheme 129. 
5.3. Reaction Optimization and Substrate Scope 
 As previously mentioned, Hong and Johnston recently reported a highly efficacious 
iodine(III)-mediated inter/intramolecular oxidative diamination of terminal alkenes.169 By 
employing a PhI(OAc)2/KI oxidant/additive combination in the presence of electron-rich amines, 
                                                          
170 Chávez, P.; Kirsch, J.; Hövelmann, C. H.; Streuff, J.; Martínez-Belmonte, M.; Escudero-Adán, E. C.; Martin, E.; 
Muñiz, K. Chem. Sci. 2012, 3, 2375-2382. 
171 Zhang, J.; Wu, W.; Zhang, X.; Zhang, G.; Xu, S.; Shi, M. Chem. Asian. J. 2015, 10, 544-547. 
172 Mizar, P.; Laverny, A.; El-Sherbini, M.; Farid, U.; Brown, M.; Malmedy, F.; Wirth, T. Chem. Eur. J. 2014, 20, 
9910-9913. 
Scheme 128. PhI(OAc)2/NIS-Mediated Intramolecular Diamination of Formamidines 
Scheme 129. Wirth’s Enantioselective Intramolecular Diaminations en Route to Diamino Bicycles 
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tosylated ortho-vinyl aniline 327 was readily converted to a number of 3-aminoindolines (328) 
under mild and metal-free conditions (Scheme 130). Monosubstituted alkyl and aryl amines as 
well as disubstituted amines were tolerated, ultimately furnishing a library of over 20 
aminoindolines. This metal-free approach is unique as it promotes alkene diamination using a 
combination of electron-rich and electron-deficient (aryl sulfonamide) nitrogen sources without 
the need for amine preactivation or protection. 
 Inspired by the success of this system, we sought to expand this methodology to vinyl 
phenol motifs with ambitions of directly accessing 3-aminodihydrobenzofurans via an 
inter/intramolecular aminohydroxylation reaction. Upon subjecting 2-vinyl phenol (336) to 
stoichiometric quantities of PhI(OAc)2 and KI in the presence of excess thiomorpholine and 
CH3CN, we found that the desired 3-aminodihydrobenzofuran (337) was not observed (Scheme 
131). Instead, diamine 338a was acquired in 48% isolated yield under these reaction conditions 
(Table 13, entry 1). This result garnered immediate interest as the observed diamine can only be 
afforded via an unexpected doubly intermolecular alkene diamination pathway. 
 With this result in hand, optimization studies of this diamination reaction ensued. Previous 
mechanistic hypotheses indicate that interaction between PhI(OAc)2 and KI results in the 
formation of an electrophilic iodinating reagent, which in turn can react with nucleophilic amine 
to generate an electrophilic N-iodamine species.169 As an alternative to the PhI(OAc)2/KI 
combination, NIS could be used as the electrophilic iodinating reagent to provide the iodamine 
Scheme 130. Hong and Johnston’s Iodine(III)-Mediated Inter/Intramolecular Diamination of Terminal Alkenes 
Scheme 131. Initial Findings of an Iodine(III)-Mediated Doubly Intermolecular Alkene Diamination 
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species required for reactivity. When NIS was employed as the iodinating agent in the presence of 
2-vinyl phenol and thiomorpholine, diamine 338a was furnished in 40% yield indicating a slightly 
inferior reactivity profile compared to the oxidant/additive combination (Table 13, entry 2). 
Different halide sources in combination with PhI(OAc)2 were examined next. Use of 
stoichiometric potassium bromide and ammonium iodide provided diamine 338a in 36% and 40% 
yields, respectively (Table 13, entries 3 and 4). The combination of oxidant and additive proved 
essential as starving the reaction conditions of KI or PhI(OAc)2 resulted in little or no reactivity 
(Table 13, entries 5 and 6). Upon increasing the amount of amine to 3 equivalents, full conversion 
of starting material was observed leading to a 78% isolated yield of 338a after chromatographic 
separation (Table 13, entry 7). Interestingly, when 4 equivalents of thiomorpholine were used, 
inhibition of product formation was observed as 338a was provided in only 57% yield (Table 13, 
entry 8). The use of another hypervalent iodine reagent, iodosobenzene, in combination with KI, 
afforded diamine 338a, but in depressed yield relative to PhI(OAc)2 and KI (Table 13, entry 9). 
 With sufficient reactivity achieved, a variety of solvents were evaluated to see if yield could 
be further improved. Dichloromethane mitigated product acquisition as 338a was provided in 21% 
yield (Table 14, entry 2). Product formation was further inhibited when toluene was employed as 
the solvent (Table 14, entry 3). Ethereal solvents such as THF and 1,4-dioxane proved inferior as 
the desired diamine was afforded in 6% and 17% yields, respectively (Table 14, entries 4 and 5). 
entry oxidant additive 
amine 
equiv. 
yield 
(%) 
1 PhI(OAc)2 KI 2 48 
2 -- NIS 2 40 
3 PhI(OAc)2 KBr 2 36 
4 PhI(OAc)2 NH4I 2 40 
5 PhI(OAc)2 -- 2 10 
6 -- KI 2 N/A 
7 PhI(OAc)2 KI 3 78 
8 PhI(OAc)2 KI 4 57 
9 PhIO KI 3 36 
Table 13. Initial Optimization Studies of the Doubly Intermolecular Alkene Diamination 
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Therefore, it is evident that CH3CN is necessary in order to achieve maximum conversion to 
product. 
 In regards to the most optimal reaction conditions up to this point (Table 13, entry 7), one 
observation of interest for this particular experiment was the cleanliness of the crude NMR data. 
First off, there was no sign of starting material (2-vinyl phenol) indicating that this reaction 
proceeded to full conversion. The only compounds that could be observed by NMR of the crude 
reaction mixture were iodobenzene (as a result of reaction and subsequent decomposition of 
PhI(OAc)2) and the desired diamine. Additionally, there were no discernible side products. 
Therefore, quantitative or near-quantitative yield of diamine 338a for this run was expected. Yet 
after column chromatography, a 78% isolated yield of 338a indicated that there was indeed room 
for improved yield. Based on the cleanliness of the reaction and the non-quantitative yield 
acquired, it was hypothesized that the diamine product may decompose to a degree in situ, 
ultimately owing to a 78% isolated yield rather than a more fruitful and expected yield (>95%). 
To probe this hypothesis, diamine 338a was subjected to the optimized reaction conditions, but 
with no amine, to obtain evidence for product decomposition (Scheme 132). Decomposition was 
observed as only trace quantities of the submitted diamine were isolated upon chromatographic 
separation. 
entry solvent 
yield 
(%) 
1 CH3CN 78 
2 CH2Cl2 21 
3 toluene 7 
4 THF 6 
5 1,4-dioxane 17 
Table 14. Solvent Screen of the Doubly Intermolecular Alkene Diamination 
Scheme 132. Decomposition Experiment with Diamine 338a 
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 This evidence for decomposition provided a basis for yield optimization. When the 
temperature was lowered to 0 °C, complete and clean conversion of starting material to product 
was seen, analogous to that of the run at 25 °C. However, upon chromatographic separation, we 
were delighted to see that diamine 338a was acquired in 99% isolated yield (Table 15, entry 2). 
Further chilling the reaction to -20 °C mitigated product formation as diamine 338a was afforded 
in 59% yield after column chromatography (Table 15, entry 3). 0 °C was used as the optimal 
temperature as desired diamine can be produced while minimizing decomposition or undesired 
side reactivity. 
 Before developing an amine scope, two things needed to be confirmed: 1) that the 
PhI(OAc)2/KI combination exhibits superior reactivity relative to NIS, and 2) that the hydroxyl 
motif of 2-vinyl phenol is essential for reactivity. This involved examining a multitude of alkenes 
with both sets of reaction conditions. As shown in Table 16, treatment of ortho-hydroxystyrene 
(2-vinyl phenol) with thiomorpholine (3 equivalents) at room temperature and 0 °C led to diamine 
338a in 78% and 99% yields respectively (entries 1 and 2). When NIS was employed as the 
entry 
T 
(°C) 
yield 
(%) 
1 25 78 
2 0 99 
3 -20 59 
Table 15. Effects of Temperature on the Doubly Intermolecular Alkene Diamination 
Table 16. Diamination of 2-Vinyl Phenol with PhI(OAc)2/KI and NIS 
entry Method 
T 
(°C) 
yield 
(%) 
1 A 25 78 
2 A 0 99 
3 B 25 74 
4 B 0 91 
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electrophilic iodinating reagent at room temperature, the desired diamine was afforded but in 
slightly lower yield relative to the PhI(OAc)2/KI run (Table 16, entry 3). When the reaction 
temperature was lowered to 0 °C, NIS once again engaged in diamination, furnishing diamine 338a  
in 91% isolated yield (Table 16, entry 4). The results acquired with NIS were analogous to those 
of PhI(OAc)2/KI in the sense that higher yields were acquired when reaction temperature was 
lowered. Yet, when directly comparing reaction efficacy between PhI(OAc)2/KI and NIS, it was 
evident that the iodine(III)/additive combination consistently proves superior yield. 
 The next alkene that was examined was para-hydroxystyrene (4-vinyl phenol). This 
particular alkene was of interest as the lone pairs of the hydroxyl group should still be in 
conjugation with the terminal alkene. In other words, because the hydroxyl motifs of both 2-vinyl 
phenol and 4-vinyl phenol are in conjugation with the terminal olefin, nucleophilicity of 2-vinyl 
phenol and 4-vinyl phenol should be similar. Consequently, diamination with 4-vinyl phenol (339) 
should be observed. When 4-vinyl phenol was treated with PhI(OAc)2 and KI in the presence of 
thiomorpholine at room temperature, we were delighted to see that diamine 340a was provided in 
51% yield, upon chromatographic separation (Table 17, entry 1). Parallel to the 2-vinyl phenol 
system, lowering the reaction temperature resulted in increased yield of the desired diamine (62% 
yield) (Table 17, entry 2). NIS also engaged in diamination at both room temperature and 0 °C, 
furnishing diamine 340a in 40% and 50% yields, respectively (Table 17, entries 3 and 4). These 
results once again indicate that better yields are obtained at lower temperature and that the 
PhI(OAc)2/KI oxidant/additive combination is the superior set of reaction conditions. 
 3-Vinyl phenol (meta-hydroxystyrene) was examined next. Unlike ortho-hydroxystyrene 
and arap-hydroxystyrene, the lone pairs of the hydroxyl group of meta-hydroxystyrene should not 
entry Method 
T 
(°C) 
yield 
(%) 
1 A 25 51 
2 A 0 62 
3 B 25 40 
4 B 0 50 
Table 17. Diamination of 4-Vinyl Phenol with PhI(OAc)2/KI and NIS 
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be in conjugation with the terminal alkene. As a result, 3-vinyl phenol (341) should have a 
decreased nucleophilicity compared to its 2-vinyl phenol and 4-vinyl phenol counterparts. When 
treating 3-vinyl phenol with the PhI(OAc)2/KI combination in the presence of thiomorpholine at 
room temperature, no conversion of starting material could be seen after an 18 hour reaction period 
(Scheme 133). The same result was observed even after elevation of reaction temperature. 
Additionally, NIS proved fruitless as only starting material was observed after prolonged reaction 
times at both room temperature and 65 °C. These results clearly indicate that having the hydroxyl 
motif ortho or para to the terminal alkene is vital for sufficient reactivity. 
 To further probe the necessity of a hydroxyl unit at the ortho and/or para positions of 
styrene, 2-vinylanisole (343) was submitted to the diamination protocol. This substrate was of 
interest as it possesses an electron-donating motif ortho to the alkene functionality, similar to that 
of 2-vinyl phenol. Furthermore, the lone pairs of the methoxy motif should be in conjugation with 
the terminal olefin, giving it a reactivity profile comparable to its ortho-hydroxystyrene analog. 
However, when 2-vinylanisole was treated with PhI(OAc)2/KI or NIS in the presence of 
thiomorpholine, reactivity was mitigated as no corresponding diamine (344) was observed, even 
with the application of higher temperature (Scheme 134). Based on these findings, it is evident 
that having a free hydroxyl group as the electron-donating species is critical for the nucleophilicity 
of the alkene. 
Scheme 133. Unsuccessful Diamination of 3-Vinyl Phenol with PhI(OAc)2/KI and NIS 
Scheme 134. Unsuccessful Diamination of 2-Vinylanisole with PhI(OAc)2/KI and NIS 
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Styrene (146) was the next alkene to be evaluated. With decreased nucleophilicity relative 
to ortho-hydroxystyrene and para-hydroxystyrene, the expectations for diamination with styrene 
as the substrate were relatively low. When subjected to the diamination protocol with PhI(OAc)2 
and KI, styrene appeared to be unreactive as predicted (Scheme 135). The same results were 
observed when NIS was used as the iodinating agent. 
 The next alkene that was employed was allylbenzene (346). With the terminal alkene out 
of conjugation with the aromatic ring, it was expected that this substrate would be unreactive. 
Consequently, no diamination (347) was observed when allylbenzene was subjected to either 
diamination method at ambient or elevated temperatures (Scheme 136). 
 ortho-Nitrostyrene (348) was also examined as this was an alkene that benefits from 
conjugation while being resistant to direct oxidation by PhI(OAc)2. This, too, failed to convert to 
Scheme 135. Unsuccessful Diamination of Styrene with PhI(OAc)2/KI and NIS 
Scheme 136. Unsuccessful Diamination of Allylbenzene with PhI(OAc)2/KI and NIS 
Scheme 137. Unsuccessful Diamination of ortho-Nitrostyrene with PhI(OAc)2/KI and NIS 
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its corresponding diamine (349) when treated with either the oxidant/additive combination or NIS 
(Scheme 137). Additionally, higher temperatures were implemented, but to no avail. 
 Given that 2-vinyl phenol and 4-vinyl phenol successfully engaged in diamination, whereas 
3-vinyl phenol, 2-vinylanisole, styrene, allylbenzene, and ortho-nitrostyrene proved fruitless, it is 
evident that the hydroxyl motif of 2-vinyl phenol and/or 4-vinyl phenol is essential for the 
promotion of reactivity. Furthermore, the diamination protocol employing the PhI(OAc)2/KI 
combination consistently gave higher yields, in successful cases, compared to the NIS variation. 
With these findings in hand, one final parameter was to be examined before developing the amine 
scope: the necessity of a terminal alkene.  
All alkenes subjected to diamination up to this point have been terminal alkenes. Given 
previous findings, we were interested in seeing if internal alkenes could readily undergo 
diamination. ortho-Styryl phenol (350) was the reagent of choice as it was a 2-vinyl phenol analog 
that possessed an internal alkene. When ortho-styryl phenol was treated with PhI(OAc)2 and KI in 
the presence of thiomorpholine, no diamination (351) was observed, resulting in a 45% recovery 
of starting material (Scheme 138). NIS also proved ineffective, once again resulting in the 
reacquisition of o-styrylphenol (67% recovery). 
Subsequent studies specifically applied the protocol using PhI(OAc)2/KI and the most 
reactive styrene (ortho-hydroxystyrene) to explore the amine scope of the intermolecular 
diamination. Beginning with disubstituted amines, diamination with morpholine led to 338b in 
79% yield (Table 18, entry 2). Piperidine and isoindoline, a pyrrolidine derivative, led to vicinal 
diamines 338c and 338d, but with depressed yield (Table 18, entries 3 and 4). Cbz-, Boc-, and 
ethyl carboxylate-protected piperazines successfully engaged in diamination providing 338e-338g 
in moderate (59%) to good (90%) yield (Table 18, entries 5-7). These three diamines are notable 
as they allow for subsequent unmasking of the piperazine moieties under neutral, acidic, or basic 
Scheme 138. Unsuccessful Diamination of o-Styrylphenol with PhI(OAc)2/KI and NIS 
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conditions. N-Arylpiperazines, however, proved less reactive under the diamination protocol as 1-
phenylpiperazine and 1-(3-methoxyphenyl)piperazine furnished 338h and 338i in 31% and 16% 
yields, respectively (Table 18, entries 8 and 9). N-Cinnamylpiperazine displayed high reactivity as 
vicinal diamine 338j was acquired in 94% isolated yield upon chromatographic separation (Table 
18, entry 10). Acyclic disubstituted amines engaged in diamination as dibenzylamine and N-
methylbenzylamine led to 338k and 338l in 35% and 65% yields, respectively (Table 18, entries 
11 and 12). 
Primary amines were examined next. Subjection of aniline to the diamination protocol at 
0 °C led to diamine 338m in 48% yield (Table 19, entry 1). Interestingly, when the same reaction 
was repeated at room temperature, an improvement of reactivity was observed (Table 19, entry 2). 
The same phenomenon proved consistent with 4-tert-butylaniline and 3,5-dimethylaniline as 
diamines 338n and 338o were acquired in significantly higher yields at room temperature relative 
to 0 °C (Table 19, entries 3-6). One exception to this trend, however, was 4-fluoroaniline as vicinal 
diamine 338p was isolated in identical yield (47%) at both room temperature at 0 °C (Table 19, 
entries 7 and 8). Seeing that a number of anilines displayed higher reactivity at room temperature 
was interesting, since this was opposite the trend observed with disubstituted amines. One 
hypothesis for explaining these higher yields at room temperature may be the fact that 
entry 338 R 
yield 
(%) 
1 a C4H8S (thiomorpholine) 99 
2 b C4H8O (morpholine) 79 
3 c C5H10 (piperidine) 29 
4a d C8H8 (isoindoline) 30 
5 e 
R’ = Cbz 62 
6b f R’ = Boc 59 
7 g R’ = CO2Et 90 
8 h R’ = Ph 31 
9 i R’ = mMeOC6H4 16 
10 j R’ = CH2CHCHC6H5 94 
11 k C14H14 (dibenzylamine) 35 
12 l Me, Bn (N-methylbenzylamine) 65 
Table 18. Doubly Intermolecular Alkene Diamination: Secondary Amine Scope 
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corresponding aniline diamines (338m-338p) are less prone to decomposition compared to their 
secondary amine counterparts. 
For reasons not clear, one class of amines that proved troublesome in this diamination 
protocol was primary aliphatic amines. Subjection of these amines to the PhI(OAc)2/KI 
combination in the presence of 2-vinyl phenol gave no sign of desired diamination. A common 
feature among a number of examples, however, was intermolecular aminoacetoxylation (Scheme 
139). For example, when isopropylamine, cyclohexylamine, and 3-methoxypropylamine were 
subjected to standard reaction conditions, aminoacetoxylation products 352-354 were the only 
products that were cleanly isolated post-column chromatography. 
para-Hydroxystyrene was also an effective precursor for intermolecular vicinal 
diamination. Although this was previously exemplified with thiomorpholine, successful 
diamination with morpholine and aniline (340b and 340c) further illustrate that 4-vinyl phenol can 
entry 338 R 
T 
(°C) 
yield 
(%) 
1 m Ph 0 48 
2 m Ph 25 60 
3 n 4-tBu-C6H4 0 26 
4 n 4-tBu-C6H4 25 53 
5 o 3,5-dimethyl-C6H3 0 29 
6 o 3,5-dimethyl-C6H3 25 60 
7 p 4-F-C6H4 0 47 
8 p 4-F-C6H4 25 47 
Table 19. Doubly Intermolecular Alkene Diamination: Primary Amine Scope 
Scheme 139. Intermolecular Aminoacetoxylation with Primary Aliphatic Amines 
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tolerate a number of amine substrates (Table 20, entries 2 and 3). Once again, higher yield was 
achieved at room temperature for the aniline case. 
Modifications to the vinylphenol precursor were explored, specifically with 
thiomorpholine, illustrating further generality. Halogen substituents at the 4-position were 
tolerated as diamination products 338q-338s were furnished in moderate to good yield (Table 21, 
entries 2-4). Substrates with electron-withdrawing or electron-donating groups at the 4-position 
also engaged in diamination as 338t and 338u were provided in 50% and 54% yields, respectively 
(Table 21, entries 5 and 6). Diamination with a hydroquinone species was possible as 338v was 
afforded, albeit in low yield (Table 21, entry 7). Lastly, vinylphenol substrates possessing electron-
rich methoxy groups at the 5- and 6-positions delivered their diamination products (338w and 
338x) in moderate (57%) to good yield (83%) (Table 21, entries 8 and 9). 
entry 340 R 
yield 
(%) 
1 a C4H8S (thiomorpholine) 62 
2 b C4H8O (morpholine) 59 
3a c Ph 85 
Table 20. Doubly Intermolecular Alkene Diamination: Amine Scope with para-Hydroxystyrene 
entry 338 R 
yield 
(%) 
1 a H 99 
2 q 4-F 83 
3a r 4-Cl 64 
4a s 4-Br 70 
5 t 4-NO2 50 
6 u 4-MeO 54 
7 v 4-HO 23 
8 w 5-MeO 57 
9 x 6-MeO 83 
Table 21. Doubly Intermolecular Alkene Diamination: Vinylphenol Scope 
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5.4. Control Experiments and Mechanistic Hypothesis 
 Throughout the course of these exploratory studies for the doubly intermolecular alkene 
diamination, a number of experiments were directed at the isolation of key intermediates or 
products along the preferred or competing reaction pathways. Chief among these co-products is 
bis(oxygenation) product 355. This particular product arose from a control experiment in which 2-
vinyl phenol was treated with PhI(OAc)2 and KI alone (no amine). 
1H NMR analysis of the crude 
reaction mixture showed 3-acetoxydihydrobenzofuran (355) as the major product, and subsequent 
chromatographic separation provided compound 355 in 69% isolated yield (Scheme 140).  
 Another key product isolated was that of iodoacetoxylation product 356. Based on our 
previous success of alkene diamination with electron-rich amines, we wanted to see if electron-
withdrawing amines could also be tolerated. When combining 2-vinyl phenol with the 
PhI(OAc)2/KI combination in the presence of electron-deficient bistosylimide (Ts2NH), iodide 356 
was furnished, albeit in low yield (12%) (Scheme 141). 
Isolation of bis(oxygenation) and iodoacetoxylation products 355 and 356 enabled further 
studies that could determine if these compounds indeed serve as intermediates en route to 
diamination. When 355 and 356 were individually subjected to the standard diamination protocol 
(PhI(OAc)2, KI, thiomorpholine, and CH3CN) at room temperature, no sign of diamine 338a could 
be detected (Scheme 142). Furthermore, neither of those intermediates is observed directly during 
the conversion of 2-vinyl phenol (336) to diamination product 338a under the same reaction 
conditions. What has been determined, however, is iodide 356 and 3-acetoxydihydrobenzofuran 
(355) are united in a common pathway. This was confirmed as phenol 356 converts to 355 when 
exposed to PhI(OAc)2/KI in the absence of amine or when treated with amine alone. 
Scheme 140. Generation of Bis(oxygenation) Product 355 
Scheme 141. Generation of Iodoacetoxylation Product 356 
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These intermediates were of interest as they provide useful mechanistic insight. These 
products appear to collectively arise from electrophile addition to the terminal carbon, followed 
by nucleophilic addition to the benzylic carbon. It is speculated that carbon-nitrogen bond 
formation via an electrophilic amine formed in situ is a key aspect of the actual mechanism leading 
to diamination. Additionally, this speculation of electrophilic amine addition (terminal carbon) and 
subsequent nucleophilic addition (benzylic position) is reflective of the aminoacetoxylation 
products depicted in Scheme 139. Non-nucleophilic amines such as Ts2NH did not provide 
diamination product, even when applying the protocol developed by Muñiz (Scheme 143).166 
Instead, monoamination product 357 was afforded in low yield, perhaps through a pathway 
analogous to 336 → 356 → 355. This result is also consistent with the unique reactivity of an 
electrophilic amine using the PhI(OAc)2/KI protocol. 
A plausible reaction mechanism is depicted in Figure 24. When KI interacts with 
PhI(OAc)2, it is believed that the iodide substitutes for one of the acetoxy groups, generating 
electrophilic iodinating agent A. This particular iodane (A) can activate the amine (B) through 
iodamine formation (C). The success of NIS in this transformation further suggests that the 
formation of an iodamine is key in the reaction pathway. Subsequent attack of the halamine by the 
Scheme 142. Other Findings with Bis(oxygenation) and Iodoacetoxylation Products 355 and 356 
Scheme 143. Acquisition of Monoamination Product 357 via Muñiz’s Protocol 
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alkene moiety of 2-vinylphenol generates intermediate D. The lone pairs of electrons on the 
hydroxyl unit can resonate in order to break open the aziridinium, resulting in ortho-quinone 
methide E. This intermediate serves as a suitable electrophile for nucleophilic attack of amine en 
route to homodiamination (F). 
One of the key features in regard to the mechanistic pathway described above is the 
regeneration of iodide. Because it is hypothesized that iodide is regenerated in situ, it is plausible 
that diamination can be achieved when employing substoichiometric or catalytic quantities of 
halide. While previous studies employed a full equivalent of KI in order to apply general conditions 
Figure 24. Mechanistic Hypothesis for PhI(OAc)2/KI-Mediated Intermolecular Diamination 
Table 22. KI Loading Study 
entry 
catalyst 
loading 
yield 
(%) 
1 0 mol% 6 
2 1 mol% 34 
3 2 mol% 54 
4 3 mol% 60 
5 4 mol% 68 
6 5 mol% 73 
7 10 mol% 74 
8 30 mol% 86 
9 50 mol% 86 
10 100 mol% 94 
11 120 mol% 96 
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to a broad collection of substrates, a series of experiments were designed to vary KI loading in the 
diamination of 2-vinyl phenol (336) with thiomorpholine. 
Starving the reaction conditions of the additive resulted in minimal background reactivity 
(6% yield) (Table 22, entry 1). Yet, when a 1 mol% loading of KI was used, reactivity increased 
nearly six-fold as diamination product 338a was isolated in 34% yield (Table 22, entry 2). 
Progressively increasing the iodide loading led to higher yield (Table 22, entries 3-6). This was 
reflected through a 10 mol% loading, which correlated to a 74% yield of 338a (Table 22, entry 7). 
Despite observing sufficient reactivity with catalytic halide loadings, further studies confirmed 
that substoichiometric and even stoichiometric amounts of KI (Table 22, entries 8-11) were 
necessary in order to achieve optimal yield (Figure 25). 
5.5. Future Work 
Although this doubly intermolecular diamination with 2-vinylphenol was met with a high 
degree of success, other avenues can be explored in order to make this system even more efficient. 
One particular direction to pursue is heterodiamination of 2-vinylphenol. As described previously, 
this diamination protocol was tolerant to a wide array of amines. One of the main drawbacks, 
however, is that the amine moieties are identical at both sites of diamination (i.e. 
homodiamination). If two different amines, such as aniline and thiomorpholine, can be 
regioselectively installed at these positions through reaction optimization, a much higher level of 
generality would be achieved for this reaction system (Scheme 144). 
Figure 25. Relative Comparison of KI Loading and Reactivity  
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 The enantioselective variation of this system is another route to be taken. This can be 
probed by subjecting a number of chiral organocatalysts (e.g. PBAM) to the previously developed 
protocol (Scheme 145). Another plausible approach towards achieving enantioselection would be 
the use of a chiral hypervalent iodine reagent as employed by Muñiz and Ishihara.164,165 If this 
strategy proves fruitless, in situ generation of chiral iodine(III) via incorporation of chiral 
iodoarenes and MCPBA would be another possibility. These investigations are currently ongoing 
within our laboratory. 
 
 
 
 
 
 
Scheme 144. Proposed Heterodiamination of 2-Vinyl Phenol 
Scheme 145. Potential Enantioselective Variations of the Doubly Intermolecular Alkene Diamination 
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Chapter 6. A Unified Approach to the Four Azaindoline Families by Inter-
/Intramolecular Annulative Diamination of Vinylpyridines 
6.1. Background 
The indoline scaffold is considered to be one of the most privileged structures in nature.173 
It is found in a variety of naturally bioactive alkaloids and is the structural component of several 
pharmaceutically active compounds. Because of their strong biological profile, indolines have 
garnered a high degree of interest and have been synthesized via a number of methodologies as a 
result.174 
 Vinblastine (358) is among the bioactive alkaloids that possess an indoline core (Figure 
26). This natural product is of considerable importance as it has been used to treat numerous types 
of cancer such as Hodgkin’s lymphoma,175 non-small cell lung cancer,176 bladder cancer,177 brain 
cancer,178 and testicular cancer.179 Other indoline-containing alkaloids with biological significance 
                                                          
173 Modern Alkaloids: Structure, Isolation, Synthesis and Biology; Fattorusso, E.; Tagliatela-Scafati, O., Ed.; Wiley-
VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2008.   
174 For a review of methods that access the indoline scaffold, see Liu, D.; Zhao, G.; Xiang, L. Eur. J. Org. Chem. 
2010, 3975-3984.  
175 Eichenauer, D. A.; Bredenfeld, H.; Haverkamp, H.; Müller, H.; Franklin, J.; Fuchs, M.; Borchmann, P.; Müller-
Hermelink, H.-K.; Eich, H. T.; Müller, R.-P.; Diehl, V.; Engert, A. J. Clin. Oncol. 2009, 27, 6079-6085.  
176 Curran Jr., W. J.; Paulus, R.; Langer, C. J.; Komaki, R.; Lee, J. S.; Hauser, L.; Movsas, B.; Wasserman, T.; 
Rosenthal, S. A.; Gore, E.; Machtay, M.; Sause, W.; Cox, J. D. J. Natl. Cancer Inst. 2011, 103, 1452-1450. 
177 Petrioli, R.; Roviello, G.; Fiaschi, A. I.; Laera, L.; Miano, S. T.; Bianco, V.; Francini, E. Colloq. Inse. 2015, 26, 
878-883. 
178 Rebbaa, A.; Chou, P. M.; Vucic, I.; Mirkin, B. L.; Tomita, T.; Bermer, E. G. Clin. Cancer Res. 1999, 5, 3661-
3668. 
179 Hanna, N.; Einhorn, L. H. J. Clin. Oncol. 2014, 32, 3085-3092. 
Figure 26. Examples of Naturally Bioactive Alkaloids Possessing an Indoline Scaffold 
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include ajmaline (359), an antiarrhythmic agent,180 (−)-physostigmine (360), a cholinesterase 
inhibitor,181 and (+)-aspidospermidine (361), which shows strong antimalarial activity.182 
Although strychnine (362) is classified as an alkaloid that bears an indoline moiety, this particular 
natural product suffers from a high toxicity profile and is therefore used as a common pesticide.183 
One of the most notable pharmaceutical agents with an indoline backbone is pentopril 
(363). Previous studies confirm that pentopril displays angiotensin-converting enzyme (ACE) 
inhibition and is therefore considered an antihypertensive drug (Figure 27).184 Silodosin (364) is 
another pharmaceutical that possesses an indoline framework. This compound is an α1a-
adrenoceptor (AR) antagonist and is used as medication for the treatment of problems associated 
with the human prostate.185 Other indoline-bearing pharmaceutical candidates include small-
molecule MDM2 inhibitor MI-219 (365), a promising anticancer agent,186 as well as 3-aryl-N-
acylindoline 366, which has been recently reported to target inhibitors of apoptosis proteins 
(IAP).187 These listed examples constitute only a small portion of the biological impact that these 
compounds have as SciFinder identifies more than 1300 references where indolines have been 
described as antibacterials, kinase inhibitors for cancer targets, antidiabetic agents, anti-
inflammatory agents, and analgesics.188 
Despite its prominence in natural products and pharmaceutical agents, one of the main 
limitations of the indoline scaffold from a pharmacological standpoint is that it possesses a 
                                                          
180 Wang, T.; Xu, Q.; Yu, P.; Liu, X.; Cook, J. M. Org. Lett. 2001, 3, 345-348. 
181 Cho, Y.; Kim, W.-S.; Hur, G.-H.; Ha, Y.-C. Environ. Toxicol. Phar. 2012, 33, 1-8. 
182 Mitaine-Offer, A.-C.; Sauvain, M.; Valentin, A.; Callapa, J.; Mallié, M.; Zèches-Hanrot, M. Phytomedicine 2002, 
9, 142-145. 
183 Zhang, H.; Boonsombat, J.; Padwa, A. Org. Lett. 2007, 9, 279-282. 
184 Rakhit, A.; Hurley, M. E.; Tipnis, V.; Coleman, J.; Rommel, A.; Brunner, H. R. J. Clin. Pharmacol. 1986, 26, 
156-164. 
185 Barve, I. J.; Chen, L.-H.; Wei, P. C. P.; Hung, J.-T.; Sun, C.-M. Tetrahedron 2013, 69, 2834-2843. 
186 Rajesh, S. M.; Perumal, S.; Menéndez, J. C.; Yogeeswari, P.; Sriram, D. Med. Chem. Commun. 2011, 2, 626-630. 
187 Beaud, R.; Guillot, R.; Kouklovsky, C.; Vincent, G. Chem. Eur. J. 2014, 20, 7492-7500. 
188 Chekler, E. L. P.; Khan, T. A.; Mamidala, R.; Anderson, J. T.; Tangirala, R. S.; Verhoest, P. R.; Gilbert, A. M. 
Tetrahedron Lett. 2012, 53, 377-379. 
Figure 27. Examples of Pharmaceutical Agents Possessing an Indoline Scaffold 
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constrained aniline motif. The aniline moiety is a well-known structural alert, a chemical fragment 
that is associated with adverse in vivo outcomes and/or adverse drug reactions (ADRs).189 These 
outcomes include but are not limited to mutagenicity, direct toxicity, carcinogenicity, DNA 
intercalation, or idiosyncratic toxicity. ADRs (and subsequent toxicity) from anilines are caused 
by two types of bioactivations: 1) hydroxylation of the aromatic ring resulting in reactive 
iminoquinones (367) and 2) oxidation of the amine which leads to reactive nitrenium (368) or 
nitroso (369) derivatives (Scheme 146).188 
One of the most direct ways to de-risk the aniline structural alert is to incorporate one or 
more nitrogens into the phenyl ring. These nitrogens will reduce the electron density of the 
aromatic ring, rendering oxidation to species 367-369 more difficult. Thus, the development of 
azaindoline pharmaceuticals is seen as novel approach to improve pharmacological profiles. 
Devillers and colleagues demonstrate this in their respective synthesis of a potent 
phosphodiesterase-4 (PED4) inhibitor.190 They report that high throughput screening and initial 
structure activity relationship (SAR) studies led to the identification of 9-amino-
tetrahydrodiazepinoindole compound CI-1044 (370). Despite showing high potency for PED4 
inhibition, the aniline structural fragment within CI-1044 (370) was considered to be a 
toxicophore. To address for this unwanted toxicity, the aniline moiety was replaced with an 
azaindoline residue via the synthesis of triaza-benzoazulen-9-one 371 (Figure 28). Other 
substituents such as a methoxy group at the 9-position and a nicotinic acyl side chain were chosen 
based on further SAR evaluation. When tested for PDE4 inhibition, compound 371 showed 
                                                          
189 Kalgutkar, A. S.; Dalvie, D. K.; O’Donnell, J. P.; Taylor, T. J.; Sahakian, D. C. Curr. Drug Metab. 2002, 3, 379-
424. 
190 Devillers, I.; Pevet, I.; Jacobelli, H.; Durand, C.; Fasquelle, V.; Puaud, J.; Gaudillière, B.; Idrissi, M.; Moreau, F.; 
Wrigglesworth, R. Bioorg. Med. Chem. Lett. 2004, 14, 3303-3306. 
Scheme 146. Aniline Bioactivation Pathways 
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comparable potency relative to 370 indicating that the activity range was conserved with the 
replacement of the aniline moiety. The difference, however, is that benzoazulenone 371 has a 
better pharmacological profile since the azaindoline scaffold derisks the aniline structural alert 
contained within the indoline analog (370). 
Sumiyoshi and co-workers utilized a similar approach in their search for selective M1 and 
M4 muscarinic acetylcholine receptor (mAChRs) agonists.
191 High throughput screening led to the 
identification of indoline spiropiperidine 372 as a hit compound (Figure 29). To account for 
potential ADRs from the aniline motif within compound 372, azaindoline analog 373 was 
synthesized as an initial lead compound. Further SAR studies led to the identification of compound 
374, which showed selective M1 and M4 mAChRs agonist activity and has good potential as an 
orally available antipsychotic with a novel mechanism of action. 
                                                          
191 Takai, K.; Inoue, Y.; Konishi, Y.; Suwa, A.; Uruno, Y.; Matsuda, H.; Nakako, T.; Sakai, M.; Nishikawa, H.; 
Hashimoto, G.; Enomoto, T.; Kitamura, A.; Uematsu, Y.; Kiyoshi, A.; Sumiyoshi, T. Bioorg. Med. Chem. Lett. 
2014. 24, 3189-3193. 
Figure 28. Phosphodiesterase Inhibition of Aniline and Azaindoline Compounds 370 and 371  
Figure 29. mAChR Agonist Activity of 7-Azaindoline Compounds 373 and 374 
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Based on these examples, it is evident that the azaindoline scaffold serves as a nice 
surrogate for the aniline moiety. Because of their reduced risk of ADRs and minimal effect on 
promising biological activity, acquisition of azaindoline-containing pharmaceutical candidates is 
of high importance. The most efficient means of accelerating the syntheses of these types of 
compounds is through developing new methodologies that readily access azaindoline 
functionalities.  
6.2. Known Methods for the Preparation of Azaindolines 
 The azaindoline motif has been successfully synthesized via a variety of protocols. 
Although numerous methods have been employed in order to arrive at each azaindoline ring 
system, there is only one unified approach that readily accesses all four isomeric azaindolines.192 
Of these four isomeric families, the most accessible azaindoline backbone to date is the 7-
azaindoline core. 
Among the earliest reports of successfully synthesizing the 7-azaindoline framework is that 
of van der Plas and colleagues. Here, they utilize an intramolecular inverse electron demand Diels-
Alder reaction of pyrimidines with side chain dienophiles in order to furnish the desired bicyclic 
system.193,194 When pyrimidine 375 is subjected to high temperature, the intramolecular [4+2] 
cycloaddition provides intermediate 376 (Scheme 147). This intermediate is then converted to 
acetylated 7-azaindoline 377 in situ upon the release of hydrogen cyanide (HCN). 
In a closely related manner, Taylor and co-workers report the use of an intramolecular 
inverse electron demand Diels-Alder reaction of 1,2,4-triazines bearing side chain dienophiles to 
promote the formation of 7-azaindoline motifs.195,196 Exposure of these triazine compounds (378) 
to elevated temperatures facilitates the cycloaddition generating the corresponding tricyclic 
                                                          
192 Bailey, W. F.; Salgaonkar, P. D.; Brubaker, J. D.; Sharma, V. Org. Lett. 2008, 10, 1071-1074. 
193 Frissen, A. E.; Marcelis, A. T. M.; van der Plas, H. C. Tetrahedron Lett. 1987, 28, 1589-1592. 
194 Frissen, A. E.; Marcelis, A. T. M.; van der Plas, H. C. Tetrahedron 1989, 45, 803-812. 
195 Taylor, E. C.; Macor, J. E.; Pont, J. L. Tetrahedron 1987, 43, 5145-5158. 
196 Taylor, E. C.; Pont, J. L. Tetrahedron Lett. 1987, 28, 379-382. 
Scheme 147. Synthesis of 7-Azaindolines via an Inverse Electron Demand Diels-Alder Reaction of Pyrimidines 
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intermediates (379) in situ (Scheme 148). Conversion of these cycloadducts to their desired 
azaindolines (380) is driven by the expulsion of nitrogen gas, a pathway analogous to that of van 
der Plas’s chemistry. 
In 2004, Sanders and colleagues inadvertently discovered that a highly functionalized 2-
aminopyridine can be transformed to a 7-azaindole core via a periodinane-mediated formation of 
a 7-azaindoline scaffold.197 Their initial goal was to treat advanced aminopyridine 381 with Dess-
Martin periodinane in order to arrive at aldehyde 382, which can then undergo a spontaneous 
intramolecular aldol cyclization to yield pyrido[2,3-b]azepinone 383. Upon exposure to DMP, the 
primary alcohol of compound 381 was oxidized as expected (Scheme 149). However, the resultant 
aldehyde did not react with the enol of the ketoester functionality. Instead, what they observed was 
                                                          
197 Sanders, W. J.; Zhang, X.; Wagner, R. Org. Lett. 2004, 6, 4527-4530. 
Scheme 148. Synthesis of 7-Azaindolines via an Inverse Electron Demand Diels-Alder Reaction of Triazines 
Scheme 149. Sanders’s Iodine(III)-Mediated Synthesis of 7-Azaindole 386 via 7-Azaindoline 385 
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a Friedel-Crafts-type cyclization en route to 7-azaindoline cationic intermediate 384. 
Rearomatization via intermolecular transfer of malonate to a reaction byproduct (not shown) 
affords a 3-hydroxy azaindoline (385) that leads to azaindole 386 upon dehydration. The proposed 
cationic intermediate (384) is exceptionally resonance-stabilized by three nitrogen atoms, and this 
thermodynamic stabilization combined with the kinetic advantage of five-membered ring 
formation could explain why the azaindoline moiety was generated in this reaction. 
Recently, Sumiyoshi and co-workers utilized an intramolecular nucleophilic aromatic 
substitution reaction to construct a 7-azaindoline scaffold (387) en route to synthesizing small 
molecule therapeutic candidates.198,191 Formation of this azaindoline core proceeded in a 
straightforward manner as commercially available (2-chloro-3-pyridinyl)methanol 388 was 
converted to chloride 389 in high yield upon treatment with POCl3 (Scheme 150). Nucleophilic 
displacement of the chloride with cyanide gave 390 in 98% yield. Treatment of 390 with N-benzyl-
bis(2-chloroethyl)amine in the presence of base afforded spiropiperidine 391 in modest yield. 
Reduction of the nitrile functionality in compound 391 and subsequent exposure to heat promoted 
the desired SNAr reaction, providing 7-azaindoline 387 in 84% isolated yield. This azaindoline 
serves as a key scaffold as a multitude of synthetic routes can be pursued in order to arrive at 
various pharmaceutical candidates. 
One compound of interest was that of N-sulfonyl-7-azaindoline 392. This compound can 
be delivered via a five-step synthetic sequence from 387. Azaindoline 387 was converted to 
intermediate 393 by mesylation and debenzylation (Scheme 151). Free amine 393 then underwent 
reductive amination with N-Boc-4-formylpiperidine (394) to afford compound 395 in quantitative 
                                                          
198 Suwa, A.; Konishi, Y.; Uruno, Y.; Takai, K.; Nakako, T.; Sakai, M.; Enomoto, T.; Ochi, Y.; Matsuda, H.; 
Kitamura, A.; Uematsu, Y.; Kiyoshi, A.; Sumiyoshi, T. Bioorg. Med. Chem. Lett. 2014, 24, 2909-2912. 
Scheme 150. Sumiyoshi’s Synthesis of a Key 7-Azaindoline Scaffold 
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yield. Boc-deprotection and subsequent acylation with ethyl chloroformate furnished desired 
compound 392 in good yield (68% yield over 2 steps).198 Target compound 374 could also be 
readily accessed from azaindoline 387 in a highly efficacious manner. Acylation of the free amine 
moiety with N,N-dimethylcarbamoyl chloride delivered urea 396 in quantitative yield. 
Debenzylation and reductive amination with ethyl 4-formylpiperidine-1-carboxylate 397 led to the 
desired target (374) in 86% yield over two steps.191 These two compounds (392 and 374) showed 
selective M1 and M4 mAChRs agonist activity and are promising antipsychotic candidates with 
novel mechanisms of action. 
Radical cyclization is another method that can be implemented in order to access the 7-
azaindoline backbone. Burgos and colleagues demonstrated this approach when utilizing an 
intramolecular radical pyridylation en route to synthesizing annulated 2-aminopyridines.199 
Treatment of aminopyridine 398 with AIBN and tris(trimethylsilyl)silane (TTMSS) produced aryl 
radical 399, which subsequently engaged in a number of mechanistic pathways ultimately 
generating a series of products (Scheme 152). Isolation of 7-azaindoline 400 (28% yield), suggests 
that the aryl radical underwent a 5-exo trig cyclization with the terminal alkene. Conversely, 
                                                          
199 Sánchez, A.; Núñez, A.; Burgos, C.; Alvarez-Builla, J. Tetrahedron Lett. 2006, 47, 8343-8346. 
Scheme 151. Synthesis of Antipsychotic Candidates 392 and 374 
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acquisition of tetrahydronaphthyridine 401 (10% yield) indicates that radical 399 proceeded 
through a 6-endo trig cyclization with the olefin. The main product (402) however, is thought to 
result from [1,5]-hydrogen transfer followed by a 5-exo trig cyclization (32% yield). 
Consequently, 403 was prepared in order to suppress the unwanted hydrogen atom transfer 
process. Under similar cyclization conditions, aryl radical 404 was generated, which gave rise to 
7-azaindoline 405 and naphthyridinone 406 via the 5-exo trig and 6-endo trig pathways (Scheme 
153). For this particular case, azaindoline 405 was the minor product. Another substrate that was 
employed in these studies was that of internal alkene 407. When 407 was treated with AIBN and 
TTMSS, radical 408 was generated subsequently affording 7-azaindoline 409 in 54% isolated 
Scheme 152. Burgos’s Synthesis of 7-Azaindoline 400 and Byproducts via Radical Cyclization 
Scheme 153. Radical Cyclizations en Route to 7-Azaindolines 405 and 409 
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yield. The favorability of the 5-exo trig cyclization for this experiment was thought to be driven 
by the stabilization of the resulting tertiary radical. 
Zard and co-workers were able to effectively synthesize 7-azaindoline cores via radical 
cyclizations using xanthate esters. As illustrated in their earliest report, treatment of xanthate 410 
with stoichiometric quantities of lauroyl peroxide results in the formation of radical 411 (Scheme 
154).200 Propagation of this radical with the pyridine ring generates radical species 412 and 
subsequent rearomatization furnishes the desired azaindoline (413) in modest yield (42%). This 
methodology was later extended to the synthesis of 3-alkyl-7-azaindolines (415) as well as fluoro-
7-azaindolines (417).201,202 These advanced azaindoline scaffolds arose through mechanistic 
pathways analogous to the one previously described. 
Radical cyclizations with azomethine have also been employed in order to arrive at the 7-
azaindoline framework. In 2001, Johnston and colleagues successfully synthesized this bicyclic 
                                                          
200 Ly, T.-M.; Quiclet-Sire, B.; Sortais, B.; Zard, S. Z. Tetrahedron Lett. 1999, 40, 2533-2536. 
201 Bacqué, E.; El Qacemi, M.; Zard, S. Z. Org. Lett. 2004, 6, 3671-3674. 
202 Liu, Z.; Qin, L.; Zard, S. M. Org. Lett. 2014, 16, 2704-2707. 
Scheme 154. Zard’s Radical-Mediated Synthesis of 7-Azaindolines Using Xanthate Esters 
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system via an unconventional aryl radical addition to azomethine nitrogen.203 Herein, amine 418 
was condensed with benzophenone to provide azomethine 419 (Scheme 155). Treatment of 419 
with AIBN and nBu3SnH at elevated temperatures results in the formation of radical 420. This 
radical then undergoes a regioselective 5-exo trig cyclization at the nitrogen position of the 
azomethine yielding 421. Termination of 421 with nBu3SnH affords the desired 7-azaindoline 
(422) in 50% yield over two steps. 
Johnston later extended this regioselective aryl radical addition to the synthesis of 7-
azaindoline α-amino esters.204 Subjection of enantioenriched α-amino ester 423 to the radical 
cyclization protocol afforded the desired 7-azaindoline α-amino ester (426) in 50% yield upon 
purification (Scheme 156). What is notable about this cyclization is that no diminishment in 
enantiopurity was observed. This indicates that ring fragmentation and subsequent radical 
                                                          
203 Johnston, J. N.; Plotkin, M. A.; Viswanathan, R.; Prabhakaran, E. N. Org. Lett. 2001, 3, 1009-1011.  
204 Viswanathan, R.; Mutnick, D.; Johnston, J. N. J. Am. Chem. Soc. 2003, 125, 7266-7271. 
Scheme 155. Johnston’s Regioselective Synthesis of 7-Azaindoline 422 
Scheme 156. Johnston’s Radical-Mediated Synthesis of 7-Azaindoline 426 with Complete Stereoretention 
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isomerization of the stereocenter does not occur en route to making the azaindoline system. This 
is unique as the phenyl analog (427) succumbs to loss of ee during the cyclization process, 
signifying that ring fragmentation and isomerization occurs for this particular substrate. The loss 
of stereochemical integrity can ultimately be owed to A1,3-strain. 
After seeing the retention of stereochemistry for the azaindoline system, Johnston and co-
workers then applied this free radical-mediated aryl amination to the synthesis of enantiopure 7-
azaindoline α-amino acids (Scheme 157).205,206 Formylation and reduction of commercially 
available 2-bromopyridine (433) affords compound 434 in modest yield (47% over 2 steps). 
Treatment of primary alcohol 434 with PBr3 furnishes alkyl bromide 435, which then undergoes a 
phase transfer-catalyzed glycine alkylation with azomethine 436 to deliver the R and S enantiomers 
(separately) of 423 in high yield and with high enantioselection. Subjection of both enantiomers 
of 423 to the 5-exo trig cyclization provides the respective 7-azaindoline α-amino esters (426a and 
426b) in modest yield and with complete stereoretention. Subsequent deprotection of the tert-butyl 
ester moiety under acidic conditions generates acid salts 439a and 439b in modest to good yield. 
Other methods for the synthesis of 7-azaindoline scaffolds include base- and metal-
mediated cyclizations. In 2004, Davies and colleagues utilized a directed ortho-
                                                          
205 Srinivasan, J. M.; Burks, H. E.; Smith, C. R.; Viswanathan, R.; Johnston, J. N. Synthesis 2005, 2, 330-333. 
206 Majumdar, K. C.; Basu, P. K.; Mukhopadhyay, P. P. Tetrahedron 2005, 61, 10603-10642. 
Scheme 157. Johnston’s Synthesis of Enantiopure 7-Azaindoline α-Amino Acids 
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metallation/transmetallation reaction in order to access annulated pyridines.207 For example, when 
Boc-protected aminopyridine 440 is treated with 2.2 equivalents of nBuLi in the presence of 
copper(I) bromide dimethyl sulfide (CuBr•Me2S) and TMEDA, dianion 441 is formed (Scheme 
158). The more reactive anion of species 441 undergoes alkylation with 1-chloro-2-iodoethane to 
deliver intermediate 442. Subsequent in situ cyclization gave the desired 7-azaindoline (443) in 
45% isolated yield. 
Shortly thereafter, Nguyen and Wang were able to promote an intramolecular SNAr 
reaction in the presence of potassium carbonate to furnish 7-azaindoline cores (Scheme 159).208 
Treatment of Boc-protected 1-fluoro-2-alkylamino-3-iodopyridine 444 with TFA afforded the 
precursor amine, which then succumbed to SNAr upon exposure to K2CO3 providing 4-iodo-7-
azaindoline 445 in good yield (66% yield over 2 steps). Similarly, subjection of benzyl-protected 
1-fluoro-2-alkylamino-3-iodopyridine 446 to K2CO3 facilitated the intramolecular cyclization 
delivering N-benzyl-4-iodo-7-azaindoline 447 in modest yield (55%). 
As for metal-mediated approaches, Desarbre and Mérour reported a palladium 
heteroannulation process for the synthesis of 7-azaindolines.209 To illustrate, aminopyridine 448 
was treated with 1-methoxypropadiene (449) and substoichiometric quantities of Pd(PPh3)2Cl2 at 
elevated temperature to afford 7-azaindoline 450 in 80% yield (Scheme 160). Mechanistically, it 
is proposed that aminopyridine 448 undergoes palladation followed by π-allylic complexation to 
arrive at allyl cation 451. With methoxyallene, the methoxy group stabilizes the carbocation at C1 
                                                          
207 Davies, A. J.; Brands, K. M. J.; Cowden, C. J.; Dolling, U.-H.; Lieberman, D. R. Tetrahedron Lett. 2004, 45, 
1721-1724. 
208 Nguyen, H. N.; Wang, Z. J. Tetrahedron Lett. 2007, 48, 7460-7463. 
209 Desarbre, E.; Mérour, J.-Y. Tetrahedron Lett. 1996, 37, 43-46.  
Scheme 158. Davies’s ortho-Metallation/Transmetallation Approach to 7-Azaindolines 
Scheme 159. Nguyen’s Base-Mediated Synthesis of 7-Azaindolines 
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rendering it the most electrophilic position. Regioselective attack by the nitrogen of the amide 
provides the corresponding azaindoline, consequently. 
In 2012, Moss and co-workers employed a one-pot magnesium-mediated ring-opening-
cyclization sequence in order to arrive at azaindoline scaffolds.210 To demonstrate the efficacy of 
this process, pyrimidine 452 was subjected to tetramethylpiperidine magnesium chloride lithium 
chloride complex (TMPMgCl•LiCl) resulting in the formation of magnesiated chloropyrimidine 
453 (Scheme 161). This motif can then undergo a facile ring opening with chiral Boc-protected 
sulfamidate 454 to furnish intermediate 455 upon loss of SO3. After an acidic workup (removal of 
the Boc group), this adduct engages in a rapid intramolecular cyclization upon basicification to 
give highly functionalized stereodefined azaindoline 456 in 85% isolated yield. 
Compared to 7-azaindoline backbones, methods to prepare the 6-azaindoline, 5-
azaindoline, and 4-azaindoline congeners are relatively scarce. As for 6-azaindolines, one way to 
access this bicyclic system is through van der Plas’s inverse electron demand Diels-Alder 
reaction.211 When pyrazine 457 is subjected to high temperature, the intramolecular 4+2 
cycloaddition proceeds to provide tricyclic intermediate 458 in situ (Scheme 162). Conversion of 
                                                          
210 Moss, T. A.; Hayter, B. R.; Hollingsworth, I. A.; Nowak, T. Synlett 2012, 23, 2408-2412. 
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Scheme 160. Mérour’s Palladium Heteroannulation en Route to 7-Azaindolines 
Scheme 161. Moss’s One-Pot Ring-Opening-Cyclization Sequence en Route to Azaindolines 
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this cycloadduct (458) to its corresponding 6-azaindoline (459) is driven by the elimination of 
hydrogen cyanide. The 7-azaindoline analog (460) is also furnished via tricycle 458, but as the 
minor product. 
Dodd and colleagues inadvertently accessed a 6-azaindoline moiety en route to making 6-
azaindole-5-carboxylates.212 After successfully synthesizing acyclic acetal 461, this intermediate 
was subjected to a Pomeranz-Fritsch cyclization using polyphosphoric acid (PPA) and phosphorus 
oxychloride (POCl3). Aside from furnishing the desired azaindole (462) in 23% yield, 6-
azaindoline 463 was also acquired, but as the minor product (Scheme 163). Due to the low yields 
observed under the Pomeranz-Fritsch protocol, other cyclization conditions were investigated. It 
was found that refluxing 461 in benzene in the presence of p-toluene sulfonic acid led to an 
improved overall yield of 462 and 463 (45%). For this particular case, however, 4,5,6,7-tetrahydro-
6-azaindole-5-carboxylate derivative 464 was formed as a minor byproduct. 
In 2005, Fayol and Zhu reported a highly efficacious three-component synthesis of 6-
azaindolines.213 The three substrates employed in this reaction system were that of an 
isocyanoacetamide, an amine, and an aldehyde. Treatment of morpholine with heptanal and 
isocyanoacetamide 465 in the presence of toluene at elevated temperature provided polysubstituted 
6-azaindoline 466 in modest yield (Scheme 164). Mechanistically, it is envisioned that morpholine 
                                                          
212 Dekhane, M.; Potier, P.; Dodd, R. H. Tetrahedron 1993, 49, 8139-8146. 
213 Fayol, A.; Zhu, J. Org. Lett. 2005, 7, 239-242. 
Scheme 162. Synthesis of 6-Azaindolines via an Inverse Electron Demand Diels-Alder Reaction of Pyrazines 
Scheme 163. Dodd’s Synthesis of 6-Azaindoline Scaffolds 
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condenses onto heptanal to deliver iminium 467. Addition of the isocyanoacetamide into the 
iminium yields nitrilium 468. Intramolecular attack of the amide to the nitrilium and subsequent 
tautomerization/aromatization provides oxazole 469. Interception of the resultant oxazole by the 
tethered dienophile via an intramolecular Diels-Alder cycloaddition affords oxa-bridge 
intermediate 470. Dehydration of the oxa-bridge compound leads to the desired 6-azaindoline 
(466). 
For the 5-azaindoline backbone, earliest reports of successfully constructing this bicyclic 
system include that of Yakhontov and co-workers.214 Herein, treatment of 3-alkyl-4,6-
dichloropyridine 471 with ammonia in ethanol at elevated temperature leads to the formation of 5-
azaindoline 472 (Scheme 165). This azaindoline is thought to arise via SN2 displacement of the 
alkyl chloride with ammonia followed by SNAr. Reduction of the aryl chloride with Pd/C and H2 
provides 5-azaindoline 473 in 71% yield over 2 steps. Additionally, subjection of 6-hydroxy-5-
azabenzofuran 474 to an excess of benzylamine at 190 °C led to benzyl-protected 6-hydroxy-5-
                                                          
214 Yakhontov, L. N.; Azimov, V. A.; Lapan, E. I. Tetrahedron Lett. 1969, 10, 1909-1912. 
Scheme 164. Zhu’s Three-Component Synthesis of 6-Azaindolines 
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azaindoline 475 in good yield (72%). Treatment of 475 with POCl3 converts the hydroxyl motif to 
a chloride and subsequent deprotection/reduction delivers free 5-azaindoline 473 in quantitative 
yield. 
Kauffmann and Fischer later reported that base-mediated side chain cyclizations can also 
be employed in order to access 5-azaindoline cores.215 Exposure of 3-(2-aminoethyl)-5-
bromopyridine 476 to lithium diethylamide not only deprotonates the free amine, it also promotes 
the formation of benzyne intermediate 477 (Scheme 166). Intramolecular addition of the amine to 
the benzyne affords the desired 5-azaindoline in moderate yield (56%). 
In 1998, Spivey and colleagues successfully synthesized N-methyl-5-azaindoline 478 as a 
precursor to atropisomeric analogues of DMAP.216,217 Beginning with commercially available 4-
aminopyridine (479), Boc-protection with (Boc)2O proceeded well as tert-butyl carbamate 480 
was furnished in excellent yield (95%) (Scheme 167). Base-mediated ortho-lithiation of 480 
followed by alkylation with ethylene oxide provided alcohol 481 in 75% yield. Mesylation and in 
situ cyclization delivered N-Boc azaindoline 482 (not shown). This intermediate was then reduced 
with DIBAL to give 1-methyl-5-azaindoline 483 in modest yield (52% over 2 steps). meta-
Bromination with NBS produced bromoarene 484 and the stage was now set for a palladium-
mediated Suzuki coupling. Treatment of 484 with 1-naphthylboronic acid (485) in the presence of 
palladium tetrakis and base delivered atropisomeric DMAP analog 478 in 96% yield. Other 
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Scheme 165. Yakhontov’s Synthesis of 5-Azaindolines 
Scheme 166. Kauffmann and Fischer’s Synthesis of 5-Azaindoline 473 via a Benzyne Intermediate 
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arylboronic acids underwent Suzuki cross couplings with bromoarene 484 to afford a library of 
DMAP derivatives. These biaryl 5-azaindoline scaffolds were then subjected to acylation reactions 
in order to test their efficacy as organocatalysts. 
Radical annulations have also been used as a means to access 5-azaindoline cores. In 2008, 
Wipf and co-workers developed a novel titanocene(III) chloride catalyzed epoxide-opening arene 
annulation that affords 3,3-disubstituted-5-azaindolines.218 To illustrate, when tethered epoxide 
486 is subjected to titanocene(III) chloride in the presence of stoichiometric magnesium metal, 
Cbz-protected 5-azaindoline 487 is produced (Scheme 168). Subsequent debenzylation delivers 
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Scheme 167. Synthesis of DMAP Analogs via 5-Azaindoline Intermediates 
Scheme 168. Titanocene(III)-Catalyzed Formation of 5-Azaindolines 
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3,3-disubstituted-5-azaindoline 488 in modest yield (52% over 2 steps). Mechanistically, it is 
proposed that formation of the β-titanoxy radical 489 is followed by a reversible annulation, which 
generates aryl radical 490. Oxidative rearomatization affords 491, and protodemetalation by 
collidinium hydrochloride leads to azaindoline 487 upon the regeneration of the precatalyst 
Cp2TiCl2. 
Zard and colleagues utilized xanthate esters in order to promote an unconventional radical-
mediated ipso substitution en route to generating 5-azaindolines.219 For example, treatment of 
polysubstituted aminopyridine 492 with di-tert-butyl peroxide in the presence of 1,2-
dichlorobenzene furnished fluorinated 5-azaindoline 493 in 45% isolated yield (Scheme 169). This 
azaindoline scaffold was acquired through a mechanistic pathway analogous to the previously 
reported 7-azaindoline studies.200,201,202 
As for 4-azaindoline scaffolds, few approaches have been reported that provide direct 
access to this bicyclic system. Among these methods is the use of photochemistry as described by 
Donati and co-workers.220 For example, 2-methyloxazolo[5,4-b]pyridine 494 is treated with ethyl 
vinyl ether in order to promote a photocycloaddition en route to pyridooxazepine 495 (Scheme 
170). This unstable intermediate then undergoes hydrolysis to give amide-aldehyde 496. Attack of 
the amide to the aldehyde generates the more stable 2-hydroxy-4-azaindoline (497) in low yield 
(23%). 
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Scheme 169. Zard’s Synthesis of 5-Azaindolines Using Xanthate Esters 
Scheme 170. Synthesis of 4-Azaindoline 497 via Photocycloaddition 
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Ciufolini and colleagues describe an alkoxyamine-mediated radical synthesis of 4-
azaindoline backbones.221 Treatment of aminopyridine 498 with alkoxyamine 499 affords 3,3-
disubstituted-4-azaindoline 500 in 30% yield upon chromatographic separation (Scheme 171). 
Mechanistically, it is postulated that alkoxyamine 499 (a tert-butyl radical source) propagates with 
the external alkene of 498 resulting in the formation of tertiary radical 501. Propagation of this 
radical with the pyridine moiety generates radical 502, which later furnishes 4-azaindoline 500 
after rearomatization. 
As previously mentioned, there is only one known unified approach that readily accesses 
all four isomeric azaindoline families. In 2008, Bailey and co-workers introduced an 
intramolecular carbolithiation sequence as a means of synthesizing 3-alkyl 4-, 5-, 6-, and 7-
azaindoline backbones.192 Precursor substrates were furnished via allylation of 
aminobromopyridines 503-506 (Scheme 172). The corresponding N,N-diallyl compounds (507-
510) were afforded in reproducible yields of 70-90%. Treatment of substrates 507 and 509 with 
2.2 equivalents of t-BuLi in the presence of dry n-pentane-diethyl ether generates the desired 
aryllithium intermediates. These aryllithium compounds were allowed to stand under argon 
atmosphere at 0 °C for 2 hours before being quenched with MeOH to provide 1-allyl-3-methyl-4-
azaindoline 511 and 1-allyl-3-methyl-6-azaindoline 512 in 80% and 56% yields, respectively. 
When diallyl aminopyridine 510 was subjected to nearly identical reaction conditions, 7-
azaindolines 513 and 514 were isolated in 22% and 70% yields. The same phenomenon was 
observed with precursor substrate 508 as 5-azaindoline products 515 and 516 were furnished in 
low to modest yield (27% and 43%). Repetition of the cyclization with substrates 508 and 510 
                                                          
221 Leroi, C.; Bertin, D.; Dufils, P.-E.; Gigmes, D.; Marque, S.; Tordo, P.; Couturier, J.-L.; Guerret, O.; Ciufolini, M. 
A. Org. Lett. 2003, 5, 4943-4945. 
Scheme 171. Ciufolini’s Alkoxy-Mediated Radical Synthesis of 4-Azaindolines 
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followed by reduction of the crude products delivered 3-methyl-7-azaindoline 518 and 3-methyl-
5-azaindoline 517 in 85% and 69% yields, respectively. 
6.3. Reaction Optimization and Substrate Scope 
 Hong and Johnston recently described a new method for the inter-/intramolecular 
annulative diamination of terminal alkenes via the use of an oxidant/additive combination (Scheme 
173).169 Treatment of tosylated vinylaniline (327) with PhI(OAc)2, KI, and a broad range of 
electron-rich amines effectively delivered a library of 3-aminoindolines without the need for amine 
preactivation and protection. This approach displayed a high degree of generality as both mono- 
and disubstituted amines were successfully converted to their respective indoline products. 
Scheme 172. Bailey’s Unified Approach to All Four Isomeric Azaindoline Families 
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Based on the success of the aforementioned reaction system, we sought to extend this 
methodology to the synthesis of all four azaindoline heterocycle families. The goal was to convert 
four isomeric vinylpyridine substrates to their corresponding 3-amino azaindoline scaffolds via a 
hypervalent iodine-/iodide-mediated inter-/intramolecular annulative diamination, an approach 
analogous to that of Hong and Johnston’s (Scheme 174). Introduction of pyridine-derived starting 
materials provides an opportunity to evaluate the compatibility of Lewis basic pyridine nitrogens 
with the oxidative, electrophilic (I+) conditions. 
The first substrate to be examined was that of 3-vinyl-2-tosylaminopyridine (519). 
Acquisition of this starting alkene was straightforward as commercially available 2-amino-3-
bromopyridine (506) was subjected to a Stille coupling with tributyl(vinyl)tin to afford free vinyl 
aminopyridine 520 in 90% yield upon chromatographic separation (Scheme 175). Subsequent 
tosylation of 520 under basic conditions and at elevated temperature gave 3-vinyl-2-
tosylaminopyridine (519) in 23% isolated yield. 
Scheme 173. Hong and Johnston’s Iodine(III)-Mediated Inter-/Intramolecular Diamination of Terminal Alkenes 
Scheme 174. Inter-/Intramolecular Diamination of Vinylpyridines en Route to All Four Azaindoline Families 
Scheme 175. Synthesis of Vinyl Aminopyridine 519 
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With vinyl aminopyridine 519 in hand, the stage was now set for reaction optimization. 
Electrophilic iodinating reagents were the first variant to be examined. When NIS was employed 
as the iodinating agent in the presence of vinylpyridine 519 and aniline (the amine source), 3-
amino-7-azaindoline 521a was provided but in low yield (Table 23, entry 1). When the iodonium 
source was generated through PhI(OAc)2 and KI, the desired azaindoline was furnished in 96% 
isolated yield, once again proving the superiority of the oxidant/additive combination (Table 23, 
entry 2). Use of tetrabutylammonium iodide as the halide source proved slightly inferior as 
azaindoline 521a was afforded in 80% yield (Table 23, entry 3). Ammonium iodide further 
mitigated reactivity as 521a was acquired in only 29% yield (Table 23, entry 4). Use of both 
components of the oxidant/additive combination proved vital, as no conversion to product was 
observed when starving the reaction conditions of either the oxidant or the halide additive (Table 
23, entries 5-7). Catalytic quantities of iodide proved effective as 30 mol% and 50 mol% loadings 
of KI led to 63% and 65% isolated yields of azaindoline 521a, respectively (Table 23, entries 8-
9). Despite the success seen with substoichiometric amounts of halide, stoichiometric quantities 
were necessary as they provided the most fruitful results. 
With optimum reactivity achieved, the next goal was to expand the 3-amino-7-azaindoline 
library. Monosubstituted aliphatic amines in benzylamine and allylamine successfully engaged in 
diamination as 3-amino-7-azaindoline products 521b and 521c were afforded in 73% and 62% 
yields, respectively (Table 24, entries 2-3). Heterocyclic disubstituted amines were also tolerated 
entry oxidant 
oxidant 
equiv 
additive 
additive 
equiv 
conversion 
(%) 
yield 
(%) 
1 NIS 1.2 - - 100 11 
2 PhI(OAc)2 1.5 KI 1.0 100 96 
3 PhI(OAc)2 1.5 nBu4NI 1.0 100 80 
4 PhI(OAc)2 1.5 NH4I 1.0 77 29 
5 PhI(OAc)2 1.5 - - 0 - 
6 - - nBu4NI 1.0 0 - 
7 - - KI 1.0 0 - 
8 PhI(OAc)2 1.5 KI 0.3 75 63 
9 PhI(OAc)2 1.5 KI 0.5 88 65 
Table 23. Initial Optimization Studies of the Inter-/Intramolecular Annulative Diamination 
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as thiomorpholine and morpholine delivered their corresponding azaindolines (521d and 521e), 
albeit in depressed yields (39% and 57%) (Table 24, entries 4-5). 
Efforts then shifted towards generating a 3-amino-6-azaindoline library from vinyl 
aminopyridine 522. Synthesis of this vinylpyridine substrate was initiated when commercially 
available 3-amino-4-bromopyridine (505) was treated with tosyl chloride in the presence of 
KHMDS to afford tosylated bromopyridine 523 in 34% yield (Scheme 176). Intermediate 523 was 
then subjected to a palladium-mediated Stille coupling with tributyl(vinyl)tin at elevated 
temperature to provide 4-vinyl-3-tosylaminopyridine 522 in modest yield (41%). 
This vinylpyridine substrate (522) was then treated with aromatic, primary, and secondary 
amines in order to generate a series of 6-azaindoline scaffolds. Aniline and benzylamine proved 
tolerant in this system as the desired 3-amino-6-azaindoline products (524a and 524b) were 
furnished in 11% and 48% yields, respectively (Table 25, entries 1-2). Furthermore, Cbz-, Boc-, 
and ethyl carboxylate-protected piperazines were readily converted to their corresponding 6-
azaindolines (524c-524e) with good yields (Table 25, entries 3-5). These three diamines are 
notable as they allow for subsequent unmasking of the piperazine moiety under neutral, acidic, or 
basic conditions. 
Table 24. 3-Amino-7-Azaindoline Scope 
entry 521 R 
yield 
(%) 
1 a Ph (aniline) 96 
2 b CH2Ph (benzylamine) 73 
3 c CH2CHCH2 (allylamine) 62 
4a d C4H8S (thiomorpholine) 39 
5 e C4H8O (morpholine) 57 
Scheme 176. Synthesis of Vinyl Aminopyridine 522 
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Our focus then centered upon successfully generating the 5-azaindoline congener. Vinyl 
aminopyridine 525, the precursor to 5-azaindoline diamines, was synthesized via a pathway 
analogous to those of the 7-azaindoline and 6-azaindoline precursor substrates. 4-Amino-3-
bromopyridine (504) underwent tosylation with KHMDS, providing intermediate 526 in 51% yield 
post column chromatography (Scheme 177). This tosylated amino bromopyridine was then 
subjected to a Stille coupling with tributyl(vinyl)stannane in order to arrive at vinylpyridine 525 
in low yield (15%). 
This vinyl aminopyridine (525) proved to be an effective substrate as it was compatible 
with a wide array of amines. Aniline performed well under optimal conditions, as 5-azaindoline 
product 527a was furnished in 81% yield (Table 26, entry 1). Benzylamine and derivatives were 
converted to 3-amino-5-azaindolines 527b-527d in 43-51% yield (Table 26, entries 2-4). Alkyl 
amines including 3-methoxypropylamine and phenethylamine performed similarly (Table 26, 
entries 5-6). Other primary amines such as 4-amino tetrahydropyran and 3-picolylamine delivered 
their corresponding 3-amino-5-azaindolines (527g and 527h) in 33% and 64% yields respectively, 
when subjected to the reaction protocol (Table 26, entries 7-8). A secondary amine in 
thiomorpholine also engaged in diamination as 5-azainodline 527i was afforded, albeit in lower 
yield (Table 26, entry 9). 
entry 524 R 
yield 
(%) 
1 a Ph (aniline) 11 
2 b CH2Ph (benzylamine) 48 
3 c 
R’ = Cbz 63 
4 d R’ = CO2Et 66 
5 e R’ = Boc 74 
Table 25. 3-Amino-6-Azaindoline Scope 
Scheme 177. Synthesis of Vinyl Aminopyridine 525 
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The next objective was to apply this inter-/intramolecular annulative diamination protocol 
towards the synthesis of 3-amino-4-azaindolines and consequently confirm that all four isomeric 
azaindoline families could be readily accessed. Synthesis of 2-vinyl-3-tosylaminopyridine (528) 
proceeded in a straightforward manner as tosylation of commercially available 3-amino-2-
bromopyridine (503) delivered tosylated bromopyridine 529 (Scheme 178). This compound, 
carried on quantitatively, underwent a Stille coupling with tributyl(vinyl)tin in order to generate 
vinyl aminopyridine 528 in 37% yield over two steps. 
Development of the 4-azaindoline library was straightforward and suitable with aromatic, 
primary, and secondary amines. Aniline and 4-tert-butyl aniline were successfully converted to 
their corresponding 3-amino-4-azaindolines (530a and 530b) in 70% and 41% yields, respectively 
(Table 27, entries 1-2). Benzylamine performed well as its 4-azaindoline (530c) was provided in 
good yield (Table 27, entry 3). Other primary amines in the form of cyclopentylamine and 
phenethylamine also engaged in diamination as vicinal diamines 530d and 530e were afforded in 
59% and 68% yields (Table 27, entries 4-5). Disubstituted amines in piperidine and ethyl 
isonipecotate proved compatible under optimal conditions as 4-azaindoline diamines 530f and 
530g were isolated in modest to good yields (Table 27, entries 6-7). N-Protected piperazines led 
Table 26. 3-Amino-5-Azaindoline Scope 
entry 527 R 
yield 
(%) 
1 a Ph (aniline) 81 
2 b CH2Ph (benzylamine) 43 
3 c CH3C6H4CH2 (4-methylbenzylamine) 45 
4 d FC6H4CH2 (4-fluorobenzylamine) 51 
5 e (CH2)3OMe (3-methoxypropylamine) 48 
6 f CH2CH2C6H5 (phenethylamine) 48 
7 g C5H9O (4-aminotetrahydropyran) 33 
8 h 3CH2C5H4N (3-picolylamine) 64 
9 i C4H8S (thiomorpholine) 34 
Scheme 178. Synthesis of Vinyl Aminopyridine 528 
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to 3-amino-4-azaindolines 530h and 530i in good yields, allowing for subsequent unmasking of 
the piperazine under both basic and acidic conditions (Table 27, entries 8-9). Further success with 
piperazines was demonstrated when N-cinnamyl piperazine delivered 3-amino-4-azaindoline 530j 
in 66% isolated yield (Table 27, entry 10). Lastly, the HCl salt of glycine methyl ester underwent 
annulative diamination as 4-azaindoline 530k was furnished in moderate yield (Table 27, entry 
11). For this particular case, K2CO3 was incorporated in the reaction system with the sole purpose 
of liberating the free base of the glycine methyl ester. This modification had little or no effect on 
reaction progression as azaindoline 530k could be cleanly isolated in a straightforward manner. 
This entry demonstrates that amino acid derivatives can be readily incorporated into azaindoline 
motifs. 
6.4. Mechanistic Hypothesis 
A mechanistic hypothesis is depicted in Figure 30. It is believed that electrophilic 
iodinating agent A is generated upon the interaction of PhI(OAc)2 with KI. Attack of iodane A 
with nucleophilic amine results in the formation of iodamine B. Association of B with the alkene 
moiety of vinylpyridine C leads to aziridinium D. This intermediate (D) then succumbs to 
intramolecular cyclization via nucleophilic attack of the tosylated amine at the least-hindered 
position of the aziridinium ring to yield the desired azaindoline product (E). 
entry 530 R 
yield 
(%) 
1 a Ph (aniline) 70 
2 b 4-tBu-C6H4  41 
3 c CH2Ph (benzylamine) 88 
4 d C5H9 (cyclopentylamine) 59 
5 e CH2CH2C6H5 (phenethylamine) 68 
6 f C5H10 (piperidine) 63 
7 g C8H14O2 (ethyl isonipecotate) 71 
8 h 
R’ = CO2Et 86 
9 i R’ = Boc 74 
10 j R’ = CH2CHCHC6H5 66 
11a k CH2COOCH3•HCl (glycine methyl ester•HCl) 63 
Table 27. 3-Amino-4-Azaindoline Scope 
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6.5. Future Work  
Based on the high degree of success observed with this annulative diamination, there are several 
directions that can be pursued in order to make this system more efficacious. One pathway to 
explore would be the extension of this methodology to the synthesis of 3-alkyl-3-
aminoazaindolines (Scheme 179). If α-alkylated vinyl pyridines can successfully engage in the 
PhI(OAc)2/KI-mediated annulative diamination, this would give rise to azaindoline products 
bearing tetrasubstituted carbons. Not only would this approach be seen as a novel method to 
prepare heterocycles with quaternary carbon centers, these scaffolds may also garner interest as 
they can serve as structural cores for compounds of medicinal importance. 
 The enantioselective variation of this inter-/intramolecular alkene diamination is another 
route to be taken. This can be probed by subjecting a number of chiral organocatalysts (e.g. PBAM) 
to the previously developed protocol (Scheme 180). Application of chiral hypervalent iodine 
reagents, as described by Muñiz and Ishihara, is another plausible approach that could readily 
achieve enantioselection. If the use of organocatalysts and/or transition-metal-free methods prove 
Figure 30. Mechanistic Hypothesis for the Inter-/Intramolecular Annulative Diamination 
Scheme 179. Proposed Synthesis of 3-Alkyl-3-Amino-Azaindolines 
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fruitless, transition-metal catalysis can also be employed in order to induce enantioselectivity. Due 
to the evidence of halamine formation, it is feasible for a transition metal to oxidatively add 
between the nitrogen-iodine bond and have a chiral bidentate ligand (e.g. Box ligand) promote 
enantioselection via coordination to the metal-halamine complex. These investigations are 
currently ongoing within our laboratory. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 180. Potential Enantioselective Variation of the Annulative Diamination 
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Chapter 7. Efforts Towards the Enantioselective Synthesis of Sesbanine: A 
Potential Antileukemic 
7.1. Background 
 Leukemia is a type of cancer of the blood or bone marrow that is characterized by the 
uncontrolled proliferation and accumulation of leukocytes (i.e. white blood cells). As there are 
many different types of leukocytes, there can be many different forms of leukemia. The four most 
important forms of leukemia, however, are derived from only two types of cells.222 
 Acute and chronic lymphocytic leukemias constitute two of the four important forms of 
this cancer. Lymphocytic leukemia results from malignancies of lymphocytes, which are cells 
produced in the lymphoid organs (i.e. the spleen, lymph nodes, and thymus) and in the bone 
marrow. Acute and chronic myelogenous leukemias make up the other two important forms of this 
cancer. Myelogenous leukemias (also known as myelocytic leukemias) are disorders of 
granulocytes. Granulocytes, a category of white blood cells produced by bone marrow, are 
responsible for engulfing and digesting bacteria as well as other small particles.222 
 Acute leukemias typically appear suddenly, with symptoms like those of a cold, and 
progress rapidly. Upon progression, the lymph nodes, spleen, and liver may become infiltrated 
with leukocytes and enlarged. Additional symptoms may include bone pain, paleness, a tendency 
to bleed easily, and a high susceptibility to infections. Immediate treatment of acute leukemias is 
necessary as failure to treat these types may result in death in as little as three months after onset.222 
 Chronic leukemias, however, begin much more slowly. Many cases are discovered during 
routine blood examinations, and several years may pass before significant symptoms appear. 
Although the symptoms of chronic leukemias are similar to those of acute leukemias, patients with 
the chronic types can live as long as three years after onset without having to undergo any form of 
treatment.222 
 Leukemia can affect people of all ages, and can be a considerably fatal disease if not treated 
properly. A World Health Organization study conducted in 2000 estimated that 255,932 children 
and adults around the world had developed some form of leukemia, and 209,328 have died from 
it indicating an 82% mortality rate.223 It is also known that certain types of leukemia are more 
                                                          
222 Maugh II, T. H. Science 1974, 185, 48-51. 
223 Mathers, C. D.; Boschi-Pinto, C.; Lopez, A. D.; Murray, C. J. L.: Cancer incidence, mortality and survival by site 
for 14 regions of the world. Geneva: World Health Organization; 2001.  
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prominent in select stages of life. Acute lymphocytic leukemia (ALL), for example, is the most 
common type of childhood cancer, accounting for approximately one-third of all childhood 
neoplasms in developed countries.224,225 It is estimated that 2,900 children and adolescents under 
age 20 are diagnosed with ALL each year. It is most common in younger children, especially 
children ages two and three. The five-year survival rate of children with ALL is 85% for children 
younger than 15 and 50% for teens aged 15 to 19.225 
 Conversely, chronic lymphocytic leukemia (CLL) is the most common type of leukemia 
among adults in the western world. The incidence of CLL in the United States alone is 
approximately 3.9 cases per 100,000 inhabitants, and the median age of diagnosis is 72. The 
clinical course of CLL is heterogeneous and survival times range from a few years to several 
                                                          
224 Rudant, J.; Amigou, A.; Orsi, L.; Althaus, T.; Leverger, G.; Baruchel, A.; Bertrand, Y.; Nelken, B.; Plat, G.; 
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225 Cancer.Net Editorial Board (2015). Leukemia – Acute Lymphoblastic – ALL – Childhood – Statistics. [Online]. 
Available: http://www.cancer.net/cancer-types/leukemia-acute-lymphoblastic-all-childhood/statistics [2016, Jan 18]. 
Figure 31. Chemotherapeutic Agents Used in the Treatment of Acute Lymphocytic Leukemia (ALL) 
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decades. However, approximately 5 to 20% of CLL patients develop Richter’s syndrome, an 
aggressive lymphoma, which results in a short survival time.226  
 A variety of methods are used to treat leukemia, the most common being chemotherapy. 
The combinations of drugs used in chemotherapeutic treatments are ultimately dependent upon the 
type of leukemia present in the patient. For patients diagnosed with ALL, the first combination of 
drugs to be used successfully for induction chemotherapy included vincristine and corticosteroids, 
most often prednisone. Forty to sixty percent of patients treated with this combination achieved 
complete remission, although the median remission duration was only three to seven months. 
Anthracyclines, such as doxorubicin and daunorubicin, were later incorporated into this 
combination, and the complete remission rate rose from 47% to 85%. Other chemotherapeutic 
agents have been incorporated into induction regimens to improve results including 
cyclophosphamide, L-asparaginase, cytarabine, etoposide, teniposide, and amsacrine (Figure 31). 
Though these agents proved effective in treating ALL, the overall results seem to be equivalent to 
those with vincristine, anthracyclines, and corticosteroids.227 
For consolidation chemotherapy, the use of high dose methotrexate, sometimes in 
combination with 6-mercaptopurine (6MP) or with teniposide and cytarabine, and asparaginase 
has significantly contributed to a cure rate of 70-80% among children with ALL (Figure 31). As 
for adults however, some reviews concluded that consolidation chemotherapy has not improved 
                                                          
226 Zhou, X.-X.; Wang, X. Mol. Med. Rep. 2013, 8, 719-725.  
227 Cortes, J. E.; Kantarjian, H. M. Cancer 1995, 76, 2393-2417. 
Figure 32. Purines and Other Agents Used in the Treatment of Chronic Lymphocytic Leukemia (CLL) 
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results, whereas others disagreed. Maintenance chemotherapy has proven valuable, especially in 
cases of childhood ALL. Similar to consolidation chemotherapy, this therapy is usually given with 
6MP and methotrexate and is continued for 2 years.227 
Patients diagnosed with CLL are typically subjected to purine-based chemotherapeutic 
treatments. Three purine analogues are currently used in CLL chemotherapy: fludarabine, 
pentostatin, and cladribine. Fludarabine remains by far the best studied compound of the three in 
CLL, and fludarabine monotherapy produces superior overall response rates compared with other 
treatment regimens containing alkylating agents or corticosteroids. Additionally, it has been 
demonstrated that fludarabine induces more remissions and more complete remissions than other 
conventional chemotherapies, such as CHOP (cyclophosphamide, doxorubicin, vincristine, 
prednisone), CAP (cyclophosphamide, doxorubicin, prednisone), or chlorambucil (Figure 32). 
Though fludarabine has proven to be a powerful therapeutic, chemotherapy for CLL is not limited 
to monotherapy with purine analogues. A number of monoclonal antibodies have been approved 
and can be used in combination with fludarabine. Some monoclonal antibodies include 
alemtuzumab, ofatumumab, and rituximab (Figure 33). The most thoroughly studied combination 
chemotherapy for CLL is fludarabine plus cyclophosphamide (FC). In preliminary, non-
comparative trials, the overall response rates did not improve relative to using fludarabine alone. 
However, the addition of cylcophosphamide appeared to improve the quality of responses.228 
Additional studies have also confirmed that fludarabine and cyclophosphamide (FC) have 
achieved complete remission in approximately 24% to 39% of patients. Yet when introducing the 
monoclonal antibody rituximab to fludarabine and cyclophosphamide (FCR), the complete 
remission rates rose to 70% in chemotherapy-naïve patients. Thus, incorporation of a monoclonal 
antibody in CLL chemotherapy yields vast improvements.229 
Myelogenous leukemias are treated with a much smaller range of chemotherapeutic agents. 
Patients diagnosed with acute myelogenous leukemia (AML) are often subjected to a “3+7” 
induction chemotherapy regimen. This “3+7” therapy consists of treating the patient with an 
anthracycline (most commonly daunorubicin) for 3 days followed by a 7-day treatment with 
cytarabine. These “3+7” regimens have proven effective as complete remission is achieved in 60% 
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to 80% of younger adults.230 Patients diagnosed with chronic myelogenous leukemia (CML) are 
often treated with imatinib (also known as Gleevec) (Figure 34). Imatinib is effective as a single 
agent for the treatment of patients in all stages of CML, with the most encouraging results seen in 
patients in chronic phase disease. Hematologic and cytogenetic responses to imatinib for the 
treatment of chronic phase CML have permitted imatinib to be registered as the first-line treatment 
for newly diagnosed CML.231 
Although it has been shown that a number of clinically effective drugs can treat leukemia, 
there are other agents that have shown promising antileukemic activity as well. Amongst these 
agents is sesbanine, a novel alkaloid compound that has been produced from the tissue of a 
leguminous plant known as Sesbania drummondii (commonly known as coffeebean, rattle bush, 
or rattle box).232,233 First isolated by Powell and colleagues in 1979, sesbanine and other members 
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Figure 33. Monoclonal Antibodies Used in the Treatment of Chronic Lymphocytic Leukemia (CLL) 
Figure 34. Agents Used in the Treatments of Acute and Chronic Myelogenous Leukemias (AML and CML) 
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of Sesbania drummondii are significantly active against lymphocytic leukemia P-388 in 
vivo.234,235,236 Along with its potential as an antileukemic, sesbanine also possesses a unique 
structural composition. Structural elucidation shows that this molecule has a previously unreported 
and highly unusual spirocyclic structure based on the 2,7-naphthyridine framework (Figure 35).234 
With the combination of its potent antileukemic activity and unconventional structure, sesbanine 
serves as an attractive target for organic synthesis. 
7.2. Previous Syntheses of Sesbanine  
 A number of stereospecific and stereoselective syntheses of sesbanine have previously 
been reported in literature. These approaches are highly efficacious as the desired alkaloid can be 
successfully furnished within five to eight synthetic steps. Furthermore, these syntheses feature a 
variety of key reactions that ultimately facilitate the access of sesbanine. 
 In 1980, Kende and Demuth reported a stereospecific synthesis of sesbanine (531) utilizing 
a key cycloannelation reaction.237 Beginning with 4-methylnicotinonitrile (532), a direct 
carbethoxylation reaction with diethyl carbonate and NaHMDS provided cyanoester 533 in 40% 
yield, setting the stage for the key cycloannelation step (Scheme 181). Treatment of 533 with 1,2-
epoxy-4-bromobutane in the presence of absolute ethanol and K2CO3 afforded cyclopentanol 
product 534 as a single racemic diastereomer (40-45% yield). Further experimentation and 
characterization determined that 534 was indeed the undesired cis-stereoisomer. To account for 
the incorrect stereochemistry, the free alcohol of compound 534 was tosylated furnishing tosylate 
535 in 67% yield. Nucelophilic displacement of the tosylate with tetraethylammonium acetate and 
subsequent mild hydrolysis gave cyclopentanol 536 in good yield (83% over 2 steps) and with the 
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Figure 35. Structure of Sesbanine 
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desired stereochemistry. The synthesis was completed when cyclopentanol 536 underwent a mild 
hydrolytic cyclization to arrive at sesbanine (531) in 60% yield. 
 Shortly after the publication of Kende and Demuth’s synthesis, Tomioka and Koga 
described their respective synthesis of sesbanine, which utilized a very similar approach.238,239 4-
methylnicotinonitrile was converted to cyanoester 533 via an alkoxycarbonylation reaction with 
diethyl carbonate and NaH (Scheme 182). When 533 underwent cycloannelation with racemic 1,4-
dibromobutan-2-ol, cyclopentanol 534 was provided, but only as the cis-stereoisomer. Because of 
the selectivity for the cis-isomer, optically active 1,4-dibromobutan-2-ol (537) was later employed 
in the key cycloannelation step delivering cyclized product 534 in 27% yield. The stereoinversion 
of the hydroxyl group in compound 534 was achieved via a Mitsunobu reaction affording acetate 
538 in high yield (91%). Cleavage of the acetate moiety under basic conditions furnished desired 
alcohol 536 in 98% yield. Treatment of 536 with alkaline hydrogen peroxide in aqueous ethanol 
promoted a cyclic-imide formation to give sesbanine (531) in modest yield (67%). 
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Scheme 181. Kende and Demuth’s Stereospecific Synthesis of Sesbanine 
Scheme 182. Tomioka and Koga’s Synthesis of Sesbanine 
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In 1983, Iwao and Kuraishi reported the synthesis of sesbanine via the directed metalation 
of tertiary nicotinamides.240 This synthetic route was initiated when readily available N,N-
diisopropylnicotinamide (539) was selectively lithiated at the 4-position with LiTMP to provide 
lithiated species 540 (not isolated) (Scheme 183). Condensation of 540 with 3-cyclopentenone and 
subsequent treatment with TFA afforded spirolactone 541 (63% yield over 3 steps). Lactone 541 
was reductively cleaved with zinc-copper couple to give acid 542 in 94% yield. This acid was once 
again lithiated with LiTMP, generating dianion 543. This dianionic species was then carboxylated 
with dry ice, neutralized with methanolic HCl, and subsequently treated with freshly prepared 
diazomethane to furnish diester 544 in 52% yield over the course of 3 steps. Treatment of 544 with 
NBS in aqueous DMSO gave bromohydrins 545 and 546 in 38% and 21% yields, respectively. 
Both bromohydrins were converted to their corresponding alcohols (547 and 548) via a reductive 
dehalogenation with nBu3SnH and AIBN. The undesired alcohol (547) was epimerized to desired 
alcohol 548 via a Mitsunobu reaction and subsequent hydrolysis of the acetate functionality (85% 
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Scheme 183. Iwao and Kuraishi’s Synthesis of Sesbanine 
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yield over 2 steps). Alcohol 548 was successfully converted to sesbanine in 80% yield upon heating 
in methanolic NH3. 
Pandit, Wanner, and Koomen demonstrate that the condensation of a carboxylate ester with 
N-benzylnicotinamide can serve as a viable approach in order to arrive at sesbanine.241,242 Known 
methyl 3-oxocyclopentanecarboxylate (549) was converted to acetal 550 in 92% yield upon 
treatment with ethylene glycol under acidic conditions (Scheme 184). 550 was then deprotonated 
with LDA, and the corresponding anion was allowed to react with N-benzylnicotinamide 551 in 
order to provide tricyclic system 552 after workup. The dihydropyridine ring of 552 was oxidized 
with N-benzylquinolinium bromide in acetonitrile, and the resulting pyridinium salt was 
debenzylated by heating under vacuum. Subsequent deprotection of the acetal moiety furnished 
sesbanine precursor 553 in modest yield (44% over 3 steps). Ketone 553 was then subjected to a 
Meerwein-Ponndorf-Verley reduction with Al(iPrO)3 affording a mixture of sesbanine (531) and 
epi-sesbanine (554) in a 6:1 ratio (58% yield). 
Wada, Nishihara, and Akiba later describe a synthesis of sesbanine that utilizes a 
regioselective γ-addition of a silyl enol ether into a quaternized methyl nicotinate.243 Treatment of 
commercially available methyl nicotinate with methyl chloroformate generates a pyridinium salt, 
which is then condensed in situ with the ketene silyl acetal of methyl 3-cyclopentenecarboxylate 
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Scheme 184. Pandit, Wanner, and Koomen’s Synthesis of Sesbanine 
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to provide compound 556 (Scheme 185). Subsequent oxidation of 1,4-dihydropyridine 556 with 
DDQ furnished diester 544 in good yield (77% over 3 steps). Subjection of diester 544 to an 
oxymercuration protocol delivered alcohols 547 and 548 upon careful reduction with NaBH4. 
Fortunately, the desired alcohol (548) was obtained stereoselectively in 64% yield along with 
undesired epimeric alcohol 547 (7% yield). Imide formation en route to sesbanine was successfully 
achieved in 86% yield when 548 was heated in methanolic HCl at 100 °C in a sealed tube. 
Bottaro and Berchtold employ a key halolactonization reaction in their respective synthesis 
of racemic sesbanine.244 Beginning with known 4-(methoxycarbonyl)nicotinic acid, reduction with 
LiAlH4 and subsequent treatment with PCl5 led to chloromethyl acyl chloride 558 (Scheme 186). 
Methanolysis of the acyl chloride and nucleophilic displacement of the alkyl chloride with NaCN 
delivered cyanoester 559 in 19% yield over the course of 4 steps. Cyanoester 559 then underwent 
an inter/intramolecular bis-substitution reaction at the benzylic position with (Z)-1,4-dichlorobut-
2-ene providing intermediate 560 in modest yield (42% yield). With intermediate 560 in hand, the 
stage was now set for the stereospecific iodolactonization step. Ester 560 was saponified with base 
generating the precursor acid (not isolated). The resulting saponification mixture was immediately 
treated with I2, KI, and NaHCO3 in order to promote the halolactonization in situ. Upon isolation 
of the desired iodolactone (561), this compound underwent reductive dehalogenation with 
nBu3SnH and AIBN, furnishing lactone 562 (not shown) in satisfactory yield (60% yield over 3 
steps). Aminolysis of lactone 562, intramolecular addition of the amide anion to the nitrile group, 
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Scheme 185. Wada, Nishihara, and Akiba’s Synthesis of Sesbanine 
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and hydrolysis to the imide via aqueous workup afforded racemic sesbanine in good yield (70% 
yield over 3 steps). 
7.3. Initial Efforts Towards the Enantioselective Synthesis of Sesbanine 
 The use of a halolactonization reaction in Bottaro and Berchtold’s synthesis of sesbanine 
garnered interest as similar chemistry has been pursued within our laboratory. Recently, Dobish 
and Johnston employed a chiral proton catalyst-N-iodosuccinimide (NIS) reagent system to 
facilitate highly enantioselective iodolactonizations of alkenes.245 Herein, the triflimide salt of a 
chiral stilbene diamine-derived bis(amidine) organocatalyst (StilbPBAM•HNTf2, 88•HNTf2) 
promotes the transformation of a broad range of unsaturated carboxylic acids to their 
corresponding γ-lactones in high yields and with excellent levels of enantioselection (Scheme 
187). Based on this success and on Bottaro and Berchtold’s synthesis, we saw this as an 
opportunity to achieve two primary objectives: 1) to extend this methodology to carboxylic acids 
bearing internal Z-alkenes and 2) to apply this system towards an enantioselective synthesis of 
sesbanine. 
Retrosynthetically, the endgame strategy for our respective synthesis will be identical to 
that of Bottaro and Berchtold’s. Sesbanine (531) can arise from intermediate 563 through a base-
promoted addition of the amide functionality to the nitrile motif followed by acid-mediated 
hydrolysis (Scheme 188). Amide 563 can be provided via reductive dehalogenation and 
subsequent aminolysis of iodolactone 561. We can then arrive at this iodolactone upon subjection 
                                                          
245 Dobish, M. C.; Johnston, J. N. J. Am. Chem. Soc. 2012, 134, 6068-6071. 
Scheme 186. Bottaro and Berchtold’s Synthesis of Sesbanine 
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of precursor acid 564 to an enantioselective, BAM-catalyzed halolactonization. Nucleophilic 
aromatic substitution between cyclopentene carbonitrile 565 and methyl nicotinate 566 will deliver 
ester 560, which in turn can be saponified to give acid 564. Carbonitrile 565 will be afforded from 
ethyl cyanoacetate (567) via substitution and decarboxylation, and nicotinate 566 can be 
synthesized upon acylation with the acid chloride of nicotinic acid 568. 
In the forward sense, treatment of commercially available ethyl cyanoacetate 567 with (Z)-
1,4-dichlorobut-2-ene under basic conditions promoted the desired inter/intramolecular bis-
substitution reaction as cyclopentene compound 569 was furnished in 99% yield after 
chromatographic purification (Scheme 189). Subsequent decarboxylation of 569 with sodium 
Scheme 187. Dobish and Johnston’s BAM-Catalyzed Enantioselective Iodolactonization 
Scheme 188. Retrosynthetic Analysis of Sesbanine 
Scheme 189. Synthesis of Cyclopentene Carbonitrile 565 
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chloride (NaCl) in DMF at high temperature delivered the cyclopentene carbonitrile nucleophile 
(565) in modest yield upon vacuum distillation (44%). 
Synthesis of the electrophilic species for the proposed SNAr reaction proceeded in a 
straightforward manner. Treatment of 4-chloronicotinic acid 568 with SOCl2 provided acid 
chloride 570 quantitatively (Scheme 190). Immediate exposure of 570 to methanol in the presence 
of base facilitated esterification to give methyl nicotinate 566 in 82% yield.246 With carbonitrile 
565 and nicotinate 566 in hand, the stage was now set for nucleophilic aromatic substitution. After 
several attempts, it was found that subjection of carbonitrile 565 to a solution of KHMDS in THF 
promoted nucleophilic attack as SNAr product 560 was cleanly furnished upon incorporation of 
the nicotinate electrophile. It is worth noting that nicotinate 566 was chosen as the electrophile 
since SNAr attempts with nicotinic acid 568 proved fruitless. The inability to isolate carboxylic 
acid 564 (if formed in situ) may be owed to the fact that it is too water soluble to withstand an 
aqueous work-up. Therefore, it was deemed necessary to use nicotinate 566 since the 
corresponding substitution product (560) will have a lower affinity for the aqueous layer relative 
to 564. 
After successfully acquiring ester 560, the next goal was to isolate acid 564 as its own 
entity. Ester 560 was subjected to a saponification protocol using sodium hydroxide (NaOH), 
methanol, and water. Aqueous acidic work-up delivered a compound in which the 1H NMR data 
                                                          
246 Goodacre, S. C.; Williams, K.; Price, S.; Dyke, H. J.; Montana, J. G.; Stanley, M. S.; Bao, L.; Lee, W. 
Preparation of Aminoazaindolecarboxamides as MEK Kinase Inhibitors. U.S. Patent WO 2008/067481 A1, June 5, 
2008. 
Scheme 190. Acquisition of Nicotinate 566 and SNAr en Route to Ester 560 
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was consistent with that of desired acid 564. However, when analyzing the IR spectrum for this 
compound, no absorption band corresponding to a nitrile motif could be found. Further data 
evaluation determined that the isolated intermediate was that of spirocyclic imide 571 (Scheme 
191). Since this imide was obtained in only 17% yield, it is plausible that the desired acid (564) 
was formed in situ but resisted isolation since the pyridine and carboxylic acid moieties increase 
water solubility. 
To account for the potential water solubility of the pyridine ring, carbonitrile 565 and 
methyl-2-chlorobenzoate (572) were subjected to the SNAr protocol with ambitions of accessing 
compound 573 (not shown), the phenyl analog of ester 560. Interestingly, when the cyclopentene 
carbonitrile was treated with KHMDS (1 M in THF) and benzoate 572, iminopiperidinone 574 
was the only compound that could be cleanly isolated (Scheme 192). Acquisition of this 
intermediate not only indicated that SNAr was successful, it also showed that amidation and 
addition to the nitrile functionality occurred as well. To further confirm that this structure was 
indeed an imidopiperidinone, 574 was treated with NaOH in the presence of aqueous methanol to 
provide imide 575 in good yield upon hydrolysis of the imine. 
Since the isolation of acid 564 and ester 573 proved troublesome, the next avenue that was 
explored was a one-pot saponification-iodolactonization reaction. Bottaro and Berchtold utilized 
this approach by treating ester 560 with NaOH in aqueous methanol providing acid 564 in situ. 
Immediate incorporation of iodine, iodide, NaHCO3, and DCM in water promoted the biphasic 
halolactonization reaction, and the desired iodolactone was successfully isolated. When this one-
pot reaction was repeated within our laboratory, the desired lactone (561) was acquired but in very 
Scheme 191. Isolation and Confirmation of Imide 571 
Scheme 192. Acquisition and Confirmation of Imidopiperidinone 574 
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low yield (3%) (Scheme 193). Nevertheless, this was an opportunity to see if our Brønsted basic 
BAM catalysts could promote reactivity and induce enantioselection in this one-pot saponification-
lactonization system. 
Initial investigations of this enantioselective saponification-iodolactonization reaction 
consisted of using the same saponification conditions as described by Bottaro and Berchtold. For 
the halolactonization stage, the same reagents were used with the exception of replacing NaHCO3, 
an achiral base, with PBAM, a Brønsted basic chiral organocatalyst. When substoichiometric 
amounts of PBAM (19) were employed in this reaction system, no desired lactone could be 
detected as small quantities of the startingester were recovered (Table 28, entry 1). The reaction 
conditions were further modified when NIS replaced the I2-KI combination as the iodine source. 
Unfortunately, this variation also proved fruitless (Table 28, entry 2). Substituting the DCM-H2O 
solvent combination with toluene showed no improvement as no product was seen even at elevated 
temperatures (Table 28, entries 3 and 4). Additionally, stilbene diamine-derived organocatalyst 
StilbPBAM (88) was subjected in lieu of PBAM, but to no avail (Table 28, entry 5). 
 
Scheme 193. Repetition of Bottaro and Berchtold’s One-Pot Saponification-Iodolactonization 
entry 
iodine 
source 
additive catalyst solvent 
T 
(°C) 
result 
1 I2 KI PBAM DCM:H2O 25 no lactone, SM recovered 
2 NIS -- PBAM DCM:H2O 25 no lactone 
3 NIS -- PBAM toluene 25 no lactone 
4 NIS -- PBAM toluene 80 no lactone 
5 NIS -- StilbPBAM toluene 25 no lactone 
Table 28. Initial Investigations of the Enantioselective Saponification-Iodolactonization Reaction 
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7.4. Enantioselective Halolactonizations with Z-Alkenes: Model Studies 
Due to the lack of success within these initial saponification-halolactonization attempts, it 
was determined that the next approach to be taken would be the investigation of a model system. 
Model studies of a smaller, more accessible substrate would provide insight into the feasibility of 
achieving halolactonizations with unsaturated carboxylic acids bearing Z-alkenes. Thus, 
cyclopentenyl cyanocarboxylic acid 576 was seen as an attractive model substrate due to its ease 
of availability from previously synthesized material. Saponification of ethyl ester 569 with NaOH 
in aqueous ethanol furnished cyanoacid 576 in good yield (Scheme 194). To our delight, 
subsequent treatment of acid 576 with NIS and catalytic quantities of DMAP in the presence of 
DCM delivered the desired iodolactone (577) albeit in modest yield (37%). Acquisition of lactone 
577 now set the stage for enantioselective investigations. 
Based on the high degree of success in their respective halolactonization system, reaction 
conditions described by Dobish and Johnston were used as a template for initial enantioselective 
studies.245 Herein, PBAM was employed as the chiral organocatalyst, NIS as the iodine source, 
and toluene (0.05 M) as the solvent. The first variable that was examined was reaction time. When 
cyanoacid 576 was subjected to the lactonization protocol, iodolactone 577 was afforded in low 
yield and with minimal levels of enantioselection (12% yield, 5% ee) (Table 29, entry 1). 
Prolonged reaction times of 12 hours, 24 hours, and 48 hours did not result in any significant 
change as 577 was acquired in comparable yields and ee’s (Table 29, entries 2-4). Yet when this 
lactonization was run over the course of 72 hours, lactone 577 was furnished in 4% yield and 17% 
ee (Table 29, entry 5). Despite this minor improvement in enantioselection, subsequent studies 
utilized a 24 hour reaction time for the sake of acquiring data in a more timely manner. 
The next variable that was probed was solvent concentration. Increasing the concentration 
from 0.05 M to 0.1 M resulted in higher yield, but minimal loss in enantioselection as iodolactone 
577 was furnished in 11% yield and 5% ee (Table 29, entry 6). Further concentrated systems (0.5 
M and 1.0 M) confirmed the trends of improved yield and diminished ee (Table 29, entries 7 and 
Scheme 194. Racemic Synthesis of Iodolactone 577 
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8). Due to the gradual decrease in enantioselection upon increased solvent concentration, 0.05 M 
remained as the optimal concentration up to this point. 
Introduction of counterions ensued as Brønsted acid salts of BAM ligands led to higher 
selectivity in previous work.245 When the triflic acid salt of PBAM (19•HOTf) was used as the 
catalyst for this system, little change was seen relative to the free base as lactone 577 was afforded 
in 9% yield and 3% ee (Table 30, entry 2). The triflimide salt of PBAM (19•HNTf2) performed 
similarly (Table 30, entry 3). Since acid salts proved ineffective in promoting reactivity and/or 
selectivity, efforts then shifted towards the use of more Brønsted basic organocatalysts.  
8(MeO)PBAM (19d) was employed delivering iodolactonization product 577 in increased yield 
and diminished ee (11% yield, 1% ee) (Table 30, entry 4).6(MeO)PBAM (19e) furnished 577 in  
Table 29. Preliminary Time and Concentration Studies 
entry 
time 
(h) 
conc. 
(M) 
yield 
(%) 
ee 
(%) 
1 6 0.05 12 5 
2 12 0.05 8 5 
3 24 0.05 6 6 
4 48 0.05 8 3 
5 72 0.05 4 17 
6 24 0.1 11 5 
7 24 0.5 13 2 
8 24 1.0 12 1 
Table 30. Effects of Acid Salts and More Brønsted Basic Organocatalysts 
entry catalyst 
yield 
(%) 
ee 
(%) 
1 PBAM 6 6 
2 PBAM•HOTf 9 3 
3 PBAM•HNTf2 4 6 
4 8(MeO)PBAM 11 1 
5 6(MeO)PBAM 8 7 
6 6,7(MeO)2PBAM 0 N/A 
7 -- 7 0 
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8% yield and 7% ee and 6,7(MeO)2PBAM (19c) failed to provide product (Table 30, entries 
5 and 6). Furthermore, when this lactonization was run in the absence of catalyst, iodolactone 577 
was isolated in 7% yield as a racemate (Table 30, entry 7). This indicates that the use of 
organocatalysts, thus far, have had little or no effect on reactivity and/or selectivity as previously 
acquired yields are comparable to that of the background reaction. 
When the racemic version of this iodolactonization was run, CH2Cl2 was employed as the 
solvent resulting in the acquisition of lactone 577 in 37% yield (Scheme 194). Since a reasonable 
yield was observed with CH2Cl2, this solvent was used in the enantioselective variant with 
ambitions of increasing product formation. Unfortunately, CH2Cl2 performed poorly in the 
presence of PBAM as lactone 577 was furnished in only 10% yield and 3% ee (Scheme 195). 
Toluene, therefore, remained as the solvent of choice. 
It should be noted that a 5 mol% loading of PBAM performed similarly relative to when a 
10 mol% loading was employed (Table 31, entry 1). Because of these comparable results and for 
the sake of catalyst economy, 5 mol% catalyst loadings were to be used for subsequent studies. 
Scheme 195. Iodolactonization Attempt with CH2Cl2 as the Solvent 
entry catalyst 
T 
(°C) 
iodine 
source 
yield 
(%) 
ee 
(%) 
1 PBAM 25 NIS 8 8 
2 StilbPBAM 25 NIS 23 19 
3 3,5(CF3)2BenzAM 25 NIS 8 6 
4 PivalAM 25 NIS 1 0 
5 StilbPBAM 0 NIS 21 22 
6 StilbPBAM -20 NIS 15 30 
7 StilbPBAM -50 NIS 0 N/A 
8 StilbPBAM -20 DIDMH 19 28 
Table 31. Application of Different Catalyst Backbones and Reevaluation of Temperature and Iodine Sources 
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Amidine catalysts possessing different backbones were submitted to the halolactonization 
protocol with the hope of introducing different bite angles that can ultimately promote 
enantioselection. When StilbPBAM (88) was used as the catalyst, noticeable improvements in 
yield and selectivity were seen as iodolactone 577 was furnished in 23% yield and 19% ee (Table 
31, entry 2). Amidine-amide catalysts in 3,5(CF3)2BenzAM (78a) and PivalAM (78m) performed 
poorly, however, as loss in yield and/or enantioselection were observed for both of these cases 
(Table 31, entries 3-4). Encouraged by these results seen with StilbPBAM, lower temperatures 
were reevaluated in order to see if selectivity could be further improved. When the reaction was 
chilled to 0 °C and -20 °C respectively, we were delighted to see consistent improvement in ee 
albeit the gradual depression in yield (Table 31, entries 5 and 6). Unfortunately, running the 
reaction at -50 °C completely mitigated product formation as no sign of lactone 577 could be 
detected (Table 31, entry 7). Nevertheless, these improved degrees of enantioselection clearly 
indicate that the StilbPBAM catalyst is influential in this iodolactonization reaction. Additionally, 
DIDMH was also reapplied as the iodo source, but still proved inferior relative to NIS (Table 31, 
entry 8).  
Acid salts were employed once more with the ambition of further enhancing selectivity. 
Unfortunately, both the triflic acid and triflimide salts of StilbPBAM (88•HOTf and 88•HNTf2) 
gave lower yield and diminished enantioselection reaffirming the superiority of the free base 
catalyst (Table 32, entries 2 and 3). These results led to the examination of more Brønsted basic 
stilbene diamine-derived ligands. When 6(MeO)StilbPBAM (88a) was employed as the 
organocatalyst, mild improvement was observed as lactone 577 was furnished in 24% yield and 
entry catalyst solvent 
yield 
(%) 
ee 
(%) 
1 StilbPBAM toluene 15 30 
2 StilbPBAM•HOTf toluene 7 19 
3 StilbPBAM•HNTf2 toluene 9 28 
4 6(MeO)StilbPBAM toluene 24 32 
5 7(MeO)StilbPBAM toluene 11 26 
6 6(MeO)StilbPBAM xylenes 0 N/A 
7 6(MeO)StilbPBAM THF 0 N/A 
8 6(MeO)StilbPBAM CH3CN 4 3 
Table 32. Reexamination of Acid Salts and Brønsted Basic Catalysts 
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32% ee (Table 32, entry 4). 7(MeO)StilbPBAM (88b) did not fare as well as 577 was acquired in 
only 11% yield and 26% ee (Table 32, entry 5). 
With 6(MeO)StilbPBAM (88b) chosen as the new optimal catalyst, the effects of different 
solvents were examined more extensively. Interestingly, xylenes, a solvent similar to that of 
toluene, failed to yield any product when subjected to the halolactonization protocol (Table 32, 
entry 6). The same was observed with an ethereal solvent in THF (Table 32, entry 7). CH3CN was 
also used, but proved inferior relative to toluene as lactone 577 was afforded in only 4% yield and 
3% ee (Table 32, entry 8). Once again, toluene remained the solvent of choice. 
Non-BAM catalysts were submitted next in order to see their respective influence on 
product yield and enantioselection. 2,4,6-Triisopropyl-phenyl-based binaphthol phosphoric acid 
(TRIP) catalyst 578247 was ineffective as no product was furnished upon its use (Table 33, entry 
2). Deng’s248 and Takemoto’s249 thiourea organocatalysts (579 and 68) were also employed, but to 
no avail as lactone 577 was isolated in minimal yield and as a racemate in both cases (Table 33, 
entries 3 and 4). 
                                                          
247 Čorić, I.; Vellalath, S.; List, B. J. Am. Chem. Soc. 2010, 132, 8536-8537. 
248 Song, J.; Wang, Y.; Deng, L. J. Am. Chem. Soc. 2006, 128,6048-6049. 
249 Okino, T.; Nakamura, S.; Furukawa, T.; Takemoto, Y. Org. Lett. 2004, 6, 625-627. 
entry catalyst 
yield 
(%) 
ee 
(%) 
1 6(MeO)StilbPBAM  24 32 
2 TRIP 0 N/A 
3 Deng Thiourea 1 0 
4 Takemoto Thiourea 1 0 
Table 33. Studies with Non-BAM Catalysts 
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At this point, every variable within this reaction system has been examined to an extent 
with the optimal result being a 24% isolated yield of lactone 577 with 32% ee. Since modification 
of these variables did not provide good yields and promising levels of enantioselection, efforts 
then shifted towards the use of other electrophilic halogen sources (i.e. bromine and chlorine). 
With aspirations of achieving bromolactonization, cyanoacid 576 was treated with N-
bromosuccinimide (NBS) and DMAP in the presence of CH2Cl2. Gratifyingly, the desired 
bromolactone 580 was successfully acquired albeit in 19% yield (Scheme 196).  
Investigation of the enantioselective variant of this bromolactonization commenced when 
acid 576 was treated with PBAM (5 mol%) and NBS in the presence of toluene at -20 °C. After a 
24 hour reaction period, no sign of bromolactone 580 could be detected (Table 34, entry 1). The 
same result was seen when StilbPBAM was employed as the catalyst (Table 34, entry 2). The use 
of a different bromine source in N-bromophthalimide (NBP) also proved fruitless as this too failed 
to provide product (Table 34, entry 3). 
Due to the limitations of this bromolactonization reaction, efforts shifted towards the 
development of a chlorolactonization system. This approach was even more problematic as 
treatment of cyanoacid 576 with N-chlorosuccinimide (NCS) and DMAP in the presence of 
CH2Cl2 failed to deliver racemic chlorolactone 581 (Scheme 197). Since chlorolactone 581 could 
not be isolated as a racemate, no analytical assay could be developed ultimately preventing 
enantioselective studies. 
Scheme 196. Racemic Synthesis of Bromolactone 580 
entry catalyst 
bromine 
source 
yield 
(%) 
ee 
(%) 
1 PBAM NBS 0 N/A 
2 StilbPBAM NBS 0 N/A 
3 StilbPBAM NBP 0 N/A 
Table 34. Brief Investigation of an Enantioselective Bromolactonization 
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Selenolactonization with acid 576 was the next avenue that was explored. Subjection of 
acid 576 to N-(phenylseleno)phthalimide (PSP) and DMAP in the presence of CH2Cl2 provided 
selenolactone 582 in 21% yield as a racemate (Scheme 198). Acquisition of this selenolactone set 
the stage for the enantioselective variation of this reaction system. 
Enantioselective investigations began when cyanoacid 576 was treated with PBAM (5 
mol%) and PSP in the presence of toluene at room temperature. After 24 hours, no promising 
levels of enantioselection were observed as selenolactone 582 was furnished in 26% yield and 2% 
ee (Table 35, entry 1). Replacing PBAM with StilbPBAM did not show any improvement as a 
racemic mixture of 582 was delivered in 23% yield (Table 35, entry 2). Both PBAM and 
StilbPBAM were reemployed in the selenolactonization protocol at -20 °C. Chilled temperatures 
did not show improvement as selenolactone 582 was isolated but as a racemate in 18% and 21% 
yields, respectively (Table 35, entries 3 and 4). Furthermore, the triflic acid and triflimide salts of 
StilbPBAM also proved ineffective as no improvement in yield and/or ee were observed (Table 
35, entries 5 and 6). 
Scheme 197. Failed Attempt Towards Chlorolactonization 
Scheme 198. Racemic Synthesis of Selenolactone 582 
entry catalyst 
T 
(°C) 
yield 
(%) 
ee 
(%) 
1 PBAM 25 26 2 
2 StilbPBAM 25 23 0 
3 PBAM -20 18 0 
4 StilbPBAM -20 21 0 
5 StilbPBAM•HOTf -20 13 2 
6 StilbPBAM•HNTf2 -20 23 0 
Table 35. Brief Investigation of an Enantioselective Selenolactonization 
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The focus then centered upon the development of a 6-membered model system as multiple 
variations of the 5-membered system showed little or no promise. The substrate of choice for these 
6-membered model studies was that of cyanoacid 583, the homologated analog of cyanoacid 576. 
Thus, compound 583 could be readily accessed upon subjecting acid 576 to an Arndt-Eistert 
homologation process.250 Treatment of 576 with SOCl2 provided acid chloride 584 (Scheme 199). 
Subsequent exposure of this acyl chloride to diazomethane in diethyl ether furnished diazoketone 
585 in modest yield (38% over 2 steps). 585 then underwent homologation when treated with silver 
benzoate (AgOBz) under basic conditions ultimately delivering methyl ester 586 in 64% yield. 
Saponification of ester 586 with hydroxide in aqueous methanol afforded the desired precursor 
acid 583 (88% yield). Acid 583 was successfully converted to [6.5]-bicyclic iodolactone 587 in 
moderate yield when treated with NIS and DMAP in the presence of CH2Cl2 (37%). 
Investigation of the enantioselective version of this 6-membered iodolactonization began 
when acid 583 was treated with PBAM (5 mol%) and NIS in toluene at room temperature. Lactone 
587 was acquired in 12% yield and 4% ee after a 24 hour reaction time (Table 36, entry 1). 
StilbPBAM showed no improvement as lactone 587 was obtained in 14% yield as a racemate 
(Table 36, entry 2). Triflic acid and triflimide salts of StilbPBAM also proved fruitless as yields 
and enantioselection remained relatively unchanged (Table 36, entries 3 and 4). 
Various solvents were examined next in order to see their respective influence on this 
lactonization protocol. CH2Cl2 resulted in an improvement in yield as lactone 587 was furnished 
in 25% yield (Table 36, entry 5). However, the enantiopurity was similar to that observed with 
toluene (3% ee). Nitromethane (MeNO2) did not show any enhancement as iodolactone 587 was 
delivered in 19% yield as a racemate (Table 36, entry 6). Alcoholic (MeOH) and nitrile 
(CH3CH2CN) solvents performed similarly to that of MeNO2, and THF failed to give product 
                                                          
250 Gaucher, A.; Dutot, L.; Barbeau, O.; Hamchaoui, W.; Wakselman, M.; Mazaleyrat, J.-P. Tetrahedron-Asummetr. 
2005, 16, 857-864. 
Scheme 199. Racemic Synthesis of [6.5]-Bicyclic Iodolactone 587 
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completely (Table 36, entries 7-9). Although CH2Cl2 led to improved yield, toluene was taken onto 
further studies as noticeable levels of enantioselection were achieved with this solvent in the 5-
membered lactonization system. 
Other non-amidine organocatalysts were also employed with aspirations of increasing yield 
and selectivity. When 3,5-(bistrifluoromethyl)phenyl-based binaphthol (BINOL) 588 was used as 
the catalyst, little change was seen relative to PBAM as lactone 587 was isolated in 14% yield and 
3% ee (Table 37, entry 2). BINOL phosphoric acid 589 and phenanthrene-derived BINOL 
phosphoric acid 590 performed similarly (Table 37, entries 3 and 4). Anthracene-derived BINOL 
phosphoric acid catalyst 591 showed mild improvement as the iodolactone product was isolated in 
17% yield and 8% ee (Table 37, entry 5). 2,6-Dimethyl-4-methoxy-phenyl-based BINOL 
phosphoric acid 592 did not fare as well as this catalyst delivered lactone 587 in 7% yield as a 
racemate (Table 37, entry 6). TRIP as well as Deng’s and Takemoto’s thioureas also proved 
entry catalyst solvent 
yield 
(%) 
ee 
(%) 
1 PBAM toluene 12 4 
2 StilbPBAM toluene 14 0 
3 StilbPBAM•HOTf toluene 17 -5 
4 StilbPBAM•HNTf2 toluene 17 1 
5 PBAM CH2Cl2 25 3 
6 PBAM MeNO2 19 0 
7 PBAM MeOH 11 1 
8 PBAM CH3CH2CN 8 1 
9 PBAM THF 0 N/A 
Table 36. 6-Membered Iodolactonization: Catalyst and Solvent Studies 
Figure 36. Potential Unwanted Electronic Interaction in the Binding Mode 
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ineffective as diminished yields and selectivities were observed relative to when PBAM was used 
(Table 37, entries 7-9). 
The inability to achieve promising levels of enantioselection with a multitude of Z-alkene 
substrates resulted in the analysis of potential problems. One commonality between the starting 
materials employed throughout the course of these lactonization studies is that they all possess a 
cyano motif. Also, the fact that 32% ee was observed within the 5-membered iodolactonization 
system suggests that the starting cyanoacid is indeed binding to the organocatalyst (Table 32, entry 
4). With these observations in mind, it is reasonable to infer that the cyano group of the acid may 
be involved in an unwanted electronic interaction when binding to the organocatalyst (Figure 36). 
In other words, the cyano motif may be preventing the acid from orienting itself with the catalyst 
in such a way that favors higher levels of enantioselection. In order to neutralize this potential 
problem, the cyano functionality should be replaced with a moiety less prone to undesired 
electronic interaction (i.e. a phenyl group). Therefore, phenyl cyclopentene carboxylic acid 593 
was the next substrate of interest. 
entry catalyst 
yield 
(%) 
ee 
(%) 
1 PBAM 12 4 
2 BINOL 588 14 0 
3 phosphoric acid 589 17 -5 
4 phosphoric acid 590 17 1 
5 phosphoric acid 591 25 3 
6 phosphoric acid 592 19 0 
7 TRIP 11 1 
8 Deng Thiourea 8 1 
9 Takemoto Thiourea 0 N/A 
Table 37. 6-Membered Iodolactonization: Examination of Non-Amidine Catalysts 
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Acid 593 was synthesized via a known procedure as described by Takacs and colleagues.251 
Treatment of commercially available methyl phenylacetate (594) with NaH and cis-1,4-dichloro-
2-butene in the presence of N,N’-dimethylpropylene urea (DMPU) and THF at elevated 
temperature provided methyl phenylcyclopentene carboxylate 595 in 42% isolated yield (Scheme 
200). Subsequent saponification of 595 with KOH in ethanol furnished known acid 593 in 95% 
yield. When this acid was treated with NIS and DMAP in CH2Cl2, iodolactone 596 was afforded 
setting the stage for enantioselective studies.  
With a phenyl motif in place of the cyano group, we were hopeful that acid 593 would 
achieve a binding mode that would ultimately increase selectivity. When PBAM was used as the 
organocatalyst, we were disappointed to see that this substrate was not immediately better behaved 
as lactone 596 was acquired in 9% yield and 1% ee (Table 38, entry 1). However, when StilbPBAM 
was employed, increased yield and promising levels of enantioselection were observed as the 
lactone product was isolated in 25% yield and 48% ee (Table 38, entry 2). This jump in selectivity 
between the PBAM and StilbPBAM entries indicates that the bite angle of the catalyst is critical 
for inducing high levels of enantioselection. Encouraged by the StilbPBAM result, the triflic acid 
and triflimide salts of StilbPBAM were also submitted with aspirations of further enhancing 
enantioselection. Unfortunately, neither of these fared as well relative to the free base catalyst 
(Table 38, entries 3 and 4). 
 With StilbPBAM taken on as the catalyst, the effects of temperature were examined next. 
Subjection of StilbPBAM to the reaction protocol at 0 °C led to an increase in both yield and 
enantioselection as lactone 596 was afforded in 41% yield and 58% ee (Table 38, entry 5). A -20 
°C reaction temperature provided the lactone product in 30% yield and 65% ee confirming that 
                                                          
251 Hoang, G. L.; Yang, Z.-D.; Smith, S. M.; Pal, R.; Miska, J. L.; Pérez, D. E.; Pelter, L. S. W.; Zheng, X. C.; 
Takacs, J. M. Org. Lett. 2015, 17, 940-943. 
Scheme 200. Racemic Synthesis of Iodolactone 596 
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lower temperatures correlate to higher ee (Table 38, entry 6). However, when the lactonization 
was further chilled to -50 °C and -78 °C, product formation was completely mitigated (Table 38, 
entries 7 and 8). 
 After identifying -20 °C as the optimum temperature, organocatalysts with higher Brønsted 
basicity profiles were studied next. When 7(MeO)StilbPBAM was employed as the catalyst, we 
were disappointed to see a dramatic drop in yield and selectivity as lactone 596 was provided in 
only 11% yield and 12% ee (Table 38, entry 9). An anthracenyl-bearing analog, dubbed 
7(MeO)AnthPBAM (597), was also examined in the iodolactonization system. Unfortunately, this 
catalyst also proved fruitless as lactone 596 was delivered in 10% yield and -3% ee (Table 38, 
entry 10). 
 With promising levels of enantioselection achieved, other variables are to be examined in 
order to further improve this system. These variables include different iodine sources, solvents, 
and other catalysts modifications. These efforts are currently ongoing within our laboratory by 
Matthew Knowe and Zachary Carter. 
7.5. Future Directions 
 The immediate objectives are to improve the yield of this iodolactonization and to achieve 
levels of enantioselection that are high enough for synthetic utility (i.e. >90% ee). The most direct 
avenues of accomplishing these goals include examining the effects of catalysts modifications as 
well as different iodine sources and solvents. Additionally, substrates with different steric and 
entry catalyst 
temp. 
(°C) 
yield 
(%) 
ee 
(%) 
1 PBAM 25 9 1 
2 StilbPBAM 25 25 48 
3 StilbPBAM•HOTf 25 14 41 
4 StilbPBAM•HNTf2 25 12 16 
5 StilbPBAM 0 41 58 
6 StilbPBAM -20 30 65 
7 StilbPBAM -50 0 N/A 
8 StilbPBAM -78 0 N/A 
9 7(MeO)StilbPBAM -20 11 12 
10 7(MeO)AnthPBAM -20 10 -3 
Table 38. Initial Iodolactonization Studies with Phenyl-Derived Acid 593 
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electronic properties can be employed in order to see their respective influence on this reaction 
system. Once this iodolactonization is achieved in sufficient yield and optimal levels of 
enantioselection, this protocol can be applied to a multitude of Z-alkene bearing carboxylic acids 
in order to demonstrate the generality of this methodology (Scheme 201). 
 Another future direction would be to apply this newly developed methodology towards the 
synthesis of sesbanine (531). Pyridyl cyclopentene carboxylic acid 598 can be synthesized as a 
precursor substrate to the iodolactonization protocol. Subjection of acid 598 to optimal reaction 
conditions can theoretically deliver iodolactone 599 in good yield and with high levels of 
enantioselection. This lactone intermediate can then be converted to sesbanine (531) via a short 
synthetic sequence (Scheme 202). 
  
 
 
 
 
 
 
 
 
 
 
Scheme 201. Reaction Optimization and Substrate Scope Development 
Scheme 202. Revised Proposed Synthesis of Sesbanine 
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Chapter 8. Experimentals 
 Glassware was flame-dried under vacuum for all non-aqueous reactions. All reagents and 
solvents were commercial grade and purified prior to use when necessary. Tetrahydrofuran (THF), 
dichloromethane (CH2Cl2), and toluene was dried by passage through a column of activated 
alumina as described by Grubbs.252 This was done to accurately quantitate the amount of water in 
each reaction. 
 Thin layer chromatography (TLC) was performed using glass-backed silica get (250 µm) 
plates and flash chromatography utilized 230-400 mesh silica gel from Sorbent Technologies. UV 
light and/or the use of potassium permanganate solutions were used to visualize products.  
 IR spectra were recorded on a Nicolet Avatar 360 spectrophotometer and are reported in 
wavenumbers (cm-1). All compounds were analyzed as neat films on a NaCl plate (transmission). 
Nuclear magnetic resonance spectra (NMR) were acquired on a Bruker DRX-500 (500 MHz), 
Bruker AV-400 (400 MHz) or Bruker AV II-600 (600 MHz) instrument. Chemical shifts are 
measured relative to residual solvent peaks as an internal standard set to δ 7.26 and δ 77.0 for 
CDCl3. Mass spectra were recorded on a Thermo Electron Corporation MAT 95XP-Trap mass 
spectrometer by use of electron impact ionization (EI) or electrospray ionization (ESI) by the 
Indiana University Mass Spectrometry Facility. Optical rotations were measured on a Perkin 
Elmer-341 polarimeter. Chiral HPLC analysis was conducted on an Agilent 1100 series instrument 
using the designated ChialPak column. 
2,4-Dichloro-N-((1-((1-methyl-1H-imidazol-4-yl) sulfonyl)azetidin-3-yl)(phenyl) methyl) 
benzamide (1). To a flame dried flask equipped with a stir bar was added the amine (36.1 mg, 118 
µmol) and dichloromethane (1 mL), immediately followed by addition of N,N-
                                                          
252 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. K.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518-
1520. 
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diisopropylethylamine (30.5 mg, 236 µmol) and the benzoyl chloride (42.1 mg, 201 µmol). The 
reaction was stirred at rt for 16 h, quenched with 1 M HCl and extracted with dichloromethane. 
The organic extracts were then washed with NaHCO3, extracted with dichloromethane, dried 
(MgSO4), filtered and concentrated in vacuo. Flash column chromatography of the residue (SiO2, 
0-10% methanol in dichloromethane) yielded the desired dichlorinated product as an off white 
viscous oil (15.3 mg, 27% over 2 steps). The major enantiomer was determined to be 87% ee by 
chiral HPLC analysis. Chiral HPLC analysis (Chiralpak AD, 65% isopropyl alcohol/hexanes, 1.2 
mL/min, tr(e1, major) = 3.65 min, tr(e2, minor) = 7.05 min); 

D
20
[]  -4.6 (c 0.41, CHCl3); Rf = 0.40 
(5% MeOH/dichloromethane); IR (film) 3262, 3061, 2925, 2855, 1649 cm-1; 1H NMR (400 MHz, 
CDCl3)  7.52 (s, 1H), 7.48 (d, J = 8.4 Hz, 1H), 7.40 (d, J = 2.0 Hz, 1H), 7.38 (s, 1H), 7.31 (m, 
4H), 7.22 (d, J = 6.8 Hz, 2H), 6.83 (br d, J = 8.4 Hz, 1H), 5.06 (dd, J = 8.8, 8.8 Hz, 1H), 4.07 (dd, 
J = 8.4, 8.4 Hz, 1H), 3.96 (dd, J =8.4, 8,4 Hz, 1H), 3.95 (d, J = 7.2 Hz, 2H), 3.79 (s, 3H), 3.03 
(ddddd, J = 8.8, 8.4, 8.4, 7.2, 7.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) ppm 165.3, 138.6, 136.9, 
133.4, 131.5, 131.0, 129.9, 129.0, 128.2, 127.5, 126.5, 55.5, 54.0, 53.6, 34.2, 33.3; HRMS (ESI): 
Exact mass calcd for C21H21Cl2N4O3S [M+H]
+ 479.0679, found 479.0714. HSQC indicated that 
the methylene carbons of the azetidine ring are diastereotopic, as would be expected for the 
assigned structure.  
Summary of Structural Elucidation for Azetidine 1. 
Key Features 
The structure was assigned as the desired azetidine using standard 1D and 2D NMR techniques. 
1H NMR indicated the presence of a doublet of doublets integrating to 1H at 4.07 ppm, a doublet 
of doublets integrating to 1H at 3.96 ppm and a doublet integrating to 2H at 3.95. These 4 
hydrogens account for both methylenes of the azetidine ring. The unorthodox splitting of the 
azetidine methylenes supported the proposal that the hydrogens on the methylenes of the azetidine 
ring were diasterotopic (all magnetically inequivalent). 1H NMR also indicated the presence of a 
doublet of doublets integrating to 1H at 5.06 ppm, assigned as the benzylic methine. A singlet 
integrating to 3H at 3.79 ppm was assigned as the methyl group of the methyl imidazole ring. A 
doublet of doublets of doublets of doublets of doublets integrating to 1H at 3.03 ppm was assigned 
as the methine of the azetidine ring. Also, the presence of 10H in the aromatic region further 
supports the desired azetidine structure. 13C NMR clearly indicates the presence of an amide at 
165 ppm. Peaks at 54.0 ppm and 53.6 ppm indicates that the methylene carbons of the azetidine 
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ring are diastereotopic. DEPT 135 experimentation further confirms this finding as the peaks at 
54.0 ppm and 53.6 ppm are inverted indicating that they are methylene carbons.  
Additional Features 
Further evidence supporting the structural assignment includes an HSQC, which clearly showed 
that the methylene hydrogens and carbons on the azetidine ring were diastereotopic via anticipated 
1JHC couplings. C1 (54.0 ppm) of the azetidine ring showed correlations to methylene hydrogens 
H3 (4.07 ppm) and H4 (3.95 ppm). C2 (53.6 ppm) of the azetidine ring also showed correlations 
to methylene hydrogens H5 (3.96 ppm) and H4’ (3.95 ppm). 
Benzyl 3-(((tert-butoxycarbonyl)amino)(phenyl)methyl)azetidine-1-carboxylate (21). To a 
solution of the nitro azetidine (75.0 mg, 170 µmol) in toluene (2.1 mL) at room temperature was 
added nBu3SnH (99.0 mg, 340 mol). The resulting mixture was heated to 110 C, immediately 
followed by the addition of azobisisobutyronitrile (AIBN) (6.00 mg, 34.0 µmol). After the reaction 
mixture stirred for 1 h at 110 C, additional AIBN (6.00 mg, 34.0 µmol) was added and the mixture 
was stirred at 110 C for an additional 3 h. The reaction was cooled, concentrated, diluted with 
diethyl ether and washed with satd aq KF. The organic layer was dried (MgSO4), filtered through 
a Celite pad with additional diethyl ether and concentrated. Flash column chromatography of the 
residue (SiO2, 20-30% ethyl acetate in hexanes) yielded the desired azetidine as a white solid (45.0 
mg, 67%). 

D
20
[]  -26.7 (c 0.69, CHCl3); mp 110-112 C; Rf = 0.20 (25% EtOAc/hexanes); IR 
(film) 3328, 3032, 2973, 2886, 1705 cm-1; 1H NMR (400 MHz, CDCl3)  7.31 (m, 8H), 7.21 (d, J 
Key HSQC Correlations for 1 (600 MHz) 
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= 7.2 Hz, 2H), 5.09 (s, 2H), 4.89 (br s, 1H), 4.82 (br s, 1H), 4.10 (dd, J = 8.4, 8.4 Hz, 1H), 3.98 
(br dd, J = 5.6, 5.6 Hz, 1H), 3.91 (br dd, J = 8.8, 8.8 Hz, 1H), 3.69 (br dd, J = 6.0, 6.0 Hz, 1H), 
2.94 (br s, 1H), 1.41 (s, 9H); 13C NMR (100 MHz, CDCl3) ppm 156.3, 155.4, 140.1, 136.5, 128.7, 
128.3, 127.9, 127.8, 127.7, 126.5, 79.7, 66.5, 56.8, 51.6, 51.1, 34.1, 28.2; HRMS (ESI): Exact 
mass calcd for C23H28N2NaO4 [M+Na]
+ 419.1898, found 419.1927.  
Benzyl 3-(amino(phenyl)methyl)azetidine-1-carboxylate (22). To a flame dried flask equipped 
with a stir bar was added the carbamate (90.0 mg, 227 µmol) and 4 M HCl·dioxane (426 µL, 1.71 
mmol). The resulting mixture was allowed to stir at rt for 16 h prior to TLC analysis. Concentration 
of the reaction mixture yielded the chloride salt of the desired amine as a light yellow foam. The 
unpurified material was used in the next step.  
Benzyl 3-((2,4-dichlorobenzamido)(phenyl)methyl)azetidine-1-carboxylate (24). To a flame 
dried flask equipped with a stir bar was added the chloride salt of the amine (76.0 mg, 228 µmol) 
and dichloromethane (2 mL). The resulting solution was chilled to 0 C, immediately followed by 
addition of N,N-diisopropylethylamine (70.7 mg, 547 µmol) and the benzoyl chloride (71.8 mg, 
343 µmol). The mixture was warmed to room temperature, stirred for 16 h, quenched with 1 M 
HCl and extracted with dichloromethane. The organic extracts were then washed with NaHCO3, 
extracted with dichloromethane, dried (MgSO4), filtered and concentrated. Flash column 
chromatography of the residue (SiO2, 10-40% ethyl acetate in hexanes) yielded the desired amide 
as an off white oil (44.4 mg, 42% over 2 steps). 

D
20
[]  -13.4 (c 0.90, CHCl3); Rf = 0.41 (40% 
EtOAc/hexanes); IR (film) 3264, 3064, 2925, 2854, 1710, 1643 cm-1, 1H NMR (400 MHz, CDCl3) 
 7.64 (d, J = 8.4 Hz, 1H), 7.44 (br d, J = 1.2 Hz, 1H), 7.35 (m, 11H), 7.17 (br d, J = 8.4 Hz, 1H), 
5.57 (br t, J = 8.0, 8.0 Hz, 1H), 5.41 (br s, 1H), 5.11 (s, 1H), 3.66 (dd, J = 11.6, 3.6 Hz, 1H), 3.57 
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(dd, J = 11.6, 4.4Hz, 1H), 3.43 (m, 1H), 3.36 (m, 1H), 2.63 (br s, 1H); 13C NMR (100 MHz, CDCl3) 
ppm 165.2, 156.6, 138.6, 137.2, 131.5, 130.2, 129.1, 128.5, 128.2, 128.1, 128.0, 127.7, 126.5, 66.9, 
53.5, 44.8, 43.8, 40.6; HRMS (ESI): Exact mass calcd for C25H23Cl2N2O3 [M+H]
+ 469.1079, found 
469.1080.  
Methyl (((2S)-1-(2,4-dichlorobenzoyl) -2-phenylazetidin-3-yl) methyl)carbamate (26). To a 
flame dried flask equipped with a stir bar was added the benzamide (37.0 mg, 79.0 µmol), 
methanol (2 mL) and 40% KOH (301 µL, 3.15 mmol). The reaction mixture was heated to 45 C, 
allowed to stir for 16 h, and then concentrated. The resulting residue was diluted with water, 
extracted with dichloromethane and the organic extracts were dried (MgSO4), filtered and 
concentrated. Flash column chromatography of the crude material (SiO2, 10-50% ethyl acetate in 
hexanes) yielded the desired methyl ester as an off white viscous oil (12.4 mg, 40%). 

D
20
[]  +24.5 
(c 1.24, CHCl3); Rf = 0.24 (40% EtOAc/hexanes); IR (film) 3327, 3062, 3029, 2927, 2361, 1716, 
1663 cm-1; 1H NMR (600 MHz, CDCl3)  7.55 (d, J = 7.8 Hz, 1H), 7.44 (d, J = 1.8 Hz, 1H), 7.37 
(dd, J = 7.8, 7.8 Hz, 2H), 7.28 (m, 4H), 4.82 (br s, 1H), 4.54 (d, J = 6.0 Hz, 1H), 4.31 (dd, J = 11.4, 
3.6 Hz, 1H), 4.16 (dd, J = 10.8, 6.6 Hz, 1H), 3.67 (s, 3H), 3.33 (m, 2H), 2.22 (br s, 1H); 13C NMR 
(150 MHz, CDCl3) ppm 157.3, 155.7, 142.2, 136.0, 133.3, 132.5, 131.3, 130.0, 128.6, 127.4, 
127.2, 127.0, 65.1, 58.9, 52.3, 41.0, 39.2; HRMS (ESI): Exact mass calcd for C19H19Cl2N2O3 
[M+H]+ 393.0779, found 393.0766. HMBC (600 MHz) analysis further confirmed the compound 
structure. 
Structural Elucidation for Methyl Ester 26 
Key Features 
The structure was assigned as the methyl ester using standard 1D and 2D NMR techniques. 1H 
NMR indicated the presence of a singlet integrating to 3H at 3.67 ppm, assigned as the CH3O- 
fragment. The presence of a multiplet integrating to 2H at 3.33 ppm indicates the presence of a 
methylene group alpha to the nitrogen of the carbamate. The presence of this methylene group also 
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supports the proposal of an azetidine isomerization. The absence of the benzyl peak at 5.1 ppm 
supports that the Cbz was successfully cleaved. Also, the presence of approximately 8H in the 
aromatic region is consistent with the cleavage of the Cbz group. 13C NMR clearly indicates the 
presence of a carbamate at 157.3 ppm and an amide at 155.7 ppm. DEPT 135 experimentation 
shows the presence of two methylenes, one cyclic at 65.1 ppm, and one acyclic at 41.0 ppm. The 
presence of these two methylenes with such a large difference in chemical shift further supports 
the assignment based on azetidine ismoerization. 
 
Additional Features 
Further evidence supporting the structural assignment includes an HMBC, which clearly showed 
the anticipated 3JHC couplings for desired methyl ester 26. C1 (157 ppm) of the carbamate showed 
correlations to H2/H2’/H2’’ (3.67 ppm) and H3/H3’(3.33 ppm). C4 (156 ppm) of the amide 
showed correlations to diastereotopic methylene hydrogens H5 (4.31 ppm) and H6 (4.16 ppm) as 
well as to H7 (7.55 ppm) and methine hydrogen H8 (4.54 ppm). Furthermore, methylene C9 (41.0 
ppm) showed correlations to diastereotopic methylene hydrogens H5 (4.31 ppm) and H6 (4.16 
ppm) and to methine hydrogen H8 (4.54 ppm). 
Benzyl (((2S)-1-(2,4-dichlorobenzoyl)-2-phenylazetidin-3-yl)methyl)carbamate (27). To a 
flame dried flask equipped with a stir bar was added the benzamide (37.0 mg, 79.0 µmol), 
methanol (2 mL) and 40% KOH (301 µL, 3.15 mmol). The reaction mixture was heated to 45 C, 
Key HMBC Correlations for Methy Ester 26 (600 MHz) 
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allowed to stir for 16 h then concentrated in vacuo. The resulting residue was diluted with water, 
extracted with dichloromethane and the organic extracts were dried (MgSO4), filtered and 
concentrated in vacuo. Flash column chromatography of the crude material (SiO2, 10-50% ethyl 
acetate in hexanes) yielded the desired azetidine as a light yellow oil (5.8 mg, 16%). 

D
20
[]  +13.9 
(c 1.24, CHCl3); Rf = 0.37 (40% EtOAc/hexanes); IR (film) 3328, 3031, 2924, 2853, 1713, 1664 
cm-1; 1H NMR (400 MHz, CDCl3)  7.54 (d, J = 8.4 Hz, 1H), 7.43 (d, J = 2.0 Hz, 1H), 7.35 (m, 
8H), 7.28 (m, 3H), 5.10 (m, 2H), 4.88 (br s, 1H), 4.54 (d, J = 5.6 Hz, 1H), 4.31 (dd, J = 11.2, 3.2 
Hz, 1H), 4.16 (dd, J = 11.2, 6.8 Hz, 1H), 3.35 (dd, J = 10.0, 6.0 Hz, 2H), 2.24 (br d, J = 3.2 Hz, 
1H); 13C NMR (150 MHz, CDCl3) ppm 156.6, 155.8, 142.2, 136.3, 136.0, 133.3, 132.5, 131.3, 
130.0, 128.7, 128.6, 128.3, 128.1, 127.4, 127.2, 127.0, 67.0, 65.0, 58.7, 41.1, 39.1; HRMS (ESI): 
Exact mass calcd for C25H23Cl2N2O3 [M+H]
+ 469.1079, found 469.1098. HMBC (600 MHz) 
analysis further confirmed the compound structure. 
Structural Elucidation for Azetidine Isomer 27 
Key Features 
The structure was assigned as the azetidine isomer using standard 1D and 2D NMR techniques. 
1H NMR indicated the presence of a doublet integrating to 2H at 5.10 ppm, assigned as the benzyl 
methylene of the Cbz protecting group. The presence of a multiplet integrating to 2H at 3.35 ppm 
indicates the presence of a methylene group alpha to the nitrogen of the carbamate. The presence 
of this methylene group also supports the proposal of the azetidine isomerization. Also, the 
presence of approximately 13H in the aromatic region further supports that the Cbz group 
remained intact. 13C NMR clearly indicates the presence of a carbamate at 156.6 ppm and an amide 
at 155.8 ppm. DEPT 135 experimentation shows the presence of three methylenes, one cyclic at 
65.0 ppm, and two acyclic at 67.0 ppm and 41.1 ppm. The methylene at 67.0 ppm is indicative of 
the benzyl carbon of the Cbz. The presence of the two methylenes with such a large difference in 
chemical shift (65.0 ppm and 41.1 ppm) further supports the idea that azetidine ismoerization did 
occur. 
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Additional Features 
Further evidence supporting the structural assignment includes an HMBC,which clearly showed 
the anticipated 3JHC couplings for desired isomer 27. C1 (157 ppm) of the carbamate showed 
correlations to H3/H3’ (3.35 ppm) and H2/H2’ (5.10 ppm). C4 (156 ppm) of the amide showed 
correlations to diastereotopic methylene hydrogens H5 (4.31 ppm) and H6 (4.16 ppm) as well as 
to H7 (7.54 ppm) and methine hydrogen H8 (4.54 ppm). Furthermore, methylene C9 (41.1 ppm) 
showed correlations to diastereotopic methylene hydrogen H5 (4.31 ppm) and to methine hydrogen 
H8 (4.54 ppm). 
tert-Butyl (azetidin-3-yl(phenyl)methyl)carbamate (28). To a flame dried flask equipped with a 
stir bar was added the carbamate (50.0 mg, 126 µmol) followed by the addition of 5% Pd/C (27.0 
mg, 130 µmol). Methanol (1 mL) was then added and the resulting suspension was allowed to stir 
for 5 minutes. The flask and its contents were purged with H2 gas and left to stir under H2 
atmosphere (balloon) at rt for 3 h. The reaction mixture was filtered through a Celite pad with 
methanol and dichloromethane and then concentrated in vacuo to afford the desired amine as a 
colorless oil. The unpurified material was used in the next step. 
 
 
Key HMBC Correlations for Azetidine Isomer 27 (600 MHz) 
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tert-Butyl((1-((1-methyl-1H-imidazol-4-yl)sulfonyl)azetidin-3-yl)(phenyl)methyl) carbamate 
(30). To a flame dried flask equipped with a stir bar was added the azetidine (33.0 mg, 126 µmol) 
and dichloromethane (3 mL), immediately followed by addition of the sulfonyl chloride (27.0 mg, 
151 µmol) and N,N-diisopropylethylamine (19.5 mg, 151 µmol). The reaction was stirred at rt for 
16 h, diluted with water and extracted with ethyl acetate. The organic extracts were then washed 
with brine, dried (MgSO4), filtered and concentrated. Flash column chromatography of the residue 
(SiO2, 0-10% methanol in dichloromethane) yielded the sulfonamide as an off white viscous oil 
(28.7 mg, 56% over 2 steps). 

D
20
[]  -12.5 (c 0.77, CHCl3); Rf = 0.4 (5% MeOH/dichloromethane); 
IR (film) 3368, 3134, 2977, 1703, 1526 cm-1; 1H NMR (400 MHz, CDCl3)  7.62 (s, 1H), 7.51 (s, 
1H), 7.25 (m, 3H), 7.12 (d, J = 7.2 Hz, 2H), 5.21 (br d, J = 5.2 Hz, 1H), 4.48 (dd, J = 8.8, 8.8 Hz, 
1H), 3.97 (dd, J = 8.4, 8.4 Hz, 1H), 3.85 (dd, J = 8.4, 8.4 Hz, 1H), 3.84 (d, J = 8.0 Hz, 2H), 3.79 
(s, 3H), 2.84 (ddddd, J = 8.8, 8.4, 8.4, 8.0, 8.0 Hz, 1H), 1.38 (s, 9H); 13C NMR (100 MHz, CDCl3) 
ppm 155.3, 139.8, 139.6, 136.2, 128.7, 127.7, 126.2, 125.9, 79.6, 56.3, 53.9, 53.5, 34.1, 33.6, 28.2; 
HRMS (ESI): Exact mass calcd for C19H26N4NaO4S [M+Na]
+ 429.1597, found 429.1565.  
 (1-((1-Methyl-1H-imidazol-4-yl)sulfonyl)azetidin-3-yl)(phenyl)methanamine (31). To a 
flame dried flask equipped with a stir bar was added the sulfonamide (48.0 mg, 118 µmol) and 4 
M HCl·dioxane (220 µL, 886 µmol). The resulting mixture was allowed to stir at rt for 16 h before 
it was diluted with dichloromethane and washed with NaHCO3. The organic layer was then 
separated, dried (MgSO4), filtered, and concentrated to afford the desired amine as a cloudy oil. 
The unpurified material was used in the next step.  
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General procedure for (1S,(S)S)-N-(p-Tolylsulfinyl)-2-nitro-1-phenyl-1-methyl-ethanamine 
(54a) and (1R,(S)S)-N-(p-Tolylsulfinyl)-2-nitro-1-phenyl-1-methyl-ethanamine (54b). This 
procedure was modified off of a previous protocol found in literature.27 To a flame-dried vial 
equipped with a stirbar was added the ketimine (31.7 mg, 123 µmol) and nitromethane (1.00 mL, 
18.6 mmol). Tetra-n-butylammonium fluoride (6.43 mg, 24.6 µmol) was then added and the 
mixture was allowed to stir at rt for 18 h. The reaction mixture was filtered through a silica pad 
with dichloromethane and ethyl acetate and concentrated in vacuo. Flash column chromatography 
of the residue (SiO2, 10-40% ethyl acetate in hexanes) yielded the desired adduct as a colorless oil 
(23.2 mg, 59%). For characterization data of this compound, refer to the supporting information 
of the literature reference cited in this experimental. 
General Procedure for (S)-4-Methyl-N-(1-nitro-2-phenylpropan-2-yl)benzenesulfonamide 
(58). To a vial equipped with a stir bar was added the ketimine (15.0 mg, 54.9 µmol), PBAM (5.60 
mg, 11.0 µmol), and dichloroethane (440 µL). Once the mixture was homogenous, nitromethane 
(5.90 µL, 110 µmol) was added in one portion and the reaction mixture stirred for 96 h. The 
reaction mixture was filtered through a silica pad with dichloromethane and ethyl acetate and was 
then concentrated in vacuo. Flash column chromatography of the residue (SiO2, 15-20% ethyl 
acetate in hexanes) yielded the desired adduct as a white amorphous solid (2.4 mg, 13%). The 
characterization data for this compound was found in the literature.28 
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 (E)-4-Nitro-N-(1-phenylethylidene)benzenesulfonamide (59). This procedure was modified 
off of protocols found in literature.32,253 To an oven dried 2-necked round bottom flask equipped 
with a condesor and a stir bar was added the sulfonamide (937 mg, 4.63 mmol), acetophenone 
(1.11g, 9.27 mmol), ZnCl2 (156 mg, 927 µmol), and Ti(OEt)4 (5.29 mg, 23.2 mmol). The resulting 
mixture stirred under vacuum for 15 minutes. Toluene (24.0 mL) was then added and the solution 
was heated to reflux for 72 h. The solution was then cooled to 0 °C followed by the addition of 
MeOH (15 mL), DCM (15 mL), and sat aq NaHCO3 (13 mL). The resulting solid was filtered and 
washed with dichloromethane. Organic extracts were dried (MgSO4), filtered, and concentrated. 
Flash column chromatography of the residue (SiO2, 3%-50% ethyl acetate in hexanes) affored the 
desired ketimine as a yellow to orange solid (93 mg, 7%). The characterization data for this 
compound was found in the literature.254 
 (E)-4-Methoxy-N-(1-phenylethylidene)benzenesulfonamide (60). This procedure was 
modified off of protocols found in literature.253 To an oven dried 2-necked round bottom flask 
equipped with a condesor and a stir bar was added the sulfonamide (810 mg, 4.33 mmol), 
acetophenone (1.04g, 8.65 mmol), ZnCl2 (118 mg, 865 µmol), and Ti(OEt)4 (4.93 mg, 21.6 mmol). 
The resulting mixture stirred under vacuum for 15 minutes. Toluene (22.0 mL) was then added 
and the solution was heated to reflux for 48 h. The solution was then cooled to 0 °C followed by 
the addition of MeOH (13 mL), DCM (13 mL), and sat aq NaHCO3 (11 mL). The resulting solid 
was filtered and washed with dichloromethane. Organic extracts were dried (MgSO4), filtered, and 
concentrated. Flash column chromatography of the residue (SiO2, 5%-40% ethyl acetate in 
                                                          
253 Nakamura, S.; Hayashi, M.; Hiramatsu, Y.; Shibata, N.; Funahashi, Y.; Toru, T. J. Am. Chem. Soc. 2009, 131, 
18240-18241. 
254 Shintani, R.; Takeda, M.; Soh, Y-.T.; Ito, T.; Hayashi, T. Org. Lett. 2011, 13, 2977-2979.  
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hexanes) affored the desired ketimine as a white solid (260 mg, 21%). The characterization data 
for this compound was found in the literature.253  
General Procedure for (S)-4-Methoxy-N-(1-nitro-2-phenylpropan-2-yl)benzenesulfonamide 
(63). To a vial equipped with a stir bar was added the ketimine (15.0 mg, 52.0 µmol), the catalyst 
(6.80 mg, 10.4 µmol), and dry dichloroethane (416 µL). Nitromethane (6.35 mg, 104 µmol) was 
then added and the resulting mixture was allowed to stir at rt for 96 h. The reaction mixture was 
filtered through a silica pad with dichloromethane and ethyl acetate and concentrated in vacuo. 
Flash column chromatography of the residue (SiO2, 25-35% ethyl acetate in hexanes) yielded the 
desired adduct as a white amorphous solid (4.9 mg, 27%). The major enantiomer was determined 
to be 11% ee by chiral HPLC analysis. Chiral HPLC analysis (Chiralpak IA, 20% isopropyl 
alcohol/hexanes, 1.0 mL/min, tr(e1, major) = 15.2 min, tr(e2, minor) = 16.2 min); Rf = 0.26 (33% 
EtOAc/hexanes); 1H NMR (600 MHz, CDCl3)  7.67 (dd, J = 6.6 Hz, 1.8 Hz, 2 H), 7.29 (m, 5H), 
6.89 (dd, J = 7.2 Hz, 1.8 Hz, 2H), 5.88 (br s, 1H), 4.88 (AB system, J = 13.2 Hz, 2H), 3.86 (s, 3H), 
1.70 (s, 3H); 13C NMR (150.9 MHz, CDCl3) ppm 162.9, 139.7, 133.7, 129.2, 128.9, 128.4, 125.3, 
114.1, 82.8, 60.0, 55.6, 24.7; HRMS (ESI): Exact mass calcd for C16H18N2NaO5S [M+Na]
+ 
373.0834, found 373.0849. 
 
General Procedure for (S)-4-Nitro-N-(1-nitro-2-phenylpropan-2-yl)benzenesulfonamide 
(64). To a vial equipped with a stir bar was added the ketimine (6.00 mg, 19.7 µmol), the catalyst 
(1.30 mg, 1.97 µmol), and dry dichloroethane (158 µL). Nitromethane (2.40 mg, 39.4 µmol) was 
then added and the resulting mixture was allowed to stir at rt for 20 h. The reaction mixture was 
filtered through a silica pad with dichloromethane and ethyl acetate and concentrated in vacuo. 
Flash column chromatography of the residue (SiO2, 25-50% ethyl acetate in hexanes) yielded the 
 
 
 
 
 
 
189 
 
desired adduct as a white amorphous solid (3.1 mg, 43%). The major enantiomer was determined 
to be 12% ee by chiral HPLC analysis. Chiral HPLC analysis (Chiralpak IA, 20% isopropyl 
alcohol/hexanes, 1.0 mL/min, tr(e1, major) = 18.7 min, tr(e2, minor) = 19.8 min); Rf = 0.32 (33% 
EtOAc/hexanes); 1H NMR (600 MHz, CDCl3)  8.20 (d, J = 9.0 Hz, 2H), 7.74 (d, J = 9.0 Hz, 2H), 
7.27 (m, 1H), 7.22 (m, 4H), 6.12 (br s, 1H), 4.88 (AB system, J = 12.6 Hz, 2H), 1.81 (s, 3H) ); 13C 
NMR (150.9 MHz, CDCl3) ppm 147.4, 138.0, 128.9, 128.9, 128.3, 125.8, 124.0, 83.3, 60.1, 24.6.  
2-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)isoindoline-1,3-dione (74). A flame 
dried flask equipped with a stir bar was charged with Pd(dba)2 (208 mg, 362 µmol), rac-BINAP 
(225 mg, µmol), cesium carbonate (8.84 g, 27.1 mmol), the amine (2.21 g, 9.05 mmol), and 2,4-
dichloroquinoline (1.79 g, 9.05 mmol). An oven dried condenser was attached and the apparatus 
was purged twice with argon. Toluene (45 mL) was added and the resulting solution was stirred 
under reflux for 27 h. The reaction mixture was then cooled to rt, filtered through a Celite pad with 
CH2Cl2 and EtOAc, and concentrated. Flash column chromatography of the residue afforded the 
desired product as a light yellow foam (1.53 g, 42%). 

D
20
[]  +96 (c 0.68, CHCl3); Rf = 0.31 (20% 
EtOAc/hexanes); IR (film) 3381, 3060, 2935, 2858, 1767, 1705, 1606, 1567, 1531 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.65 (d, J = 7.6 Hz, 1H), 7.49 (m, 3H), 7.38 (ddd, J = 8.0, 6.8, 1.2 Hz, 1H), 
7.31 (dd, J = 5.6, 3.2 Hz, 2H), 7.06 (ddd, J = 8.0, 8.0, 1.2 Hz, 1H), 6.59 (s, 1H), 4.84 (dddd, J = 
10.8, 10.8, 10.8, 4.0 Hz, 1H), 4.74 (d, J = 10.0 Hz, 1H), 4.08 (ddd, J = 10.8, 10.8, 4.0 Hz, 1H), 
2.66 (dddd, J = 12.8, 12.8, 12.8, 3.6 Hz, 1H), 2.23 (br m, 1H), 1.85 (m, 3H), 1.66 (ddddd, J = 13.2, 
13.2, 13.2, 3.2, 3.2 Hz, 1H), 1.42-1.30 (m, 2H); 13C NMR (125.8 MHz, CDCl3) ppm 168.8, 156.0, 
148.1, 142.3, 133.1, 131.3, 129.9, 126.3, 123.3, 122.4, 122.3, 120.9, 111.0, 56.1, 51.3, 33.4, 28.7, 
25.5, 24.8; HRMS (ESI) Exact mass calcd for C23H21ClN3O2 [M+H]
+ 406.1322, found 406.1308. 
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 (1R,2R)-N1-(4-Chloroquinolin-2-yl)cyclohexane-1,2-diamine (75). To a flask equipped with a 
stir bar was added the quinoline (596 mg, 1.47 mmol) and ethanol (3 mL), and the resulting 
solution was allowed to stir at rt for 5 min. Hydrazine monohydrate (264 µL, 5.43 mmol) was 
added and the reaction mixture was stirred under reflux for 3 h whereupon a white solid 
precipitated out of solution. After cooling the reaction mixture to rt, the solid was washed with 
ether and filtered. The remaining solid was triturated with ether, filtered once more and the filtrate 
was concentrated to an orange foam (401 mg, 99%). 

D
20
[]  −3.3 (c 0.61, CHCl3); Rf = 0.25 (10% 
MeOH/1%AcOH/CH2Cl2); IR (film) 3268, 2930, 2857, 1609, 1538 cm
-1; 1H NMR (400 MHz, 
CDCl3) δ 7.91 (d, J = 8.0 Hz, 1H), 7.61 (d, J = 8.4 Hz, 1H), 7.49 (ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 
7.20 (ddd, J = 8.0, 8.0, 0.8 Hz, 1H), 6.75 (s, 1H), 5.19 (d, J = 8.4 Hz, 1H), 3.64 (m, 1H), 2.44 (ddd 
J = 10.0, 10.0, 4.0 Hz, 1H), 2.07 (br m, 1H), 1.90 (br m, 1H), 1.69-1.64 (br m, 4H), 1.39-1.14 (m, 
3H), 1.07 (ddd, J = 12.8, 12.8, 3.2 Hz, 1H); 13C NMR (125.8 MHz, CDCl3) ppm 156.7, 148.5, 
142.4, 130.2, 126.1, 123.7, 122.3, 121.3, 111.0, 57.4, 55.8, 35.2, 32.5, 24.9, 24.8; HRMS (ESI) 
Exact mass calcd for C15H19ClN3 [M+H]
+ 276.1268, found 276.1260. 
N-((1R,2R)-2-((4-(Pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)-2-(pyrrolidine-1-
carbonyl)benzamide (78). A 0.5-2 mL microwave vial was charged with the 4-chloroquinoline 
(200 mg, 492 µmol), pyrrolidine (162 µL, 1.97 mmol), and trifluorotoluene (2.00 mL). This 
suspension was heated at 150 °C and stirred in the microwave for 90 min. The reaction was 
concentrated and purified by flash column chromatography (1-10% methanol in dichloromethane 
w/ 1% AcOH) to provide a yellow oil. This material was diluted with dichloromethane and washed 
with 6 M aq NaOH. The organic layers were combined and washed three times more with 3 M aq 
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NaOH. The combined organic layers were dried (MgSO4) and concentrated to afford a yellow 
foam (201 mg, 80%). 

D
20
[]  +166 (c 0.90, CHCl3); Rf = 0.18 (5% MeOH/1% AcOH/CH2Cl2); IR 
(film) 3313, 3054, 2932, 2868, 1621, 1590, 1535 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.47 (br s, 
1H), 7.96 (d, J = 8.4 Hz, 1H), 7.55 (br d, J = 6.6 Hz, 1H), 7.39 (dd, J = 7.2, 7.2 Hz, 1H), 7.23 (dd, 
J = 7.2, 7.2 Hz, 1H), 7.14 (d, J = 7.8 Hz, 1H), 7.06 (dd, J = 7.2, 7.2 Hz, 2H), 6.78 (br s, 1H), 5.68 
(s, 1H), 4.63 (br s, 1H), 4.16 (m, 1H), 3.75 (br s, 1H), 3.62-3.52 (m, 6H), 3.08 (m, 1H), 3.01 (m, 
1H), 2.33 (br s, 1H), 2.14 (br d, J = 10.2 Hz, 1H), 1.97 (m, 4H), 1.84-1.74 (m, 5H), 1.65 (m, 1H), 
1.40 (m, 4H); 13C NMR (150.9 MHz, CDCl3) ppm 169.9, 167.4, 157.9, 153.9, 149.4, 137.5, 132.8, 
130.2, 128.7, 128.3, 127.6, 126.7, 126.3, 124.8, 119.8, 118.6, 91.8, 57.4, 53.3, 52.0, 48.5, 45.4, 
33.1, 32.0, 25.8, 25.6, 25.1, 24.4; HRMS (ESI): Exact mass calcd for C31H38N5O2 [M+H]
+ 
512.3026, found 512.3005.  
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)-3,5-bis(trifluoromethyl)benzamide 
(80a). To a flame dried flask equipped with a stir bar was added the amine (200 mg, 725 µmol), 
the carboxylic acid (187 mg, 725 µmol), and dichloromethane (4 mL). The resulting solution was 
chilled to 0 °C and EDC (181 mg, 943 µmol) and DMAP (9.00 mg, 72.5 µmol) were added. The 
reaction mixture was stirred and allowed to gradually warm to room temperature. After 20 h, the 
reaction mixture was diluted with water and extracted with CH2Cl2. The combined organic layers 
were washed once with water, dried over MgSO4, and concentrated. Flash column chromatography 
of the residue (SiO2, 5-40% ethyl acetate in hexanes) afforded the desired amide as a white 
amorphous solid (291 mg, 78%). 

D
20
[]  +291 (c 1.11, CHCl3); Rf = 0.43 (30% EtOAc/hexanes); 
IR (film) 3335, 2937, 2861, 1654, 1608, 1536 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.60 (br d, J = 
5.4 Hz, 1H), 7.94 (s, 2H), 7.93 (dd, J = 9.0, 0.6 Hz, 1H), 7.74 (s, 1H), 7.61 (d, 7.8 Hz, 1H), 7.55 
(ddd, J = 7.8, 7.8, 0.6 Hz, 1H), 7.29 (ddd, J = 7.8, 7.8, 0.6 Hz, 1H), 6.71 (s, 1H), 4.70 (d, J = 7.2 
Hz, 1H), 4.26 (m, 1H), 3.86 (m, 1H), 2.46 (m, 1H), 2.12 (m, 1H), 1.90 (br dd, J = 5.4, 1.8 Hz, 1H), 
1.83 (br s, 1H), 1.47 (m, 4H); 13C NMR (150.9 MHz, CDCl3) ppm 164.9, 156.8, 147.6, 143.3, 
137.0, 131.7 (q, JFC = 34.0 Hz), 131.2, 127.1, 125.7, 124.5 (q, JFC = 3.5 Hz), 124.1, 123.4, 122.7 
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(q, JFC = 273.0 Hz), 121.7, 112.1, 58.9, 53.4, 33.2, 32.1, 25.3, 24.3; HRMS (ESI): Exact mass 
calcd for C24H21ClF6N3O [M+H]
+ 516.1278, found 516.1254. 
N-((1R,2R)-2-((4-(Pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)-3,5-bis(trifluoromethyl) 
benzamide (78a). A 2-5 mL microwave vial was charged with the 4-chloroquinoline (291 mg, 
564 µmol), pyrrolidine (185 µL, 2.26 mmol), and trifluorotoluene (3.52 mL). This suspension was 
heated at 150 °C and stirred in the microwave for 90 min. The reaction was concentrated and 
purified by flash column chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to 
provide a yellow oil. This material was diluted with dichloromethane and washed with 6 M aq 
NaOH. The organic layers were combined and washed twice more with 3 M aq NaOH. The 
combined organic layers were dried over MgSO4 and concentrated to afford a white amorphous 
solid (215 mg, 69%). 

D
20
[]  +184 (c 0.93, CHCl3); Rf = 0.15 (5% MeOH/1% AcOH/CH2Cl2); IR 
(film) 3343, 2935, 2861, 1655, 1589, 1531 cm-1; 1H NMR (600 MHz, CDCl3) δ 9.52 (d, J = 4.2 
Hz, 1H), 7.98 (s, 2H), 7.96 (dd, J = 8.4, 0.6 Hz, 1H), 7.73 (s, 1H), 7.51 (d, J = 8.4 Hz, 1H), 7.39 
(ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 7.07 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 5.65 (s, 1H), 4.34 (br s, 1H), 
4.21 (m, 1H), 3.73 (m, 1H), 3.55 (m, 4H), 2.51 (d, J = 12.0 Hz, 1H), 2.07 (m, 1H), 1.98 (m, 4H), 
1.87 (d, J = 4.8 Hz, 1H), 1.81 (d, J = 6.0 Hz, 1H), 1.44 (m, 4H); 13C NMR (150.9 MHz, CDCl3) 
ppm 165.2, 158.3, 154.0, 149.0, 137.6, 131.5 (q, JFC = 33.7 Hz), 129.3, 127.3, 126.1, 124.9, 124.2, 
122.8 (q, J = 273.1 Hz), 120.3, 118.6, 91.2, 59.6, 53.1, 51.9, 33.3, 31.9, 25.8, 25.5, 24.4; HRMS 
(ESI) Exact mass calcd for C28H29F6N4O [M+H]
+ 551.2246, found 551.2237. 
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)benzamide (80b). To a flame dried 
flask equipped with a stir bar was added the amine (60.0 mg, 218 µmol), benzoic acid (26.6 mg, 
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218 µmol), and dichloromethane (2 mL). The resulting solution was chilled to 0 °C and EDC (54.3 
mg, 283 µmol) and DMAP (2.70 mg, 22.0 µmol) were added. The reaction mixture was stirred 
and allowed to gradually warm to room temperature. After 30 h, the reaction mixture was diluted 
with water and extracted with CH2Cl2. The combined organic layers were washed once with water, 
dried over MgSO4, and concentrated. Flash column chromatography of the residue (SiO2, 10-50% 
ethyl acetate in hexanes) afforded the desired amide as a white amorphous solid (65.2 mg, 79%). 

D
20
[]  +433 (c 0.42, CHCl3); Rf = 0.23 (30% EtOAc/hexanes); IR (film) 3305, 3061, 2933, 2857, 
1643, 1608, 1574, 1537 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.18 (br d, J = 5.4 Hz, 1H), 7.94 (dd, 
J = 8.4, 1.2 Hz, 1H), 7.74 (d, J = 8.4 Hz, 1H), 7.62 (ddd, J = 8.4, 7.2, 1.8 Hz, 1H), 7.52 (dd, J = 
7.8, 0.6 Hz, 2H), 7.30 (ddd, J = 8.4, 6.6, 1.2 Hz, 1H), 7.25 (dd, J = 7.2, 7.2 Hz, 1H), 7.04 (d, J = 
7.8 Hz, 2H), 6.68 (s, 1H), 5.04 (br d, J = 7.8 Hz, 1H), 4.28 (m, 1H), 3.86 (m, 1H), 2.46 (d, J = 12.0 
Hz, 1H), 2.16 (m, 1H), 1.88 (br dd, J = 6.0, 1.8 Hz, 1H), 1.82 (br dd, J = 4.8, 1.8 Hz, 1H), 1.48 (m, 
4H); 13C NMR (150.9 MHz, CDCl3) ppm 167.3, 156.9, 148.1, 142.3, 134.2, 130.9, 130.6, 128.1, 
126.8, 126.1, 124.2, 122.9, 121.8, 112.5, 58.0, 53.4, 33.1, 32.4, 25.3, 24.5; HRMS (ESI): Exact 
mass calcd for C22H23ClN3O [M+H]
+ 380.1530, found 380.1543.  
N-((1R,2R)-2-((4-(pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)benzamide (78b). A 0.5-2 
mL microwave vial was charged with the 4-chloroquinoline (48.0 mg, 128 µmol), pyrrolidine 
(42.2 µL, 514 µmol), and trifluorotoluene (1.5 mL). This suspension was heated at 150 °C and 
stirred in the microwave for 2 h. The reaction was concentrated and purified by flash column 
chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to provide a yellow oil. This 
material was diluted with dichloromethane and washed with 6 M aq NaOH. The organic layers 
were combined and washed twice more with 3 M aq NaOH. The combined organic layers were 
dried over MgSO4 and concentrated to afford a light yellow amorphous solid (25.6 mg, 48%). 

D
20
[]  +225 (c 0.47, CHCl3); Rf = 0.12 (5% MeOH/1% AcOH/CH2Cl2); IR (film) 3325, 2930, 
2857, 1644, 1588, 1533 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.89 (br s, 1H), 7.98 (d, J = 7.8 Hz, 
1H), 7.68 (d, J = 7.8 Hz, 1H), 7.52 (d, J = 7.8 Hz, 2H), 7.48 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 7.21 
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(dd, J = 7.8, 7.8 Hz, 1H), 7.10 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 6.99 (dd, J = 7.8, 7.8 Hz, 2H), 5.61 
(s, 1H), 4.52 (br s, 1H), 4.30 (m, 1H), 3.74 (m, 1H), 3.48 (m, 4H), 2.51 (d, J = 12.0 Hz, 1H), 2.09 
(d, J = 7.2 Hz, 1H), 1.94 (m, 4H), 1.85 (d, J = 3.6 Hz, 1H), 1.78 (d, J = 8.4 Hz, 1H), 1.41 (m, 4H); 
13C NMR (150.9 MHz, CDCl3) ppm 167.2, 158.3, 153.8, 149.4, 134.6, 130.5, 128.8, 127.9, 127.0, 
126.5, 125.0, 119.9, 118.8, 91.8, 59.0, 52.5, 51.9, 33.3, 32.1, 25.8, 25.5, 24.5; HRMS (ESI): Exact 
mass calcd for C26H31N4O [M+H]
+ 415.2499, found 415.2480.  
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)-1-naphthamide (80c). To a flame 
dried flask equipped with a stir bar was added the amine (60.0 mg, 218 µmol), the carboxylic acid 
(37.5 mg, 218 µmol), and dichloromethane (2 mL). The resulting suspension was chilled to 0 °C 
and EDC (54.3 mg, 283 µmol) and DMAP (2.70 mg, 22.0 µmol) were added. The reaction mixture 
was stirred and allowed to gradually warm to room temperature. After 30 h, the reaction mixture 
was diluted with water and extracted with CH2Cl2. The combined organic layers were washed once 
with water, dried over MgSO4, and concentrated. Flash column chromatography of the residue 
(SiO2, 10-40% ethyl acetate in hexanes) afforded the desired amide as a white solid (48.4 mg, 
52%). Mp 208.0-210.0 °C; 

D
20
[]  +292 (c 0.49, CHCl3); Rf = 0.40 (40% EtOAc/hexanes); IR (film) 
3296, 3058, 2928, 2855, 2362, 1642, 1607, 1575, 1536 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.17 
(d, J = 8.4 Hz, 1H), 7.89 (dd, J = 8.4, 0.6 Hz, 1H), 7.80 (br d, J = 6.6 Hz, 1H), 7.68 (d, J = 7.8 Hz, 
1H), 7.64 (d, J = 8.4 Hz, 1H), 7.36 (dddd, J = 9.0, 6.6, 4.8, 1.2 Hz, 2H), 7.32 (ddd, J = 8.4, 6.6, 
1.2, 1H), 7.21 (m, 2H), 6.97 (dd, J = 6.6, 0.6 Hz, 1H), 6.89 (dd, J = 8.4, 8.4 Hz, 1H), 6.72 (s, 1H), 
5.07 (d, J = 7.2 Hz, 1H), 4.22 (m, 1H), 4.02 (m, 1H), 2.50 (br d, J = 11.4 Hz, 1H), 2.20 (br m, 1H), 
1.87 (m, 2H), 1.48 (m, 4H); 13C NMR (150.9 MHz, CDCl3) ppm 169.9, 156.5, 147.9, 142.9, 134.4, 
133.4, 130.4, 130.0, 129.9, 128.0, 126.6, 125.98, 125.97, 125.2, 124.5, 124.4, 123.8, 122.7, 121.5, 
112.2, 57.1, 54.0, 33.0, 32.6, 25.2, 24.6; HRMS (ESI): Exact mass calcd for C26H25ClN3O [M+H]
+ 
430.1686, found 430.1673. 
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N-((1R,2R)-2-((4-(Pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)-1-naphthamide (78c). A 
0.5-2 mL microwave vial was charged with the 4-chloroquinoline (30.0 mg, 69.8 µmol), 
pyrrolidine (23.0 µL, 279 µmol), and trifluorotoluene (446 µL). This suspension was heated at 150 
°C and stirred in the microwave for 90 min. The reaction was concentrated and purified by flash 
column chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to provide a light 
yellow oil. This material was diluted with dichloromethane and washed with 6 M aq NaOH. The 
organic layers were combined and washed three times more with 3 M aq NaOH. The combined 
organic layers were dried (MgSO4) and concentrated to afford a tan amorphous solid (17.6 mg, 
54%). 

D
20
[]  +172 (c 0.79, CHCl3); Rf = 0.39 (5% MeOH/1% AcOH/CH2Cl2); IR (film) 3329, 
3047, 2930, 2857, 1643, 1588, 1532 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.65 (br s, 1H), 8.33 (dd, 
J = 9.0, 1.8 Hz, 1H), 7.94 (d, J = 8.4 Hz, 1H), 7.69 (dd, J = 9.0, 1.8 Hz, 1H), 7.60 (d, J = 8.4 Hz, 
1H), 7.36 (m, 2H), 7.20 (br dd, J = 7.2, 7.2 Hz, 1H), 7.14 (br s, 1H), 7.02 (dd, J = 7.2, 7.2 Hz, 1H), 
6.81 (br s, 1H), 6.70 (br s, 1H), 5.70 (s, 1H), 4.60 (br s, 1H), 4.26 (br s, 1H), 3.89 (br d, J = 5.4 Hz, 
1H), 3.51 (br m, 4H), 2.56 (br d, J = 7.8 Hz, 1H), 2.14 (br d, J = 5.4 Hz, 1H), 1.96 (m, 4H), 1.88 
(br s, 1H), 1.82 (br s, 1H), 1.49 (m, 4H); 13C NMR (150.9 MHz, CDCl3) ppm 169.7, 157.9, 154.0, 
149.1, 134.4, 133.5, 130.2, 129.6, 128.6, 127.9, 126.4, 125.8, 125.7, 124.9, 124.7, 124.4, 119.8, 
118.5, 91.7, 58.5, 52.7, 51.9, 33.3, 32.4, 25.8, 25.4, 24.6; HRMS (ESI): Exact mass calcd for 
C30H33N4O [M+H]
+ 465.2654, found 465. 2672.  
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)-3,5-dimethylbenzamide (80d). To a 
flame dried flask equipped with a stir bar was added the amine (60.0 mg, 218 µmol), the carboxylic 
acid (32.7 mg, 218 µmol), and dichloromethane (2 mL). The resulting solution was chilled to 0 °C 
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and EDC (54.3 mg, 283 µmol) and DMAP (2.70 mg, 22.0 µmol) were added. The reaction mixture 
was stirred and allowed to gradually warm to room temperature. After 30 h, the reaction mixture 
was diluted with water and extracted with CH2Cl2. The combined organic layers were washed once 
with water, dried over MgSO4, and concentrated. Flash column chromatography of the residue 
(SiO2, 10-40% ethyl acetate in hexanes) afforded the desired amide as a white amorphous solid 
(66.9 mg, 75%). 

D
20
[]  +387 (c 0.45, CHCl3); Rf = 0.34 (40% EtOAc/hexanes); IR (film) 3303, 
3060, 2929, 2857, 2361, 1643, 1605, 1574, 1536 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.00 (br d, 
J = 6.6 Hz, 1H), 7.93 (dd, J = 7.8, 0.6 Hz, 1H), 7.72 (d, J = 8.4 Hz, 1H), 7.57 (ddd, J = 8.4, 7.2, 
1.2 Hz, 1H), 7.27 (ddd, J = 7.8, 7.8, 0.6 Hz, 1H), 7.02 (s, 2H), 6.87 (s, 1H), 6.69 (s, 1H), 5.22 (d, 
J = 7.8 Hz, 1H), 4.33 (m, 1H), 3.87 (m, 1H), 2.44 (d, J = 13.2 Hz, 1H), 2.15 (m, 1H), 1.94 (s, 6H), 
1.89 (dd, J = 6.0, 2.4 Hz, 1H), 1.83 (m, 1H), 1.57-1.36 (m, 4H); 13C NMR (150.9 MHz, CDCl3) 
ppm 167.9, 157.0, 148.2, 142.7, 137.9, 134.3, 132.6, 130.7, 126.2, 124.5, 124.1, 122.8, 121.7, 
112.6, 58.0, 53.0, 33.0, 32.4, 25.4, 24.6, 20.8; HRMS (ESI) Exact mass calcd for C24H27N3O 
[M+H]+ 408.1843, found 408.1847. 
3,5-Dimethyl-N-((1R,2R)-2-((4-(pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)benzamide 
(78d). A 0.5-2 mL microwave vial was charged with the 4-chloroquinoline (40.0 mg, 98.1 µmol), 
pyrrolidine (32.0 µL, 392 µmol), and trifluorotoluene (620 µL). This suspension was heated at 150 
°C and stirred in the microwave for 90 min. The reaction was concentrated and purified by flash 
column chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to provide a yellow 
oil. This material was diluted with dichloromethane and washed with 6 M aq NaOH. The organic 
layers were combined and washed twice more with 3 M aq NaOH. The combined organic layers 
were dried over MgSO4 and concentrated to afford a yellow amorphous solid (23.7 mg, 55%). 

D
20
[]  +238 (c 0.75, CHCl3); Rf = 0.51 (10% MeOH/1% AcOH/CH2Cl2); IR (film) 3320, 2929, 
2858, 2361, 1643, 1590, 1533 cm-1, 1H NMR (600 MHz, CDCl3) δ 8.68 (br s, 1H), 7.98 (d, J = 8.4 
Hz, 1H), 7.66 (d, J = 7.8Hz, 1H), 7.43 (ddd, J = 7.8, 7.8, 0.6 Hz, 1H), 7.08 (ddd, J = 8.4, 8.4, 1.2 
Hz, 1H), 7.05 (s, 2H), 6.85 (s, 1H), 5.64 (s, 1H), 4.49 (br s, 1H), 4.33 (br m, 1H), 3.74 (m, 1H), 
 
 
 
197 
 
3.50 (br m, 4H), 2.49 (d, J = 11.4 Hz, 1H), 2.07 (br d, J = 2.4 Hz, 1H), 1.95 (br m, 4H), 1.91 (s, 
6H), 1.84 (br d, J = 3.0 Hz, 1H), 1.78 (br d, J = 6.0 Hz, 1H), 1.46-1.35 (m, 4H); 13C NMR (150.9 
MHz, CDCl3) ppm 167.8, 158.3, 153.9, 149.5, 137.7, 134.8, 132.2, 129.0, 126.7, 125.0, 124.7, 
120.0, 118.9, 91.9, 58.9, 52.3, 51.9, 33.4, 32.2, 25.8, 25.6, 24.5, 20.7; HRMS (ESI) Exact mass 
calcd for C28H35N4O [M+H]
+ 443.2811, found 443.2813.  
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)-2-naphthamide (80e). To a flame 
dried flask equipped with a stir bar was added the amine (61.0 mg, 221 µmol), the carboxylic acid 
(38.1 mg, 221 µmol), and dichloromethane (2 mL). The resulting suspension was chilled to 0 °C 
and EDC (55.2 mg, 288 µmol) and DMAP (2.70 mg, 22.0 µmol) were added. The reaction mixture 
was stirred and allowed to gradually warm to room temperature. After 30 h, the reaction mixture 
was diluted with water and extracted with CH2Cl2. The combined organic layers were washed once 
with water, dried (MgSO4), and concentrated. Flash column chromatography of the residue (SiO2, 
10-40% ethyl acetate in hexanes) afforded the desired amide as a white solid (68.8 mg, 72%). 

D
20
[]  +318 (c 0.42, CHCl3); Rf = 0.40 (40% EtOAc/hexanes); IR (film) 3305, 3058, 2932, 2857, 
2361, 1643, 1607, 1572, 1537 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.36 (br d, J = 6.6 Hz, 1H), 
7.96 (dd, J = 8.4, 1.2 Hz, 1H), 7.79 (d, J = 8.4 Hz, 1H), 7.76 (s, 1H), 7.69 (dd, J = 9.0, 2.4 Hz, 
2H), 7.62 (ddd, J = 8.4, 7.2, 1.8 Hz, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.41 (ddd, J = 7.8, 7.2, 1.2 Hz, 
1H), 7.33 (ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 7.29 (ddd, J = 7.8, 7.8, 0.6 Hz, 1H), 7.05 (d, J = 8.4 Hz, 
1H), 6.71 (s, 1H), 5.15 (d, J = 7.8 Hz, 1H), 4.37 (m, 1H), 3.93 (m, 1H), 2.53 (d, J = 12.0 Hz, 1H), 
2.17 (br m, 1H), 1.90 (dd, J = 6.0, 1.8 Hz, 1H), 1.84 (dd, J = 5.4, 1.2 Hz, 1H), 1.58-1.42 (m, 4H); 
13C NMR (150.9 MHz, CDCl3) ppm 167.5, 157.0, 148.1, 142.9, 134.4, 132.2, 131.6, 130.8, 128.8, 
128.0, 127.4, 127.2, 126.8, 126.2, 126.1, 124.3, 123.9, 122.9, 121.8, 112.6, 58.4, 53.2, 33.1, 32.5, 
25.4, 24.5; HRMS (ESI): Exact mass calcd for C26H25ClN3O [M+H]
+ 430.1686, found 430.1668.  
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N-((1R,2R)-2-((4-(Pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)-2-naphthamide (78e). A 
0.5-2 mL microwave vial was charged with the 4-chloroquinoline (35.0 mg, 81.4 µmol), 
pyrrolidine (27.0 µL, 326 µmol), and trifluorotoluene (520 µL). This suspension was heated at 150 
°C and stirred in the microwave for 90 min. The reaction was concentrated and purified by flash 
column chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to provide a light 
yellow oil. This material was diluted with dichloromethane and washed with 6 M aq NaOH. The 
organic layers were combined and washed three times more with 3 M aq NaOH. The combined 
organic layers were dried (MgSO4) and concentrated to afford a light yellow amorphous solid (21.2 
mg, 56%). 

D
20
[]  +150 (c 0.91, CHCl3); Rf = 0.39 (5% MeOH/1% AcOH/CH2Cl2); IR (film) 3324, 
3054, 2930, 2857, 2361, 1644, 1588, 1533, 1502 cm-1; 1H NMR (600 MHz, CDCl3) δ 9.00 (br s, 
1H), 8.02 (d, J = 8.4 Hz, 1H), 7.76 (s, 1H), 7.73 (m, 2H), 7.68 (d, J = 8.4 Hz, 1H), 7.53 (d, J = 8.4 
Hz, 1H), 7.48 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 7.39 (ddd, J = 7.8, 7.8, 1.2 Hz, 1H), 7.26 (dd, J = 
7.2, 7.2 Hz, 1H), 7.15 (dd, J = 7.2, 7.2 Hz, 1H), 6.95 (d, J = 7.8 Hz, 1H), 5.61 (s, 1H), 4.62 (br s, 
1H), 4.39 (m, 1H), 3.82 (m, 1H), 3.42 (m, 4H), 2.55 (br d, J = 12.0 Hz, 1H), 2.12 (d J = 10.2 Hz, 
1H), 1.86 (m, 5H), 1.82 (br m, 1H), 1.56-1.41 (m, 4H); 13C NMR (150.9 MHz, CDCl3) ppm 167.4, 
158.5, 153.8, 149.5, 134.3, 132.4, 132.0, 129.1, 129.0, 127.7, 127.2, 126.9, 126.7, 125.8, 125.2, 
124.3, 120.0, 118.9, 91.8, 59.3, 52.4, 51.9, 33.3, 32.7, 25.7, 25.6, 24.6; HRMS (ESI): Exact mass 
calcd for C30H33N4O [M+H]
+ 465.2654, found 465.2646.  
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)picolinamide (80f). To a flame dried 
flask equipped with a stir bar was added the amine (40.0 mg, 145 µmol), picolinic acid (17.9 mg, 
145 µmol), and dichloromethane (1 mL). The resulting solution was chilled to 0 °C and EDC (36.2 
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mg, 189 µmol) and DMAP (1.80 mg, 15.0 µmol) were added. The reaction mixture was stirred 
and allowed to gradually warm to room temperature. After 14 h, the reaction mixture was diluted 
with water and extracted with CH2Cl2. The combined organic layers were washed once with water, 
dried (MgSO4), and concentrated. Flash column chromatography of the residue (SiO2, 40-80% 
ethyl acetate in hexanes) afforded the desired amide as a viscous yellow oil (29.7 mg, 54%). 

D
20
[]  
+158 (c 0.59, CHCl3); Rf = 0.14 (20% EtOAc/hexanes); IR (film) 3319, 2932, 2857, 1658, 1609, 
1570, 1534 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.87 (br d, J = 7.2 Hz, 1H), 8.04 (dd, J = 6.6, 0.6 
Hz, 1H), 8.04 (s, 1H), 7.86 (dd, J = 8.4, 1.2 Hz, 1H), 7.79 (d, J = 7.8 Hz, 1H), 7.68 (ddd, J = 7.2, 
7.2, 1.2 Hz, 1H), 7.57 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 7.23 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 7.17 (m, 
1H), 6.64 (s, 1H), 5.17 (d, J = 7.2 Hz, 1H), 4.26 (dddd, J = 11.4, 11.4, 7.8, 4.2 Hz, 1H), 3.94 (dddd, 
J = 10.8, 10.8, 7.8, 3.6 Hz, 1H), 2.28 (m, 2H), 1.85 (dd, J = 12.0, 1.8 Hz, 2H), 1.57-1.44 (m, 3H), 
1.43-1.34 (m, 1H); 13C NMR (100.6 MHz, CDCl3) ppm 165.0, 156.3, 149.7, 148.6, 147.7, 142.2, 
136.8, 130.0, 126.8, 125.7, 123.7, 122.4, 121.8, 121.4, 112.1, 55.5, 54.6, 32.7, 32.4, 24.9, 24.8; 
HRMS (ESI) Exact mass calcd for C21H22ClN4O [M+H]
+ 381.1482, found 381.1495. 
N-((1R,2R)-2-((4-(Pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)picolinamide (78f). A 2-5 
mL microwave vial was charged with the 4-chloroquinoline (50.0 mg, 131 µmol), pyrrolidine (130 
µL, 1.58 mmol), and trifluorotoluene (800 µL). This suspension was heated at 150 °C and stirred 
in the microwave for 3 h. More pyrrolidine (65.0 µL, 788 µmol) was added and the reaction 
mixture was heated to 180 °C and stirred in the microwave for an additional 1.5 h. The reaction 
was concentrated and purified by flash column chromatography (1-10% methanol in 
dichloromethane w/ 1% AcOH) to provide a dark-yellow oil. This material was diluted with 
dichloromethane and washed twice with 6 M aq NaOH. The organic layers were combined and 
washed twice more with 3 M aq NaOH. The combined organic layers were dried over MgSO4 and 
concentrated to afford an off-white amorphous solid (24.7 mg, 45%). 

D
20
[]  +144 (c 0.49, CHCl3); 
Rf = 0.49 (10% MeOH/1% AcOH/CH2Cl2); IR (film) 3337, 2930, 2857, 1657, 1588, 1531 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 9.36 (br d, J = 6.8 Hz, 1H), 8.00 (d, J = 8.0 Hz, 1H), 7.97 (br d, J 
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= 4.4 Hz, 1H), 7.89 (d, J = 8.4 Hz, 1H), 7.80 (d, J = 8.4 Hz, 1H), 7.63 (ddd, J = 8.0, 8.0, 1.6 Hz, 
1H), 7.46 (ddd, J = 8.0, 8.0, 1.2 Hz, 1H), 7.13 (dd, J = 6.4, 4.8 Hz, 1H), 7.04 (br ddd, J = 8.0, 8.0, 
1.2 Hz, 1H), 5.61 (s, 1H), 4.52 (br d, J = 6.8 Hz, 1H), 4.32 (dddd, J = 11.2, 11.2, 8.0, 4.0 Hz, 1H), 
3.84 (br dddd, J = 10.8, 10.8, 7.6, 4.4 Hz, 1H), 3.45 (br m, 4H), 2.33 (m, 1H), 2.22 (d, J = 12.4 Hz, 
1H), 1.92 (m, 4H), 1.81 (br s, 2H), 1.54-1.33 (m, 4H); 13C NMR (125.8 MHz, CDCl3) ppm 164.9, 
157.8, 153.7, 150.2, 150.0, 147.8, 136.5, 128.2, 127.4, 125.3, 124.6, 121.6, 119.4, 118.6, 92.0, 
56.7, 53.3, 51.8, 33.2, 32.2, 25.7, 25.2, 24.7; HRMS (ESI) Exact mass calcd for C25H30N5O 
[M+H]+ 416.2450, found 416.2432. 
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)-2,4,6-trimethylbenzamide (80g). 
To a flame dried flask equipped with a stir bar was added the amine (60.0 mg, 218 µmol) and 
dichloromethane (3 mL), immediately followed by the addition of N,N-diisopropyl ethylamine 
(45.0 µL, 261 µmol), the acid chloride (43.0 µL, 261 µmol), and DMAP (2.70 mg, 22.0 µmol). 
The reaction mixture was stirred at rt for 30 h, quenched with 1 M HCl and extracted with 
dichloromethane. The organic extracts were then washed with satd aq NaHCO3, extracted with 
dichloromethane, dried (MgSO4), filtered and concentrated. Flash column chromatography of the 
residue (SiO2, 10-80% ethyl acetate in hexanes) afforded the desired amide as an off white solid 
(74.1 mg, 81%). Mp 261.0-264.0 °C; 

D
20
[]  +193 (c 0.58, CHCl3); Rf = 0.46 (40% 
EtOAc/hexanes); IR (film) 3250, 3101, 3059, 2930, 2856, 2363, 1642, 1608, 1540 cm-1; 1H NMR 
(600 MHz, CDCl3) δ 7.93 (dd, J = 7.8, 1.8 Hz, 1H), 7.38 (ddd, J = 7.2, 7.2, 1.2 Hz, 1H), 7.26 (br 
s, 1H), 7.22 (m, 2H), 6.71 (s, 1H), 6.56 (s, 2H), 5.25 (br d, J = 6.0 Hz, 1H), 4.05 (m, 1H), 3.94 (m, 
1H), 2.36 (m, 1H), 2.26 (m, 1H), 2.14 (s, 3H), 1.98 (s, 6H), 1.83 (br m, 2H), 1.48-1.34 (m, 4H); 
13C NMR (150.9 MHz, CDCl3) ppm 171.1, 156.1, 148.0, 142.6, 137.9, 134.9, 133.6, 130.2, 127.8, 
126.0, 123.8, 122.6, 121.3, 112.1, 55.5, 54.6, 32.8, 32.5, 24.9, 24.6, 21.0, 18.6; HRMS (ESI): Exact 
mass calcd for C25H29ClN3O [M+H]
+ 422.1999, found 422.1983. 
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2,4,6-Trimethyl-N-((1R,2R)-2-((4-(pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl) 
benzamide (78g). A 0.5-2 mL microwave vial was charged with the 4-chloroquinoline (40.0 mg, 
94.8 µmol), pyrrolidine (31.0 µL, 379 µmol), and trifluorotoluene (680 µL). This suspension was 
heated at 150 °C and stirred in the microwave for 90 min. The reaction was concentrated and 
purified by flash column chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to 
provide a yellow oil. This material was diluted with dichloromethane and washed with 6 M aq 
NaOH. The organic layers were combined and washed four times more with 3 M aq NaOH. The 
combined organic layers were dried (MgSO4) and concentrated to afford a tan foam (20.9 mg, 
48%). 

D
20
[]  +120 (c 0.43, CHCl3); Rf = 0.32 (5% MeOH/1% AcOH/CH2Cl2); IR (film) 3317, 
2926, 2856, 2362, 1644, 1590, 1533 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.55 (br s, 1H), 7.91 (d, 
J = 7.8 Hz, 1H), 7.12 (dd, J = 6.6, 6.6 Hz, 1H), 6.99 (dd, J = 7.2, 7.2 Hz, 1H), 6.90 (br d, J = 7.2 
Hz, 1H), 6.47 (s, 2H), 5.68 (s, 1H), 4.57 (br s, 1H), 4.03 (br m, 1H), 3.78 (br m, 1H), 3.55 (br m, 
2H), 3.50 (br m, 2H), 2.50 (br d, J = 10.8 Hz, 1H), 2.14 (br d, J = 11.4 Hz, 1H), 2.12 (s, 3H), 2.05-
1.96 (m, 4H), 1.94 (s, 6H), 1.82 (br s, 1H), 1.78 (br s, 1H), 1.48-1.35 (m, 4H); 13C NMR (150.9 
MHz, CDCl3) ppm 170.8, 157.7, 153.9, 149.0, 137.2, 135.4, 133.5, 128.4, 127.6, 126.1, 124.5, 
119.6, 118.3, 91.8, 57.2, 53.4, 51.9, 33.2, 32.3, 25.8, 25.2, 24.4, 21.0, 18.6; HRMS (ESI): Exact 
mass calcd for C29H36N4NaO [M+Na]
+ 479.2787, found 479.2774. 
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)-2,6-dimethoxybenzamide (80h). To 
a flame dried flask equipped with a stir bar was added the amine (60.0 mg, 218 µmol) and 
dichloromethane (3 mL), immediately followed by the addition of N,N-diisopropyl ethylamine 
(45.0 µL, 261 µmol), the acid chloride (52.4 mg, 261 µmol), and DMAP (2.70 mg, 22.0 µmol). 
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The reaction mixture was stirred at rt for 48 h, quenched with 1 M HCl and extracted with 
dichloromethane. The organic extracts were then washed with satd aq NaHCO3, extracted with 
dichloromethane, dried (MgSO4), filtered and concentrated. Flash column chromatography of the 
residue (SiO2, 10-60% ethyl acetate in hexanes) afforded the desired amide as a white solid (68.3 
mg, 71%). Mp 256.0-258.0 °C; 

D
20
[]  +166 (c 0.56, CHCl3); Rf = 0.16 (40% EtOAc/hexanes); IR 
(film) 3284, 3060, 2933, 2857, 2361, 1646, 1607, 1538 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.92 
(d, J = 8.4 Hz, 1H), 7.42 (m, 2H), 7.21 (ddd, J = 8.4, 6.0, 2.4 Hz, 1H), 7.10 (dd, J = 8.4, 8.4 Hz, 
1H), 6.78 (br d, J = 6.6 Hz, 1H), 6.75 (s, 1H), 6.32 (d, J = 8.4 Hz, 2H), 5.50 (d, J = 5.4 Hz, 1H), 
4.02 (m, 2H), 3.47 (s, 6H), 2.34 (d, J = 13.2 Hz, 1H), 2.27 (d, J = 10.8 Hz, 1H), 1.82 (dd, J = 6.6, 
2.4 Hz, 2H), 1.48-1.32 (m, 4H); 13C NMR (150.9 MHz, CDCl3) ppm 166.7, 157.0, 156.5, 148.5, 
141.9, 130.3, 130.2, 126.1, 123.7, 122.3, 121.3, 115.7, 112.7, 103.6, 55.6, 55.5, 54.6, 32.7, 32.4, 
24.80, 24.75; HRMS (ESI): Exact mass calcd for C24H27ClN3O3 [M+H]
+ 440.1741, found 
440.1746. 
2,6-Dimethoxy-N-((1R,2R)-2-((4-(pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl) 
benzamide (78h). A 0.5-2 mL microwave vial was charged with the 4-chloroquinoline (40.0 mg, 
90.9 µmol), pyrrolidine (30.0 µL, 364 µmol), and trifluorotoluene (650 µL). This suspension was 
heated at 150 °C and stirred in the microwave for 90 min. The reaction was concentrated and 
purified by flash column chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to 
provide a yellow oil. This material was diluted with dichloromethane and washed with 6 M aq 
NaOH. The organic layers were combined and washed twice more with 3 M aq NaOH. The 
combined organic layers were dried (MgSO4) and concentrated to afford a tan amorphous solid 
(18.4 mg, 43%). Mp 238.0-242.0 °C; 

D
20
[]  +98.6 (c 0.76, CHCl3); Rf = 0.30 (5% MeOH/1% 
AcOH/CH2Cl2); IR (film) 3287, 2931, 2857, 2361, 1645, 1593, 1533 cm
-1; 1H NMR (600 MHz, 
CDCl3) δ 8.01 (br s, 1H), 7.90 (d, J = 7.8 Hz, 1H), 7.20 (br dd, J = 7.2, 7.2 Hz, 1H), 7.14 (br d, J 
= 7.2 Hz, 1H), 7.04 (dd, J = 8.4, 8.4 Hz, 1H), 7.00 (dd, J = 6.6 Hz, 1H), 6.23 (d, J = 7.8 Hz, 2H), 
 
 
 
203 
 
5.75 (s, 1H), 4.70 (br s, 1H), 4.03 (br m, 1H), 3.87 (br m, 1H), 3.57 (br s, 2H), 3.49 (br s, 2H), 3.39 
(s, 6H), 2.44 (br d, J = 7.2 Hz, 1H), 2.20 (br d, J = 11.4 Hz, 1H), 2.04-1.95 (m, 4H), 1.80 (br s, 
1H), 1.76 (br s, 1H), 1.43-1.36 (br m, 4H); 13C NMR (150.9 MHz, CDCl3) ppm 166.1, 157.8, 
157.0, 153.8, 149.4, 129.7, 128.5, 126.2, 124.4, 119.5, 118.5, 116.5, 103.6, 92.4, 56.4, 55.5, 53.7, 
52.0, 33.2, 32.2, 25.7, 25.1, 24.5; HRMS (ESI): Exact mass calcd for C28H35N4O3 [M+H]
+ 
475.2709, found 475.2726. 
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)-2-methyl-6-nitrobenzamide (80i). 
To a flame dried flask equipped with a stir bar was added the amine (70.0 mg, 254 µmol) and 
dichloromethane (3 mL), immediately followed by the addition of N,N-diisopropyl ethylamine 
(53.0 µL, 305 µmol), the acid chloride (66.0 mg, 330 µmol), and DMAP (3.10 mg, 25.4 µmol). 
The reaction mixture was stirred at rt for 30 h, quenched with 1 M HCl and extracted with 
dichloromethane. The organic extracts were then washed with satd aq NaHCO3, extracted with 
dichloromethane, dried (MgSO4), filtered and concentrated. Flash column chromatography of the 
residue (SiO2, 10-40% ethyl acetate in hexanes) afforded the desired amide as a light yellow 
amorphous solid (98.7 mg, 89%). Mp 200.0-202.0 °C; 

D
20
[]  +302 (c 0.62, CHCl3); Rf = 0.23 (40% 
EtOAc/hexanes); IR (film) 3299, 3059, 2933, 2858, 2361, 1653, 1608, 1533 cm-1; 1H NMR (600 
MHz, CDCl3) δ 8.75 (br d, J = 3.0 Hz, 1H), 7.89 (dd, J = 7.8, 1.2 Hz, 1H), 7.57 (d, J = 7.8 Hz, 
1H), 7.23 (ddd, 8.4, 7.2, 1.2 Hz, 1H), 7.17 (dddd, J = 8.4, 7.2, 1.2 Hz, 1H), 7.14 (m, 2H), 6.89 (d, 
J = 8.4 Hz, 1H), 6.71 (s, 1H), 5.21 (br d, J = 6.6 Hz, 1H), 4.03 (dddd, J = 10.2, 10.2, 6.6, 3.6 Hz, 
1H), 3.85 (m, 1H), 2.56 (br m, 1H), 2.13 (br dd, J = 12.0, 2.4 Hz, 1H), 2.08 (s, 3H), 1.84 (m, 2H), 
1.45 (m, 4H); 13C NMR (150.9 MHz, CDCl3) ppm 166.3, 156.7, 147.2, 145.2, 142.7, 137.3, 135.5, 
132.7, 130.3, 128.6, 124.9, 123.8, 122.6, 121.5, 121.3, 112.4, 58.1, 53.6, 32.7, 32.0, 25.1, 24.2, 
18.4; HRMS (ESI) Exact mass calcd for C23H23ClN4NaO3 [M+Na]
+ 461.1356, found 461.1357. 
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2-Methyl-6-nitro-N-((1R,2R)-2-((4-(pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl) 
benzamide (78i). A 0.5-2 mL microwave vial was charged with the 4-chloroquinoline (50.0 mg, 
114 µmol), pyrrolidine (38.0 µL, 456 µmol), and trifluorotoluene (820 µL). This suspension was 
heated at 150 °C and stirred in the microwave for 90 min. The reaction was concentrated and 
purified by flash column chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to 
provide a yellow oil. This material was diluted with dichloromethane and washed with 6 M aq 
NaOH. The organic layers were combined and washed three times more with 3 M aq NaOH. The 
combined organic layers were dried (MgSO4) and concentrated to afford a dark yellow amorphous 
solid (38.3 mg, 71%). Mp 217.0-223.0 °C; 

D
20
[]  +193 (c 0.63, CHCl3); Rf = 0.37 (5% MeOH/1% 
AcOH/CH2Cl2); IR (film) 3329, 2929, 2858, 1653, 1588, 1532 cm
-1; 1H NMR (600 MHz, CDCl3) 
δ 9.82 (br s, 1H), 7.88 (dd, J = 8.4, 0.6 Hz, 1H), 7.55 (d, J = 7.8 Hz, 1H), 7.09 (m, 2H), 7.00 (br 
ddd, J = 7.8, 7.8 Hz, 1H), 6.93 (br ddd, J = 7.2, 7.2 Hz, 1H), 6.66 (d, J = 8.4 Hz, 1H), 5.66 (s, 1H), 
4.48 (br s, 1H), 4.00 (m, 1H), 3.72 (m, 1H), 3.54 (m, 4H), 2.63 (br dd, J = 8.4, 1.8 Hz, 1H), 2.10 
(s, 3H), 2.08-1.94 (m, 5H), 1.84 (br m, 1H), 1.78 (br m, 1H), 1.42 (m, 4H); 13C NMR (150.9 MHz, 
CDCl3) ppm 166.2, 158.0, 154.0, 148.3, 145.2, 137.3, 135.3, 133.2, 128.5, 128.2, 125.0, 124.7, 
121.4, 119.6, 118.3, 91.6, 59.2, 53.1, 51.9, 33.0, 31.7, 25.8, 25.3, 24.1, 18.4; HRMS (ESI): Exact 
mass calcd for C27H31N5NaO3 [M+Na]
+ 496.2325, found 496.2315. 
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)anthracene-9-carboxamide (80j). 
To a flame dried flask equipped with a stir bar was added the amine (70.0 mg, 254 µmol) and 
dichloromethane (3 mL), immediately followed by the addition of N,N-diisopropyl ethylamine 
(53.0 µL, 305 µmol), the acid chloride (79.4 mg, 330 µmol), and DMAP (3.10 mg, 25.4 µmol). 
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The reaction mixture was stirred at rt for 48 h, quenched with 1 M HCl and extracted with 
dichloromethane. The organic extracts were then washed with satd aq NaHCO3, extracted with 
dichloromethane, dried (MgSO4), filtered and concentrated. Flash column chromatography of the 
residue (SiO2, 10-40% ethyl acetate in hexanes) afforded the desired amide as a light yellow foam 
(87.5 mg, 72%). 

D
20
[]  +169 (c 0.66, CHCl3); Rf = 0.38 (40% EtOAc/hexanes); IR (film) 3288, 
3055, 2932, 2857, 1642, 1607, 1535 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.44 (br s, 1H), 8.20 (s, 
1H), 8.13 (br d, J = 6.0 Hz, 1H), 7.95 (br d, J = 7.2 Hz, 1H), 7.71 (dd, J = 8.4, 0.6 Hz, 1H), 7.53 
(br s, 2H), 7.45 (br m, 2H), 7.03 (dd, J = 6.6, 6.6 Hz, 1H), 6.98 (dd, J = 6.6, 6.6 Hz, 1H), 6.95 (br 
m, 1H), 6.72 (s, 1H), 6.68 (br m, 1H), 6.45 (d, J = 7.8 Hz, 1H), 5.23 (d, J = 5.4 Hz, 1H), 4.1 (m, 
2H), 2.65 (br m, 1H), 2.15 (br m, 1H), 1.86 (br m, 2H), 1.54-1.39 (m, 4H); 13C NMR (150.9 MHz, 
CDCl3) ppm 169.7, 156.2, 147.3, 142.8, 132.1, 130.8, 130.7, 129.9, 128.4, 127.8, 127.6, 127.2, 
126.3, 125.6, 125.5, 125.1, 125.0, 124.7, 124.0, 123.5, 122.4, 121.2, 111.9, 57.6, 53.8, 32.8, 32.7, 
25.1, 24.4; HRMS (ESI) Exact mass calcd for C30H26ClN3NaO [M+Na]
+ 502.1662, found 
502.1653.  
N-((1R,2R)-2-((4-(Pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)anthracene-9-
carboxamide (78j). A 0.5-2 mL microwave vial was charged with the 4-chloroquinoline (50.0 
mg, 104 µmol), pyrrolidine (34.0 µL, 417 µmol), and trifluorotoluene (750 µL). This suspension 
was heated at 150 °C and stirred in the microwave for 90 min. The reaction was concentrated and 
purified by flash column chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to 
provide a yellow oil. This material was diluted with dichloromethane and washed with 6 M aq 
NaOH. The organic layers were combined and washed three times more with 3 M aq NaOH. The 
combined organic layers were dried (MgSO4) and concentrated to afford a tan amorphous solid 
(26.3 mg, 49%). Mp 273.0-278.0 °C; 

D
20
[]  +145 (c 0.43, CHCl3); Rf = 0.35 (5% MeOH/1% 
AcOH/CH2Cl2); IR (film) 3331, 3052, 2929, 2856, 1640, 1588, 1531 cm
-1; 1H NMR (600 MHz, 
CDCl3) δ 9.35 (br s, 1H), 8.19 (s, 1H), 8.19 (br s, 1H), 7.95 (br d, J = 6.0 Hz, 1H), 7.67 (d, J = 7.8 
Hz, 1H), 7.52 (br m, 4H), 6.89 (br s, 1H), 6.76 (m, 2H), 6.62 (br s, 1H), 6.21 (br d, J = 7.8 Hz, 
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1H), 5.69 (s, 1H), 4.68 (br s, 1H), 4.09 (br s, 2H), 3.48 (m, 4H), 2.76 (br d, J = 6.0 Hz, 1H), 2.15 
(br d, J = 12.0 Hz, 1H), 1.98 (m, 4H), 1.88 (br d, J = 10.2 Hz, 2H), 1.59-1.46 (m, 4H); 13C NMR 
(150.9 MHz, CDCl3) ppm 169.6, 157.5, 154.0, 148.4, 132.7, 130.9, 130.8, 128.3, 128.0, 127.4, 
127.3, 126.1, 125.5, 125.2, 125.0, 124.8, 124.4, 124.2, 119.4, 118.2, 91.5, 58.5, 53.4, 51.9, 33.3, 
32.5, 25.8, 25.3, 24.5; HRMS (ESI) Exact mass calcd for C34H34N4NaO [M+Na]
+ 537.2630, found 
537.2607.  
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)-2,2,2-triphenylacetamide (80k). To 
a flame dried flask equipped with a stir bar was added the amine (60.0 mg, 218 µmol) and 
dichloromethane (3 mL), immediately followed by the addition of N,N-diisopropyl ethylamine 
(46.0 µL, 261 µmol), the acid chloride (86.8 mg, 283 µmol), and DMAP (2.70 mg, 21.8 µmol). 
The reaction mixture was stirred at rt for 18 h, quenched with 1 M HCl and extracted with 
dichloromethane. The organic extracts were then washed with satd aq NaHCO3, extracted with 
dichloromethane, dried (MgSO4), filtered and concentrated. Flash column chromatography of the 
residue (SiO2, 5-40% ethyl acetate in hexanes) afforded the desired amide an off white solid (105 
mg, 88%). Mp 185.0-188.0 °C; 

D
20
[]  +72.8 (c 0.43, CHCl3); Rf = 0.47 (40% EtOAc/hexanes); IR 
(film) 3334, 3059, 2931, 2361, 1652, 1607, 1533 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.95 (dd, J 
= 7.8, 0.6 Hz, 1H), 7.48 (ddd, J = 7.8, 7.8, 0.6 Hz, 1H), 7.34 (d, J = 8.4 Hz, 1H), 7.25 (ddd, J = 
7.8, 7.8, 0.6 Hz, 1H), 7.14-7.07 (m, 15H), 6.55 (s, 1H), 6.46 (d, J = 7.2 Hz, 1H), 5.21 (br d, J = 6.6 
Hz, 1H), 4.00 (dddd, J = 10.8, 10.8, 7.2, 3.6 Hz, 1H), 3.93 (dddd, J = 11.4, 11.4, 7.8, 4.2, 1H), 2.23 
(br d, J = 13.2 Hz, 1H), 2.15 (br d, J = 13.2 Hz, 1H), 1.77 (br m, 2H), 1.39 (m, 2H), 1.30-1.22 (m, 
2H); 13C NMR (150.9 MHz, CDCl3) ppm 174.1, 155.9, 148.4, 143.2, 142.3, 130.2, 130.1, 127.7, 
126.7, 126.5, 123.8, 122.4, 121.5, 112.3, 67.8, 55.1, 54.5, 32.9, 32.1, 24.7 (2C); HRMS (ESI): 
Exact mass calcd for C35H33ClN3O [M+H]
+ 546.2312, found 546.2285. 
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2,2,2-Triphenyl-N-((1R,2R)-2-((4-(pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl) 
acetamide (78k). A 0.2-0.5 mL microwave vial was charged with the 4-chloroquinoline (20.0 mg, 
36.6 µmol), pyrrolidine (12.0 µL, 146 µmol), and trifluorotoluene (270 µL). This suspension was 
heated at 150 °C and stirred in the microwave for 90 min. The reaction was concentrated and 
purified by flash column chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to 
provide a yellow oil. This material was diluted with dichloromethane and washed with 6 M aq 
NaOH. The organic layers were combined and washed three times more with 3 M aq NaOH. The 
combined organic layers were dried (MgSO4) and concentrated to afford a light yellow amorphous 
solid (18.1 mg, 85%). Mp 168.0-173.0 °C; 

D
20
[]  +10.2 (c 0.55, CHCl3); Rf = 0.44 (5% MeOH/1% 
AcOH/CH2Cl2); IR (film) 3353, 3057, 2927, 2856, 1653, 1589, 1528, 1496 cm
-1; 1H NMR (400 
MHz, CDCl3) δ 7.93 (d, J = 8.4, 0.8 Hz, 1H), 7.32 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.17 (br d, J = 
8.0 Hz, 1H), 7.18-7.01 (m, 15H), 6.73 (br d, J = 6.8 Hz, 1H), 5.61 (s, 1H), 4.65 (br s, 1H), 4.02 
(dddd, J = 11.2, 11.2, 7.6, 4.0 Hz, 1H), 3.84 (dddd, J = 11.2, 11.2, 7.6, 3.6 Hz, 1H), 3.52 (m, 4H), 
2.16 (br m, 2H), 2.01 (m, 4H), 1.73 (br d, J = 7.6 Hz, 3H), 1.37 (br m, 2H), 1.26 (br m, 2H); 13C 
NMR (100 MHz, CDCl3) ppm 173.7, 157.3, 153.8, 149.7, 143.4, 130.4, 128.3, 127.6, 127.0, 126.4, 
124.6, 119.5, 118.8, 92.3, 67.7, 56.0, 53.4, 52.0, 33.4, 32.0, 25.8, 24.9, 24.8; HRMS (ESI): Exact 
mass calcd for C39H41N4O [M+H]
+ 581.3280, found 581.3264. 
 (3R,5R,7R)-N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)adamantane-1-
carboxamide (80l). To a flame dried flask equipped with a stir bar was added the amine (70.0 mg, 
254 µmol) and dichloromethane (3 mL), immediately followed by the addition of N,N-diisopropyl 
ethylamine (53.0 µL, 305 µmol), the acid chloride (65.6 mg, 330 µmol), and DMAP (3.10 mg, 
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25.4 µmol). The reaction mixture was stirred at rt for 20 h, quenched with 1 M HCl and extracted 
with dichloromethane. The organic extracts were then washed with satd aq NaHCO3, extracted 
with dichloromethane, dried (MgSO4), filtered and concentrated. Flash column chromatography 
of the residue (SiO2, 10-40% ethyl acetate in hexanes) afforded the desired amide as an off white 
amorphous solid (96.5 mg, 87%). Mp 195.0-199.0 °C; 

D
20
[]  +234 (c 0.65, CHCl3); Rf = 0.33 (40% 
EtOAc/hexanes); IR (film) 3310, 3101, 3062, 2909, 2853, 1638, 1608, 1573, 1535 cm-1; 1H NMR 
(600 MHz, CDCl3) δ 7.93 (dd, J = 8.4, 1.2 Hz, 1H), 7.66 (d, J = 8.4 Hz, 1H), 7.54 (ddd, J = 8.4, 
7.2, 1.2 Hz, 1H), 7.24 (ddd, J = 7.8, 7.8, 0.6 Hz, 1H), 6.94 (d, J = 7.2 Hz, 1H), 6.84 (s, 1H), 5.49 
(d, J = 8.4 Hz, 1H), 4.26 (m, 1H), 3.72 (dddd, J = 10.8, 10.8, 7.2, 4.2 Hz, 1H), 2.15 (m, 2H), 1.84 
(dd, J = 6.0, 2.4 Hz, 1H), 1.79 (dd, J = 12.6, 2.4 Hz, 1H), 1.67 (br s, 3H), 1.45 (m, 12 H), 1.32 (dq, 
J = 12.0, 3.0 Hz, 1H), 1.21 (br d, J = 12.0 Hz, 3H); 13C NMR (150.9 MHz, CDCl3) ppm 178.5, 
157.0, 148.4, 142.5, 130.4, 126.1, 124.0, 122.5, 121.6, 112.6, 56.5, 52.8, 40.3, 38.8, 36.1, 32.9, 
32.8, 27.9, 25.2, 24.7; HRMS (ESI) Exact mass calcd for C26H32ClN3NaO [M+Na]
+ 460.2132, 
found 460.2119.  
 (3R,5R,7R)-N-((1R,2R)-2-((4-(Pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)adamantane-
1-carboxamide (78l). A 0.5-2 mL microwave vial was charged with the 4-chloroquinoline (50.0 
mg, 114 µmol), pyrrolidine (37.5 µL, 457 µmol), and trifluorotoluene (820 µL). This suspension 
was heated at 150 °C and stirred in the microwave for 90 min. The reaction was concentrated and 
purified by flash column chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to 
provide a yellow oil. This material was diluted with dichloromethane and washed with 6 M aq 
NaOH. The organic layers were combined and washed three times more with 3 M aq NaOH. The 
combined organic layers were dried (MgSO4) and concentrated to afford a tan solid (33.6 mg, 
62%). Mp 239.0-243.0 °C; 

D
20
[]  +139 (c 0.56, CHCl3); Rf = 0.38 (5% MeOH/1% AcOH/CH2Cl2); 
IR (film) 3324, 2908, 2852, 1637, 1589, 1531 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.94 (dd, J = 
8.4, 0.6 Hz, 1H), 7.60 (d, J = 7.8 Hz, 1H), 7.41 (ddd, J = 7.8, 7.8, 0.6 Hz, 1H), 7.34 (br d, J = 5.4 
Hz, 1H), 7.04 (ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 5.63 (s, 1H), 4.34 (br s, 1H), 4.26 (m, 1H), 3.57 
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(dddd, J = 10.8, 10.8, 6.6, 4.2 Hz, 1H), 3.51 (br s, 4H), 2.17 (d, J = 11.4 Hz, 1H), 2.05 (dd, J = 
12.0, 1.8 Hz, 1H), 1.98 (m, 4H), 1.79 (dd, J = 13.2, 1.8 Hz, 1H), 1.73 (d, J = 12.0 Hz, 1H), 1.62 
(s, 3H), 1.43 (m, 10H), 1.35(m, 3H), 1.20 (d, J = 12.0 Hz, 3H); 13C NMR (150.9 MHz, CDCl3) 
ppm 178.4, 158.2, 154.1, 149.6, 128.7, 126.6, 124.8, 119.8, 118.8, 92.1, 57.5, 52.0, 51.9, 40.2, 
38.6, 36.2, 33.3, 32.7, 28.0, 25.7, 25.4, 24.6; HRMS (ESI): Exact mass calcd for C30H40N4NaO 
[M+Na]+ 495.3100, found 495.3089.  
N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)pivalamide (80m). To a flame dried 
flask equipped with a stir bar was added the amine (60.0 mg, 218 µmol) and dichloromethane (3 
mL), immediately followed by the addition of N,N-diisopropyl ethylamine (46.0 µL, 261 µmol), 
the acid chloride (32.0 µL, 261 µmol), and DMAP (2.70 mg, 22.0 µmol). The reaction mixture 
was stirred at rt for 24 h, quenched with 1 M HCl and extracted with dichloromethane. The organic 
extracts were then washed with satd aq NaHCO3, extracted with dichloromethane, dried (MgSO4), 
filtered and concentrated. Flash column chromatography of the residue (SiO2, 20-50% ethyl 
acetate in hexanes) afforded the desired amide as a white solid (57.9 mg, 74%). Mp 213.0-216.0 
°C; 

D
20
[]  +281 (c 0.45, CHCl3); Rf = 0.38 (40% EtOAc/hexanes); IR (film) 3313, 2932, 2858, 
1607, 1576, 1535 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.96 (dd, J = 7.8, 0.6 Hz, 1H), 7.64 (d, J = 
7.8 Hz, 1H), 7.56 (ddd, J = 8.4, 6.6, 1.2 Hz, 1H), 7.27 (ddd, J = 7.8, 7.8, 1.2 Hz, 1H), 6.84 (d, J = 
6.0 Hz, 1H), 6.71 (s, 1H), 5.03 (br d, J = 7.8 Hz, 1H), 4.18 (m, 1H), 3.71 (m, 1H), 2.16 (m, 2H), 
1.82 (m, 1H), 1.78 (d, J = 10.8 Hz, 1H), 1.47-1.28 (m, 4H), 0.87 (s, 9H); 13C NMR (150.9 MHz, 
CDCl3) ppm 179.1, 156.7, 148.3, 142.6, 130.5, 126.2, 124.0, 122.6, 121.6, 112.2, 56.1, 53.5, 38.4, 
33.1, 32.5, 27.3, 25.1, 24.7; HRMS (ESI) Exact mass calcd for C20H26ClN3NaO [M+Na]
+ 
382.1662, found 382.1658.  
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N-((1R,2R)-2-((4-(Pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)pivalamide (78m). A 0.5-2 
mL microwave vial was charged with the 4-chloroquinoline (40.0 mg, 111 µmol), pyrrolidine 
(37.0 µL, 445 µmol), and trifluorotoluene (800 µL). This suspension was heated at 150 °C and 
stirred in the microwave for 90 min. The reaction was concentrated and purified by flash column 
chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to provide a yellow oil. This 
material was diluted with dichloromethane and washed with 6 M aq NaOH. The organic layers 
were combined and washed three times more with 3 M aq NaOH. The combined organic layers 
were dried (MgSO4) and concentrated to afford a tan amorphous solid (23.5 mg, 54%). Mp 251.0-
256.0 °C; 

D
20
[]  +143 (c 0.69, CHCl3); Rf = 0.35 (5% MeOH/1% AcOH/CH2Cl2); IR (film) 3299, 
2929, 2856, 2361, 1630, 1588, 1534 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.97 (d, J = 7.8 Hz, 1H), 
7.58 (br d, J = 7.8 Hz, 1H), 7.47 (br s, 1H), 7.42 (dd, J = 7.8, 7.8 Hz, 1H), 7.06 (dd, J = 7.8, 7.8 
Hz, 1H), 5.64 (s, 1H), 4.34 (br s, 1H), 4.21 (m, 1H), 3.60-3.54 (m, 5H), 2.22 (br d, J = 11.4 Hz, 
1H), 2.06 (br m, 1H), 1.99 (m, 4H), 1.80 (br d, J = 10.8 Hz, 1H), 1.73 (br d, J = 12.0 Hz, 1H), 
1.46-1.28 (m, 4H), 0.84 (s, 9H); 13C NMR (150.9 MHz, CDCl3) ppm 178.9, 158.1, 153.9, 149.6, 
128.7, 126.6, 124.9, 119.8, 118.8, 92.0, 57.5, 52.3, 52.0, 38.3, 33.5, 32.4, 27.3, 25.8, 25.4, 24.6; 
HRMS (ESI) Exact mass calcd for C24H34N4NaO [M+Na]
+ 417.2630, found 417.2630.  
2,2,2-Trichloro-N-((1R,2R)-2-((4-chloroquinolin-2-yl)amino)cyclohexyl)acetamide (80n). To 
a flame dried flask equipped with a stir bar was added the amine (70.0 mg, 254 µmol) and 
dichloromethane (3 mL), immediately followed by the addition of N,N-diisopropyl ethylamine 
(53.0 µL, 305 µmol), the acid chloride (846 mg, 4.65 mmol), and DMAP (3.10 mg, 25.4 µmol). 
The reaction mixture was stirred at rt for 48 h, quenched with 1 M HCl and extracted with 
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dichloromethane. The organic extracts were then washed with satd aq NaHCO3, extracted with 
dichloromethane, dried (MgSO4), filtered and concentrated. Flash column chromatography of the 
residue (SiO2, 5-40% ethyl acetate in hexanes) afforded the desired amide as a tan solid (76.3 mg, 
71%). Mp 197.0-201.0 °C; 

D
20
[]  +287 (c 0.47, CHCl3); Rf = 0.27 (20% EtOAc/hexanes); IR (film) 
3363, 2936, 2859, 1697, 1608, 1570, 1532 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.85 (br s, 1H), 
7.97 (dd, J = 8.4, 1.2 Hz, 1H), 7.65 (d, J = 8.4 Hz, 1H), 7.57 (ddd, J = 8.4, 7.8, 1.2 Hz, 1H), 7.30 
(ddd, J = 7.8, 6.6, 0.6 Hz, 1H), 6.72 (s, 1H), 4.66 (br d, J = 7.2 Hz, 1H), 4.31 (dddd, J = 11.4, 11.4, 
7.8, 4.2 Hz, 1H), 3.61 (m, 1H), 2.38 (br dd, J = 9.0, 5.4 Hz, 1H), 2.10 (m, 1H), 1.88 (m, 1H), 1.83 
(m, 1H), 1.48-1.41 (m, 4H), 13C NMR (150.9 MHz, CDCl3) ppm 162.3, 156.5, 147.9, 143.2, 130.7, 
126.4, 124.1, 123.2, 121.8, 112.0, 92.7, 60.2, 52.6, 33.0, 31.2, 25.2, 24.2; HRMS (ESI) Exact mass 
calcd for C17H18Cl4N3O [M+H]
+ 420.0204, found 420.0222. 
2,2,2-Trichloro-N-((1R,2R)-2-((4-(pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl) 
acetamide (78n). A 0.5-2 mL microwave vial was charged with the 4-chloroquinoline (30.0 mg, 
71.0 µmol), pyrrolidine (24.0 µL, 285 µmol), and trifluorotoluene (525 µL). This suspension was 
heated at 150 °C and stirred in the microwave for 90 min. The reaction was concentrated and 
purified by flash column chromatography (1-10% methanol in dichloromethane w/ 1% AcOH) to 
provide a yellow oil. This material was diluted with dichloromethane and washed with 6 M aq 
NaOH. The organic layers were combined and washed three times more with 3 M aq NaOH. The 
combined organic layers were dried (MgSO4) and concentrated to afford a yellow solid (9.3 mg, 
29%). Mp 189.0-194.0 °C; 

D
20
[]  +144 (c 0.64, CHCl3); Rf = 0.42 (5% MeOH/1% AcOH/CH2Cl2); 
IR (film) 3374, 2930, 1700, 1588, 1528 cm-1; 1H NMR (600 MHz, CDCl3) δ 9.57 (br s, 1H), 7.98 
(d, J = 8.4 Hz, 1H), 7.58 (br d, J = 7.2 Hz, 1H), 7.42 (dd, J = 7.8, 7.8 Hz, 1H), 7.08 (dd, J = 7.8, 
7.8 Hz, 1H), 5.65 (s, 1H), 4.28 (br s, 2H), 3.57 (br m, 4H), 3.51 (br s, 1H), 2.39 (br s, 1H), 2.06 
(br d, J = 9.6 Hz, 1H), 2.00 (m, 4H), 1.85 (br d, J = 9.6 Hz, 1H), 1.80 (br d, J = 4.8 Hz, 1H), 1.47-
1.37 (br m, 4H); 13C NMR (150.9 MHz, CDCl3) ppm 162.4, 157.9, 154.0, 149.2, 128.8, 126.8, 
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124.9, 120.1, 118.7, 92.9, 91.4, 60.8, 52.1, 52.0, 33.2, 30.8, 25.8, 25.3, 24.3; HRMS (ESI) Exact 
mass calcd for C21H26Cl3N4O [M+H]
+ 455.1172, found 455.1160. 
N-((1R,2R)-2-((4-(Pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)-3,5-bis(trifluoromethyl) 
benzothioamide (78o).255 A flame dried flask equipped with a stir bar was charged with the amide 
(68.0 mg, 124 µmol) and toluene (3 mL) at room temperature. To the resulting solution was added 
Lawesson’s reagent (45.0 mg, 111 µmol) and the reaction mixture was heated to reflux and stirred. 
The reaction mixture was monitored by TLC; after 5 h, complete conversion was observed and the 
reaction mixture was concentrated. Flash column chromatography of the residue (SiO2, 0.5-10% 
methanol in dichloromethane w/ 1% AcOH) afforded a yellow oil. This material was diluted with 
dichloromethane and washed with 6 M aq NaOH. The organic layers were combined and washed 
twice more with 3 M aq NaOH. The combined organic layers were dried over MgSO4 and 
concentrated to yield the desired thioamide as a yellow amorphous solid (32.0 mg, 46%). 

D
20
[]  
+304 (c 0.53, CHCl3); Rf = 0.19 (5% MeOH/1% AcOH/CH2Cl2); IR (film) 2930, 1588, 1527 cm
-
1; 1H NMR (600 MHz, CDCl3) δ 7.93 (d, J = 7.8 Hz, 1H), 7.80 (s, 2H), 7.61 (s, 1H), 7.23 (dd, J = 
7.2, 7.2 Hz, 1H), 7.15 (d, J = 7.8 Hz, 1H), 7.01 (ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 5.66 (s, 1H), 4.38 
(d, J = 5.4 Hz, 1H), 4.30 (m, 1H), 4.16 (ddd, J = 14.4, 10.8, 3.6 Hz, 1H), 3.57 (m, 4H), 2.89 (d, J 
= 12.6 Hz, 1H), 2.08 (d, J = 13.2 Hz, 1H), 2.00 (m, 4H), 1.90 (br s, 1H), 1.85 (d, J = 9.0 Hz, 1H), 
1.58-1.38 (m, 4H); 13C NMR (150.9 MHz, CDCl3) ppm 195.3, 158.0, 154.1, 148.2, 144.6, 131.1 
(q, J = 33.3 Hz, 1C), 129.0, 126.8, 125.6, 124.9, 123.1 (q, J = 3.6 Hz), 122.8 (q, J = 273.0 Hz,), 
120.3, 118.5, 90.9, 65.7, 53.6, 52.0, 33.1, 29.1, 25.9, 25.5, 24.1; HRMS (ESI) Exact mass calcd 
for C28H29F6N4S [M+H]
+ 567.2018, found 567.2029.  
                                                          
255 Modification of: Raucher, S.; Klein, P. Tetrahedron Lett. 1980, 21, 4061-4064. 
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N-((1R,2R)-2-((4-Chloroquinolin-2-yl)amino)cyclohexyl)-3,5-bis(trifluoromethyl) benzene 
sulfonamide (80p). To a flame dried flask equipped with a stir bar was added the amine (60.0 mg, 
218 µmol) and dichloromethane (3 mL), immediately followed by the addition of N,N-diisopropyl 
ethylamine (45.0 µL, 261 µmol), the sulfonyl chloride (82.0 mg, 261 µmol), and DMAP (2.70 mg, 
22.0 µmol). The reaction mixture was stirred at rt for 25 h, quenched with 1 M HCl and extracted 
with dichloromethane. The organic extracts were then washed with NaHCO3, extracted with 
dichloromethane, dried (MgSO4), filtered and concentrated. Flash column chromatography of the 
residue (SiO2, 5-30% ethyl acetate in hexanes) afforded the desired amide as a white solid (97.5 
mg, 81%). Mp 206.0-208.0 °C; 

D
20
[]  +198 (c 0.58, CHCl3); Rf = 0.64 (40% EtOAc/hexanes); IR 
(film) 3379, 3065, 2937, 2862, 2361, 1609, 1535 cm-1; 1H NMR (600 MHz, CDCl3) δ 9.31 (br s, 
1H), 7.99 (dd, J = 8.4, 1.2 Hz, 1H), 7.85 (s, 1H), 7.84 (s, 2H), 7.75 (d, J = 8.4 Hz, 1H), 7.66 (ddd, 
J = 8.4, 7.2, 1.8 Hz, 1H), 7.38 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 6.37 (s, 1H), 4.18 (br d, J = 4.8 Hz, 
1H), 3.81 (m, 1H), 2.99 (dt, J = 10.8, 4.2 Hz, 1H), 2.37 (d, J = 10.2 Hz, 1H), 1.98 (m, 1H), 1.78 
(m, 2H), 1.59 (m, 1H), 1.38-1.30 (m, 3H); 13C NMR (150.9 MHz, CDCl3) ppm 156.0, 146.7, 144.0, 
143.7, 132.0 (q, JFC = 34.3 Hz), 131.6, 126.7, 125.8, 125.2 (q, JFC = 3.5 Hz), 124.2, 124.0, 122.3 
(q, JFC = 273.3 Hz), 121.7, 111.3, 62.4, 54.9, 35.2, 33.2, 24.7, 24,0; HRMS (ESI): Exact mass 
calcd for C23H21ClF6N3O2S [M+H]
+ 552.0947, found 552.0938.  
N-((1R,2R)-2-((4-(Pyrrolidin-1-yl)quinolin-2-yl)amino)cyclohexyl)-3,5-bis(trifluoromethyl) 
benzenesulfonamide (78p). A 0.5-2 mL microwave vial was charged with 4-chloroquinoline 
(50.0 mg, 90.6 µmol), pyrrolidine (30.0 µL, 362 µmol), and trifluorotoluene (650 µL). This 
suspension was heated at 150 °C and stirred in the microwave for 90 min. The reaction was 
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concentrated and purified by flash column chromatography (1-10% methanol in dichloromethane 
w/ 1% AcOH) to provide a light yellow oil. This material was diluted with dichloromethane and 
washed with 6 M aq NaOH. The organic layers were combined and washed twice more with 3 M 
aq NaOH. The combined organic layers were dried (MgSO4) and concentrated to afford an off-
white solid (36.5 mg, 69%). Mp 238.0-240.0 °C; 

D
20
[]  +177 (c 0.72, CHCl3); Rf = 0.53 (10% 
MeOH/1% AcOH/CH2Cl2); IR (film) 3378, 2931, 2361, 1586, 1534 cm
-1; 1H NMR (600 MHz, 
CDCl3) δ 8.03 (dd, J = 8.4, 0.6 Hz, 1H), 7.86 (s, 2H), 7.79 (s, 1H), 7.72 (d, J = 7.8 Hz, 1H), 7.50 
(ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 7.14 (ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 5.32 (s, 1H), 3.81 (br s, 1H), 
3.69 (m, 1H), 3.56 (m, 4H), 2.77 (dt, J = 10.8, 4.2 Hz, 1H), 2.40 (br d, J = 13.2 Hz, 1H), 2.02 (m, 
4H), 1.93 (br d, J = 11.4 Hz, 1H), 1.76 (m, 2H), 1.58 (m, 1H), 1.35-1.23 (m, 4H); 13C NMR (150.9 
MHz, CDCl3) ppm 157.4, 154.1, 148.0, 143.8, 131.7 (q, JFC = 34.0 Hz), 129.6, 127.1, 126.2, 125.0, 
124.9 (q, J = 3.5 Hz), 122.5 (q, J = 273.3 Hz), 120.8, 118.3, 90.0, 62.3, 55.2, 51.9, 34.9, 33.3, 25.9, 
24.9, 24.1; HRMS (ESI): Exact mass calcd for C27H29F6N4O2S [M+H]
+ 587.1915, found 587.1893.  
 (Z)-tert-Butyl (2,2,2-trifluoro-1-phenylethylidene)carbamate (82).256 To a flame dried flask 
equipped with a stir bar was added trifluoroacetophenone (1.22 mL, 8.69 mmol) and the 
iminophosphorane (3.61 g, 9.56 mmol). Toluene (35 mL) was added and the resulting solution 
was heated to reflux for 18 h. The reaction mixture was then cooled to room temperature, diluted 
with hexanes, and allowed to stir at rt for an additional 2 h whereupon a white solid precipitated 
out of solution. The mixture was then filtered with hexanes and the filtrate was concentrated. Flash 
column chromatography of the residue (SiO2, 2-10% ethyl acetate in hexanes) afforded the desired 
ketimine as a clear colorless oil (1.46 g, 61%). Rf = 0.54 (20% EtOAc/hexanes); IR (film) 3067, 
2983, 2938, 1738, 1684 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.60 (br s, 2H), 7.54 (t, J = 7.2 Hz, 
1H), 7.46 (t, J = 7.8 Hz, 2H), 1.39 (s, 9H); 13C NMR (150.9 MHz, CDCl3) ppm 158.3, 131.9, 
130.0, 128.7, 127.9, 119.1 (q, J = 284.4 Hz), 84.1, 27.8; HRMS (ESI) Exact mass calcd for 
C13H15F3NO2 [M+H]
+ 274.1055, found decomposition upon submission. 
                                                          
256 Modification of: Sangamesh, B. et al., Oxazine Derivatives and Their Use as BACE Inhibitors for the Treatment 
of Neurological Disorders. U.S. Patent WO 2011/009943 A1, January 27, 2011. 
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 (R)-tert-Butyl (1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)carbamate (87). To a flame dried 
vial equipped with a stir bar was added PBAM·HNTf2 (11.5 mg, 14.6 µmol), toluene (293 µL) and 
nitromethane (79.0 µL, 1.46 mmol). The resulting mixture was chilled to -20 °C before addition 
of the ketimine (20.0 mg, 73.2 µmol). The reaction stirred at -20 °C for 5 days. The reaction was 
directly filtered through a pad of silica gel with CH2Cl2 and EtOAc and the filtrate was 
concentrated. Flash column chromatography of the residue (SiO2, 1-10% ethyl acetate in hexanes) 
afforded the desired adduct as a white crystalline solid (8.40 mg, 34%) that was found to be 66% 
ee by chiral HPLC; (Chiralpak AD, 5% iPrOH/hexanes, 1 mL/min, tr(major) 12.7 min, tr(minor) 
11.2 min); Mp 80.0-82.0 °C; 

D
20
[]  +13.9 (c 0.49, CHCl3); Rf = 0.43 (20% EtOAc/hexanes); IR 
(film) 3259, 3159, 2979, 2361, 1717, 1563, 1502 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.44 (s, 5H), 
5.55 (br d, J = 12.0 Hz, 1H), 5.48 (br d, J = 12.0 Hz, 1H), 5.42 (s, 1H), 1.46 (s, 9H); 13C NMR 
(150.9 MHz, CDCl3) ppm 153.6, 132.6, 129.7, 129.0, 126.1, 123.9 (q, JCF = 286.0 Hz), 81.8, 73.1, 
63.9 (q, JCF = 28.1 Hz), 28.1; HRMS (ESI): Exact mass calcd for C14H17F3N2NaO4 [M+Na]
+ 
357.1038, found 357.1040. 
 (R)-tert-Butyl (3-amino-1,1,1-trifluoro-2-phenylpropan-2-yl)carbamate (90). The nitroalkane 
(192 mg, 574 µmol) was dissolved in MeOH (2.3 mL) at rt. CoCl2 (74.5 mg, 574 µmol) was added 
and the reaction mixture was chilled to 0 °C before NaBH4 (327 mg, 8.62 mmol) was added in 
three portions over 40 min. The reaction mixture was warmed to rt and allowed to stir for an 
additional 2 h before being quenched with 1 M HCl. The reaction mixture was adjusted to pH 10 
with conc aq NH4OH. The solution was then filtered through a glass frit with water and CH2Cl2 
and the layers were separated. The organic layer was dried (MgSO4) and concentrated to afford 
the amine as an off-white crystalline solid (150 mg, 86%) which was determined to be 69% ee by 
chiral HPLC analysis (Chiralcel OJ, 10% iPrOH/hexanes, 1 mL/min tr(major) = 10.8 min, tr(minor) 
= 6.2 min). Mp 77.0-79.0 °C; Rf = 0.47 (5% MeOH/1%AcOH/CH2Cl2); IR (film) 3328, 2978, 
1719 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.44 (d, J = 8.4 Hz, 2H), 7.38 (dd, J = 7.2, 7.2 Hz, 2H), 
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7.34 (m, 1H), 5.67 (br s, 1H), 3.65 (br d, J = 11.4 Hz, 1H), 3.26 (br d, J = 8.4 Hz, 1H), 1.39 (br s, 
9H), 1.26 (br s, 2H); 13C NMR (150.9 MHz, CDCl3) ppm 154.0, 128.5, 128.3, 126.3, 126.0 (q, J 
= 287 Hz), 80.5, 65.1 (q, J = 25.7 Hz), 46.7, 29.7, 28.1; HRMS (EI) Exact mass calcd for 
C15H19ClN3 [M+] 304.1399, found 304.1393. 
tert-Butyl (1,1,1-trifluoro-3-(2-isopropoxy-4-methoxybenzamido)-2-phenylpropan-2-
yl)carbamate (92). To a flame dried flask equipped with a stir bar was added the amine (231 mg, 
759 µmol), the carboxylic acid (159 mg, 759 µmol), and dichloromethane (4 mL). The resulting 
solution was chilled to 0 °C and EDC (189 mg, 987 µmol) and DMAP (9.30 mg, 76.0 µmol) were 
added. The reaction mixture was stirred and allowed to gradually warm to room temperature. After 
16 h, the reaction mixture was diluted with water and extracted with CH2Cl2. The combined 
organic layers were washed once with water, dried (MgSO4), and concentrated. Flash column 
chromatography of the residue (SiO2, 10-40% ethyl acetate in hexanes) afforded the desired amide 
as a white foam (367 mg, 97%). Rf = 0.77 (5% MeOH/1%AcOH/CH2Cl2); IR (film) 3388, 3281, 
2979, 1734, 1643, 1605, 1532 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.39 (dd, J = 6.0, 6.0 Hz, 1H), 
8.19 (d, J = 9.0 Hz, 1H), 7.50 (d, J = 7.8 Hz, 2H), 7.38 (dd, J = 7.2, 7.2 Hz, 2H), 7.33 (dd, J = 7.2, 
7.2 Hz, 1H), 6.58 (dd, J = 9.0, 2.4 Hz, 1H), 6.45 (d, J = 1.8 Hz, 1H), 6.42 (br s, 1H), 4.65 (qq, J = 
6.0, 6.0 Hz, 1H), 4.21 (br dd, J = 12.6, 5.4 Hz, 1H), 4.03 (dd, J = 14.4, 5.6 Hz, 1H), 3.83 (s, 3H), 
1.39 (br s, 9H), 1.33 (d, J = 6.6 Hz, 3H), 1.27-1.24 (m, 3H); 13C NMR (150.9 MHz, CDCl3) ppm 
166.9, 163.6, 157.3, 153.9, 135.2, 134.3, 128.4, 128.2, 126.3, 125.7 (q, J = 288 Hz), 114.3, 105.2, 
100.2, 80.3, 71.6, 66.4 (q, J = 25.8 Hz), 55.5, 45.5, 28.1, 21.7, 21.6; HRMS (ESI) Exact mass calcd 
for C25H31F3N2NaO5 [M+Na]
+ 519.2083, found 519.2067. 
N-(2-Amino-3,3,3-trifluoro-2-phenylpropyl)-2-isopropoxy-4-methoxybenzamide (93). The 
amide (367 mg, 739 µmol) was dissolved in CH2Cl2 (8 mL), treated with TFA (2.27 mL, 29.6 
mmol), and stirred at rt for 16 h. The reaction mixture was poured into satd aq NaHCO3 and 
extracted with CH2Cl2. The combined organic layers were dried (MgSO4), filtered, and 
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concentrated to afford the amine as a light orange solid (293 mg, 100%). Mp 87.0-90.0 °C; Rf = 
0.65 (5% MeOH/1%AcOH/CH2Cl2); IR (film) 3384, 2980, 1645, 1605, 1531 cm
-1; 1H NMR (600 
MHz, CDCl3) δ 8.16 (d, J = 9.0 Hz, 1H), 8.11 (dd, J = 5.4 Hz, 1H), 7.64 (d, J = 7.8 Hz, 2H), 7.40 
(m, 2H), 7.35 (dt, J = 5.4, 1.2 Hz, 1H), 6.54 (dd, J = 8.4, 2.4 Hz, 1H), 6.38 (d, J = 2.4 Hz, 1H), 
4.55 (qq, J = 6.0, 6.0 Hz, 1H), 4.20 (dd, J = 13.8, 6.0 Hz, 1H), 4.14 (dd, J = 13.8, 6.0 Hz, 1H), 3.80 
(s, 3H), 1.97 (br s, 2H), 1.14 (d, J = 6.0 Hz, 3H), 1.13 (d, J = 6.0 Hz, 3H); 13C NMR (150.9 MHz, 
CDCl3) ppm 166.1, 163.3, 157.2, 136.1, 134.2, 128.6, 128.5, 127.0, 126.5 (q, J = 286 Hz), 114.5, 
105.1, 100.2, 71.4, 62.1 (q, J = 24.1 Hz), 55.4, 43.8, 21.59, 21.55; HRMS (ESI) Exact mass calcd 
for C20H24F3N2O3 [M+H]
+ 397.1715, found 397.1725. 
2-Isopropoxy-4-methoxy-N-(3,3,3-trifluoro-2-phenyl-2-(3-phenylureido)propyl)benzamide 
(99). To a vial equipped with a stir bar was added the amine (40.0 mg, 101 µmol) and isocyanate 
(331 µL, 3.03 mmol). The resulting mixture was stirred at rt 24 h, diluted with dichloromethane 
and washed with satd aq NaHCO3. The aqueous layer was extracted with dichloromethane and the 
organic extracts were dried (MgSO4), filtered and concentrated. Flash column chromatography of 
the residue (SiO2, 5-100% diethyl ether in hexanes) afforded the desired urea as an off-white 
viscous oil (47.4 mg, 91%). Rf = 0.46 (40% EtOAc/hexanes); IR (film) 3349, 3062, 2980, 2361, 
1712, 1626, 1603, 1553 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.61 (dd, J = 6.4, 6.4 Hz, 1H), 8.11 
(d, J = 8.8 Hz, 1H), 7.54 (d, J = 7.6 Hz, 2H), 7.38-7.31 (m, 3H), 7.26 (dd, J = 8.4, 8.4 Hz, 3H), 
7.18 (dd, J = 7.6, 7.6 Hz, 2H), 7.07 (br s, 1H), 6.96 (dd, J = 7.2, 7.2 Hz, 1H), 6.53 (dd, J = 8.8, 2.0 
Hz, 1H), 6.42 (br d, J = 2.0 Hz, 1H), 4.63 (qq, J = 6.4, 6.4 Hz, 1H), 4.18 (br dd, J = 14.0, 6.8 Hz, 
1H), 4.04 (dd, J = 14.4, 6.0 Hz, 1H), 3.83 (s, 3H), 1.30 (d, J = 6.0 Hz, 3H), 1.26 (d, J = 6.0 Hz, 
3H); 13C NMR (125.8 MHz, CDCl3) ppm 167.8, 163.8, 157.6, 153.7, 138.7, 135.4, 134.1, 128.8, 
128.6, 128.3, 126.2, 125.9 (q, J = 288.6 Hz), 123.0, 119.7, 113.7, 105.3, 100.3, 71.9, 67.2 (q, J = 
25.9 Hz), 55.5, 46.8, 21.63, 21.61; HRMS (ESI) Exact mass calcd for C27H29F3N3O4 [M+H]
+ 
516.2110, found 516.2094. 
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2-Isopropoxy-4-methoxy-N-(3,3,3-trifluoro-2-(3-(4-nitrophenyl)ureido)-2-phenylpropyl) 
benzamide (102). To a vial equipped with a stir bar was added the amine (40.0 mg, 101 µmol) 
and isocyanate (166 mg, 1.01 mmol). Benzene (1 mL) was added and the resulting mixture was 
stirred at rt 72 h. The solution was then diluted with dichloromethane and washed with satd aq 
NaHCO3. The aqueous layer was extracted with dichloromethane and the organic extracts were 
dried (MgSO4), filtered and concentrated. Flash column chromatography of the residue (SiO2, 50-
100% diethyl ether in hexanes) afforded the desired urea as a light yellow viscous oil (30.4 mg, 
55%). Rf = 0.23 (100% diethyl ether); IR (film) 3352, 3094, 2928, 1722, 1626, 1603, 1555, 1501 
cm-1; 1H NMR (600 MHz, CDCl3) δ 8.72 (dd, J = 6.0, 6.0 Hz, 1H), 8.09 (d, J = 9.0 Hz, 1H), 8.04 
(d, J = 9.0 Hz, 2H), 7.84 (br s, 1H), 7.77 (s, 1H), 7.56 (d, J = 7.8 Hz, 2H), 7.46-7.41 (m, 4H), 7.37 
(m, 1H), 6.52 (dd, J = 8.4, 1.8 Hz, 1H), 6.42 (d, J = 1.8 Hz, 1H), 4.67 (qq, J = 6.0, 6.0 Hz, 1H), 
4.10 (dd, J = 14.4, 7.2 Hz, 1H), 3.94 (dd, J = 15.0, 6.0 Hz, 1H), 3.83 (s, 3H), 1.33 (d, J = 6.0 Hz, 
3H), 1.31 (d, J = 6.0 Hz, 3H); 13C NMR (150.9 MHz, CDCl3) ppm 168.7, 164.2, 157.7, 152.5, 
145.3, 142.2, 134.8, 133.9, 128.9, 128.6, 125.8, 125.8 (q, J = 289.3 Hz), 125.0, 117.8, 112.9, 105.6, 
100.2, 72.0, 67.7 (q, J = 26.4 Hz), 55.6, 48.0, 21.72, 21.69; HRMS (ESI) Exact mass calcd for 
C27H28F3N4O6 [M+H]
+ 561.1961, found 561.1944. 
General procedure for Hypervalent Iodine-Mediated Intermolecular Diamination: A vial 
equipped with a stir bar was charged with potassium iodide (60.0 mg, 360 µmol), iodobenzene 
diacetate (193 mg, 600 µmol), and acetonitrile (3 mL) and was chilled to 0 °C. The amine (900 
µmol) and vinylphenol (300 µmol) were added and the resulting mixture was stirred at 0 °C for 18 
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h. The reaction mixture was then diluted with ethyl acetate and concentrated. No reductive workup 
was used in these studies, but is recommended for a larger scale. 
2-(1,2-Dithiomorpholinoethyl)phenol (338a). Prepared according to the general procedure using 
thiomorpholine (91.0 µL, 900 µmol) and 2-vinylphenol (36.0 mg, 300 µmol). Flash column 
chromatography of the residue (SiO2, 5-60% diethyl ether in hexanes) afforded the desired product 
as a light orange amorphous solid (97.0 mg, 99%). Mp 82.0-86.0 °C; Rf = 0.06 (10% 
EtOAc/hexanes); IR (film) 3040 (br), 2910, 2810, 1607, 1587 cm-1; 1H NMR (600 MHz, CDCl3) 
δ 11.18 (br s, 1H), 7.15 (ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 7.02 (dd, J = 7.8, 0.6 Hz, 1H), 6.80 (d, J = 
7.8 Hz, 1H), 6.79 (ddd, J = 7.2, 7.2, 1.2 Hz, 1H), 3.77 (dd, J = 6.6, 6.6 Hz, 1H), 3.10 (dd, J = 7.2, 
3.0 Hz, 1H), 3.08 (dd, J = 6.6, 3.0 Hz, 1H), 2.92-2.88 (m, 3H), 2.77-2.65 (m, 9H), 2.64-2.61 (m, 
4H); 13C NMR (150 MHz, CDCl3) ppm 157.3, 128.7, 128.4, 124.8, 119.1, 116.7, 65.6, 59.2, 55.6, 
52.2, 28.04, 27.97; HRMS (ESI): Exact mass calcd for C16H25N2OS2 [M+H]
+ 325.1408, found 
325.1395. 
4-(1,2-Dithiomorpholinoethyl)phenol (340a). Prepared according to the general procedure using 
thiomorpholine (91.0 µL, 900 µmol) and 4-vinylphenol (36.0 mg, 300 µmol). Flash column 
chromatography of the residue (SiO2, 25-50-75-100% diethyl ether in hexanes) afforded the 
desired product as a light brown solid (60.4 mg, 62%). Mp 139.0-143.0 °C; Rf = 0.21 (80% 
EtOAc/hexanes); IR (film) 3200 (br), 2916, 2815, 1611, 1513 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.74  (br s, 1H), 6.99 (d, J = 8.4 Hz, 2H), 6.67 (d, J = 8.4 Hz, 2H), 3.69 (dd, J = 6.4, 6.4 Hz, 1H), 
2.97 (dd, J = 13.2, 6.4 Hz, 1H), 2.91-2.86 (m, 2H), 2.80-2.71 (m, 7H), 2.66-2.58 (m, 8H); 13C 
NMR (125 MHz, CDCl3) ppm 155.6, 129.7, 129.1, 115.1, 66.6, 60.6, 55.3, 52.1, 27.9, 27.4; HRMS 
(ESI): Exact mass calcd for C16H25N2OS2 [M+H]
+ 325.1408, found 325.1411. 
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2-(1,2-Dimorpholinoethyl)phenol (338b). Prepared according to the general procedure using 
morpholine (78.0 µL, 900 µmol) and 2-vinylphenol (36.0 mg, 300 µmol). Flash column 
chromatography of the residue (SiO2, 10-100% diethyl ether in hexanes) afforded the desired 
product as an off-white solid (69.2 mg, 79%). Mp 86.0-89.0 °C; Rf = 0.27 (100% Et2O); IR (film) 
3040 (br), 2958, 2851, 1588 cm-1; 1H NMR (400 MHz, CDCl3) δ 10.60 (br s, 1H), 7.15 (dd, J = 
7.6, 7.6 Hz, 1H), 6.99 (d, J = 7.6 Hz, 1H), 6.79 (d, J = 8.0 Hz, 1H), 6.78 (dd, J = 8.0, 8.0 Hz, 1H), 
3.79-3.69 (m, 4H), 3.64 (dd, J = 4.0 Hz, 4H), 3.54 (dd, J = 5.6, 5.6 Hz, 1H); 2.94 (dd, J = 13.6, 6.4 
Hz, 1H), 2.81-2.74 (br m, 2H), 2.63-2.56 (m, 3H), 2.49-2.36 (m, 4H); 13C NMR (125 MHz, CDCl3) 
ppm 156.7, 129.1, 128.7, 124.8, 119.2, 116.6, 67.3, 67.0, 66.9, 60.4, 54.2, 51.6; HRMS (ESI): 
Exact mass calcd for C16H25N2O3 [M+H]
+ 293.1865, found 293.1852. 
2-(1,2-Di(piperidin-1-yl)ethyl)phenol (338c). A vial equipped with a stir bar was charged with 
potassium iodide (60.0 mg, 360 µmol), iodobenzene diacetate (290 mg, 900 µmol), and acetonitrile 
(3 mL) and was chilled to 0 °C. Piperidine (89.0 µL, 900 µmol) and 2-vinylphenol (36.0 mg, 300 
µmol) were added and the resulting mixture was stirred at 0 °C for 18 h. The reaction mixture was 
then diluted with ethyl acetate and concentrated. Flash column chromatography of the residue 
(SiO2, 50-100% diethyl ether in hexanes) afforded the desired product as a light brown solid (25.4 
mg, 29%). Mp 59.0-62.0 °C; Rf = 0.11 (20% EtOAc/hexanes); IR (film) 3050 (br), 2933, 2851, 
1588 cm-1; 1H NMR (400 MHz, CDCl3) δ 10.17 (br s, 1H), 7.13 (ddd, J = 7.6, 7.6, 1.6 Hz, 1H), 
7.08 (dd, J = 7.6, 1.2 Hz, 1H), 6.80 (dd, J = 8.0, 1.2 Hz, 1H), 6.76 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 
3.77 (dd, J = 6.0, 6.0 Hz, 1H), 2.93 (dd, J = 13.6, 5.6 Hz, 1H), 2.79-2.72 (m, 2H), 2.62 (dd, J = 
13.2, 6.0 Hz, 1H), 2.61-2.54 (m, 2H), 2.51-2.39 (m, 4H), 1.70-1.52 (m, 8H), 1.51-1.45 (m, 2H), 
1.45-1.36 (m, 2H); 13C NMR (125 MHz, CDCl3) ppm 157.9, 128.4, 128.2, 126.2, 118.6, 116.6, 
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65.6, 59.6, 55.1, 51.1, 26.2, 25.9, 24.3, 24.2; HRMS (ESI): Exact mass calcd for C18H29N2O 
[M+H]+ 289.2280, found 289.2294. 
2-(1,2-Di(isoindolin-2-yl)ethyl)phenol (338d). Prepared according to the general procedure using 
isoindoline (102 µL, 900 µmol) and 2-vinylphenol (36.0 mg, 300 µmol). Flash column 
chromatography of the residue (SiO2, 5-100% diethyl ether in hexanes) afforded the desired 
product as a dark-brown viscous oil (31.9 mg, 30%). Rf = 0.68 (40% EtOAc/hexanes); IR (film) 
3047, 2937, 2797, 1690, 1588 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.25-7.15 (m, 9H), 7.12 (dd, J 
= 7.6, 1.6 Hz, 1H), 6.88 (dd, J = 8.0, 0.8 Hz, 1H), 6.83 (ddd, J = 7.2, 7.2, 0.8 Hz, 1H), 4.11 (s, 4H), 
4.03-3.94 (m, 4H), 3.91 (dd, J = 6.0, 6.0 Hz, 1H), 3.47 (dd, J = 13.2, 6.0 Hz, 1H), 3.16 (dd, J = 
13.2, 6.4 Hz, 1H); 13C NMR (125 MHz, CDCl3) ppm 156.9, 139.7, 139.0, 129.0, 128.9, 127.0, 
126.8, 125.9, 122.3, 122.2, 119.3, 116.7, 69.3, 60.2, 60.1, 57.9; HRMS (ESI): Exact mass calcd 
for C24H25N2O [M+H]
+ 357.1967, found 357.1968. 
Dibenzyl 4,4'-(1-(2-hydroxyphenyl)ethane-1,2-diyl)bis(piperazine-1-carboxylate) (338e). 
Prepared according to the general procedure using benzyl piperazine-1-carboxylate (174 µL, 900 
µmol) and 2-vinylphenol (36.0 mg, 300 µmol). Flash column chromatography of the residue (SiO2, 
5-80% ethyl acetate in hexanes) afforded the desired product as a yellow viscous oil (105 mg, 
62%). Rf = 0.04 (20% EtOAc/hexanes); IR (film) 3033, 2940, 2897, 2859, 2823, 1702, 1588 cm
-
1; 1H NMR (400 MHz, CDCl3) δ 10.79 (br s, 1H); 7.39-7.28 (m, 10H), 7.16 (ddd, J = 8.4, 8.4, 1.6 
Hz, 1H), 6.97 (dd, J = 7.6, 1.6 Hz, 1H), 6.80 (d, J = 8.4 Hz, 1H), 6.78 (ddd, J = 7.2, 7.2, 1.2 Hz, 
1H), 5.13 (s, 2H), 5.12 (s, 2H), 3.62-3.42 (m, 9H), 2.95 (dd, J = 13.6, 6.4 Hz, 1H), 2.75 (br s, 2H), 
2.59 (dd, J = 13.6, 5.2 Hz, 1H), 2.63-2.52 (m, 2H), 2.50-2.27 (m, 4H); 13C NMR (125 MHz, CDCl3) 
ppm 156.7, 155.1, 155.0, 136.6, 136.5, 128.83, 128.81, 128.5, 128.4, 128.1, 128.0, 127.9, 127.8, , 
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124.7, 119.3, 116.7, 67.2, 67.1, 66.8, 59.9, 53.4, 50.6, 43.7; HRMS (ESI): Exact mass calcd for 
C32H39N4O5 [M+H]
+ 559.2920, found 559.2897. 
Di-tert-butyl 4,4'-(1-(2-hydroxyphenyl)ethane-1,2-diyl)bis(piperazine-1-carboxylate) (338f). 
Prepared according to the general procedure using tert-butyl piperazine-1-carboxylate (117 mg, 
630 µmol) and 2-vinylphenol (36.0 mg, 300 µmol). Flash column chromatography of the residue 
(SiO2, 20-80% ethyl acetate in hexanes) afforded the desired product as a light-yellow non-viscous 
oil (86.4 mg, 59%). Rf = 0.10 (20% EtOAc/hexanes); IR (film) 3040 (br), 2975, 2929, 2857, 1697, 
1589 cm-1; 1H NMR (400 MHz, CDCl3) δ 11.00 (br s, 1H), 7.14 (ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 
6.98 (dd, J = 7.6, 0.8 Hz, 1H), 6.79 (d, J = 8.0 Hz, 1H), 6.77 (dd, J = 8.0, 8.0 Hz, 1H), 3.57 (dd, J 
= 6.0, 6.0 Hz, 1H), 3.53-3.40 (m, 4H), 3.39-3.32 (m, 4H), 2.95 (dd, J = 13.6, 6.4 Hz, 1H), 2.78-
2.68 (br m, 2H), 2.57 (dd, J = 13.2, 5.2 Hz, 1H), 2.61-2.51 (m, 2H), 2.48-2.28 (m, 4H), 1.45 (s, 
9H), 1.44 (s, 9H); 13C NMR (125 MHz, CDCl3) ppm 156.8, 154.7, 154.5, 128.8, 128.7, 125.0, 
119.3, 116.7, 79.9, 79.6, 66.9, 60.0, 53.5, 50.7, 44.0, 43.2, 28.4; HRMS (ESI): Exact mass calcd 
for C26H43N4O5 [M+H]
+ 491.3234, found 491.3233. 
Diethyl 4,4'-(1-(2-hydroxyphenyl)ethane-1,2-diyl)bis(piperazine-1-carboxylate) (338g). 
Prepared according to the general procedure using ethyl 1-piperazinecarboxylate (132 µL, 900 
µmol) and 2-vinylphenol (36.0 mg, 300 µmol). Flash column chromatography of the residue (SiO2, 
10-80% ethyl acetate in hexanes) afforded the desired product as a viscous transparent yellow oil 
(117 mg, 90%). Rf = 0.22 (40% EtOAc/hexanes); IR (film) 3000 (br), 2982, 2860, 1699, 1589 cm
-
1; 1H NMR (400 MHz, CDCl3) δ 10.39 (br s, 1H), 7.13 (ddd, J = 8.8, 1.6 Hz, 1H), 6.97 (dd, J = 
7.2, 1.2 Hz, 1H), 6.78 (d, J = 8.4 Hz, 1H), 6.77 (ddd, J = 8.4, 0.8 Hz, 1H), 4.11 (dq, J = 6.8, 6.8 
Hz, 4H), 3.57 (dd, J = 5.6, 5.6 Hz, 1H), 3.54-3.43 (m, 4H), 3.42-3.35 (m, 4H), 2.94 (dd, J = 13.6, 
6.4 Hz, 1H), 2.78-2.69 (m, 2H), 2.60-2.52 (m, 3H), 2.45-2.30 (m, 4H), 1.25-1.21 (m, 6H); 13C 
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NMR (125 MHz, CDCl3) ppm 156.7, 155.4, 155.2, 128.8, 124.8, 119.3, 116.7, 66.8, 61.5, 61.3, 
60.0, 53.4, 50.6, 43.6, 14.6; HRMS (ESI): Exact mass calcd for C22H35N4O5 [M+H]
+ 435.2607 
found 435.2599. 
2-(1,2-Bis(4-phenylpiperazin-1-yl)ethyl)phenol (338h). Prepared according to the general 
procedure using 1-phenylpiperazine (137 µL, 900 µmol) and 2-vinylphenol (36.0 mg, 300 µmol). 
Flash column chromatography of the residue (SiO2, 5-100% diethyl ether in hexanes) afforded the 
desired product as an off-white solid (41.7 mg, 31%). Mp 179.0-182.0 °C; Rf = 0.57 (100% Et2O); 
IR (film) 3038, 2946, 2881, 2823, 1600 cm-1; 1H NMR (400 MHz, CDCl3) δ 11.29 (br s, 1H), 7.32-
7.27 (m, 4H), 7.20 (ddd, J = 9.2, 9.2, 1.6 Hz, 1H), 7.09 (dd, J = 7.6, 1.2 Hz, 1H), 6.94 (dd, J = 7.6, 
3.6 Hz, 4H), 6.91-6.82 (m, 4H), 3.68 (dd, J = 6.0, 6.0 Hz, 1H), 3.34-3.28 (m, 2H), 3.26-3.22 (m, 
2H), 3.19 (dd, J = 5.2, 5.2 Hz, 4H), 3.10 (dd, J = 13.6, 6.4 Hz, 1H), 3.04-2.99 (m, 2H), 2.83 (ddd, 
J = 10.4, 6.4, 2.8 Hz, 2H), 2.72-2.68 (m, 3H), 2.65-2.60 (m, 2H); 13C NMR (100 MHz, CDCl3) 
ppm 157.0, 151.2, 150.9, 129.2, 129.1, 129.0, 128.7, 125.3, 120.1, 119.7, 119.2, 116.7, 116.2, 
116.0, 66.9, 60.1, 53.8, 50.9, 49.4, 49.2; HRMS (ESI): Exact mass calcd for C28H35N4O [M+H]
+ 
443.2811, found 443.2802. 
2-(1,2-Bis(4-(3-methoxyphenyl)piperazin-1-yl)ethyl)phenol (338i). Prepared according to the 
general procedure using 1-(3-methoxyphenyl)piperazine (155 µL, 900 µmol) and 2-vinylphenol 
(36.0 mg, 300 µmol). Flash column chromatography of the residue (SiO2, 20% ethyl acetate in 
hexanes) afforded the desired product as a light-brown viscous oil (23.4 mg, 16%). Rf = 0.15 (20% 
EtOAc/hexanes); IR (film) 2938, 2829, 1602, 1494 cm-1; 1H NMR (600 MHz, CDCl3) δ 11.15 (br 
s, 1H), 7.19-7.15 (m, 3H), 7.05 (dd, J = 7.2, 1.2 Hz, 1H), 6.83 (d, J = 8.4 Hz, 1H), 6.81 (ddd, J = 
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7.8, 7.8, 1.2 Hz, 1H), 6.52 (ddd, J = 7.2, 4.2, 1.8 Hz, 2H), 6.47-6.40 (m, 4H), 3.79 (s, 3H), 3.79 (s, 
3H), 3.66 (dd, J = 6.0, 6.0 Hz, 1H), 3.30-3.24 (m, 2H), 3.22-3.12 (m, 6H), 3.06 (dd, J = 13.2, 6.6 
Hz, 1H), 3.00-2.94 (m, 2H), 2.81-2.76 (m, 2H), 2.68-2.62 (m, 3H), 2.61-2.55 (m, 2H); 13C NMR 
(150 MHz, CDCl3) ppm 160.6, 160.5, 156.9, 152.6, 152.3, 129.8, 129.7, 129.0, 128.7, 125.2, 
119.2, 116.7, 108.9, 108.8, 104.8, 104.5, 102.6, 102.5, 66.9, 60.1, 55.2, 53.7, 50.9, 49.3, 49.1; 
HRMS (ESI): Exact mass calcd for C30H39N4O3 [M+H]
+ 503.3022, found 503.3006. 
2-(1,2-bis(4-cinnamylpiperazin-1-yl)ethyl)phenol (338j). Prepared according to the general 
procedure using trans-1-cinnamylpiperazine (182 mg, 900 µmol) and 2-vinylphenol (36.0 mg, 300 
µmol). Flash column chromatography of the residue (SiO2, 0.5-1-2-5-10% methanol in 
dichloromethane) afforded the desired product as a light-brown viscous oil (146.8 mg, 94%). Rf = 
0.29 (5% MeOH/DCM); IR (film) 3385 (br), 3026, 2937, 2811, 1588 cm-1; 1H NMR (600 MHz, 
CDCl3) δ 7.92 (br s, 1H), 7.38-7.36 (m, 4H), 7.31 (dd, J = 7.2 Hz, 4H), 7.26-7.23 (m, 2H), 7.14 
(ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 6.99 (dd, J = 7.8, 1.2 Hz, 1H), 6.79 (d, J = 8.4 Hz, 1H), 6.77 (dd, J 
= 7.2, 7.2 Hz, 1H), 6.54 (dd, J = 16.2, 8.4 Hz, 2H), 6.23-6.24 (m, 2H), 3.59 (dd, J = 5.4, 5.4 Hz, 
1H), 3.27 (d, J = 6.6 Hz, 2H), 3.22 (dddd, J = 6.6, 6.6, 6.6, 6.6 Hz, 2H), 2.95 (dd, J = 13.8, 6.0 Hz, 
1H), 3.10-2.40 (m, 17H); 13C NMR (150 MHz, CDCl3) ppm 157.0, 136.5, 136.3, 134.9, 134.2, 
128.9, 128.7, 128.59, 128.57, 127.9, 127.7, 126.5, 126.4, 125.0, 124.9, 123.8, 119.1, 116.6, 66.7, 
60.6, 60.4, 59.3, 53.0, 52.7, 52.6, 50.0; HRMS (ESI): Exact mass calcd for C34H43N4O [M+H]
+ 
523.3437, found 523.3416. 
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2-(1,2-Bis(dibenzylamino)ethyl)phenol (338k). Prepared according to the general procedure 
using dibenzylamine (173 µL, 900 µmol) and 2-vinylphenol (36.0 mg, 300 µmol). Flash column 
chromatography of the residue (SiO2, 0.25-0.5-1-2% ethyl acetate in hexanes) afforded the desired 
product as a light-yellow viscous oil (53.1 mg, 35%). Rf = 0.84 (40% EtOAc/hexanes); IR (film) 
3061, 3028, 2835, 1585, 1493 cm-1; 1H NMR (400 MHz, CDCl3) δ 10.77 (br s, 1H), 7.30-7.18 (m, 
16H), 7.17-7.12 (m, 6H), 6.82 (dd, J = 8.4, 1.2 Hz, 1H), 6.76 (ddd, J = 7.6, 1.2 Hz, 1H), 4.10 (dd, 
J = 8.8, 4.0 Hz, 1H), 3.62 (s, 2H), 3.62 (s, 2H), 3.52 (d, J = 13.2 Hz, 2H), 3.41 (d, J = 13.2 Hz, 
2H), 3.11 (dd, J = 13.2, 4.0 Hz, 1H), 2.97 (dd, J = 13.2, 8.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) 
ppm 157.0, 138.6, 137.7, 129.29, 129.27, 129.2, 128.6, 128.5, 128.2, 127.4, 127.1, 125.6, 119.0, 
116.6, 61.3, 59.1, 54.1, 52.5; HRMS (ESI): Exact mass calcd for C36H37N2O [M+H]
+ 513.2906, 
found 513.2894. 
2-(1,2-Bis(benzyl(methyl)amino)ethyl)phenol (338l). Prepared according to the general 
procedure using N-benzylmethylamine (116 µL, 900 µmol) and 2-vinylphenol (36.0 mg, 300 
µmol). Flash column chromatography of the residue (SiO2, 5-10-20-40% ethyl acetate in hexanes) 
afforded the desired product as a light-yellow transparent viscous oil (70.0 mg, 65%). Rf = 0.43 
(30% EtOAc/hexanes); IR (film) 3061, 3028, 2948, 2844, 2791, 1587 cm-1; 1H NMR (600 MHz, 
CDCl3) δ 7.35-7.23 (m, 10H), 7.19 (ddd, J = 9.0, 9.0, 1.2 Hz, 1H), 7.16 (d, J = 7.8 Hz, 1H), 6.87 
(d, J = 7.8 Hz, 1H), 6.83 (dd, J = 7.2, 7.2 Hz, 1H), 3.89 (dd, J = 6.0, 6.0 Hz, 1H), 3.78 (d, J = 13.2 
Hz, 1H), 3.69 (d, J = 12.6 Hz, 1H), 3.59 (d, J = 13.2 Hz, 1H), 3.52 (d, J = 13.2 Hz, 1H), 3.11 (dd, 
J = 13.2, 5.4 Hz, 1H), 2.83 (13.2, 6.0 Hz, 1H), 2.24 (s, 3H), 2.22 (s, 3H); 13C NMR (150.9 MHz, 
CDCl3) ppm 157.3, 138.6, 137.6, 129.2, 129.0, 128.6, 128.51, 128.45, 128.3, 127.4, 127.1, 126.0, 
119.0, 116.7, 65.9, 63.1, 59.0, 58.2, 42.6, 38.0; HRMS (ESI): Exact mass calcd for C24H29N2O 
[M+H]+ 361.2280, found 361.2288. 
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2-(1,2-Bis(phenylamino)ethyl)phenol (338m). A vial equipped with a stir bar was charged with 
potassium iodide (60.0 mg, 360 µmol), iodobenzene diacetate (193 mg, 600 µmol), and acetonitrile 
(3 mL). Aniline (82.0 µL, 900 µmol) and 2-vinylphenol (36.0 mg, 300 µmol) were added and the 
resulting mixture was stirred at rt for 18 h. The reaction mixture was then diluted with ethyl acetate 
and concentrated. Flash column chromatography of the residue (SiO2, 2-5-10-20% ethyl acetate in 
hexanes) afforded the desired product as a brown viscous oil (54.6 mg, 60%). Rf = 0.26 (10% 
EtOAc/hexanes); IR (film) 3391, 3050, 1602, 1499 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.69 (br 
s, 1H), 7.25-7.20 (m, 4H), 7.16 (dd, J = 8.4, 7.6 Hz, 2H), 6.94 (ddd, J = 7.2, 7.2, 0.8 Hz, 1H), 6.91-
6.78 (m, 5H), 6.74 (d, J = 7.6 Hz, 2H), 4.70 (br s, 1H), 4.53 (dd, J = 9.6, 4.8 Hz, 1H), 3.91 (br s, 
1H), 3.63 (dd, J = 13.2, 9.6 Hz, 1H), 3.51 (dd, J = 13.2, 4.4 Hz, 1H); 13C NMR (125 MHz, CDCl3) 
ppm 156.7, 147.4, 146.7, 129.5, 129.3, 129.1, 128.0, 124.2, 121.2, 120.3, 118.9, 117.3, 116.7, 
113.7, 60.2, 49.1; HRMS (ESI): Exact mass calcd for C20H21N2O [M+H]
+ 305.1648, found 
305.1643. 
2-(1,2-Bis((4-(tert-butyl)phenyl)amino)ethyl)phenol (338n). A vial equipped with a stir bar was 
charged with potassium iodide (60.0 mg, 360 µmol), iodobenzene diacetate (193 mg, 600 µmol), 
and acetonitrile (3 mL). The aniline (143 µL, 900 µmol) and 2-vinylphenol (36.0 mg, 300 µmol) 
were added and the resulting mixture was stirred at rt for 18 h. The reaction mixture was then 
diluted with ethyl acetate and concentrated. Flash column chromatography of the residue (SiO2, 
0.5-1-2-5-10% ethyl acetate in hexanes) afforded the desired product as a brown viscous oil (66.5 
mg, 53%). Rf = 0.49 (20% EtOAc/hexanes); IR (film) 3307, 3049, 2961, 2903, 2866, 1614, 1588, 
1518 cm-1; 1H NMR (400 MHz, CDCl3) δ 10.06 (br s, 1H), 7.26-7.16 (m, 6H), 6.92 (ddd, J = 7.2, 
7.2, 1.2 Hz, 1H), 6.84 (d, J = 8.0 Hz, 1H), 6.74 (d, J = 8.4 Hz, 2H), 6.69 (d, J = 8.8 Hz, 2H), 4.69 
(br s, 1H), 4.47 (dd, J = 9.6, 4.4 Hz, 1H), 3.81 (br s, 1H), 3.61 (dd, J = 13.2, 10.8 Hz, 1H), 3.47 
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(dd, J = 13.2, 4.4 Hz, 1H); 1.29 (s, 9H), 1.24 (s, 9H); 13C NMR (125 MHz, CDCl3) ppm 157.1, 
144.9, 144.2, 141.9, 129.01, 128.03, 126.3, 126.1, 124.3, 120.1, 117.3, 116.5, 113.5, 60.8, 49.4, 
34.0, 33.9, 31.5, 31.4; HRMS (ESI): Exact mass calcd for C28H37N2O [M+H]
+ 417.2906, found 
417.2917. 
2-(1,2-Bis((3,5-dimethylphenyl)amino)ethyl)phenol (338o). A vial equipped with a stir bar was 
charged with potassium iodide (60.0 mg, 360 µmol), iodobenzene diacetate (193 mg, 600 µmol), 
and acetonitrile (3 mL). The aniline (112 µL, 900 µmol) and 2-vinylphenol (36.0 mg, 300 µmol) 
were added and the resulting mixture was stirred at rt for 18 h. The reaction mixture was then 
diluted with ethyl acetate and concentrated. Flash column chromatography of the residue (SiO2, 2-
5-10-20% ethyl acetate in hexanes) afforded the desired product as a light brown solid (64.3 mg, 
60%). Mp 120.0-124.0 °C; Rf = 0.44 (20% EtOAc/hexanes); IR (film) 3387, 3023, 2917, 2857 cm
-
1; 1H NMR (400 MHz, CDCl3) δ 9.91 (br s, 1H), 7.22 (ddd, J = 7.6, 7.6, 1.6 Hz, 1H), 7.19 (dd, J 
= 8.4, 1.6 Hz, 1H), 6.93 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 6.86 (dd, J = 8.0, 0.8 Hz, 1H), 6.55 (s, 1H), 
6.48 (s, 1H), 6.42 (s, 2H), 6.37 (s, 2H), 4.59 (br s, 1H), 4.48 (dd, J = 9.6, 4.4 Hz, 1H), 3.76 (br s, 
1H), 3.60 (dd, J =13.2, 10.0 Hz, 1H), 3.46 (dd, J = 13.2, 4.4 Hz, 1H), 2.27 (s, 6H), 2.19 (s, 6H); 
13C NMR (125 MHz, CDCl3) ppm 156.9, 147.5, 146.7, 139.1, 138.9, 128.9, 128.0, 124.4, 123.1, 
120.9, 120.1, 117.3, 114.6, 111.7, 60.4, 49.2, 21.5, 21.4; HRMS (ESI): Exact mass calcd for 
C24H29N2O [M+H]
+ 361.2280, found 361.2285. 
2-(1,2-Bis((4-fluorophenyl)amino)ethyl)phenol (338p). A vial equipped with a stir bar was 
charged with potassium iodide (60.0 mg, 360 µmol), iodobenzene diacetate (193 mg, 600 µmol), 
and acetonitrile (3 mL). The aniline (85.0 µL, 900 µmol) and 2-vinylphenol (36.0 mg, 300 µmol) 
were added and the resulting mixture was stirred at rt for 18 h. The reaction mixture was then 
diluted with ethyl acetate and concentrated. Flash column chromatography of the residue (SiO2, 1-
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2-5-10-20-50% ethyl acetate in hexanes) afforded the desired product as a dark brown viscous oil 
(48.1 mg, 47%). Rf = 0.28 (20% EtOAc/hexanes); IR (film) 3310, 3040, 2926, 2858 1588, 1510 
cm-1; 1H NMR (600 MHz, CDCl3) δ 9.72 (br s, 1H), 7.23 (ddd, J = 7.8, 7.8, 1.2 Hz, 1H), 7.16 (dd, 
J = 7.2, 1.2 Hz, 1H), 6.95-6.91 (m, 3H), 6.87-6.84 (m, 3H), 6.74-6.72 (m, 2H), 6.69-6.66 (m, 2H), 
4.65 (br s, 1H), 4.44 (dd, J = 9.6, 4.2 Hz, 1H), 3.80 (br s, 1H), 3.56 (dd J = 13.2, 10.2 Hz, 1H), 
3.46 (dd, J = 13.2, 4.8 Hz, 1H); 13C NMR (150 MHz, CDCl3) ppm 158.0 (d, J = 239.6 Hz), 156.70, 
156.65 (d, J = 236.9 Hz), 143.5, 142.7, 129.3, 128.1, 123.7, 120.3, 118.1 (d, J = 7.5 Hz), 117.4, 
116.0 (d, J = 22.5 Hz), 115.8 (d, J = 22.6 Hz), 114.8 (J = 7.5 Hz), 60.7, 49.8; HRMS (ESI): Exact 
mass calcd for C20H19F2N2O [M+H]
+ 341.1460, found 314.1451. 
1-(2-Hydroxyphenyl)-2-(isopropylamino)ethyl acetate (352). A 2-5 mL microwave vial 
equipped with a stir bar was charged with potassium iodide (60.0 mg, 360 µmol), iodobenzene 
diacetate (193 mg, 600 µmol), and acetonitrile (3 mL). Isopropylamine (77.0 µL, 900 µmol) and 
2-vinylphenol (36.0 mg, 300 µmol) were added and the resulting mixture was stirred at rt for 18 
h. The reaction mixture was then diluted with ethyl acetate and concentrated. Flash column 
chromatography of the residue (SiO2, 0.5-1-2-5% methanol in dichloromethane) afforded the 
desired product as a brown viscous oil (18.2 mg, 26%). Rf = 0.33 (50% EtOAc/hexanes); IR (film) 
3225, 2972, 2933, 1598 cm-1; 1H NMR (600 MHz, CDCl3) δ 9.23 (br s, 1H), 7.17 (ddd, J = 8.4, 
8.4, 1.2 Hz, 1H), 7.02 (dd, J = 7.8, 1.8 Hz, 1H), 6.88 (dd, J = 7.8, 0.6 Hz, 1H), 6.83 (ddd, J = 7.8, 
7.8, 1.2 Hz, 1H), 6.54 (br s, 1H), 5.00 (d, J = 8.4 Hz, 1H), 4.07 (qq, J = 6.6, 6.6 Hz, 1H), 3.88 (dd, 
J = 15.6, 9.0 Hz, 1H), 3.24 (dd, J = 15.0, 1.2 Hz, 1H), 2.22 (s, 3H), 1.30 (d, J = 6.6 Hz, 3H), 1.15 
(d, J = 6.6 Hz, 3H); 13C NMR (150.9 MHz, CDCl3) ppm 174.0, 156.2, 129.0, 126.6, 125.3, 119.6, 
117.5, 77.6, 50.4, 50.2, 21.8, 21.3, 20.6; HRMS (ESI): Exact mass calcd for C13H19NNaO3 
[M+Na]+ 260.1263, found 260.1258. HSQC (600 MHz) and HMBC (600 MHz) analyses further 
confirmed the compound structure. 
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2-(Cyclohexylamino)-1-(2-hydroxyphenyl)ethyl acetate (353). A 2-5 mL microwave vial 
equipped with a stir bar was charged with potassium iodide (60.0 mg, 360 µmol), iodobenzene 
diacetate (193 mg, 600 µmol), and acetonitrile (3 mL). Cyclohexylamine (103 µL, 900 µmol) and 
2-vinylphenol (36.0 mg, 300 µmol) were added and the resulting mixture was stirred at rt for 20 
h. The reaction mixture was then diluted with ethyl acetate and concentrated. Flash column 
chromatography of the residue (SiO2, 25-50-75-100% ethyl acetate in hexanes) afforded the 
desired product as a gray-brown solid (23.8 mg, 29%). Mp 154.0-158.0 °C; Rf = 0.45 (50% 
EtOAc/hexanes); IR (film) 3126, 2924, 2853, 1570 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.17 (ddd, 
J = 9.0, 9.0, 1.8 Hz, 1H), 7.02 (dd, J = 7.8, 1.8 Hz, 1H), 6.87 (d, J = 7.8 Hz, 1H), 6.84 (ddd, J = 
7.2, 7.2, 0.6 Hz, 1H), 4.97 (d, J = 7.8 Hz, 1H), 3.91 (dd, J = 15.0, 8.4 Hz, 1H), 3.55 (tt, J = 12.0, 
3.6 Hz, 1H), 3.27 (dd, J = 15.0, 0.6 Hz, 1H), 2.21 (s, 3H), 1.94-1.88 (m, 2H), 1.86-1.81 (m, 1H), 
1.71-1.64 (m, 2H), 1.52-1.44 (m, 1H), 1.43-1.28 (m, 3H), 1.13-1.05 (m, 1H); 13C NMR (150.9 
MHz, CDCl3) ppm 174.2, 156.2, 128.9, 126.6, 125.3, 119.6, 117.5, 77.6, 59.2, 51.1, 31.8, 31.0, 
25.9, 25.6, 25.0, 21.9; HRMS (ESI): Exact mass calcd for C16H23NNaO3 [M+Na]
+ 300.1576, found 
300.1582. HSQC (600 MHz) and HMBC (600 MHz) analyses further confirmed the compound 
structure. 
1-(2-Hydroxyphenyl)-2-((3-methoxypropyl)amino)ethyl acetate (354). A 2-5 mL microwave 
vial equipped with a stir bar was charged with potassium iodide (60.0 mg, 360 µmol), iodobenzene 
diacetate (193 mg, 600 µmol), and acetonitrile (3 mL). 3-Methoxypropylamine (92.0 µL, 900 
µmol) and 2-vinylphenol (36.0 mg, 300 µmol) were added and the resulting mixture was stirred at 
rt for 18 h. The reaction mixture was then diluted with ethyl acetate and concentrated. Flash column 
chromatography of the residue (SiO2, 25-50-75-100% ethyl acetate in hexanes) afforded the 
desired product as a light-brown viscous oil (26.5 mg, 33%). Rf = 0.17 (50% EtOAc/hexanes); IR 
(film) 3238, 2928, 1616 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.15 (ddd, J = 9.0, 9.0, 1.8 Hz, 1H), 
7.07 (dd, J = 7.2, 1.2 Hz, 1H), 6.86 (dd, J = 8.4, 0.6 Hz, 1H), 6.83 (ddd, J = 7.8, 7.8, 1.2 Hz, 1H), 
5.15 (dd, J = 7.8, 2.4 Hz, 1H), 3.67 (dd, J = 14.4, 7.8 Hz, 1H), 3.53 (dd, J = 14.4, 2.4 Hz, 1H), 
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3.38-3.34 (m, 4H), 3.30 (s, 3H), 2.16 (s, 3H), 1.85-1.75 (m, 2H); 13C NMR (150.9 MHz, CDCl3) 
ppm 174.0, 155.7, 128.9, 126.4, 125.4, 119.6, 117.2, 74.4, 69.0, 58.6, 55.3, 48.3, 28.6, 21.2; HRMS 
(ESI): Exact mass calcd for C14H21NNaO4 [M+Na]
+ 290.1368, found 290.1364. HSQC (600 MHz) 
and HMBC (600 MHz) analyses further confirmed the compound structure. 
4-(1,2-Dimorpholinoethyl)phenol (340b). Prepared according to the general procedure using 
morpholine (78.0 µL, 900 µmol) and 4-vinylphenol (36.0 mg, 300 µmol). Flash column 
chromatography of the residue (SiO2, 0.5-1-2-5-10% methanol in dichloromethane) afforded the 
desired product as a light-yellow viscous oil (51.9 mg, 59%). Rf = 0.19 (5% MeOH/DCM); IR 
(film) 3242 (br), 2959, 2857, 2820, 1613, 1595, 1516 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.07 (d, 
J = 8.4 Hz, 2H), 6.71 (d, J = 8.4 Hz, 2H), 6.16 (br s, 1H), 3.73 (br dd, J = 4.0, 4.0 Hz, 4H), 3.69 
(br dd, J = 4.8, 4.8 Hz, 5H), 3.12 (dd, J = 12.8, 6.8 Hz, 1H), 2.72 (dd, J = 13.2, 6.0 Hz, 1H), 2.62 
(m, 4H), 2.52 (m, 4H); 13C NMR (100 MHz, CDCl3) ppm 155.5, 129.8, 115.2, 66.72, 66.67, 66.5, 
61.3, 54.0, 51.0; Exact mass calcd for C16H25N2O3 [M+H]
+ 293.1865, found 293.1879. 
4-(1,2-Bis(phenylamino)ethyl)phenol (340c). A vial equipped with a stir bar was charged with 
potassium iodide (60.0 mg, 360 µmol), iodobenzene diacetate (193 mg, 600 µmol), and acetonitrile 
(3 mL). Aniline (82.0 µL, 900 µmol) and 4-vinylphenol (36.0 mg, 300 µmol) were added and the 
resulting mixture was stirred at rt for 18 h. The reaction mixture was then diluted with ethyl acetate 
and concentrated. Flash column chromatography of the residue (SiO2, 1-2-5-10-20-40% ethyl 
acetate in hexanes) afforded the desired product as a brown viscous oil (78.0 mg, 85%). Rf = 0.24 
(20% EtOAc/hexanes); IR (film) 3391, 3051, 3022, 1601, 1503 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.25 (d, J = 8.4 Hz, 2H), 7.21 (dd, J = 8.4, 7.6 Hz, 2H), 7.12 (dd, J = 8.4, 7.6 Hz, 2H), 6.80 (d, J 
= 8.4 Hz, 2H), 6.78 (dd, J = 7.2 Hz, 1H), 6.70 (dd, J = 7.2, 7.2 Hz, 1H), 6.66 (d, J = 7.6 Hz, 2H), 
6.57 (d, J = 8.0 Hz, 2H), 4.59 (dd, J = 7.6, 5.2 Hz, 1H), 4.46 (br s, 2H), 3.47 (dd, J = 12.4, 4.8 Hz, 
1H), 3.38 (dd, J = 12.4, 7.6 Hz, 1H); 13C NMR (150 MHz, CDCl3) ppm 155.0, 147.8, 147.1, 133.2, 
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129.4, 129.2, 127.7, 118.2, 117.8, 115.7, 113.7, 113.4, 56.8, 51.0; Exact mass calcd for C20H21N2O 
[M+H]+ 305.1648, found 305.1645. 
2-(1,2-Dithiomorpholinoethyl)-4-fluorophenol (338q). Prepared according to the general 
procedure using thiomorpholine (91.0 µL, 900 µmol) and 4-fluoro-2-vinylphenol (41.4 mg, 300 
µmol). Flash column chromatography of the residue (SiO2, 5-10-20-40% ethyl acetate in hexanes) 
afforded the desired product as a light-yellow solid (85.3 mg, 83%). Mp 72.0-76.0 °C; Rf = 0.38 
(20% EtOAc/hexanes); IR (film) 3030(br), 2910, 2813, 1743, 1593 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 11.00 (br s, 1H), 6.87-6.79 (m, 2H), 6.73 (dd, J = 8.4, 4.8 Hz, 1H), 3.75 (dd, J = 6.0, 6.0 
Hz, 1H), 3.09 (dd, J = 6.8, 3.2 Hz, 1H), 3.06 (dd, J = 6.0, 3.6 Hz, 1H), 2.92-2.86 (m, 3H), 2.77-
2.72 (m, 4H), 2.72-2.67 (m, 4H), 2.66-2.62 (m, 5H); 13C NMR (150 MHz, CDCl3) ppm 156.1 (d, 
1JFC = 236.9 Hz), 153.2, 125.8 (d, 
3JFC = 7.5 Hz), 117.4, 117.3, 114.9 (d, 
2JFC = 16.9 Hz), 64.9, 
58.4, 55.6, 51.9, 28.1, 27.9; HRMS (ESI): Exact mass calcd for C16H24FN2OS2 [M+H]
+ 343.1314, 
found 343.1329. 
4-Chloro-2-(1,2-dithiomorpholinoethyl)phenol (338r). A vial equipped with a stir bar was 
charged with potassium iodide (60.0 mg, 360 µmol), iodobenzene diacetate (290 mg, 900 µmol), 
and acetonitrile (3 mL) and was chilled to 0 °C. Thiomorpholine (91.0 µL, 900 µmol) and 4-chloro-
2-vinylphenol (46.4 mg, 300 µmol) were added and the resulting mixture was stirred at 0 °C for 
18 h. The reaction mixture was then diluted with ethyl acetate and concentrated. Flash column 
chromatography of the residue (SiO2, 0.5-1-2-5-10-20-40% ethyl acetate in hexanes) afforded the 
desired product as a light orange solid (69.1 mg, 64%). Mp 100.0-104.0 °C; Rf = 0.31 (20% 
EtOAc/hexanes); IR (film) 3030 (br), 2911, 2810, 1742, 1603, 1579 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 11.30 (br s, 1H), 7.10 (dd, J = 8.8, 2.4 Hz, 1H), 7.03 (d, J = 2.4 Hz, 1H), 6.73 (d, J = 8.8 
Hz, 1H), 3.72 (dd, J = 6.0, 6.0 Hz, 1H), 3.08 (dd, J = 7.2, 3.2 Hz, 1H), 3.05 (dd, J = 6.4, 3.6 Hz, 
1H), 2.91-2.85 (m, 3H), 2.75-2.61 (m, 13H); 13C NMR (125 MHz, CDCl3) ppm 156.0, 128.5, 
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128.3, 126.3, 123.7, 118.0, 65.2, 58.6, 55.6, 52.0, 28.0, 27.9; HRMS (ESI): Exact mass calcd for 
C16H24ClN2OS2 [M+H]
+ 359.1019, found 359.1033. 
4-Bromo-2-(1,2-dithiomorpholinoethyl)phenol (338s). A vial equipped with a stir bar was 
charged with potassium iodide (60.0 mg, 360 µmol), iodobenzene diacetate (290 mg, 900 µmol), 
and acetonitrile (3 mL) and was chilled to 0 °C. Thiomorpholine (91.0 µL, 900 µmol) and 4-
bromo-2-vinylphenol (59.7 mg, 300 µmol) were added and the resulting mixture was stirred at 0 
°C for 18 h. The reaction mixture was then diluted with ethyl acetate and concentrated. Flash 
column chromatography of the residue (SiO2, 0.5-1-2-5-10-20-40% ethyl acetate in hexanes) 
afforded the desired product as a light yellow solid (85.1 mg, 70%). Mp 105.0-109.0 °C; Rf = 0.31 
(20% EtOAc/hexanes); IR (film) 3030 (br), 2911, 2810, 1742, 1600, 1576 cm-1; 1H NMR (400 
MHz, CDCl3) δ 11.29 (br s, 1H), 7.24 (dd, J = 8.4, 2.4 Hz, 1H), 7.17 (d, J = 2.4 Hz, 1H), 6.68 (d, 
J = 8.4 Hz, 1H), 3.72 (dd, J = 6.4, 6.4 Hz, 1H), 3.09 (dd, J = 6.8, 3.2 Hz, 1H), 3.06 (dd, J = 6.4, 
3.6 Hz, 1H), 2.91-2.85 (m, 3H), 2.75-2.61 (m, 13H); 13C NMR (125 MHz, CDCl3) ppm 156.5, 
131.5, 131.3, 126.8, 118.6, 110.9, 65.2, 58.6, 55.6, 52.0, 27.99, 27.97; HRMS (ESI): Exact mass 
calcd for C16H24BrN2OS2 [M+H]
+ 403.0513, found 403.0518. 
2-(1,2-Dithiomorpholinoethyl)-4-nitrophenol (338t). Prepared according to the general 
procedure using thiomorpholine (91.0 µL, 900 µmol) and 4-nitro-2-vinylphenol (49.5 mg, 300 
µmol). Flash column chromatography of the residue (SiO2, 2-5-10-20-40% ethyl acetate in 
hexanes) afforded the desired product as a viscous yellow oil (55.1 mg, 50%). Rf = 0.10 (20% 
EtOAc/hexanes); IR (film) 3060 (br), 2910, 2813, 1615, 1586 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 8.12 (d, J = 2.8 Hz, 1H), 8.07 (dd, J = 8.8, 2.0 Hz, 1H), 6.83 (d, J =9.2 Hz, 1H), 3.88 (dd, J = 
7.6, 4.8 Hz, 1H), 3.13-3.08 (m, 2H), 2.95-2.89 (m, 3H), 2.87-2.65 (m, 13H); 13C NMR (125 MHz, 
CDCl3) ppm 164.3, 140.0, 125.2 (2C), 124.7, 117.1, 64.6, 57.7, 55.6, 51.6, 28.0, 27.9; HRMS 
(ESI): Exact mass calcd for C16H24N3O3S2 [M+H]
+ 370.1259, found 370.1265. 
 
 
 
 
233 
 
2-(1,2-Dithiomorpholinoethyl)-4-methoxyphenol (338u). Prepared according to the general 
procedure using thiomorpholine (91.0 µL, 900 µmol) and 4-methoxy-2-vinylphenol (45.1 mg, 300 
µmol). Flash column chromatography of the residue (SiO2, 20-40% ethyl acetate in hexanes) 
afforded the desired product as an off-white solid (57.0 mg, 54%). Mp 114.0-116.0 °C; Rf = 0.25 
(20% EtOAc/hexanes); IR (film) 2908, 2828, 1492 cm-1; 1H NMR (600 MHz, CDCl3) δ 10.56 (br 
s, 1H), 6.74-6.70 (m, 2H), 6.64 (d, J = 2.4 Hz, 1H), 3.74 (s, 3H), 3.72 (dd, J = 6.0 Hz, 1H), 3.08 
(dd, J = 7.8, 3.0 Hz, 1H), 3.06 (dd, J = 6.6, 3.0 Hz, 1H), 2.91-2.86 (m, 3H), 2.77-2.60 (m, 13H); 
13C NMR (150 MHz, CDCl3) ppm 152.5, 150.9, 125.7, 117.0, 114.6, 113.2, 65.4, 59.0, 55.7, 55.6, 
52.1, 28.03, 27.97; HRMS (ESI): Exact mass calcd for C17H27N2O2S2 [M+H]
+ 355.1514, found 
355.1521. 
2-(1,2-Dithiomorpholinoethyl)benzene-1,4-diol (338v). Prepared according to the general 
procedure using thiomorpholine (91.0 µL, 900 µmol) and 2-vinylbenzene-1,4-diol (40.9 mg, 300 
µmol). Flash column chromatography of the residue (SiO2, 50-75-100% ethyl acetate in hexanes) 
afforded the desired product as a light-brown viscous oil (23.8 mg, 23%). Rf = 0.35 (5% 
MeOH/DCM); IR (film) 3300 (br), 2911, 2817, 2362, 1731, 1560 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 6.68 (d, J = 8.4 Hz, 1H), 6.64 (dd, J = 8.8, 2.8 Hz, 1H), 6.59 (d, J = 2.8 Hz, 1H), 3.71 
(dd, J = 6.0, 6.0 Hz, 1H), 3.07 (ddd, J = 10.4, 6.4, 3.6 Hz, 2H), 2.89 (m, 3H), 2.70 (m, 13H); 13C 
NMR (150 MHz, CDCl3) ppm 150.8, 148.3, 125.8, 117.3, 115.4, 115.3, 65.2, 59.0, 55.6, 52.1, 
28.0, 27.9; Exact mass calcd for C16H25N2O2S2 [M+H]
+ 341.1357, found 341.1365. 
2-(1,2-Dithiomorpholinoethyl)-5-methoxyphenol (338w). Prepared according to the general 
procedure using thiomorpholine (91.0 µL, 900 µmol) and 5-methoxy-2-vinylphenol (45.1 mg, 300 
 
 
 
 
 
 
234 
 
µmol). The residue was diluted with dichloromethane and filtered through a silica plug with 
dichloromethane and ethyl acetate and then concentrated. Flash column chromatography of the 
residue (SiO2, 1-2-5-10-20-40% ethyl acetate in hexanes) afforded the desired product as a yellow-
orange viscous oil (60.2 mg, 57%). Rf = 0.25 (40% EtOAc/hexanes); IR (film) 3020 (br), 2911, 
2833, 1619, 1587, 1508 cm-1; 1H NMR (400 MHz, CDCl3) δ 11.31 (br s, 1H), 6.92 (d, J = 8.4 Hz, 
1H), 6.38 (d, J = 2.4 Hz, 1H), 6.36 (dd, J = 8.4, 2.8 Hz, 1H), 3.79-3.73 (m, 1H), 3.76 (s, 3H), 3.10 
(dd, J = 6.8, 3.2 Hz, 1H), 3.07 (dd, J = 6.4, 4.0 Hz, 1H), 2.92-2.83 (m, 3H), 2.76-2.62 (m, 13 H); 
13C NMR (125 MHz, CDCl3) ppm 160.3, 158.5, 128.9, 116.9, 105.0, 102.1, 64.9, 58.9, 55.6, 55.1, 
51.8, 28.0, 27.9; HRMS (ESI): Exact mass calcd for C17H27N2O2S2 [M+H]
+ 355.1514, found 
355.1528. 
2-(1,2-Dithiomorpholinoethyl)-6-methoxyphenol (338x). Prepared according to the general 
procedure using thiomorpholine (91.0 µL, 900 µmol) and 2-methoxy-6-vinylphenol (45.1 mg, 300 
µmol). Flash column chromatography of the residue (SiO2, 5-10-20-40-80% ethyl acetate in 
hexanes) afforded the desired product as an off-white solid (88.7 mg, 83%). Mp 115.0-118.0 °C; 
Rf = 0.10 (20% EtOAc/hexanes); IR (film) 3020 (br), 2908, 2829, 1585 cm
-1; 1H NMR (400 MHz, 
CDCl3) δ 9.65 (br s, 1H), 6.79 (dd, J = 8.4, 1.6 Hz, 1H), 6.73 (dd, J = 7.6, 7.6 Hz, 1H), 6.64 (dd, J 
= 8.0, 1.6 Hz, 1H), 3.85 (s, 3H), 3.82 (dd, J = 6.4, 6.4 Hz, 1H), 3.09 (dd, J = 6.8, 2.8 Hz, 1H), 3.05 
(dd, J = 6.4, 3.2 Hz, 1H), 2.94-2.86 (m, 3H), 2.80-2.71 (m, 4H), 2.71-2.65 (m, 5H), 2.65-2.59 (m, 
4H); 13C NMR (125.8 MHz, CDCl3) ppm 148.2, 146.6, 125.0, 120.2, 118.6, 110.7, 65.3, 59.3, 
55.8, 55.5, 52.1, 28.0, 27.9; HRMS (ESI): Exact mass calcd for C17H27N2O2S2 [M+H]
+ 355.1514, 
found 355.1521. 
2,3-Dihydrobenzofuran-3-yl acetate (355). A 2-5 mL microwave vial equipped with a stir bar 
was charged with potassium iodide (60.0 mg, 360 µmol), iodobenzene diacetate (193 mg, 600 
µmol), and acetonitrile (3 mL). 2-Vinylphenol (36.0 mg, 300 µmol) was added and the resulting 
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mixture was stirred at rt for 18 h. The reaction mixture was then diluted with ethyl acetate and 
concentrated. Flash column chromatography of the residue (SiO2, 2-20% diethyl ether in hexanes) 
afforded the desired product as a light yellow transparent viscous oil (36.8 mg, 69%). Rf = 0.37 
(20% Et2O/hexanes); IR (film) 3054, 2948, 2884, 1737, 1612, 1600 cm
-1; 1H NMR (400 MHz, 
CDCl3) δ 7.45 (dd, J = 7.6, 0.4 Hz, 1H), 7.30 (ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 6.95 (dd, J = 7.2, 7.2 
Hz, 1H), 6.90 (d, J = 8.0 Hz, 1H), 6.25 (dd, J = 6.8, 2.4 Hz, 1H), 4.62 (dd, J = 11.6, 6.8 Hz, 1H), 
4.51 (dd, J = 11.2, 2.4 Hz, 1H), 2.07 (s, 3H); 13C NMR (100.6 MHz, CDCl3) ppm 170.8, 161.0, 
131.3, 126.7, 124.3, 121.0, 110.5, 76.0, 74.2, 21.0; HRMS (CI): Exact mass calcd for C10H10O3 
[M]+ 178.0624, found 178.0623. 
1-(2-hydroxyphenyl)-2-iodoethyl acetate (356). A vial equipped with a stir bar was charged with 
potassium iodide (60.0 mg, 360 µmol), iodobenzene diacetate (193 mg, 600 µmol), and acetonitrile 
(3 mL). Bistosylimide (293 mg, 900 µmol) and 2-vinylphenol (36.0 mg, 300 µmol) were added 
and the resulting mixture was stirred at rt for 18 h. The reaction mixture was then diluted with 
ethyl acetate and concentrated. Flash column chromatography of the residue (SiO2, 2-5-10-20-50-
100% diethyl ether in hexanes) afforded the desired product as a yellow-orange viscous oil (11.3 
mg, 12%). Rf = 0.76 (80% Et2O/hexanes); IR (film) 3396 (br), 2923, 2852, 1719, 1598 cm
-1; 1H 
NMR (600 MHz, CDCl3) δ 7.24 (ddd, J = 9.6, 9.6, 1.8 Hz, 2H), 6.95 (ddd, J = 7.2, 7.2, 0.6 Hz, 
1H), 6.87 (d, J = 8.4 Hz, 1H), 6.42 (br s, 1H), 6.07 (dd, J = 9.0, 4.8 Hz, 1H), 3.65 (dd, J = 10.2, 
9.0 Hz, 1H), 3.55 (dd, J = 10.8, 4.8 Hz, 1H), 2.16 (s, 3H); 13C NMR (150.9 MHz, CDCl3) ppm 
171.2, 153.7, 130.4, 126.8, 124.3, 121.1, 117.5, 71.9, 20.9, 5.6; HRMS (ESI): no mass was 
observed due to decomposition upon multiple submissions.  
General procedure for Hypervalent Iodine-Mediated Intra/Intermolecular Diamination: To 
a vial equipped with a stir bar was added PhI(OAc)2 (72.5 mg, 225 µmol), KI (24.9 mg, 150 µmol), 
the vinyl aminopyridine (41.2 mg, 150 µmol), and acetonitrile (1.50 mL). The amine (300 µmol) 
was added and the resulting mixture was allowed to stir at rt for 18 h. The reaction mixture was 
then diluted with ethyl acetate and concentrated. No reductive workup was used in these studies, 
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but is recommended for a larger scale. EtOAc was used to transfer the heterogeneous reaction 
mixture to a larger flask for concentration. After concentration, the resulting residue was then 
subjected to flash column chromatography. 
N-Phenyl-1-tosyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-amine (521a). A vial equipped with 
a stir bar was charged with potassium iodide (33.2 mg, 200 µmol), iodobenzene diacetate (96.6 
mg, 300 µmol), 4-methyl-N-(3-vinylpyridin-2-yl)benzenesulfonamide (55.0 mg, 200 µmol), and 
acetonitrile (2 mL). Aniline (36.5 µL, 400 µmol) was added and the resulting mixture was stirred 
at rt for 18 h. The reaction mixture was then diluted with ethyl acetate and concentrated. Flash 
column chromatography of the residue (SiO2, 5-10-20-40% ethyl acetate in hexanes) afforded the 
desired product as a light-brown solid (70.4 mg, 96%). Mp 194.0-196.0 °C; Rf = 0.54 (50% 
EtOAc/hexanes); IR (film) 3386, 3052, 2924, 2340, 1923, 1601 cm-1; 1H NMR (600 MHz, CDCl3) 
δ 8.31 (dd, J = 5.4, 1.2 Hz, 1H), 7.96 (d, J = 8.4 Hz, 2H), 7.56 (ddd, J = 7.2, 1.2, 1.2 Hz, 1H), 7.27 
(d, J = 8.4 Hz, 2H), 7.21 (dd, J = 8.4, 7.2 Hz, 2H), 6.90 (dd, J = 7.8, 5.4 Hz, 1H), 6.81 (dd, J = 7.2, 
7.2 Hz, 1H), 6.59 (d, J = 7.2 Hz, 2H), 5.05 (br s, 1H), 4.27 (dd, J = 10.8, 7.8 Hz, 1H), 3.92 (dd, J 
= 10.8, 4.8 Hz, 1H), 3.76 (br s, 1H), 2.39 (s, 3H); 13C NMR (150 MHz, CDCl3) ppm 155.8, 149.3, 
145.5, 144.3, 134.9, 133.9, 129.6, 129.5, 128.1, 124.7, 119.0, 118.4, 113.6, 55.4, 50.9, 21.6; HRMS 
(ESI): Exact mass calcd for C20H20N3O2S [M+H]
+ 366.1276, found 366.1272. 
N-Benzyl-1-tosyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-amine (521b). Prepared according 
to the general procedure using benzylamine (32.8 µL, 300 µmol) and 4-methyl-N-(3-vinylpyridin-
2-yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash column chromatography of the residue 
(SiO2, 10-30-60% ethyl acetate in hexanes) afforded the desired product as an orange viscous oil 
(41.8 mg, 73%). Rf = 0.28 (50% EtOAc/hexanes); IR (film) 3319, 3060, 3029, 2923, 1597 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 8.18 (dd, J = 5.2, 1.2 Hz, 1H), 7.89 (d, J = 8.0 Hz, 2H), 7.46 (d, J 
= 7.2 Hz, 1H), 7.27-7.16 (m, 7H), 6.81 (dd, J = 7.2, 4.8 Hz, 1H), 4.23 (dd, J = 8.0, 4.4 Hz, 1H), 
4.01 (dd, J = 10.4, 8.0 Hz, 1H), 3.86 (dd, J = 10.8, 4.4 Hz, 1H), 3.72 (s, 2H), 2.28 (s, 3H), 1.57 (br 
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s, 1H); 13C NMR (100 MHz, CDCl3) ppm 155.7, 148.6, 144.2, 139.2, 134.9, 133.8, 129.4, 128.5, 
128.03, 127.96, 127.3, 125.8, 118.2, 55.1, 54.6, 50.5, 21.5; HRMS (ESI): Exact mass calcd for 
C21H22N3O2S [M+H]
+ 380.1433, found 380.1430. 
N-Allyl-1-tosyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-amine (521c). Prepared according to 
the general procedure using allylamine (22.4 µL, 300 µmol) and 4-methyl-N-(3-vinylpyridin-2-
yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash column chromatography of the residue (SiO2, 
50-70-90% ethyl acetate in hexanes) afforded the desired product as an orange-brown viscous oil 
(30.8 mg, 62%). Rf = 0.12 (50% EtOAc/hexanes); IR (film) 3317, 3065, 2924, 1596 cm
-1; 1H NMR 
(400 MHz, CDCl3) δ 8.24 (dd, J = 4.8, 1.2 Hz, 1H), 7.96 (d, J = 8.4 Hz, 2H), 7.54 (d, J = 6.8 Hz, 
1H), 7.25 (d, J = 7.6 Hz, 2H), 6.87 (dd, J = 7.6, 5.2 Hz, 1H), 5.86 (dddd, J = 11.6, 10.4, 6.0, 6.0 
Hz, 1H), 5.20 (dd, J = 17.2, 1.6 Hz, 1H), 5.12 (dd, J = 10.4, 1.2 Hz, 1H), 4.29 (dd, J = 8.0, 4.0 Hz, 
1H), 4.06 (dd, J = 10.8, 8.0 Hz, 1H), 3.88 (dd, J = 10.8, 4.4 Hz, 1H), 3.27 (d, J = 6.0, 0.8 Hz, 2H), 
2.37 (s, 3H), 1.62 (br s, 1H); 13C NMR (100 MHz, CDCl3) ppm 155.6, 148.7, 144.2, 135.8, 134.9, 
133.8, 129.4, 128.0, 125.7, 118.2, 116.8, 55.1, 54.6, 49.1, 21.5; HRMS (ESI): Exact mass calcd 
for C17H19N3NaO2S [M+Na]
+ 352.1096, found 352.1082. 
4-(1-Tosyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl)thiomorpholine (521d). A vial 
equipped with a stir bar was charged with potassium iodide (29.9 mg, 180 µmol), iodobenzene 
diacetate (96.6 mg, 300 µmol), 4-methyl-N-(3-vinylpyridin-2-yl)benzenesulfonamide (41.2 mg, 
150 µmol), and acetonitrile (1.5 mL). Thiomorpholine (45.3 µL, 450 µmol) was added and the 
resulting mixture was stirred at rt for 18 h. The reaction mixture was then diluted with ethyl acetate 
and concentrated. Flash column chromatography of the residue (SiO2, 20-50-80% ethyl acetate in 
hexanes) afforded the desired product as a light-brown solid (21.8 mg, 39%). Mp 182.0-186.0 °C; 
Rf = 0.27 (50% EtOAc/hexanes); IR (film) 3054, 2921, 2821, 1644, 1594 cm
-1; 1H NMR (400 
MHz, CDCl3) δ 8.27 (dd, J = 4.8, 1.2 Hz, 1H), 7.97 (d, J = 8.4 Hz, 2H), 7.51 (d, J = 7.2 Hz, 1H), 
7.26 (d, J = 8.0 Hz, 2H), 6.89 (dd, J = 7.6, 5.2 Hz, 1H), 4.28 (dd, J = 9.6, 4.0 Hz, 1H), 4.12 (dd, J 
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= 11.2, 4.0 Hz, 1H), 3.86 (dd, J = 11.2, 9.2 Hz, 1H), 2.78-2.70 (m, 2H), 2.63-2.53 (m, 6H), 2.38 
(s, 3H); 13C NMR (100 MHz, CDCl3) ppm 156.3, 149.0, 144.3, 135.1, 134.8, 129.5, 128.0, 122.6, 
118.1, 62.8, 50.7, 49.0, 28.2, 21.6; HRMS (ESI): Exact mass calcd for C18H22N3O2S2 [M+H]
+ 
376.1153, found 376.1154. 
4-(1-Tosyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl)morpholine (521e). Prepared according 
to the general procedure using morpholine (26.0 µL, 300 µmol) and 4-methyl-N-(3-vinylpyridin-
2-yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash column chromatography of the residue 
(SiO2, 50-70-90% ethyl acetate in hexanes) afforded the desired product as a dark-yellow solid 
(30.8 mg, 57%). Mp 161.0-165.0 °C; Rf = 0.10 (50% EtOAc/hexanes); IR (film) 2923, 2854, 1593 
cm-1; 1H NMR (400 MHz, CDCl3) δ 8.28 (dd, J = 5.2, 1.6 Hz, 1H), 7.95 (d, J = 8.4 Hz, 2H), 7.55 
(d, J = 7.2 Hz, 1H), 7.25 (d, J = 8.0 Hz, 2H), 6.91 (dd, J = 7.2, 5.2 Hz, 1H), 4.27 (dd, J = 9.2, 3.6 
Hz, 1H), 4.15 (dd, J = 11.6, 3.6 Hz, 1H), 3.83 (dd, J = 11.2, 9.2 Hz, 1H), 3.61 (dd, J = 4.8, 4.8 Hz, 
4H), 2.49-2.44 (m, 2H), 2.37 (s, 3H), 2.31-2.26 (m, 2H); 13C NMR (100 MHz, CDCl3) ppm 156.3, 
149.1, 144.4, 135.2, 134.8, 129.5, 127.9, 122.4, 118.2, 66.8, 61.4, 48.8, 48.4, 21.6; HRMS (ESI): 
Exact mass calcd for C18H22N3O3S [M+H]
+ 360.1382, found 360.1378. 
N-Phenyl-1-tosyl-2,3-dihydro-1H-pyrrolo[2,3-c]pyridin-3-amine (524a). A vial equipped with 
a stir bar was charged with potassium iodide (6.70 mg, 40.5 µmol), iodobenzene diacetate (19.6 
mg, 60.7 µmol), the vinyl aminopyridine (11.1 mg, 40.5 µmol), and acetonitrile (405 µL). Aniline 
(7.40 µL, 80.9 µmol) was added and the resulting mixture was stirred at rt for 18 h. The reaction 
mixture was then diluted with ethyl acetate and concentrated. Flash column chromatography of 
the residue (SiO2, 5-10-20-40-80% ethyl acetate in hexanes) afforded the desired product as a dark 
brown viscous oil (1.6 mg, 11%). Rf = 0.62 (70% EtOAc/hexanes); IR (film) 3380, 3050, 2922, 
2851, 1600 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.02 (s, 1H), 8.35 (d, J = 4.8 Hz, 1H), 7.67 (d, J 
= 8.4 Hz, 2H), 7.25 (d, J = 6.0 Hz, 2H), 7.20 (m, 3H), 6.81 (dd, J = 7.2, 7.2 Hz, 1H), 6.47 (d, J = 
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7.6 Hz, 2H), 4.97 (br m, 1H), 4.16 (dd, J = 11.6, 8.0 Hz, 1H), 3.78 (d, J = 11.6, 4.8 Hz, 1H), 3.34 
(br d, J = 8.0 Hz, 1H), 2.41 (s, 3H); 13C NMR (150 MHz, CDCl3) ppm 145.3, 145.2, 144.8, 140.8, 
139.0, 137.4, 133.2, 130.0, 129.6, 127.4, 120.0, 119.2, 113.5, 56.2, 53.3, 21.6; HRMS (ESI): Exact 
mass calcd for C20H20N3O2S [M+H]
+ 366.1276, found 366.1284. 
N-Benzyl-1-tosyl-2,3-dihydro-1H-pyrrolo[2,3-c]pyridin-3-amine (524b). A vial equipped with 
a stir bar was charged with potassium iodide (7.80 mg, 47.0 µmol), iodobenzene diacetate (22.9 
mg, 71.0 µmol), 4-methyl-N-(4-vinylpyridin-3-yl)benzenesulfonamide (12.9 mg, 47.0 µmol), and 
acetonitrile (470 µL). Benzylamine (10.3 µL, 94.0 µmol) was added and the resulting mixture was 
stirred at rt for 18 h. The reaction mixture was then diluted with ethyl acetate and concentrated. 
Flash column chromatography of the residue (SiO2, 40-60-80% ethyl acetate in hexanes) afforded 
the desired product as a yellow-orange viscous oil (8.60 mg, 48%). Rf = 0.22 (70% 
EtOAc/hexanes); IR (film) 3032, 2924, 2854, 2360, 2341, 1596 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 8.98 (s, 1H), 8.34 (br d, J = 4.0 Hz, 1H), 7.69 (d, J = 8.4 Hz, 2H), 7.34-7.18 (m, 8H), 4.23 (dd, J 
= 8.0, 4.4 Hz, 1H), 3.95 (dd, J = 11.6, 8.0 Hz, 1H), 3.77 (dd, J = 11.2, 4.4 Hz, 1H), 3.66 (s, 2H), 
2.30 (s, 3H), 1.53 (br s, 1H); 13C NMR (125 MHz, CDCl3) ppm 145.1, 144.8, 141.9, 139.0, 138.9, 
137.1, 133.2, 129.9, 128.5, 128.0, 127.4, 127.3, 120.1, 57.1, 55.7, 50.7, 21.5; HRMS (ESI): Exact 
mass calcd for C21H22N3O2S [M+H]
+ 380.1433, found 380.1427. 
Benzyl 4-(1-tosyl-2,3-dihydro-1H-pyrrolo[2,3-c]pyridin-3-yl)piperazine-1-carboxylate 
(524c). A vial equipped with a stir bar was charged with potassium iodide (8.3 mg, 50.0 µmol), 
iodobenzene diacetate (24.2 mg, 75.0 µmol), 4-methyl-N-(4-vinylpyridin-3-
yl)benzenesulfonamide (13.7 mg, 50.0 µmol), and acetonitrile (500 µL). Benzyl piperazine-1-
carboxylate (19.3 µL, 100 µmol) was added and the resulting mixture was stirred at rt for 18 h. 
The reaction mixture was then diluted with ethyl acetate and concentrated. Flash column 
chromatography of the residue (SiO2, 50-70-90% ethyl acetate in hexanes) afforded the desired 
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product as a clear viscous oil (15.6 mg, 63%). Rf = 0.48 (5% MeOH/DCM); IR (film) 3033, 2925, 
2860, 2822, 2360, 2336,1699 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.00 (br s, 1H), 8.31 (br d, J = 
4.0 Hz, 1H), 7.73 (d, J = 8.4 Hz, 2H), 7.39-7.29 (m, 5H), 7.25 (d, J = 8.8 Hz, 2H), 7.16 (d, J = 4.8 
Hz, 1H), 5.10 (s, 2H), 4.34 (dd, J = 9.2, 4.0 Hz, 1H), 3.88 (dd, J = 11.6, 4.4 Hz, 1H), 3.71 (dd, J = 
11.6, 9.2 Hz, 1H), 3.36 (br d, J = 4.8 Hz, 4H), 2.35 (s, 3H), 2.29-2.22 (m, 2H), 2.21-2.02 (br m, 
2H); 13C NMR (125 MHz, CDCl3) ppm 155.0, 144.9, 144.6, 139.6, 138.1, 136.5, 136.3, 133.2, 
130.0, 128.5, 128.1, 127.9, 127.3, 120.9, 67.2, 63.8, 49.5, 47.8, 43.7, 21.5; HRMS (ESI): Exact 
mass calcd for C26H29N4O4S [M+H]
+ 493.1910, found 493.1901. 
Ethyl 4-(1-tosyl-2,3-dihydro-1H-pyrrolo[2,3-c]pyridin-3-yl)piperazine-1-carboxylate (524d). 
A vial equipped with a stir bar was charged with potassium iodide (13.9 mg, 83.8 µmol), 
iodobenzene diacetate (40.6 mg, 126 µmol), 4-methyl-N-(4-vinylpyridin-3-
yl)benzenesulfonamide (23.0 mg, 83.8 µmol), and acetonitrile (840 µL). Ethyl 1-
piperazinecarboxylate (24.5 µL, 168 µmol) was added and the resulting mixture was stirred at rt 
for 18 h. The reaction mixture was then diluted with ethyl acetate and concentrated. Flash column 
chromatography of the residue (SiO2, 0.5-1-2-5% methanol in dichloromethane) afforded the 
desired product as a dark-yellow viscous oil (23.8 mg, 66%). Rf = 0.52 (5% MeOH/DCM); IR 
(film) 3053, 2981, 2931, 2863, 2822, 2763, 1697, 1596 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.99 
(s, 1H), 8.31 (d, J = 4.8 Hz, 1H), 7.73 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 8.4 Hz, 2H), 7.17 (d, J = 
4.8 Hz, 1H), 4.34 (dd, J = 9.6, 6.6 Hz, 1H), 4.11 (q, J = 7.2 Hz, 2H), 3.89 (dd, J = 11.6, 4.4 Hz, 
1H), 3.71 (d, J = 11.6, 9.2 Hz, 1H), 3.33 (dd, J = 4.8, 4.8 Hz, 4H), 2.39 (s, 3H), 2.26 (ddd, J = 
10.4, 4.8, 4.8 Hz, 2H), 2.19-2.05 (br s, 2H), 1.24 (t, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) 
ppm 155.3, 144.9, 144.6, 139.6, 138.1, 136.3, 133.2, 130.0, 127.3, 120.9, 63.8, 61.4, 49.6, 48.0, 
43.6, 21.5, 14.6; HRMS (ESI): Exact mass calcd for C21H27N4O4S [M+H]
+ 431.1753, found 
431.1750. 
 
 
241 
 
tert-Butyl 4-(1-tosyl-2,3-dihydro-1H-pyrrolo[2,3-c]pyridin-3-yl)piperazine-1-carboxylate 
(524e). A vial equipped with a stir bar was charged with potassium iodide (8.3 mg, 50.0 µmol), 
iodobenzene diacetate (24.2 mg, 75.0 µmol), 4-methyl-N-(4-vinylpyridin-3-
yl)benzenesulfonamide (13.7 mg, 50.0 µmol), and acetonitrile (500 µL). tert-Butyl piperazine-1-
carboxylate (18.6 mg, 100 µmol) was added and the resulting mixture was stirred at rt for 18 h. 
The reaction mixture was then diluted with ethyl acetate and concentrated. Flash column 
chromatography of the residue (SiO2, 50-70-90% ethyl acetate in hexanes) afforded the desired 
product as a light-yellow transparent viscous oil (17.0 mg, 74%). Rf = 0.22 (80% EtOAc/Hexanes); 
IR (film) 2975, 2929, 2861, 2822, 2360, 2337, 1692 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.99 (br 
s, 1H), 8.31 (br d, J = 4.8 Hz, 1H), 7.74 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 8.8 Hz, 2H), 7.17 (d, J = 
4.8 Hz, 1H), 4.34 (dd, J = 9.2, 4.0 Hz, 1H), 3.90 (dd, J = 11.6, 4.4 Hz, 1H), 3.71 (d, J = 11.6, 9.2 
Hz, 1H), 3.32-3.23 (br m, 4H), 2.39 (s, 3H), 2.28-2.21 (m, 2H), 2.19-2.00 (br m, 2H), 1.43 (s, 9H); 
13C NMR (125 MHz, CDCl3) ppm 154.5, 144.9, 144.6, 139.6, 138.1, 136.3, 133.2, 130.0, 127.4, 
120.9, 79.8, 63.8, 49.7, 48.1 (br), 43.8 (br), 28.4, 21.6; HRMS (ESI): Exact mass calcd for 
C23H31N4O4S [M+H]
+ 459.2066, found 459.2056. 
N-Phenyl-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-3-amine (527a). A vial equipped with 
a stir bar was charged with potassium iodide (12.5 mg, 75.0 µmol), iodobenzene diacetate (36.2 
mg, 113 µmol), 4-methyl-N-(3-vinylpyridin-4-yl)benzenesulfonamide (20.6 mg, 75.0 µmol), and 
acetonitrile (750 µL). Aniline (13.7 µL, 150 µmol) was added and the resulting mixture was stirred 
at rt for 18 h. The reaction mixture was then diluted with ethyl acetate and concentrated. Flash 
column chromatography of the residue (SiO2, 0.5-1-2% methanol in dichloromethane) afforded 
the desired product as a light-brown solid (22.2 mg, 81%). Mp 194.0-196.0 °C; Rf = 0.52 (5% 
MeOH/DCM); IR (film) 3393, 3249, 3106, 3030, 2924, 1600 cm-1; 1H NMR (400 MHz, CDCl3) 
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δ 8.50 (d, J = 5.6 Hz, 1H), 8.47 (s, 1H), 7.69 (d, J = 8.0 Hz, 2H), 7.59 (d, J = 5.6 Hz, 1H), 7.27 (d, 
J = 8.4 Hz, 2H), 7.20 (dd, J = 8.4, 7.6 Hz, 2H), 6.81 (dd, J = 7.2, 7.2 Hz, 1H), 6.51 (d, J = 7.6 Hz, 
2H), 5.07 (br s, 1H), 4.13 (dd, J = 11.2, 7.6 Hz, 1H), 3.86 (dd, J = 11.2, 3.6 Hz, 1H), 3.57 (br s, 
1H), 2.42 (s, 3H); 13C NMR (125 MHz, CDCl3) ppm 151.2, 149.3, 147.1, 145.3, 145.0, 133.6, 
130.1, 129.6, 127.5, 127.2, 119.0, 113.4, 109.3, 56.8, 51.8, 21.6; HRMS (ESI): Exact mass calcd 
for C20H19N3O2S [M+] 365.1192, found 365.1192. 
N-Benzyl-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-3-amine (527b). A vial equipped with 
a stir bar was charged with potassium iodide (12.5 mg, 75.0 µmol), iodobenzene diacetate (36.2 
mg, 113 µmol), the vinyl aminopyridine (20.6 mg, 75.0 µmol), and acetonitrile (750 µL). 
Benzylamine (16.4 µL, 150 µmol) was added and the resulting mixture was stirred at rt for 18 h. 
The reaction mixture was then diluted with ethyl acetate and concentrated. Flash column 
chromatography of the residue (SiO2, 0.5-1-2-5% methanol in dichloromethane) afforded the 
desired product as a yellow viscous oil (12.3 mg, 43%). Rf = 0.51 (5% MeOH/DCM); IR (film) 
3027, 2922, 2852, 2359, 2337,1595, cm-1; 1H NMR (400 MHz, CDCl3) δ 8.46 (br s, 2H), 7.71 (d, 
J = 8.4 Hz, 2H), 7.58 (d, J = 5.6 Hz, 1H), 7.34-7.29 (m, 2H), 7.28-7.22 (m, 5H), 4.36 (dd, J = 8.0, 
4.0 Hz, 1H), 3.93 (dd, J = 11.2, 8.0 Hz, 1H), 3.84 (dd, J = 11.2, 4.0 Hz, 1H), 3.70 (s, 2H), 2.60 (br 
s, 1H), 2.34 (s, 3H); 13C NMR (100 MHz, CDCl3) ppm 150.4, 149.2, 146.6, 145.0, 139.0, 133.5, 
130.0, 128.5, 128.0, 127.4, 127.1, 109.2, 56.2, 55.6, 50.4, 21.5; HRMS (ESI): Exact mass calcd 
for C21H22N3O2S [M+H]
+ 380.1433, found 380.1416. 
N-(4-Methylbenzyl)-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-3-amine (527c). A vial 
equipped with a stir bar was charged with potassium iodide (12.5 mg, 75.0 µmol), iodobenzene 
diacetate (36.2 mg, 113 µmol), 4-methyl-N-(3-vinylpyridin-4-yl)benzenesulfonamide (20.6 mg, 
75.0 µmol), and acetonitrile (750 µL). 4-Methylbenzylamine (19.1 µL, 150 µmol) was added and 
the resulting mixture was stirred at rt for 18 h. The reaction mixture was then diluted with ethyl 
acetate and concentrated. Flash column chromatography of the residue (SiO2, 0.5-1-2-5% 
methanol in dichloromethane) afforded the desired product as a clear viscous oil (13.2 mg, 45%). 
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Rf = 0.46 (5% MeOH/DCM); IR (film) 3321, 3028, 2923, 2855, 2732, 1595 cm
-1; 1H NMR (400 
MHz, CDCl3) δ 8.45 (br s, 2H), 7.71 (d, J = 8.4 Hz, 2H), 7.56 (d, J = 5.2 Hz, 1H), 7.25 (d, J = 8.4 
Hz, 2H), 7.13 (s, 4H), 4.34 (dd, J = 8.0, 3.6 Hz, 1H), 3.92 (dd, J = 10.8, 7.6 Hz, 1H), 3.83 (dd, J = 
11.2, 4.0 Hz, 1H), 3.66 (s, 2H), 2.35 (s, 3H), 2.33 (s, 3H); 13C NMR (125 MHz, CDCl3) ppm 150.6, 
149.0, 146.8, 144.9, 136.9, 135.9, 133.5, 129.9, 129.1, 128.6, 127.9, 127.1, 109.1, 56.1, 55.5, 
50.14, 21.5, 21.0; HRMS (ESI): Exact mass calcd for C22H24N3O2S [M+H]
+ 394.1589, found 
394.1571. 
N-(4-Fluorobenzyl)-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-3-amine (527d). A vial 
equipped with a stir bar was charged with potassium iodide (12.5 mg, 75.0 µmol), iodobenzene 
diacetate (36.2 mg, 113 µmol), 4-methyl-N-(3-vinylpyridin-4-yl)benzenesulfonamide (20.6 mg, 
75.0 µmol), and acetonitrile (750 µL). 4-Fluorobenzylamine (17.1 µL, 150 µmol) was added and 
the resulting mixture was stirred at rt for 18 h. The reaction mixture was then diluted with ethyl 
acetate and concentrated. Flash column chromatography of the residue (SiO2, 0.5-1-2-5% 
methanol in dichloromethane) afforded the desired product as a light-yellow transparent viscous 
oil (15.3 mg, 51%). Rf = 0.48 (5% MeOH/DCM); IR (film) 3256, 3041, 2925, 2853, 2357, 2336, 
1596 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.47 (br s, 1H), 8.45 (s, 1H), 7.71 (d, J = 8.4 Hz, 2H), 
7.57 (d, J = 5.6 Hz 1H), 7.27-7.19 (m, 4H), 6.99 (dd, J = 8.8, 8.8 Hz, 2H), 4.34 (dd, J = 8.0, 3.6 
Hz, 1H), 3.92 (dd, J = 11.2, 8.0 Hz, 1H), 3.84 (dd, J = 11.2, 3.6 Hz, 1H), 3.67 (s, 2H), 2.35 (s, 3H); 
13C NMR (125 MHz, CDCl3) ppm 162.1 (d, J = 245.3 Hz), 150.8, 149.1, 146.9, 145.0, 134.8 (d, J 
= 3.0 Hz), 133.6, 130.0, 129.5 (d, J = 7.9 Hz), 128.5, 127.2, 115.3 (d, J = 21.4 Hz), 109.2, 56.1, 
55.6, 49.6, 21.5; HRMS (ESI): Exact mass calcd for C21H18FN3O2S [M-2H]
- 395.1098, found 
395.1085. 
N-(3-Methoxypropyl)-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-3-amine (527e). A vial 
equipped with a stir bar was charged with potassium iodide (12.5 mg, 75.0 µmol), iodobenzene 
diacetate (36.2 mg, 113 µmol), 4-methyl-N-(3-vinylpyridin-4-yl)benzenesulfonamide (20.6 mg, 
75.0 µmol), and acetonitrile (750 µL). 3-Methoxypropylamine (15.3 µL, 150 µmol) was added 
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and the resulting mixture was stirred at rt for 18 h. The reaction mixture was then diluted with 
ethyl acetate and concentrated. Flash column chromatography of the residue (SiO2, 0.5-1-2-5% 
methanol in dichloromethane) afforded the desired product as a light-brown viscous oil (13.0 mg, 
48%). Rf = 0.29 (5% MeOH/DCM); IR (film) 3249, 3036, 2926, 2873, 1644, 1596 cm
-1; 1H NMR 
(600 MHz, CDCl3) δ 8.44 (s, 1H), 8.43 (s, 1H), 7.73 (d, J = 7.8 Hz, 2H), 7.54 (d, J = 5.4 Hz, 1H), 
7.28 (d, J = 8.4 Hz, 2H), 4.34 (dd, J = 7.8, 3.6 Hz, 1H), 3.91 (dd, J = 10.8, 7.8 Hz, 1H), 3.80 (dd, 
J = 10.8, 3.6 Hz, 1H), 3.38 (dd, J = 6.0, 6.0 Hz, 2H), 3.29 (s, 3H), 2.66-2.58 (m, 2H), 2.39 (s, 3H), 
1.66 (dddd, J = 6.6, 6.6, 6.6, 6.6 Hz, 2H); 13C NMR (150 MHz, CDCl3) ppm 150.6, 149.1, 146.8, 
144.9, 133.6, 130.0, 128.4, 127.2, 109.0, 71.0, 58.7, 56.3, 56.1, 43.9, 29.9, 21.6; HRMS (ESI): 
Exact mass calcd for C18H24N3O3S [M+H]
+ 362.1538, found 362.1537. 
N-Phenethyl-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-3-amine (527f). A vial equipped 
with a stir bar was charged with potassium iodide (12.5 mg, 75.0 µmol), iodobenzene diacetate 
(36.2 mg, 113 µmol), 4-methyl-N-(3-vinylpyridin-4-yl)benzenesulfonamide (20.6 mg, 75.0 µmol), 
and acetonitrile (750 µL). Phenethylamine (18.8 µL, 150 µmol) was added and the resulting 
mixture was stirred at rt for 18 h. The reaction mixture was then diluted with ethyl acetate and 
concentrated. Flash column chromatography of the residue (SiO2, 0.5-1-2-5% methanol in 
dichloromethane) afforded the desired product as an orange viscous oil (14.1 mg, 48%). Rf = 0.42 
(5% MeOH/DCM); IR (film) 3312, 3028, 2925, 2855, 1637, 1596 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 8.42 (d, J = 5.6 Hz, 1H), 8.36 (s, 1H), 7.70 (d, J = 8.4 Hz, 2H), 7.54 (d, J = 5.6 Hz, 1H), 
7.31-7.19 (m, 5H), 7.13 (dd, J = 8.4, 1.6 Hz, 2H), 4.36 (dd, J = 8.0, 4.0 Hz, 1H), 3.90 (dd, J = 11.2, 
8.4 Hz, 1H), 3.76 (dd, J = 11.2, 4.0 Hz, 1H), 2.83-2.67 (m, 4H), 2.39 (br s, 1H), 2.39 (s, 3H); 13C 
NMR (125 MHz, CDCl3) ppm 150.5, 149.1, 146.7, 144.9, 139.3, 133.6, 130.0, 128.59, 128.57, 
128.3, 127.2, 126.4, 109.0, 56.14, 56.09, 47.4, 36.4, 21.6; HRMS (ESI): Exact mass calcd for 
C22H24N3O2S [M+H]
+ 394.1587, found 394.1587. 
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N-(Tetrahydro-2H-pyran-4-yl)-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-3-amine 
(527g). A vial equipped with a stir bar was charged with potassium iodide (12.5 mg, 75.0 µmol), 
iodobenzene diacetate (36.2 mg, 113 µmol), 4-methyl-N-(3-vinylpyridin-4-
yl)benzenesulfonamide (20.6 mg, 75.0 µmol), and acetonitrile (750 µL). 4-Aminotetrahydropyran 
(15.5 µL, 150 µmol) was added and the resulting mixture was stirred at rt for 18 h. The reaction 
mixture was then diluted with ethyl acetate and concentrated. Flash column chromatography of 
the residue (SiO2, 0.5-1-2-5-10% methanol in dichloromethane) afforded the desired product as a 
light-yellow viscous oil (9.20 mg, 33%). Rf = 0.35 (5% MeOH/DCM); IR (film) 3299, 3046, 2927, 
2850, 1596 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.44 (br d, J = 5.2 Hz, 1H), 8.40 (br s, 1H), 7.73 
(d, J = 8.4 Hz, 2H), 7.55 (d, J = 5.2 Hz, 1H), 7.29 (d, J = 8.0 Hz, 2H), 4.42 (dd, J = 8.0, 4.0 Hz, 
1H), 3.95 (dd, J = 10.8, 7.6 Hz, 1H), 3.98-3.91 (br m, 2H), 3.74 (dd, J = 10.8, 4.0 Hz, 1H), 3.42-
3.33 (m, 2H), 2.78 (ddddd, J = 10.0, 3.6, 3.6, 3.6, 3.6 Hz, 1H), 2.40 (s, 3H), 1.73-1.64 (br m, 2H), 
1.49 (br s, 1H), 1.44-1.32 (m, 2H); 13C NMR (100 MHz, CDCl3) ppm 150.6, 148.9, 146.7, 145.0, 
133.6, 130.0, 129.0, 127.2, 109.1, 66.33, 66.30, 57.2, 53.0, 51.3, 33.9, 33.4, 21.6; HRMS (ESI): 
Exact mass calcd for C19H24N3O3S [M+H]
+ 374.1538, found 374.1534. 
N-(Pyridin-3-ylmethyl)-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-3-amine (527h). A vial 
equipped with a stir bar was charged with potassium iodide (39.8 mg, 240 µmol), iodobenzene 
diacetate (96.6 mg, 300 µmol), 4-methyl-N-(3-vinylpyridin-4-yl)benzenesulfonamide (54.8 mg, 
200 µmol), and acetonitrile (2 mL). 3-Picolylamine (40.4 µL, 400 µmol) was added and the 
resulting mixture was stirred at rt for 18 h. The reaction mixture was then diluted with ethyl acetate 
and concentrated. Flash column chromatography of the residue (SiO2, 0.5-1-2-5-10% methanol in 
dichloromethane) afforded the desired product as a dark-yellow viscous oil (48.4 mg, 64%). Rf = 
0.28 (5% MeOH/DCM); IR (film) 3030, 2924, 2853, 1595 cm-1; 1H NMR (600 MHz, CDCl3) δ 
8.51 (br d, J = 4.2 Hz, 1H), 8.49-8.46 (br m, 3H), 7.72 (d, J = 8.4 Hz, 2H), 7.61 (d, J = 7.8 Hz, 
1H), 7.58 (d, J = 6.0 Hz, 1H), 7.27-7.23 (m, 3H), 4.36 (dd, J = 7.8, 3.6 Hz, 1H), 3.93 (dd, J = 11.4, 
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7.8 Hz, 1H), 3.86 (dd, J = 11.4, 3.6 Hz, 1H), 3.70 (s, J = 2H), 2.34 (s, 3H); 13C NMR (150 MHz, 
CDCl3) ppm 150.9, 149.5, 149.1, 148.9, 146.9, 145.1, 135.7, 134.5, 133.5, 130.0, 128.2, 127.2, 
123.5, 109.3, 56.0, 55.7, 47.7, 21.6; Exact mass calcd for C20H21N4O2S [M+H]
+ 381.1385, found 
381.1389. 
4-(1-Tosyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-3-yl)thiomorpholine (527i). A vial equipped 
with a stir bar was charged with potassium iodide (12.5 mg, 75.0 µmol), iodobenzene diacetate 
(36.2 mg, 113 µmol), 4-methyl-N-(3-vinylpyridin-4-yl)benzenesulfonamide (20.6 mg, 75.0 µmol), 
and acetonitrile (750 µL). Thiomorpholine (15.1 µL, 150 µmol) was added and the resulting 
mixture was stirred at rt for 18 h. The reaction mixture was then diluted with ethyl acetate and 
concentrated. Flash column chromatography of the residue (SiO2, 0.5-1-2-5% methanol in 
dichloromethane) afforded the desired product as a light-yellow viscous oil (9.60 mg, 34%). Rf = 
0.46 (5% MeOH/DCM); IR (film) 2922, 2819, 1594 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.45 (br 
s, 1H), 8.41 (br s, 1H), 7.74 (d, J = 8.4 Hz, 2H), 7.57 (d, J = 5.2 Hz, 1H), 7.30 (d, J = 8.0 Hz, 2H), 
4.37 (dd, J = 9.2, 3.6 Hz, 1H), 3.95 (dd, J = 11.6, 4.0 Hz, 1H), 3.72 (dd, J = 11.2, 9.0 Hz, 1H), 
2.60-2.41 (m, 8H), 2.40 (s, 3H); 13C NMR (125 MHz, CDCl3) ppm 150.9, 149.7, 147.7, 145.1, 
133.7, 130.0, 127.2, 125.4, 108.5, 63.8, 50.6, 50.0, 28.1, 21.6; HRMS (ESI): Exact mass calcd for 
C18H22N3O2S2 [M+H]
+ 376.1153, found 376.1135. 
N-Phenyl-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-3-amine (530a). Prepared according 
to the general procedure using aniline (27.3 µL, 300 µmol) and 4-methyl-N-(2-vinylpyridin-3-
yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash column chromatography of the residue (SiO2, 
5-10-20-40% ethyl acetate in hexanes) afforded the desired product as a brown viscous oil (38.2 
mg, 70%). Rf = 0.50 (50% EtOAc/hexanes); IR (film) 3393, 3288, 3053, 3028, 2925, 2872, 1602, 
1503 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.25 (dd, J = 4.8, 1.2 Hz, 1H), 7.97 (dd, J = 8.4, 1.2 Hz, 
1H), 7.64 (d, J = 8.4 Hz, 2H), 7.25-7.17 (m, 5H), 6.79 (dd, J = 7.2, 7.2 Hz, 1H), 6.52 (d, J = 7.6 
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Hz, 2H), 4.84 (dd, J = 7.6, 5.2 Hz, 1H), 4.35 (dd, J = 10.8, 8.0 Hz, 1H), 3.99 (br s, 1H), 3.74 (dd, 
J = 11.2, 5.6 Hz, 1H), 2.39 (s, 3H); 13C NMR (100 MHz, CDCl3) ppm 152.1, 146.1, 145.2, 144.8, 
136.7, 133.3, 130.0, 129.3, 127.3, 123.9, 122.2, 118.7, 113.4, 56.4, 54.3, 21.6; HRMS (ESI): Exact 
mass calcd for C20H19N3NaO2S [M+Na]
+ 388.1096, found 388.1093. 
N-(4-(tert-Butyl)phenyl)-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-3-amine (530b). 
Prepared according to the general procedure using 4-tert-butylaniline (47.8 µL, 300 µmol) and 4-
methyl-N-(2-vinylpyridin-3-yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash column 
chromatography of the residue (SiO2, 5-10-20-40% ethyl acetate in hexanes) afforded the desired 
product as a dark-brown viscous oil (25.6 mg, 41%, 90% BRSM). Rf = 0.59 (50% EtOAc/hexanes); 
IR (film) 3391, 3060, 2961, 2867, 1614, 1519 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 4.4 
Hz, 1H), 7.95 (d, J = 8.4 Hz, 1H), 7.66 (d, J = 8.4 Hz, 2H), 7.26-7.21 (m, 5H), 6.50 (d, J = 8.8 Hz, 
2H), 4.82 (dd, J = 7.6, 6.0 Hz, 1H), 4.36 (dd, J = 11.2, 8.0 Hz, 1H), 3.98 (br s, 1H), 3.73 (dd, J = 
10.8, 5.6 Hz, 1H), 2.39 (s, 3H), 1.29 (s, 9H); 13C NMR (100 MHz, CDCl3) ppm 152.3, 145.1, 
144.8, 143.8, 141.6, 136.6, 133.3, 129.9, 127.3, 126.1, 123.8, 122.0, 113.2, 56.6, 54.6, 33.9, 31.5, 
21.6; Exact mass calcd for C24H27N3NaO2S [M+Na]
+ 444.1722, found 444.1717. 
N-Benzyl-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-3-amine (530c). Prepared according 
to the general procedure using benzylamine (32.8 µL, 300 µmol) and 4-methyl-N-(2-vinylpyridin-
3-yl)benzenesulfonamide (41.2 mg, 150 µmol).  Flash column chromatography of the residue 
(SiO2, 20-40-60-80% ethyl acetate in hexanes) afforded the desired product as a dark yellow 
viscous oil (50.2 mg, 88%). Rf = 0.34 (50% EtOAc/hexanes); IR (film) 3060, 3026, 2922, 2852, 
2338, cm-1; 1H NMR (400 MHz, CDCl3) δ 8.21 (dd, J = 4.8, 1.2 Hz, 1H), 7.91 (dd, J = 8.4, 1.6 Hz, 
1H), 7.66 (d, J = 8.4 Hz, 2H), 7.33-7.21 (m, 7H), 7.17 (dd, J = 8.0, 4.8 Hz, 1H), 4.25 (dd, J = 8.4, 
5.2 Hz, 1H), 4.00 (dd, J = 11.2, 8.4 Hz, 1H), 3.77 (d, J = 4.4 Hz, 2H), 3.70 (dd, J = 10.8, 4.8 Hz, 
1H), 2.34 (s, 3H), 1.75 (br s, 1H); 13C NMR (100 MHz, CDCl3) ppm 153.7, 144.8, 144.7, 139.3, 
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136.5, 133.4, 129.9, 128.4, 128.2, 127.2, 123.3, 121.8, 57.8, 55.3, 51.4, 21.5; HRMS (ESI): Exact 
mass calcd for C21H21N3NaO2S [M+Na]
+ 402.1252, found 402.1252. 
N-Cyclopentyl-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-3-amine (530d). Prepared 
according to the general procedure using cyclopentylamine (29.6 µL, 300 µmol) and 4-methyl-N-
(2-vinylpyridin-3-yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash column chromatography of 
the residue (SiO2, 40-60-80-100% ethyl acetate in hexanes) afforded the desired product as a dark-
brown viscous oil (31.7 mg, 59%). Rf = 0.20 (70% EtOAc/hexanes); IR (film) 2954, 2868, 1594 
cm-1; 1H NMR (400 MHz, CDCl3) δ 8.19 (dd, J = 4.8, 1.2 Hz, 1H), 7.88 (dd, J = 8.4, 1.2 Hz, 1H), 
7.68 (d, J = 8.0 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 7.15 (dd, J = 8.4, 4.8 Hz, 1H), 4.26 (dd, J = 8.0, 
5.6 Hz, 1H), 4.09 (dd, J = 10.8, 8.0 Hz, 1H), 3.69 (dd, J = 10.8, 5.6 Hz, 1H), 3.20 (dddd, J = 6.8, 
6.8, 6.8, 6.8, Hz, 1H), 2.38 (s, 3H), 1.87-1.73 (m, 3H), 1.72-1.62 (m, 2H), 1.57-1.46 (m, 2H), 1.37-
1.19 (m, 2H); 13C NMR (100 MHz, CDCl3) ppm 153.1, 144.7, 144.6, 136.5, 133.3, 129.9, 127.3, 
123.4, 121.7, 58.4, 57.4, 55.8, 33.2, 32.8, 23.9, 23.7, 21.5; HRMS (ESI): Exact mass calcd for 
C19H23N3NaO2S [M+Na]
+ 380.1409, found 380.1415. 
N-Phenethyl-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-3-amine (530e). Prepared 
according to the general procedure using phenethylamine (37.7 µL, 300 µmol) and 4-methyl-N-
(2-vinylpyridin-3-yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash column chromatography of 
the residue (SiO2, 40-60-80-100% ethyl acetate in hexanes) afforded the desired product as a dark-
orange viscous oil (40.4 mg, 68%). Rf = 0.22 (70% EtOAc/hexanes); IR (film) 3060, 3026, 2923, 
2853, 1595 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.18 (dd, J = 4.8, 1.2 Hz, 1H), 7.89 (dd, J = 8.4, 
1.2 Hz, 1H), 7.67 (d, J = 8.4 Hz, 2H), 7.29-7.13 (m, 8H), 4.26 (dd, J = 8.4, 5.2 Hz, 1H), 4.01 (dd, 
J = 10.8, 8.4 Hz, 1H), 3.70 (dd, J = 11.2, 5.2 Hz, 1H), 2.93-2.88 (m, 1H), 2.82-2.70 (m, 3H), 2.37 
(s, 3H); 13C NMR (100 MHz, CDCl3) ppm 153.3, 144.69, 144.66, 139.4, 136.5, 133.4, 129.9, 
128.6, 128.5, 127.3, 126.3, 123.3, 121.6, 58.3, 55.1, 48.4, 36.4, 21.5; HRMS (ESI): Exact mass 
calcd for C22H23N3NaO2S [M+Na]
+ 416.1409, found 416.1410. 
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 (Piperidin-1-yl)-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine (530f). Prepared according to 
the general procedure using piperidine (29.6 µL, 300 µmol) and 4-methyl-N-(2-vinylpyridin-3-
yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash column chromatography of the residue (SiO2, 
40-60-80-100% ethyl acetate in hexanes) afforded the desired product as a brown viscous oil (33.7 
mg, 63%). Rf = 0.12 (50% EtOAc/hexanes); IR (film) 2933, 2853, 1595 cm
-1; 1H NMR (400 MHz, 
CDCl3) δ 8.24 (d, J = 4.0 Hz, 1H), 7.94 (d, J = 8.4 Hz, 1H), 7.69 (d, J = 8.4 Hz, 2H), 7.26 (d, J = 
8.0 Hz, 2H), 7.17 (dd, J = 8.4, 4.8 Hz, 1H), 4.31 (dd, J = 9.2, 3.6 Hz, 1H), 4.03 (dd, J = 12.0, 3.6 
Hz, 1H), 3.76 (dd, J = 11.6, 9.6 Hz, 1H), 2.51 (br dd, J = 5.2, 5.2 Hz, 2H), 2.37 (s, 3H), 2.19 (br 
m, 2H), 1.50 (br d, J = 4.8 Hz, 4H), 1.35 (br dd, J = 5.6, 5.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) 
ppm 150.8, 144.8, 144.6, 137.5, 133.3, 129.9, 127.3, 123.4, 120.9, 64.6, 49.6, 49.5, 25.5, 23.9, 
21.5; Exact mass calcd for C19H23N3NaO2S [M+Na]
+ 380.1409, found 380.1395. 
Ethyl 1-(1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-3-yl)piperidine-4-carboxylate (530g). 
Prepared according to the general procedure using ethyl isonipecotate (46.2 µL, 300 µmol) and 4-
methyl-N-(2-vinylpyridin-3-yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash column 
chromatography of the residue (SiO2, 40-60-80-100% ethyl acetate in hexanes) afforded the 
desired product as light-brown viscous oil (45.5 mg, 71%). Rf = 0.17 (50% EtOAc/hexanes); IR 
(film) 2947, 2815, 1728, 1592 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.23 (dd, J = 5.4, 1.8 Hz, 1H), 
7.93 (dd, J = 8.4, 1.2 Hz, 1H), 7.68 (d, J = 8.4 Hz, 2H), 7.26 (d, J = 8.4 Hz, 2H), 7.17 (dd, J = 8.4, 
4.8 Hz, 1H), 4.27 (dd, J = 9.6, 4.2 Hz, 1H), 4.09 (q, J = 7.2 Hz, 2H), 3.90 (dd, J = 11.4, 3.6 Hz, 
1H), 3.76 (dd, J = 11.4, 9.6 Hz, 1H), 2.57 (br d, J = 10.8 Hz, 1H), 2.50 (br d, J = 11.4 Hz, 1H), 
2.41-2.36 (m, 1H), 2.38 (s, 3H), 2.16-2.11 (m, 1H), 1.89 (dd, 10.8, 9.0 Hz, 1H), 1.74 (ddd, J = 
14.4, 14.4, 1.8 Hz, 2H), 1.68-1.58 (m, 2H), 1.21 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) 
ppm 174.8, 151.4, 144.8, 144.6, 137.3, 133.3, 129.9, 127.2, 123.3, 121.0, 64.2, 60.2, 49.8, 48.4 
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(0.5C), 47.8 (0.5C), 40.9, 28.2 (0.5C), 28.1 (0.5C), 21.5, 14.2; Exact mass calcd for 
C22H27N3NaO4S [M+Na]
+ 452.1620, found 452.1619. 
Ethyl 4-(1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-3-yl)piperazine-1-carboxylate 
(530h). Prepared according to the general procedure using ethyl 1-piperazinecarboxylate (44.0 µL, 
300 µmol) and 4-methyl-N-(2-vinylpyridin-3-yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash 
column chromatography of the residue (SiO2, 50-75-100% ethyl acetate in hexanes) afforded the 
desired product as an orange viscous oil (55.6 mg, 86%). Rf = 0.10 (50% EtOAc/hexanes); IR 
(film) 3062, 2981, 2927, 2861, 2764, 1696, 1594 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.24 (dd, J 
= 4.8, 1.2 Hz, 1H), 7.95 (dd, J = 8.4, 1.2 Hz, 1H), 7.69 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 7.6 Hz, 
2H), 7.18 (dd, J = 8.0, 4.8 Hz, 1H), 4.30 (dd, J = 9.2, 3.6 Hz, 1H), 4.09 (q, 7.2 Hz, 2H), 3.90 (dd, 
J = 12.0, 4.0 Hz, 1H), 3.77 (dd, J = 11.2, 9.2 Hz, 1H), 3.35 (br s, 4H), 2.42 (br s, 2H), 2.39 (s, 3H), 
2.19-2.11 (br m, 2H), 1.22 (t, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) ppm 155.2, 150.6, 
144.9, 144.7, 137.4, 133.2, 129.9, 127.2, 123.6, 121.1, 64.1, 61.3, 49.5, 48.1 (br), 43.4 (br), 21.5, 
14.6; Exact mass calcd for C21H26N4NaO4S [M+Na]
+ 453.1572, found 453.1574. 
tert-Butyl 4-(1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-3-yl)piperazine-1-
carboxylateamine (530i). Prepared according to the general procedure using tert-butyl 
piperazine-1-carboxylate (55.9 mg, 300 µmol) and 4-methyl-N-(2-vinylpyridin-3-
yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash column chromatography of the residue (SiO2, 
20-40-60-80% ethyl acetate in hexanes) afforded the desired product as a golden viscous oil (50.8 
mg, 74%). Rf = 0.15 (50% EtOAc/hexanes); IR (film) 3384, 3062, 2975, 2930, 2860, 1692, 1591 
cm-1; 1H NMR (600 MHz, CDCl3) δ 8.24 (dd, J = 4.8, 1.2 Hz, 1H), 7.94 (dd, J = 8.4, 1.2 Hz, 1H), 
7.69 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 7.8 Hz, 2H), 7.18 (dd, J = 8.4, 4.8 Hz, 1H), 4.29 (dd, J = 9.0, 
3.6 Hz, 1H), 3.90 (dd, J = 11.4, 4.2 Hz, 1H), 3.77 (dd, J = 12.0, 9.6 Hz, 1H), 3.29 (br s, 4H), 2.39 
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(br s, 2H), 2.39 (s, 3H), 2.14 (br s, 2H), 1.42 (s, 9H); 13C NMR (150 MHz, CDCl3) ppm 154.5, 
150.8, 144.9, 144.7, 137.4, 133.2, 129.9, 127.2, 123.5, 121.1, 79.6, 64.1, 49.6, 48.2 (br), 44.0 (br, 
0.5C), 42.9 (br, 0.5C), 28.4, 21.5; Exact mass calcd for C23H30N4NaO4S [M+Na]
+ 481.1885, found 
481.1903. 
 (E)-3-(4-Cinnamylpiperazin-1-yl)-1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine (530j). 
Prepared according to the general procedure using trans-1-cinnamylpiperazine (60.7 mg, 300 
µmol) and 4-methyl-N-(2-vinylpyridin-3-yl)benzenesulfonamide (41.2 mg, 150 µmol). Flash 
column chromatography of the residue (SiO2, 0.5-1-2-5-10% methanol in dichloromethane) 
afforded the desired product as a light-yellow viscous oil (46.7 mg, 66%). Rf = 0.42 (5% 
MeOH/DCM); IR (film) 3026, 2935, 2812, 1673, 1595 cm-1; 1H NMR (600 MHz, CDCl3) δ 8.23 
(dd, J = 4.8, 1.2 Hz, 1H), 7.93 (dd, J = 8.4, 1.2 Hz, 1H), 7.69 (d, J = 8.4 Hz, 2H), 7.39-7.20 (m, 
7H), 7.16 (dd, J = 8.4, 5.4 Hz, 1H), 6.49 (d, J = 15.6 Hz, 1H), 6.22 (ddd, J = 15.0, 6.6, 6.6 Hz, 
1H), 4.31 (dd, J = 9.0, 3.6 Hz, 1H), 3.96 (dd, J = 11.4, 4.2 Hz, 1H), 3.76 (dd, J = 11.4, 9.6 Hz, 
1H), 3.13 (br s, 2H), 2.61-2.56 (br m, 2H), 2.53-2.38 (br m, 4H), 2.34 (s, 3H), 2.32-2.26 (br m, 
2H); 13C NMR (150 MHz, CDCl3) ppm 151.1, 144.74, 144.68, 137.3, 136.7, 133.3, 129.9, 128.5, 
127.6, 127.3, 126.3, 123.3, 120.9, 63.9, 60.8, 52.9, 49.3, 48.0, 21.5; HRMS (ESI): Exact mass 
calcd for C27H31N4O2S [M+H]
+ 475.2168, found 475.2146. 
Methyl 2-((1-tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-3-yl)amino)acetate (530k). A vial 
equipped with a stir bar was charged with potassium iodide (24.9 mg, 150 µmol), iodobenzene 
diacetate (72.5 mg, 225 µmol), 4-methyl-N-(2-vinylpyridin-3-yl)benzenesulfonamide (41.2 mg, 
150 µmol), and acetonitrile (1.5 mL). Potassium carbonate (41.5 mg, 300 µmol) and glycine 
methyl ester hydrochloride (37.7 mg, 300 µmol) were added and the resulting mixture was stirred 
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at rt for 18 h. The reaction mixture was then diluted with ethyl acetate and concentrated. Flash 
column chromatography of the residue (SiO2, 50-80-100% ethyl acetate in hexanes) afforded the 
desired product as an orange viscous oil (33.9 mg, 63%). Rf = 0.18 (70% EtOAc/hexanes); IR 
(film) 3327, 3062, 2951, 2924, 1741, 1594 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.19 (dd, J = 4.8, 
1.2 Hz, 1H), 7.90 (dd, J = 8.4, 1.2 Hz, 1H), 7.68 (d, J = 8.4 Hz, 2H), 7.26 (d, J = 8.0 Hz, 2H), 7.17 
(dd, J = 8.4, 5.2 Hz, 1H), 4.25 (dd, J = 8.4, 5.2 Hz, 1H), 4.03 (dd, J = 10.8, 8.4 Hz, 1H), 3.70 (s, 
3H), 3.68 (dd, J = 10.8, 4.8 Hz, 1H), 3.46 (s, 2H), 2,38 (s, 3H); 13C NMR (125 MHz, CDCl3) ppm 
172.1, 153.1, 144.8, 144.7, 136.4, 133.2, 129.9, 127.3, 123.5, 121.6, 57.5, 55.1, 51.9, 48.1, 21.5; 
Exact mass calcd for C17H19N3NaO4S [M+Na]
+ 384.0994, found 384.0976. 
Ethyl 1-cyanocyclopent-3-enecarboxylate (569).257 To a flame dried flask equipped with a stir 
bar was added K2CO3 (11.1 g, 80.0 mmol), ethyl cyanoacetate (2.13 mL, 20.0 mmol), and DMF 
(20 mL). The resulting mixture was stirred at room temperature followed by the dropwise addition 
of the dichlorobutene (3.16 mL, 30.0 mmol) in DMF (6 mL). After stirring for 15 hours at room 
temperature, the reaction mixture was diluted with water and extracted with ether. The combined 
organic layers were washed with brine, dried (MgSO4), and concentrated. Flash column 
chromatography of the residue (SiO2, 5-20% ethyl acetate in hexanes) afforded the desired product 
as a clear liquid (3.26 g, 99%). Rf = 0.25 (10% EtOAc/hexanes); IR (film) 2986, 2939, 2863, 2245, 
1743 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.67 (s, 2H), 4.25 (q, J = 5.6 Hz, 2H), 3.11 (d, J = 12.4 
Hz, 2H), 3.02 (d, J = 12.4 Hz, 2H), 1.31 (t, J = 5.6 Hz, 3H); 13C NMR (125.8 MHz, CDCl3) ppm 
169.0, 127.3, 121.0, 62.9, 45.3, 43.8, 13.8; HRMS (ESI) Exact mass calcd for C9H12NO2 [M+H]
+ 
166.0863, found 166.0869. 
 
 
 
 
                                                          
257 Modification of: Hu, H.; Faraldos, J. A.; Coates, R. M. J. Am. Chem. Soc. 2009, 131, 11998-12006. 
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Cyclopent-3-enecarbonitrile (565).257 To a flask equipped with a stir bar was added the 
carboxylate (9.40 g, 56.9 mmol), NaCl (13.3 g, 228 mmol), and DMSO (86 mL) and the resulting 
suspension was heated to 150 °C for 19 h. The reaction mixture was then cooled to room 
temperature, diluted with water, and extracted with ether. The combined organic layers were 
washed with brine, dried (MgSO4), and concentrated. Vacuum distillation of the crude oil afforded 
the desired carbonitrile as a clear oil (2.32 g, 44%). The characterization of this compound matched 
that of literature.257 
Methyl 4-(1-cyanocyclopent-3-en-1-yl)nicotinate (560). To a flame dried flask equipped with a 
stir bar was added the methyl nicotinate (1.37 g, 8.00 mmol) and the carbonitrile (497 mg, 5.33 
mmol). A condenser was attached, KHMDS (1 M in THF) (8 mL) was added through the 
condenser, and the resulting mixture was stirred under reflux for 16 hours. The reaction mixture 
was then cooled to room temperature, poured onto water and extracted with ether. The organic 
extracts were washed with satd aq NaHCO3, water, and brine, dried (MgSO4), and concentrated. 
Flash column chromatography of the residue (SiO2, 0.5-2% methanol in dichloromethane) 
afforded the desired product as a golden-orange viscous oil (515 mg, 42%). Rf = 0.65 (5% 
MeOH/DCM); IR (film) 3440, 3063, 2952, 2857, 2237, 1728, 1586 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 8.94 (s, 1H), 8.70 (d, J = 5.2 Hz, 1H), 7.30 (d, J = 5.2 Hz, 1H), 5.82 (s, 2H), 4.00 (s, 3H), 
3.36 (d, J = 15.6 Hz, 2H), 3.13 (d, J =15.2 Hz, 2H); 13C NMR (125.8 MHz, CDCl3) ppm 166.9, 
152.6, 151.4, 147.9, 128.1, 126.5, 123.3, 121.0, 52.9, 46.9, 43.6; HRMS (ESI) Exact mass calcd 
for C13H13N2O2 [M+H]
+ 229.0977, found 229.0972. 
4-(1-Cyanocyclopent-3-en-1-yl)nicotinic acid (571). To a flask equipped with a stir bar was 
added the ester (79.0 mg, 346 µmol) and ethanol (6.92 mL). To the solution was added NaOH (138 
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mg, 3.46 mmol) in water (1.73 mL), and the resulting mixture was stirred at room temperature for 
48 h. The reaction mixture was acidified to a pH of 2 with 1 M HCl and concentrated to remove 
ethanol. The residue was diluted with water, extracted with dichloromethane, and the organic 
extracts were dried (MgSO4) and concentrated. Flash column chromatography of the residue (SiO2, 
1-5% methanol in dichloromethane) afforded the desired product as a white viscous oil (12.6 mg, 
17%). Rf = 0.62 (5% MeOH/DCM); IR (film) 2986, 2918, 2698, 1701, 1602 cm
-1; 1H NMR (400 
MHz, CDCl3) δ 9.35 (s, 1H), 8.80 (d, J = 5.2 Hz, 1H), 8.24 (br s, 1H), 7.37 (d, J = 5.6 Hz, 1H), 
5.86 (s, 2H), 3.40 (d, J = 14.0 Hz, 2H), 2.77 (d, J = 14.0 Hz, 2H); 13C NMR (125.8 MHz, CDCl3) 
ppm 176.0, 163.0, 155.6, 155.0, 150.1, 128.5, 119.1, 118.3, 50.8, 50.0; (ESI) Exact mass calcd for 
C12H11N2O2 [M+H]
+ 215.0821, found 215.0812. 
3'-Imino-2',3'-dihydro-1'H-spiro[cyclopent[3]ene-1,4'-isoquinolin]-1'-one (574). To a flame 
dried flask equipped with a stir bar was added the benzoate (573 µL, 4.00 mmol) and the 
carbonitrile (248 mg, 2.67 mmol). A condenser was attached, KHMDS (4 mL, 1 M in THF) was 
added through the condenser, and the resulting mixture was stirred under reflux for 16 hours. The 
reaction mixture was then cooled to room temperature, poured onto water and extracted with ether. 
The organic extracts were washed with satd aq NaHCO3, water, and brine, dried (MgSO4), and 
concentrated. Flash column chromatography of the residue (SiO2, 1-2-5-10-20% methanol in 
dichloromethane) afforded the isoquinolinone as an off-white viscous oil (22.3 mg, 4%). Rf = 0.22 
(5% MeOH/DCM); IR (film) 3272, 3005, 1631, 1599, 1509 cm-1; 1H NMR (400 MHz, CDCl3) δ 
8.18 (dd, J = 7.6, 0.8 Hz, 1H), 7.58 (ddd, J = 8.0, 8.0, 1.2 Hz, 1H), 7.39 (ddd, J = 7.6, 7.6, 0.8 Hz, 
1H), 7.32 (d, J = 8.0 Hz, 1H), 5.94 (s, 2H), 3.24 (d, J = 14.8 Hz, 2H), 2.98 (d, J = 14.8 Hz, 2H); 
13C NMR (125.8 MHz, CDCl3) ppm 168.3, 147.2, 133.6, 129.6, 127.4, 127.0, 125.0, 124.5, 52.8, 
45.9; (ESI) Exact mass calcd for C13H13N2O [M+H]
+ 213.1022, found 213.1019. 
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1'H-Spiro[cyclopent[3]ene-1,4'-isoquinoline]-1',3'(2'H)-dione (575). To a flask equipped with 
a stir bar was added the isoquinolinone (22.3 mg, 98.1 µmol) and methanol (1.96 mL). To the 
solution was added NaOH (4.70 mg, 118 µmol) in water (491 µL), and the resulting mixture was 
stirred at room temperature for 18 h. The reaction mixture was acidified to a pH of 2 with 1 M HCl 
and concentrated to remove methanol. The residue was diluted with water, extracted with 
dichloromethane, and the organic extracts were dried (MgSO4) and concentrated to afford the 
isoquinolinedione as a white solid (18.3 mg, 88%). Mp 152.0-156.0 °C; Rf = 0.63 (5% 
MeOH/DCM); IR (film) 3192, 3079, 2921, 2847, 1708, 1689 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 8.54 (br s, 1H), 8.18 (dd, J = 8.4, 1.6 Hz, 1H), 7.63 (ddd, J = 9.2, 7.6, 1.2 Hz, 1H), 7.43 (m, 2H), 
5.84 (s, 2H), 3.38 (d, J = 13.6 Hz, 2H), 2.78 (d, J = 13.6 Hz, 2H); 13C NMR (125.8 MHz, CDCl3) 
ppm 177.6, 164.2, 147.9, 135.2, 128.5, 127.9, 127.4, 125.0, 122.5, 51.0, 50.7; (ESI) Exact mass 
calcd for C13H12NO2 [M+H]
+ 214.0869, found 214.0834.  
1-Cyanocyclopent-3-enecarboxylic acid (576). To a flask equipped with a stir bar was added the 
cyano carboxylate (1.00 g, 6.05 mmol) and ethanol (121 mL). To the solution was added NaOH 
(291 mg, 7.26 mmol) in water (30 mL) and the resulting mixture stirred at room temperature for 
18 hours. The reaction mixture was then acidified to a pH of 2 with 1 M HCl and concentrated. 
The residue was diluted with water, extracted with dichloromethane and the organic extracts were 
dried (MgSO4) and concentrated to afford the desired acid as an off-white crystalline solid (659 
mg, 79%). Mp 68.0-72.0 °C; Rf = 0.15 (5% MeOH/DCM); IR (film) 3488, 2929, 2604, 2250, 1730, 
1629 cm-1; 1H NMR (400 MHz, CDCl3) δ 10.0 (br s, 1H), 5.72 (s, 1H); 3.16 (m, 4H); 13C NMR 
(125.8 MHz, CDCl3) ppm 174.5, 127.4, 120.3, 45.1, 44.0; (ESI) Exact mass calcd for C7H8NO2 
[M+H]+ 137.0471, found 137.0473. 
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 (1R,4S,6R)-6-Iodo-3-oxo-2-oxabicyclo[2.2.1]heptane-4-carbonitrile (577). To a flame dried 
vial equipped with a stir bar was added 6(MeO)StilbPBAM (3.30 mg, 5.00 µmol), the carboxylic 
acid (13.7 mg, 100 µmol) and toluene (2 mL), and the reaction was cooled to -20 °C. NIS (23.4 
mg, 104 µmol) was added and the reaction mixture was stirred without light for 24 h. The mixture 
was treated with 20% aq sodium thiosulfate (2 mL) and then partitioned between dichloromethane 
(15 mL) and 3 M NaOH (15 mL). The aqueous layer was extracted twice and the organic layers 
were combined, dried (MgSO4), and concentrated. Flash column chromatography (SiO2, 5-10-20% 
ethyl acetate in hexanes) yielded the desired lactone as a light-yellow solid (6.3 mg, 24%). The 
product was determined to be 32% ee by chiral HPLC analysis (Chiralcel OD-H, 10% 
iPrOH/hexanes, 1 mL/min, tr(e1, minor) = 26.7 min, tr(e2, major) = 31.7 min). Mp 163.0-165.0 °C; 

D
20
[]  - no optical rotation taken due to low ee; Rf = 0.74 (50% EtOAc/hexanes); IR (film) 3014, 
2962, 2920, 2364, 2342, 2252, 1786 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.03 (d, J = 1.6 Hz, 1H), 
4.15 (ddddd, J = 7.2, 4.0, 2.0, 0.8 Hz, 1H), 3.00 (ddd, J = 14.4, 8.0, 2.0 Hz, 1H), 2.97 (d, J = 11.2 
Hz, 1H), 2.77 (ddd, J = 6.8, 2.4, 2.4 Hz, 1H), 2.74 (dd, J = 14.0, 4.4 Hz, 1H); 13C NMR (125.8 
MHz, CDCl3) ppm 168.4, 113.8, 84.3, 44.2, 41.2, 40.5, 12.3; (ESI) Exact mass calcd for C7H7INO2 
[M+H]+ 263.9516, found 263.9508. 
 (1R,4S,6R)-6-Bromo-3-oxo-2-oxabicyclo[2.2.1]heptane-4-carbonitrile (580). To a flame dried 
vial equipped with a stir bar was added DMAP (9.80 mg, 80.0 µmol), the carboxylic acid (54.9 
mg, 400 µmol) and dichloromethane (4 mL). NIS (23.4 mg, 104 µmol) was added and the reaction 
mixture was stirred at room temperature without light for 12 h. The mixture was treated with 20% 
aq sodium thiosulfate (4 mL) and then partitioned between dichloromethane (30 mL) and 3 M 
NaOH (30 mL). The aqueous layer was extracted twice and the organic layers were combined, 
dried (MgSO4), and concentrated. Flash column chromatography (SiO2, 5-10-20% ethyl acetate in 
hexanes) yielded the desired lactone as an off-white solid (16.8 mg, 19%). Mp 162.0-164.0 °C; Rf 
= 0.74 (50% EtOAc/hexanes); IR (film) 2922, 2255, 1787 cm-1; 1H NMR (400 MHz, CDCl3) δ 
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4.98 (d, J = 0.8 Hz, 1H), 4.22 (dddd, J = 7.6, 3.2, 1.6, 1.2 Hz, 1H), 2.96 (ddd, J = 14.4, 7.6, 2.0 
Hz, 1H), 2.85 (d, J = 11.2 Hz, 1H), 2.73 (ddd, J = 11.2, 2.0, 2.0 Hz, 1H), 2.65 (dd, J = 14.4, 4.0 
Hz, 1H); 13C NMR (125.8 MHz, CDCl3) ppm 168.2, 113.9, 82.6, 43.1, 41.0, 40.1, 39.7; (ESI) 
Exact mass calcd for C7H7BrNO2 [M+H]
+ 215.9655, found 215.9658. 
 (1R,4S,6R)-3-Oxo-6-(phenylselanyl)-2-oxabicyclo[2.2.1]heptane-4-carbonitrile) (582). To a 
flame dried vial equipped with a stir bar was added PBAM (2.50 mg, 5.00 µmol), the carboxylic 
acid (13.7 mg, 100 µmol) and toluene (2 mL). NIS (23.4 mg, 104 µmol) was added and the reaction 
mixture was stirred without light for 24 h at rt. The mixture was treated with 20% aq sodium 
thiosulfate (2 mL) and then partitioned between dichloromethane (15 mL) and 3 M NaOH (15 
mL). The aqueous layer was extracted twice and the organic layers were combined, dried (MgSO4), 
and concentrated. Flash column chromatography of the residue (SiO2, 5-10% ethyl acetate in 
hexanes) yielded the desired lactone as a tan solid (7.6 mg, 26%). The product was determined to 
be 2% ee by chiral HPLC analysis (Chiralcel OD-H, 10% iPrOH/hexanes, 1 mL/min, tr(e1, minor) 
= 28.7 min, tr(e2, major) = 38.9 min). Mp 87.0-91.0 °C; 

D
20
[]  - no optical rotation taken since 
compound was nearly racemic. Rf = 0.48 (50% EtOAc/hexanes); IR (film) 2922, 2852, 2253, 1799 
cm-1; 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 6.8 Hz, 2H), 7.36 (m, 3H), 4.77 (s, 1H), 3.64 (dd, 
7.2, 7.2 Hz, 1H), 2.73 (ddd, J = 14.0, 8.4, 1.2 Hz, 1H), 2.63 (m, 2H), 2.19 (dd, J = 13.6, 4.8 Hz, 
1H); 13C NMR (125.8 MHz, CDCl3) ppm 169.0, 134.5, 129.8, 129.0, 127.5, 114.6, 83.0, 43.2, 41.6, 
38.8, 35.7; (ESI) Exact mass calcd for C13H11NNaO2Se [M+H]
+ 315.9853, found 315.9848. 
1-Cyanocyclopent-3-enecarbonyl chloride (584). To a flask equipped with a stir bar was added 
the carboxylic acid (500 mg, 3.65 mmol) and SOCl2 (7.90 mL, 0.109 mol). The resulting mixture 
was stirred under reflux for 18 h before being cooled to rt and concentrated. The resulting residue 
was carried onto the next step quantitatively without any further purification. 
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1-(2-Diazoacetyl)cyclopent-3-enecarbonitrile (585). To a flask equipped with a stir bar was 
added the acid chloride (794 mg, 5.10 mmol). The flask was chilled to 0 °C followed by the 
addition of CH2N2 (35.7 mmol, 1.50 g) in Et2O and the resulting mixture was warmed to rt and 
allowed to stir for 18 h. The reaction mixture was then diluted with EtOAc and washed with satd 
aq NaHCO3, satd aq NH4Cl, and brine. The organic layer was dried (MgSO4), filtered, and 
concentrated. Flash column chromatography of the residue (SiO2, 1-2-5-10-20-50% ethyl acetate 
in hexanes) afforded the desired diazoketone as a non-viscous yellow oil (316 mg, 38%). Rf = 0.60 
(50% EtOAc/hexanes); IR (film) 3109, 2925, 2856, 2236, 2118, 1641 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 5.89 (s, 1H), 5.68 (s, 2H), 3.12 (d, J = 15.2 Hz, 2H), 2.96 (d, J = 14.8 Hz, 2H); 13C NMR 
(125.8 MHz, CDCl3) ppm 188.0, 127.4, 122.3, 54.6, 48.7, 43.7; (ESI) Exact mass calcd for 
C8H7N3O [M+] 161.0584, found 161.0589. 
Methyl 2-(1-cyanocyclopent-3-en-1-yl)acetate (586). To a flame-dried flask equipped with a stir 
bar and wrapped in aluminum foil was added the diazoketone (154 mg, 956 µmol), MeOH (19.3 
mL) and anhydrous THF (13.4 mL). The reaction mixture was chilled to -20 °C before a solution 
of silver benzoate (48.1 mg, 210 µmol) in freshly distilled Et3N (770 µL, 5.52 mmol) was added. 
The resulting mixture was warmed to rt and allowed to stir for 6 h. The solvents were evaporated 
and the residue was taken up in EtOAc. The organic layer was washed with satd aq solutions of 
NaHCO3, NH4Cl and brine, dried (MgSO4), filtered and concentrated to afford clean product as an 
orange-brown oil (102 mg, 64%). Rf = 0.27 (20% EtOAc/hexanes); IR (film) 2921, 2852, 2237, 
1739 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.69 (s, 2H), 3.75 (s, 3H), 3.03 (d, J = 14.8 Hz, 2H), 
2.71 (s, 2H), 2.62 (d, J = 14.8 Hz, 2H); 13C NMR (125.8 MHz, CDCl3) ppm 169.8, 127.9, 124.3, 
52.1, 44.5, 42.1, 37.2; (ESI) Exact mass calcd for C9H11NO2 [M+] 165.0784, found165.0785. 
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1-Cyanocyclopent-3-enecarboxylic acid (583). To a flask equipped with a stir bar was added the 
ester (18.7 mg, 113 µmol) and methanol (2.3 mL). To the solution was added NaOH (5.40 mg, 
136 µmol) in water (565 µL) and the resulting mixture stirred at room temperature for 18 hours. 
The reaction mixture was then acidified to a pH of 2 with 1 M HCl and concentrated. The residue 
was diluted with water, extracted with dichloromethane and the organic extracts were dried 
(MgSO4) and concentrated to afford the desired acid as a light-yellow viscous oil (15.1 mg, 88%). 
Rf = 0.31 (5% MeOH/DCM); IR (film) 3473, 3068, 2925, 2859, 2241, 1718 cm
-1; 1H NMR (400 
MHz, CDCl3) δ 10.13 (br s, 1H), 5.69 (s, 2H), 3.03 (d, J = 15.2 Hz, 2H), 2.78 (s, 2H), 2.62 (d, J = 
14.8 Hz, 2H); 13C NMR (125.8 MHz, CDCl3) ppm 175.3, 127.9, 124.1, 44.5, 41.9, 36.9; Exact 
mass calcd for C8H9NO2 [M+] 151.0628, found 151.0632. 
(1R,5S,7R)-7-Iodo-3-oxo-2-oxabicyclo[3.2.1]octane-5-carbonitrilecarbonitrile (587). To a 
flame dried vial equipped with a stir bar was added PBAM (1.00 mg, 2.10 µmol), the carboxylic 
acid (6.20 mg, 41.0 µmol) and toluene (820 µL). NIS (9.60 mg, 42.7 µmol) was added and the 
reaction mixture was stirred at rt without light for 24 h. The mixture was treated with 20% aq 
sodium thiosulfate (2 mL) and then partitioned between dichloromethane (7 mL) and 3 M NaOH 
(7 mL). The aqueous layer was extracted twice and the organic layers were combined, dried 
(MgSO4), and concentrated. Flash column chromatography (SiO2, 5-10-20% ethyl acetate in 
hexanes) yielded the desired lactone as an off-white solid (1.3 mg, 12%). The product was 
determined to be 4% ee by chiral HPLC analysis (Chiralpak IB, 10% iPrOH/hexanes, 1 mL/min, 
tr(e1, major) = 47.5 min, tr(e2, minor) = 55.8 min). 

D
20
[]  - no optical rotation taken since compound 
was nearly racemic; Rf = 0.24 (20% EtOAc/hexanes); IR (film) 3464, 2920, 2245, 1741 cm
-1; 1H 
NMR (400 MHz, CDCl3) δ 5.04 (d, J = 2.4 Hz, 1H), 4.45 (dddd, J = 8.0, 8.0, 4.4, 2.4 Hz, 1H), 
3.04 (dd, J = 18.4, 2.8 Hz, 1H), 3.02 (dd, J = 15.6, 1.6 Hz, 1H), 2.96 (ddd, J = 13.2, 2.8, 2.8 Hz, 
1H), 2.90-2.82 (m, 2H), 2.43 (d, J = 13.2 Hz, 1H); 13C NMR (125.8 MHz, CDCl3) ppm 164.1, 
119.2, 86.5, 48.2, 42.6, 36.3, 35.4, 17.5; Exact mass calcd for C8H9INO2 [M+H]
+ 277.9672, found 
277.9668. 
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(1R,4S,6R)-6-Iodo-4-phenyl-2-oxabicyclo[2.2.1]heptan-3-one (596). To a vial equipped with a 
stir bar was added StilbPBAM (6.00 mg, 10.0 µmol), the carboxylic acid (18.8 mg, 100 µmol) and 
toluene (2 mL), and the reaction was cooled to -20 °C. NIS (23.4 mg, 104 µmol) was added and 
the reaction mixture was stirred without light for 24 h. The mixture was treated with 20% aq 
sodium thiosulfate (2 mL) and then partitioned between dichloromethane (15 mL) and 6 M NaOH 
(15 mL). The aqueous layer was extracted twice and the organic layers were combined, dried 
(MgSO4), and concentrated. Flash column chromatography (SiO2, 10% ethyl acetate in hexanes) 
yielded the desired lactone as a light-yellow solid (9.4 mg, 30%). The product was determined to 
be 65% ee by chiral HPLC analysis (Chiralpak IA, 10% iPrOH/hexanes, 1 mL/min, tr(e1, minor) 
= 8.8 min, tr(e2, major) = 12.8 min). Mp 54.0-56.0 °C; 

D
20
[]  -89.0 (c 0.30, CHCl3); Rf = 0.36 (10% 
EtOAc/hexanes); IR (film) 3030, 2927, 2860, 1786 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.43-7.34 
(m, 5H), 5.05 (d, J = 1.2 Hz, 1H), 4.28 (ddd, J = 6.6, 4.2, 2.4 Hz, 1H), 2.97 (ddd, J = 13.8, 7.8, 1.8 
Hz, 1H), 2.90 (d, J = 10.8, 1H), 2.72 (dddd, J = 4.2, 2.4, 2.4, 2.4 Hz, 1H), 2.62 (dd, J = 13.8, 4.2 
Hz, 1H); 13C NMR (150.9 MHz, CDCl3) ppm 176.0, 134.0, 128.7, 128.2, 127.2, 83.3, 56.2, 42.9, 
41.1, 16.8; Exact mass calcd for C12H12IO2 [M+H]
+ 314.9876, found 314.9872. 
 
 
 
 
 
 
 
 
 
